About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
2793 genotypes with 3042 annotations displayed of selected term and subterms
Searched Term: abnormal cell proliferation
Allelic Composition
(Genetic Background)		 Annotated Term Reference
\917M/\917M+
(C57BL/6-917M) 		decreased osteoblast proliferation J:99483
\2310065F04Riktm1.1Boet/\2310065F04Riktm1.1Boet
(involves: C57BL/6 * SJL) 		increased skeletal muscle satellite cell proliferation J:306156
\A1cftm1Ddsn/\A1cftm1Ddsn
(involves: 129X1/SvJ) 		decreased cell proliferation J:114732
\A4gnttm1Jnaka/\A4gnttm1Jnaka
(B6.129S6-A4gnttm1Jnaka) 		increased cell proliferation J:184485
\AabprNZB/Slc/?
(involves: NZB/Slc * NZW/Slc) 		increased B cell proliferation J:87690
\AatfGt(pGT1.8geo)3Pgr/\AatfGt(pGT1.8geo)3Pgr
(either: (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * NMRI)) 		decreased cell proliferation J:65741
\Abattm1c(EUCOMM)Hmgu/\Abattm1c(EUCOMM)Hmgu
\Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * DBA/2) 		decreased T cell proliferation J:333883
\Abcb4tm1Bor/\Abcb4tm1Bor
\Portm1Wolf/\Portm1Wolf
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA * FVB/N) 		increased hepatocyte proliferation J:215915
\Abcb5tm1.2Nyf/\Abcb5tm1.2Nyf
(involves: 129S6/SvEvTac * C57BL/6) 		increased cell proliferation J:213708
\Abi1tm1Pen/\Abi1+
\Abi2tm1Pen/\Abi2tm1Pen
(Not Specified) 		decreased T cell proliferation J:104623
\Abi3bptm1Tac/\Abi3bptm1Tac
(involves: 129S5/SvEvBrd) 		increased cell proliferation J:251000
\Abl1tm1Mlg/\Abl1tm1Mlg
(B6.129-Abl1tm1Mlg) 		increased fetal cardiomyocyte proliferation J:156743
\Abl1tm2.1Goff/\Abl1tm2.1Goff
\Abl2tm1Ajk/\Abl2tm1Ajk
\Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * C57BL/6J * SJL) 		decreased cerebellar granule cell precursor proliferation J:166211
\Acacatm1Dejs/\Acacatm1Dejs
\Tg(Cd4-cre)1Cwi/?
\Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6 * DBA/2) 		increased T cell proliferation J:209886
\Acer1tm1a(EUCOMM)Wtsi/\Acer1tm1a(EUCOMM)Wtsi
(C57BL/6N-Acer1tm1a(EUCOMM)Wtsi) 		increased keratinocyte proliferation J:235775
\Ackr4tm1.1Rjbn/\Ackr4tm1.1Rjbn
(B6.129S6-Ackr4tm1.1Rjbn) 		decreased T cell proliferation J:166490
\Acp1tm1Lex/\Acp1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		increased fibroblast proliferation J:171883
\Actl6atm1.1Grc/\Actl6atm1.1Grc
\Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6J * CBA) 		decreased hematopoietic stem cell proliferation J:192124
\Actn2em1Kage/\Actn2em1Kage
(C57BL/6-Actn2em1Kage) 		decreased fetal cardiomyocyte proliferation J:334092
\Acvr1tm2.1Vlcg/\Acvr1+
\Tg(Prrx1-cre)1Cjt/0
(involves: C57BL/6J * C57BL/6NTac * SJL/J) 		increased chondrocyte proliferation J:239136
\Adatm1Mw/\Adatm1Mw
(involves: 129S7/SvEvBrd) 		increased vascular smooth muscle cell proliferation J:231559
\Adam17tm1.1Srj/\Adam17tm1.1Srj
(involves: 129S/SvEv * C57BL/6 * SJL) 		abnormal enterocyte proliferation J:163380
\Adam17tm1.1Wesh/\Adam17tm1.1Wesh
\Tg(Scgb1a1-rtTA)2Jaw/0
\Tg(tetO-cre)1Jaw/0
(involves: 129 * C57BL/6 * FVB/N) 		decreased cell proliferation J:210193
\Adam17tm1.1Wesh/\Adam17tm1.1Wesh
\Tg(Scgb1a1-rtTA)2Jaw/0
\Tg(tetO-cre)1Jaw/0
\Twist2tm1.1(cre)Dor/\Twist2+
(involves: 129X1/SvJ * C57BL/6 * FVB/N) 		decreased cell proliferation J:210193
\Adam17tm1Imx/\Adam17tm1Imx
(involves: 129 * C57BL/6) 		increased fetal cardiomyocyte proliferation J:85547
\Adamts7tm1a(KOMP)Wtsi/\Adamts7tm1a(KOMP)Wtsi
(involves: C57BL/6N) 		decreased vascular endothelial cell proliferation J:230573
\Adamts7tm1a(KOMP)Wtsi/\Adamts7tm1a(KOMP)Wtsi
(C57BL/6-Adamts7tm1a(KOMP)Wtsi) 		decreased hepatocyte proliferation J:221183
\Adamts14Gt(511E11)Cmhd/\Adamts14Gt(511E11)Cmhd
\Adamts2tm1Prc/\Adamts2tm1Prc
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased keratinocyte proliferation J:271185
increased T cell proliferation J:271185
\Adra2btm1Gsb/\Adra2btm1Gsb
(B6.129-Adra2btm1Gsb) 		increased mesenchymal cell proliferation involved in lung development J:166788
\Aebp1tm1Mdl/\Aebp1tm1Mdl
(involves: 129S2/SvPas * C57BL/6) 		decreased cell proliferation J:70416
\Agap2tm1.1Kye/\Agap2tm1.1Kye
(involves: C57BL/6) 		decreased mammary gland epithelial cell proliferation J:158376
\Agertm1.1Arnd/\Agertm1.1Arnd
(involves: 129P2/OlaHsd * C57BL/6) 		decreased vascular smooth muscle cell proliferation J:82620
\Agertm1.1Hyam/\Agertm1.1Hyam
(involves: 129P2/OlaHsd * C57BL/6J * CD-1) 		abnormal cell proliferation J:116507
\Ago2tm1.1Tara/\Ago2tm1.1Tara
\Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J) 		decreased pancreatic beta cell proliferation J:210552
\Agr2tm1.1Lex/\Agr2tm1.1Lex
(involves: 129S5/SvEvBrd * BALB/cJ * C57BL/6) 		increased cell proliferation J:195573
\Agr2tm1.1Lpkn/\Agr2tm1.1Lpkn
\Gt(ROSA)26Sortm1(cre/ERT)Nat/\Gt(ROSA)26Sor+
(involves: 129 * 129S6/SvEvTac * C57BL/6) 		abnormal enterocyte proliferation J:156704
\Agr2tm1Lex/\Agr2tm1Lex
\Gt(ROSA)26Sortm1(cre/ERT2)Tyj/\Gt(ROSA)26Sor+
(involves: 129S4/SvJae * 129S5/SvEvBrd * C57BL/6) 		increased cell proliferation J:195573
\Ahctf1tm1Taga/\Ahctf1tm1Taga
(involves: C57BL/6 * CBA) 		absent inner cell mass proliferation J:98254
\Ahnaktm1Vtm/\Ahnaktm1Vtm
(involves: 129S1/Sv * C57BL/6) 		decreased T cell proliferation J:131148
\Aifm2tm1Hbsh/\Aifm2tm1Hbsh
(involves: 129S6/SvEvTac) 		abnormal cell proliferation J:105660
\Airetm1Pltn/\Airetm1Pltn
(involves: 129S4/SvJae * C57BL/6) 		increased T cell proliferation J:77873
\Aktiptm1a(EUCOMM)Hmgu/\Aktiptm1a(EUCOMM)Hmgu
(C57BL/6N-Aktiptm1a(EUCOMM)Hmgu) 		decreased fibroblast proliferation J:276210
\Aktiptm1a(EUCOMM)Hmgu/\Aktiptm1a(EUCOMM)Hmgu
\Trp53tm1Tyj/\Trp53+
(involves: 129S2/SvPas * C57BL/6N) 		increased fibroblast proliferation J:276210
\Albtm1(cre/ERT2)Mtz/\Alb+
\Polr2mtm1.1Rgr/\Polr2mtm1.1Rgr
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		increased hepatocyte proliferation J:291184
\Aldh1b1tm1.1(KOMP)Vlcg/\Aldh1b1tm1.1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac * CBA) 		increased pancreatic beta cell proliferation J:232360
\Aldh3a2tm1b(EUCOMM)Wtsi/\Aldh3a2tm1b(EUCOMM)Wtsi
(involves: C57BL * C57BL/6J * C57BL/6N * DBA) 		increased keratinocyte proliferation J:234695
\Alg2tm1Lex/\Alg2+
(B6;129S5-Alg2tm1Lex/Mmucd) 		decreased dermal fibroblast proliferation J:171883
\Alms1L2131X/\Alms1L2131X
(involves: C57BL/6 * NOD) 		increased kidney cell proliferation J:118221
\Alpltm1(cre)Nagy/\Alpl+
\Pknox1tm1.1Rygo/\Pknox1tm1.1Rygo
(involves: 129 * C57BL/6 * C57BL/6JJcl) 		abnormal spermatogonia proliferation J:258387
\Ambra1Gt(pGT1.8geo)1Fcec/\Ambra1Gt(pGT1.8geo)1Fcec
(involves: C57BL/6) 		increased cell proliferation J:122795
\Amhr2tm3(cre)Bhr/\Amhr2+
\Nr5a1tm1Klp/\Nr5a1tm2Klp
(involves: 129P2/OlaHsd * 129S7/SvEvBrd) 		decreased granulosa cell proliferation J:145805
\Amhr2tm3(cre)Bhr/\Amhr2+
\Stk11tm1Rdp/\Stk11tm1Rdp
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6) 		increased Sertoli cell proliferation J:187754
\Amhr2tm3(cre)Bhr/\Amhr2+
\Tsc1tm1Djk/\Tsc1tm1Djk
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6) 		increased Sertoli cell proliferation J:187754
\Amhr2tm3(cre)Bhr/\Amhr2+
\Tsc2tm1.1Mjg/\Tsc2tm1.1Mjg
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6) 		increased Sertoli cell proliferation J:187754
\Anapc2tm1Kna/\Anapc2tm1Kna
\Tg(Ttr-cre/Esr1*)1Vco/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		increased hepatocyte proliferation J:87782
\Anapc2tm1Kna/\Anapc2tm2Kna
\Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased hepatocyte proliferation J:87782
\Angtm1Dats/\Angtm1Dats
(Not Specified) 		increased hematopoietic stem cell proliferation J:236081
\Anxa1tm1Rjf/\Anxa1tm1Rjf
(involves: 129 * C57BL/6) 		decreased vascular endothelial cell proliferation J:153690
\Ap1m2tm1.1Ohno/\Ap1m2tm1.1Ohno
(involves: 129P2/OlaHsd * C57BL/6 * CD-1) 		abnormal small intestinal crypt cell proliferation J:226582
\Apaf1tm1Mak/\Apaf1tm1Mak
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * CD-1)) 		increased cell proliferation J:49841
\ApcMin/\Apc+
(involves: C57BL/6J) 		abnormal enterocyte proliferation J:118600
\ApcMin/\Apc+
\Esr1tm1.1Mma/\Esr1+
(involves: 129S2/SvPas * C57BL/6J) 		abnormal enterocyte proliferation J:118600
\ApcMin/\Apc+
\Esr2tm1Mma/\Esr2+
(involves: 129S2/SvPas * C57BL/6J) 		abnormal enterocyte proliferation J:118600
\ApcMin/\Apc+
\Esr2tm1Mma/\Esr2tm1Mma
(involves: 129S2/SvPas * C57BL/6J) 		abnormal enterocyte proliferation J:118600
\ApcMin/\Apc+
\Tgfbr1tm1Bopa/\Tgfbr1+
(involves: 129S1/SvImJ * C57BL/6J) 		increased cell proliferation J:143706
\ApcMin/\Apctm1.1Klne
(B6.Cg-ApcMin/Apctm1.1Klne) 		abnormal enterocyte proliferation J:186132
\Apctm1.1Alew/\Apc+
(B6.129-Apctm1.1Alew) 		increased cell proliferation J:180275
\Apctm1.1Klne/\Apctm1.1Klne
(B6.129-Apctm1.1Klne) 		abnormal enterocyte proliferation J:186132
\Apctm2Rak/\Apctm2Rak
\Tg(KRT14-cre)8Brn/0
(involves: 129/Sv * C57BL/6J * FVB/N * SJL) 		abnormal cell proliferation J:114152
\Apex2tm1Yun/Y
(B6.129S-Apex2tm1Yun) 		decreased splenocyte proliferation J:95267
\Apoetm1Unc/\Apoetm1Unc
\Cdkn1atm1Tyj/\Cdkn1atm1Tyj
(B6.129-Apoetm1Unc Cdkn1atm1Tyj) 		increased vascular smooth muscle cell proliferation J:125247
\Appl1Gt(XM073)Byg/\Appl1Gt(XM073)Byg
(B6.129P2-Appl1Gt(XM073)Byg) 		increased T cell proliferation J:164696
\Appl1tm1.2Test/\Appl1tm1.2Test
(involves: 129X1/SvJ) 		increased T cell proliferation J:164696
\Arb2aTg(Tyr)TpNpln/\Arb2aTg(Tyr)TpNpln
(involves: FVB/N) 		decreased cell proliferation J:260599
decreased neural crest cell proliferation J:260599
\Arhgap1tm1Yizh/\Arhgap1tm1Yizh
(involves: 129S6/SvEvTac * C57BL/6) 		decreased fibroblast proliferation J:119516
\Arhgdiatm1Ytk/\Arhgdiatm1Ytk
\Arhgdibtm1Miyo/\Arhgdibtm1Miyo
(involves: 129S/SvEv) 		decreased T cell proliferation J:140671
increased B cell proliferation J:140671
\Arhgdibtm1Len/\Arhgdibtm1Len
(involves: 129S4/SvJae * C57BL/6) 		increased B cell proliferation J:42604
\Arhgef1tm1Kdf/\Arhgef1tm1Kdf
(involves: 129S1/Sv * 129X1/SvJ) 		decreased B cell proliferation J:99463
increased T cell proliferation J:99463
\Arhgef6tm1Kdf/\Arhgef6tm1Kdf
(involves: 129P2/OlaHsd * C57BL/6) 		decreased B cell proliferation J:137269
decreased T cell proliferation J:137269
\Arhgef11tm1Sgkd/\Arhgef11tm1Sgkd
\Arhgef12tm1Sgkd/\Arhgef12tm1Sgkd
(involves: 129 * C57BL/6J) 		abnormal fibroblast proliferation J:198274
decreased fibroblast proliferation J:198274
\Arhgef12tm1.1Wet/\Arhgef12tm1.1Wet
\Tg(Lck-cre)548Jxm/0
(involves: 129 * C57BL/6 * CBA) 		abnormal T cell proliferation J:149560
\Arid2tm1a(EUCOMM)Wtsi/\Arid2tm1a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N) 		decreased fetal cardiomyocyte proliferation J:223458
\Arl13btm1c(EUCOMM)Wtsi/\Arl13btm1c(EUCOMM)Wtsi
\Tg(Cdh16-cre)91Igr/0
(involves: C57BL/6J * C57BL/6N * ICR) 		increased kidney cell proliferation J:240795
\Arrb1tm1Jse/\Arrb1tm1Jse
\Arrb2tm1Rjl/\Arrb2tm1Rjl
(involves: 129X1/SvJ * C57BL/6) 		decreased mesenchymal cell proliferation involved in lung development J:159121
\Ascl1tm1And/\Ascl1tm1And
(involves: 129) 		decreased neuronal precursor proliferation J:203419
\Asxl1tm1.1Mjxu/\Asxl1+
(involves: 129 * C57BL/6) 		increased cell proliferation J:208085
\Asxl1tm1.1Mjxu/\Asxl1tm1.1Mjxu
(involves: 129 * C57BL/6) 		increased cell proliferation J:208085
\Atf2tm2Nicj/\Atf2tm2Nicj
\Atf7tm1Nicj/\Atf7tm1Nicj
(involves: 129P2/OlaHsd * C57BL/6) 		decreased cell proliferation J:123909
\Atf4tm1Tow/\Atf4+
\Ptprvtm1Asmi/\Ptprv+
(either: (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J * NIH Black Swiss) or (involves: 129P2/OlaHsd * C57BL/6J * NIH Black Swiss)) 		increased pancreatic beta cell proliferation J:152695
\Atf4tm1Tow/\Atf4tm1Tow
(involves: 129S1/Sv * 129X1/SvJ * NIH Black Swiss) 		decreased cell proliferation J:74479
\Atf4tm1Tow/\Atf4tm1Tow
(either: (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J * NIH Black Swiss) or (involves: 129P2/OlaHsd * C57BL/6J * NIH Black Swiss)) 		increased pancreatic beta cell proliferation J:152695
\Atf6tm1.1Rjk/\Atf6tm1.1Rjk
(involves: C57BL/6 * FVB/N) 		decreased cell proliferation J:124971
\Atg3tm1.1Ywh/\Atg3tm1.1Ywh
\Tg(Lck-cre)548Jxm/0
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * CBA) 		decreased T cell proliferation J:172749
\Atg5tm1Nmz/\Atg5tm1Nmz
\Tg(Cd4-cre)1Cwi/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		decreased T cell proliferation J:211733
\Atg7tm1Tchi/\Atg7tm1Tchi
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		increased hepatocyte proliferation J:130839
\Atg7tm1Tchi/\Atg7tm1Tchi
\Tg(Tyr-cre)1Lru/Y
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * DBA/2) 		abnormal melanocyte proliferation J:220623
\Atictm1c(EUCOMM)Hmgu/\Atictm1c(EUCOMM)Hmgu
\Gt(ROSA)26Sortm1(cre/ERT2)Tyj/\Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6J * C57BL/6N) 		decreased vascular smooth muscle cell proliferation J:338121
\Atictm1c(EUCOMM)Hmgu/\Atictm1c(EUCOMM)Hmgu
X/\Tg(Myh11-icre/ERT2)1Soff
(involves: 129S4/SvJaeSor * C57BL/6J * C57BL/6N * FVB/N) 		decreased vascular smooth muscle cell proliferation J:338121
\Atmtm1.1Mmpl/\Atmtm1.1Mmpl
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J) 		decreased cell proliferation J:226414
\Atmtm1Awb/\Atmtm1Awb
(either: 129S6/SvEvTac-Atmtm1Awb or (involves: 129S6/SvEvTac * NIH Black Swiss)) 		decreased fibroblast proliferation J:34193
\Atmtm1Bal/\Atmtm1Bal
(involves: 129S4/SvJae) 		decreased fibroblast proliferation J:42324
\Atmintm1.1Axbe/\Atmintm1.1Axbe
(involves: BALB/c * C57BL/6) 		decreased cell proliferation J:167331
\Atoh1tm3Hzo/\Atoh1+
\Gt(ROSA)26Sortm1(cre/ERT)Nat/\Gt(ROSA)26Sortm1(Smo/EYFP)Amc
(involves: 129 * 129S7/SvEvBrd * 129X1/SvJ) 		abnormal neuronal precursor proliferation J:155047
\Atoh1tm3Hzo/\Atoh1tm1Hzo
\Gt(ROSA)26Sortm1(cre/ERT)Nat/\Gt(ROSA)26Sortm1(Smo/EYFP)Amc
(involves: 129 * 129S7/SvEvBrd * 129X1/SvJ) 		abnormal neuronal precursor proliferation J:155047
\Atoh1tm3Hzo/\Atoh1tm3Hzo
(involves: 129S7/SvEvBrd) 		decreased neuronal precursor proliferation J:155047
\Atp6v0d1em1Nju/\Atp6v0d1em1Nju
\Tg(Adipoq-cre)1Evdr/0
(involves: FVB/NJ) 		increased fibroblast proliferation J:346448
\Atrtm1Bal/\Atrtm2Bal
\Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6) 		decreased cell proliferation J:123200
\Atrtm1Ofc/\Atrtm1Ofc
(involves: 129 * C57BL/6) 		decreased granulosa cell proliferation J:307570
increased granulosa cell proliferation J:307570
\Atrtm2Bal/\Atrtm2Bal
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S2/SvPas * C57BL/6 * CBA) 		abnormal neuron proliferation J:181920
\Atrtm2Bal/\Atrtm2Bal
\Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * C57BL/6 * SJL) 		abnormal neuron proliferation J:181920
decreased cerebellar granule cell precursor proliferation J:181920
\Atrtm2Bal/\Atrtm2Bal
\Trp53tm1Tyj/\Trp53tm1Tyj
\Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * C57BL/6 * SJL) 		abnormal neuron proliferation J:181920
\Atrxtm1Rjg/Y
\Tg(Gata1-cre)1Sho/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1) 		decreased cell proliferation J:115836
\Aurkatm1.1Tvd/\Aurkatm1.1Tvd
\Gt(ROSA)26Sortm1(cre/ERT)Nat/\Gt(ROSA)26Sortm1Sor
(involves: 129 * 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6J) 		decreased cell proliferation J:145744
\Axd/\Axd
(involves: BALB/c * BALB/cAnNCrl * C3H/HeN * C57BL/6) 		decreased cell proliferation J:170759
\Axin2tm1.1(cre/ERT2/tdTomato)Eem/\Axin2+
\Ctnnb1tm2Kem/\Ctnnb1tm2Kem
(involves: 129S2/SvPas * C57BL/6) 		decreased cell proliferation J:204142
\Axin2tm1Wbm/\Axin2tm1Wbm
(involves: 129P2/OlaHsd * C57BL/6) 		increased osteoblast proliferation J:98523
\Axltm1Grl/\Axltm1Grl
\Mertktm1Grl/\Mertktm1Grl
\Tyro3tm1Grl/\Tyro3tm1Grl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		increased B cell proliferation J:70420
increased T cell proliferation J:70420
\B2mtm1Jae/\B2mtm1Jae
\Rr94tm3.2Litt/\Rr94tm3.2Litt
(involves: 129P2/OlaHsd * 129S2/SvPas * FVB/N) 		increased T cell proliferation J:158962
\B2mtm1Unc/\B2mtm1Unc
\H2-Ab1b-tm1Doi/\H2-Ab1b-tm1Doi
(involves: 129P2/OlaHsd * 129S2/SvPas) 		abnormal neuron proliferation J:170591
\B3gnt2Gt(OST237555)Lex/\B3gnt2Gt(OST237555)Lex
(involves: 129S5/SvEvBrd * C57BL/6N) 		increased T cell proliferation J:125556
\B3gnt6tm1Lx/\B3gnt6tm1Lx
(involves: 129S1/Sv * C57BL/6J) 		abnormal enterocyte proliferation J:123826
\B9d2/Tgfb1tm1Flv/\Tgfb1tm2Flv
\Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased T cell proliferation J:123547
\B9d2/Tgfb1tm1Flv/\Tgfb1tm2Flv
\Tnfrsf4tm2(cre)Nik/\Tnfrsf4+
(involves: 129S6/SvEvTac * 129X1/SvJ) 		abnormal enterocyte proliferation J:169839
\B9d2/Tgfb1tm1Flv/\B9d2+
\Tnfrsf4tm2(cre)Nik/\Tnfrsf4+
(involves: 129S6/SvEvTac * 129X1/SvJ) 		abnormal enterocyte proliferation J:169839
\Babam1Gt(IST11207B9)Tigm/\Babam1Gt(IST11207B9)Tigm
(involves: C57BL/6N) 		increased hematopoietic stem cell proliferation J:223526
\Babam2tm1b(EUCOMM)Wtsi/\Babam2tm1b(EUCOMM)Wtsi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased fibroblast proliferation J:235690
\Bag6tm1Pmc/\Bag6tm1Pmc
(involves: 129S1/Sv * C57BL/6) 		increased kidney cell proliferation J:119857
\Bank1tm1Kuro/\Bank1tm1Kuro
(Not Specified) 		increased B cell proliferation J:113321
\Barx1tm1Shiv/\Barx1tm1Shiv
(either: B6.Cg-Barx1tm1Shiv or 129S.Cg-Barx1tm1Shiv or (involves: CD-1)) 		decreased cell proliferation J:180393
increased cell proliferation J:180393
\Baxtm1Sjk/\Bax+
\KitlSl/\KitlSl
\Tg(Pou5f1-GFP)1Scho/?
(involves: 129X1/SvJ * C3H * CD-1 * FVB) 		abnormal primordial germ cell proliferation J:115283
\Baxtm1Sjk/\Baxtm1Sjk
\KitlSl/\KitlSl
\Tg(Pou5f1-GFP)1Scho/?
(involves: 129X1/SvJ * C3H * CD-1 * FVB) 		abnormal primordial germ cell proliferation J:115283
\Bbs1tm1Vcs/\Bbs1tm1Vcs
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal neuronal precursor proliferation J:194096
\Bbs1tm2Vcs/\Bbs1tm2Vcs
\Tg(Pdgfra-cre)1Clc/0
(involves: 129S6/SvEvTac * C57BL/6) 		decreased neuronal precursor proliferation J:194096
\BC004004em1Nju/\BC004004em1Nju
(C57BL/6J-BC004004em1Nju) 		decreased lung fibroblast proliferation J:328326
\Bcap31tm1.1Bwang/\Bcap31tm1.1Bwang
\Tg(Lck-cre)548Jxm/0
(involves: C57BL/6 * CBA) 		decreased T cell proliferation J:274469
\Bcl2tm1Lbox/\Bcl2tm1Lbox
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		decreased B cell proliferation J:114637
\Bcl2tm1Sjk/\Bcl2tm1Sjk
(involves: 129S2/SvPas * C57BL/6) 		increased kidney cell proliferation J:15224, J:34504
\Bcl2l1tm1Cant/\Bcl2l1tm1Cant
(involves: 129S6/SvEvTac) 		decreased T cell proliferation J:77507
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
(involves: 129S1/Sv * C57BL/6) 		abnormal B cell proliferation J:90963
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
\Faslpr/\Faslpr
(B6.Cg-Bcl2l11tm1.1Ast Faslpr) 		increased kidney cell proliferation J:132217
\Bcl3tm1Sbn/\Bcl3tm1Sbn
(involves: 129S4/SvJae) 		decreased B cell proliferation J:207111
increased B cell proliferation J:207111
\Bcl6tm1.1Toka/\Bcl6+
\Tg(TcraTcrb)425Cbn/0
(involves: BALB/c * C57BL/6 * NZB) 		decreased T cell proliferation J:174014
\Bcl6tm2Rdf/\Bcl6tm2Rdf
(involves: 129S1/Sv) 		decreased B cell proliferation J:40769
\Bcl6btm1Dtf/\Bcl6btm1Dtf
(involves: 129P2/OlaHsd) 		decreased T cell proliferation J:99818
\Bcl10tm1Mak/\Bcl10tm1Mak
(involves: 129P2/OlaHsd) 		decreased B cell proliferation J:109545, J:67297
decreased T cell proliferation J:109545, J:67297
\Bcl10tm1Swm/\Bcl10tm1Swm
(involves: 129P2/OlaHsd) 		decreased B cell proliferation J:85147
\Bclaf1tm1Raz/\Bclaf1+
(involves: 129P2/OlaHsd * C57BL/6) 		decreased T cell proliferation J:158087
\Bclaf1tm1Raz/\Bclaf1tm1Raz
(involves: 129P2/OlaHsd * C57BL/6) 		decreased T cell proliferation J:158087
\Bcortm1.1Vjba/Y
(involves: 129S1/Sv) 		increased cell proliferation J:231455
\Becn1tm1.1Bflu/\Becn1tm1.1Bflu
\Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * C57BL/6 * DBA/2) 		decreased T cell proliferation J:203090
\Bgntm1Mfy/Y
\Fmodtm1Aol/\Fmodtm1Aol
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		decreased chondrocyte proliferation J:117908
\Bgntm1Mfy/\Bgntm1Mfy
\Fmodtm1Aol/\Fmodtm1Aol
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		decreased chondrocyte proliferation J:117908
\Bhlhe40tm1Tan/\Bhlhe40tm1Tan
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		decreased T cell proliferation J:72651
\Bhlhe41tm1.2Cdon/\Bhlhe41tm1.2Cdon
(B6.129S6-Bhlhe41tm1.2Cdon) 		decreased T cell proliferation J:157740
\Bin1tm1Gcp/\Bin1tm2Gcp
\Tg(MMTV-Myc)141-3Led/0
\Tg(Wap-cre)11738Mam/0
(involves: 129S6/SvEvTac * C57BL/6 * CD-1 * FVB/N * SJL) 		increased cell proliferation J:117330
\Birc2tm2.1Jda/\Birc2tm2.1Jda
(B6.Cg-Birc2tm2.1Jda) 		increased T cell proliferation J:199221
\Birc3tm1Jda/\Birc3tm1Jda
(B6.Cg-Birc3tm1Jda) 		increased B cell proliferation J:166899
\Birc3tm1Jda/\Birc3tm1Jda
(involves: 129 * C57BL/6) 		increased T cell proliferation J:199221
\Birc6tm1Sjen/\Birc6tm1Sjen
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased cell proliferation J:94169
\Blnktm1Achn/\Blnk+
(involves: 129S4/SvJae * 129X1/SvJ * BALB/c * C3H * C57BL/6) 		decreased B cell proliferation J:82430
\Blnktm1Achn/\Blnk+
\Btktm1Wk/\Btktm1Wk
\Tg(IGH-Btk)1Witt/0
(involves: 129S4/SvJae * 129X1/SvJ * BALB/c * C3H * C57BL/6) 		decreased B cell proliferation J:82430
\Blnktm1Dkit/\Blnktm1Dkit
\Prkcdtm1Kin/\Prkcdtm1Kin
(involves: 129P2/OlaHsd * C57BL/6 * NZB) 		abnormal B cell proliferation J:143854
\Blnktm1Kplm/\Blnktm1Kplm
(involves: 129P2/OlaHsd) 		decreased B cell proliferation J:61130
\Bloc1s2tm1Wli/\Bloc1s2tm1Wli
(involves: 129 * C57BL/6J) 		increased hematopoietic stem cell proliferation J:238623
increased neuronal precursor proliferation J:238623
\Bmi1tm1Brn/\Bmi1tm1Brn
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB)) 		decreased splenocyte proliferation J:17712
\Bmi1tm1Brn/\Bmi1tm1Brn
(involves: 129P2/OlaHsd) 		decreased cell proliferation J:134271
\Bmi1tm1Brn/\Bmi1tm1Brn
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N) 		decreased granulosa cell proliferation J:287217
\Bmi1tm1Brn/\Bmi1tm1Brn
\E2f6tm1Lees/\E2f6tm1Lees
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		decreased cell proliferation J:134271
\Bmp8btm1Blh/\Bmp8btm1Blh
(involves: 129/Sv * Black Swiss) 		abnormal spermatogonia proliferation J:34057
\Bmp10tm1.1(Gdf2)Minh/\Bmp10tm1.1(Gdf2)Minh
(C57BL/6N-Bmp10tm1.1(Gdf2)Minh) 		decreased fetal cardiomyocyte proliferation J:222016
\Bmpr1atm1Bhr/\Bmpr1atm1Bhr
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased embryonic epiblast cell proliferation J:30426
\Bmpr1atm1Bhr/\Bmpr1atm1Bhr
(B6.129S7-Bmpr1atm1Bhr) 		decreased embryonic epiblast cell proliferation J:30426
\Bmpr1atm1Bhr/\Bmpr1atm1Bhr
(involves: 129S7/SvEvBrd * Swiss) 		decreased embryonic epiblast cell proliferation J:30426
\Bmpr1atm1Bhr/\Bmpr1atm1Bhr
(129S7/SvEvBrd-Bmpr1atm1Bhr) 		decreased embryonic epiblast cell proliferation J:30426
\Bmpr1atm2.1Bhr/\Bmpr1atm2.2Bhr
\Isl1tm1(cre)Sev/\Isl1+
(involves: 129S4/SvJae * 129S7/SvEvBrd) 		decreased cell proliferation J:107396
decreased fetal cardiomyocyte proliferation J:107396
\Bmpr1bTg(ACTB-FLP)4917Dym/\Bmpr1bTg(ACTB-FLP)4917Dym
(involves: C57BL/6 * SJL) 		decreased cell proliferation J:59288
\Bmpr2tm1.1Enl/\Bmpr2tm1.1Enl
\Tg(Acvrl1-cre)L1Spo/0
(involves: 129S4/SvJae * FVB) 		increased lung endothelial cell proliferation J:158116
increased vascular smooth muscle cell proliferation J:158116
\Borcs6tm1.1(KOMP)Vlcg/\Borcs6tm1.1(KOMP)Vlcg
(B6N(Cg)-Borcs6tm1.1(KOMP)Vlcg/J) 		decreased embryonic epiblast cell proliferation J:329966
\BptfGt(XG023)Byg/\BptfGt(XG023)Byg
(involves: 129P2/OlaHsd) 		decreased cell proliferation J:147414
\Bptftm1.1Cwu/\Bptftm1.1Cwu
\Emx1tm1(cre)Krj/\Emx1+
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6) 		abnormal neuronal precursor proliferation J:334252
\Braftm1Cpri/\Braf+
(involves: 129P2/OlaHsd) 		increased cell proliferation J:187371
\Braftm1Cpri/\Braftm1Cpri
(involves: 129P2/OlaHsd * C57BL/6) 		increased fibroblast proliferation J:104375
\Braftm1Sva/\Braftm1Sva
\Krastm1Bbd/\Kras+
\Polr2atm1(cre/ERT2)Bbd/\Polr2atm1(cre/ERT2)Bbd
(involves: 129S1/Sv * 129X1/SvJ) 		decreased cell proliferation J:172200
\Braftm1Sva/\Braftm1Sva
\Krastm1Bbd/\Kras+
\Polr2atm1(cre/ERT2)Bbd/\Polr2atm1(cre/ERT2)Bbd
\Raf1tm2Bacc/\Raf1tm2Bacc
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ) 		decreased cell proliferation J:172200
\Braftm2.1Urr/\Braftm2.1Urr
\Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * SJL) 		increased neuronal precursor proliferation J:199842
\Braftm2Cpri/\Braf+
\Krastm4Tyj/\Kras+
(involves: 129S4/SvJae * C57BL/6) 		increased fibroblast proliferation J:187371
\Braftm2Urr/\Braftm2Urr
\Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * SJL) 		abnormal neuronal precursor proliferation J:199842
\Brca1tm1Bhk/\Brca1+
(C.129P2-Brca1tm1Bhk) 		decreased mammary gland epithelial cell proliferation J:198018
\Brca1tm1Brn/\Brca1tm1Brn
(involves: 129P2/OlaHsd) 		decreased cell proliferation J:117113
\Brca1tm1Brn/\Brca1tm1Brn
\Trp53tm1Brn/\Trp53tm1Brn
(involves: 129P2/OlaHsd) 		increased cell proliferation J:117113
\Brca1tm1Cxd/\Brca1tm2Cxd
\Tg(KRT5-cre)5132Jlj/0
(involves: 129S6/SvEvTac * C57BL/6) 		increased keratinocyte proliferation J:85354
\Brca1tm1Cxd/\Brca1tm2Cxd
\Tg(KRT5-cre)5132Jlj/0
\Tg(KRT5-E2F1)2Dgj/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL) 		increased keratinocyte proliferation J:85354
\Brca1tm1Cxd/\Brca1tm2Cxd
\Tg(KRT5-E2F1)2Dgj/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL) 		increased keratinocyte proliferation J:85354
\Brca1tm1Whl/\Brca1tm1Whl
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased cell proliferation J:34458
\Brca1tm2.1Cxd/\Brca1tm2.1Cxd
(involves: 129S6/SvEvTac * C57BL/6) 		decreased fibroblast proliferation J:177853
\Brca1tm2.1Cxd/\Brca1tm2.1Cxd
\Parp1tm1Zqw/\Parp1tm1Zqw
(involves: 129S2/SvPas * 129S6/SvEvTac) 		decreased cell proliferation J:139260
\Brca1tm2.1Cxd/\Brca1tm2.1Cxd
\Trp53tm1Brd/\Trp53+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd) 		increased fibroblast proliferation J:70271
\Brca1tm2.1Cxd/\Brca1tm2.1Cxd
\Trp53tm1Brd/\Trp53+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * Black Swiss * FVB) 		decreased cell proliferation J:81559
\Brca1tm2Cxd/\Brca1+
\Tg(KRT5-E2F1)2Dgj/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL) 		increased keratinocyte proliferation J:85354
\Brca1tm2Cxd/\Brca1tm2Cxd
\Tg(MMTV-cre)4Mam/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB) 		increased mammary gland epithelial cell proliferation J:132088
\Brca1tm2Cxd/\Brca1tm2Cxd
\Trp53tm1Brd/\Trp53+
\Tg(MMTV-cre)4Mam/0
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * FVB) 		increased mammary gland epithelial cell proliferation J:132088
\Brca1tm2Mak/\Brca1tm2Mak
\Tg(Lck-cre)548Jxm/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased T cell proliferation J:63282
\Brca1tm2Mak/\Brca1tm2Mak
\Tg(Lck-cre)548Jxm/?
\Tg(TcrLCMV)327Sdz/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased T cell proliferation J:63282
\Brca1tm2Rjbr/\Brca1tm2Rjbr
(involves: 129 * C57BL/6) 		decreased fibroblast proliferation J:177853
\Brca1tm5.1Cxd/\Brca1tm5.1Cxd
(involves: 129S6/SvEvTac * FVB/N) 		increased mammary gland epithelial cell proliferation J:155810
\Brca2tm1Cbl/\Brca2tm1Cbl
(either: (involves: 129S2/SvPas * C57BL/10) or (involves: 129S2/SvPas * C57BL/6 * DBA/2)) 		decreased fibroblast proliferation J:44386
\Brd2Gt(RRE050)Byg/\Brd2+
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased cell proliferation J:147040
\Brd2Gt(RRE050)Byg/\Brd2Gt(RRE050)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased cell proliferation J:147040
\Brip1Gt(RRI409)Byg/\Brip1Gt(RRI409)Byg
(involves: 129P2/OlaHsd) 		abnormal spermatogonia proliferation J:227337
decreased cell proliferation J:227337
decreased primordial germ cell proliferation J:227337
\Brpf1tm1c(EUCOMM)Wtsi/\Brpf1tm1c(EUCOMM)Wtsi
\Emx1tm1(cre)Krj/\Emx1+
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N) 		decreased neuronal precursor proliferation J:224155, J:241490
\Bsgtm1.1Znc/\Bsgtm1.1Znc
\Tg(Lck-cre)19Hhan/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		increased T cell proliferation J:207886
\Btg1tm1Ftir/\Btg1tm1Ftir
(Not Specified) 		decreased neuronal precursor proliferation J:217516
\Btktm1Wk/\Btktm1Wk
(involves: 129S4/SvJae * C57BL/6) 		decreased B cell proliferation J:82298
\Btktm1Wk/\Btktm1Wk
\Cd40tm1Geha/\Cd40tm1Geha
(involves: 129S4/SvJae * C57BL/6) 		decreased B cell proliferation J:82298
\Btktm1Wk/\Btktm1Wk
\Tectm1Welm/\Tectm1Welm
(involves: 129P2/OlaHsd * C57BL/6) 		decreased B cell proliferation J:66080
\Btktm1Wk/\Btktm1Wk
\Tg(IGH-Btk)1Witt/0
(involves: 129S4/SvJae * 129X1/SvJ * BALB/c * C3H * C57BL/6) 		decreased B cell proliferation J:82430
\Btkxid/Y
(CBA/HN-Btkxid) 		decreased B cell proliferation J:81429
\Btkxid/Y
(involves: CBA/HN * DBA/2N) 		decreased B cell proliferation J:81429
\Btkxid/?
(involves: BALB/c * CBA/N) 		decreased B cell proliferation J:108696
\Btkxid/?
\Ptpn6me/\Ptpn6me
(involves: C57BL/6J * CBA/N * NFS) 		increased splenocyte proliferation J:30994
\Btkxid/?
\Tg(IGH-Btk)1Witt/0
(involves: BALB/c * C3H * C57BL/6 * CBA/N) 		decreased B cell proliferation J:108696
\Btkxid/?
\Tg(IGH-Btk)1Witt/\Tg(IGH-Btk)1Witt
(involves: BALB/c * C3H * C57BL/6 * CBA/N) 		decreased B cell proliferation J:108696
\Btkxid/\Btkxid
(involves: CBA/HN * DBA/2N) 		abnormal B cell proliferation J:81429
\Btkxid/\Btkxid
(CBA/HN-Btkxid) 		decreased B cell proliferation J:81429
\Btlatm1Kmm/\Btlatm1Kmm
(involves: 129S/SvEv) 		increased B cell proliferation J:84084
increased T cell proliferation J:84084
\Btlatm1Kmm/\Btlatm1Kmm
(B6.129S-Btlatm1Kmm) 		decreased T cell proliferation J:119356
increased T cell proliferation J:119356
\Btlatm1Kmm/\Btlatm1Kmm
\Pdcd1tm1Hon/\Pdcd1tm1Hon
(B6.129S-Pdcd1tm1Hon Btlatm1Kmm) 		increased T cell proliferation J:119356
\Btlatm1Kmm/\Btlatm1Kmm
\Tg(DO11.10)10Dlo/?
(involves: 129S/SvEv * BALB/c * C3H * C57BL/6) 		increased T cell proliferation J:84084
\Btrctm1Kin/\Btrctm1Kin
(involves: C57BL/6) 		decreased fibroblast proliferation J:84639
\Bub1tm1.1Tvd/\Bub1tm1.1Tvd
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J) 		decreased fibroblast proliferation J:143035
\Bub1tm1Ssta/\Bub1tm1.1Ssta
\Tg(CAG-cre/Esr1*)5Amc/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		decreased cell proliferation J:128455
\Bub1btm1.1Hsl/\Bub1b+
(involves: 129 * C57BL/6) 		increased B cell proliferation J:201641
\Bub3tm1Jvd/\Bub3+
\Rae1tm1Jvd/\Rae1+
(Not Specified) 		decreased cell proliferation J:81546
\C1qbptm1.1Tuch/\C1qbptm1.1Tuch
(involves: C57BL/6) 		decreased cell proliferation J:196232
\C3tm1Crr/\C3tm1Crr
(involves: 129S4/SvJae * C57BL/6) 		decreased hepatocyte proliferation J:152533
\C3tm1Crr/\C3tm1Crr
\Cd59atm1Bpm/\Cd59atm1Bpm
(B6.129-Cd59atm1Bpm C3tm1Crr) 		increased T cell proliferation J:122201
\C3tm1Crr/\C3tm1Crr
\Tg(Ins2-TFRC/OVA)296Wehi/0
(involves: 129S4/SvJae * C57BL/6) 		increased T cell proliferation J:122114
\Cacfd1tm1.1Geno/\Cacfd1tm1.1Geno
(involves: 129S2/SvPas * C57BL/6J) 		decreased cell proliferation J:184968
\Cacna1dtm1Hssh/\Cacna1dtm1Hssh
(involves: 129S4/SvJae * C57BL/6J) 		decreased pancreatic beta cell proliferation J:72316
\CacybpGT(OST39970)Lex/\CacybpGT(OST39970)Lex
(involves: 129S5/SvEvBrd) 		increased fibroblast proliferation J:110899
\Cadm1Gt(Ayu21-W34)Imeg/\Cadm1Gt(Ayu21-W34)Imeg
(involves: C57BL/6 * CBA/JNCrlj) 		decreased T cell proliferation J:178612
\Cadm1tm1.2Brd/\Cadm1tm1.2Brd
(involves: 129S7/SvEvBrd) 		increased pancreatic beta cell proliferation J:210552
\Calcrltm1Kmca/\Calcrltm1Kmca
(129S6/SvEvTac-Calcrltm1Kmca) 		decreased fetal cardiomyocyte proliferation J:106927
\Calrtm1.2Osb/\Calrtm1.1Osb
\Tg(Zp3-cre)93Knw/0
(involves: 129S2/SvPas * C57BL/6J) 		decreased granulosa cell proliferation J:250114
\Camk2atm1Sva/\Camk2a+
(B6.129P2-Camk2atm1Sva/J) 		increased cell proliferation J:263327
\Cant1tm1.2Aros/\Cant1tm1.2Aros
(involves: 129 * C57BL/6J) 		increased chondrocyte proliferation J:282272
\Capslem1Xjz/\Capslem1Xjz
\Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/0
(involves: C57BL/6 * C57BL/6J * CBA) 		decreased endothelial cell proliferation J:365043
\Card11em1Welu/\Card11em1Welu
(involves: C57BL/6) 		decreased B cell proliferation J:292926
\Card11em2Welu/\Card11em2Welu
(involves: C57BL/6) 		increased B cell proliferation J:292926
\Card11m1Btlr/\Card11m1Btlr
(C57BL/6J-Card11m1Btlr) 		decreased B cell proliferation J:149767, J:139069
decreased T cell proliferation J:149767, J:139069
\Card11tm1Litt/\Card11tm1Litt
(involves: 129P2/OlaHsd) 		abnormal B cell proliferation J:89322
abnormal T cell proliferation J:89322
\Card11tm1Pngr/\Card11tm1Pngr
(involves: 129P2/OlaHsd) 		decreased B cell proliferation J:84036
\Card11tm1Vmd/\Card11+
(involves: 129S6/SvEvTac * C57BL/6N) 		decreased B cell proliferation J:95800
\Card11tm1Vmd/\Card11tm1Vmd
(involves: 129S6/SvEvTac * C57BL/6N) 		decreased B cell proliferation J:95800
decreased T cell proliferation J:95800
\Card14em9Lutzy/\Card14+
(C57BL/6J-Card14em9Lutzy/J) 		increased keratinocyte proliferation J:262723
\Card19tm1Rwen/\Card19tm1Rwen
\Tg(IghelMD4)4Ccg/0
\Tg(ML5sHEL)5Ccg/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6JSfd) 		decreased B cell proliferation J:336763
\Carmil2bas/\Carmil2bas
(involves: C3HeB/FeJ * C57BL/6) 		decreased T cell proliferation J:205441
\Carmil2bas/\Carmil2tm1a(KOMP)Mbp
(involves: C3HeB/FeJ * C57BL/6 * C57BL/6N) 		decreased T cell proliferation J:205441
\Casp3tm1Mak/\Casp3tm1Mak
\Tg(TcrLCMV)327Sdz/0
(B6.Cg-Casp3tm1Mak Tg(TcrLCMV)327Sdz) 		decreased cell proliferation J:97650
\Casp8tm1Hed/\Casp8tm1Hed
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd) 		decreased B cell proliferation J:116713
\Casp8tm1Raz/\Casp8tm1Raz
\Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		abnormal T cell proliferation J:107455
decreased T cell proliferation J:82759
\Casrtm1Wch/\Casrtm1Wch
\Tg(Vil1-cre)997Gum/0
(involves: 129S4/SvJae * C57BL/6J * SJL) 		abnormal enterocyte proliferation J:179672
\Casz1Gt(CJ0565)Wtsi/\Casz1Gt(CJ0565)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		decreased fetal cardiomyocyte proliferation J:242127
\Casz1tm1.1Flc/\Casz1tm1.1Flc
\Nkx2-5tm1(cre)Rjs/\Nkx2-5+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * C57BL/6J * SJL) 		decreased fetal cardiomyocyte proliferation J:221324
\Cav1tm1Kur/\Cav1tm1Kur
(involves: 129X1/SvJ * C57BL/6) 		decreased hepatocyte proliferation J:112452
increased lung endothelial cell proliferation J:71760
\Cav1tm1Mls/\Cav1tm1Mls
\Cdkn2atm1Rdp/\Cdkn2atm1Rdp
(involves: 129/Sv * C57BL/6 * SJL) 		increased fibroblast proliferation J:90334
\Cbltm2Hua/\Cbltm2Hua
\Cblbtm1Hua/\Cblbtm1Hua
\Tg(Lck-cre)I57Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * ICR) 		increased T cell proliferation J:80427
\Cblbtm1Hua/\Cblbtm1Hua
(Not Specified) 		increased T cell proliferation J:89761
\Cblbtm1Hua/\Cblbtm1Hua
(B6.129P2-Cblbtm1Hua) 		increased T cell proliferation J:94685
\Cblbtm1Hua/\Cblbtm1Hua
\Ubash3btm1Jni/\Ubash3btm1Jni
\Ubash3atm1Jni/\Ubash3atm1Jni
(Not Specified) 		increased T cell proliferation J:89761
\Cblbtm1Pngr/\Cblbtm1Pngr
(B6.129P2-Cblbtm1Pngr) 		increased T cell proliferation J:141390
\Cbx2tm1Cim/\Cbx2tm1Cim
(involves: 129P2/OlaHsd * BALB/c) 		decreased fibroblast proliferation J:38487
decreased splenocyte proliferation J:38487
\Cbx7tm1Afus/\Cbx7tm1Afus
(involves: C57BL/6J) 		increased fibroblast proliferation J:184383
\Ccdc6tm1Afus/\Ccdc6tm1Afus
(involves: 129 * C57BL/6J) 		decreased fibroblast proliferation J:301625
\Ccdc80tm1Ppal/\Ccdc80+
(Not Specified) 		increased fibroblast proliferation J:217742
\Ccdc80tm1Ppal/\Ccdc80tm1Ppal
(Not Specified) 		increased fibroblast proliferation J:217742
\Ccdc88bm1Pgrs/\Ccdc88bm1Pgrs
(involves: C57BL/6J * C57BL/10J) 		decreased T cell proliferation J:230618
\Ccdc134tm1.2Jhua/\Ccdc134tm1.2Jhua
(involves: C57BL/6NTac) 		decreased hepatocyte proliferation J:256995
\Ccl5tm1Hso/\Ccl5tm1Hso
(involves: 129P2/OlaHsd * C57BL/6) 		decreased T cell proliferation J:75842
\Ccm2ltm1Mlkn/\Ccm2ltm1Mlkn
\Heg1tm1Mlkn/\Heg1tm1Mlkn
(involves: 129 * C57BL/6) 		decreased fetal cardiomyocyte proliferation J:187714
\Ccn2tm1Kml/\Ccn2tm1Kml
(involves: 129X1/SvJ * BALB/cJ) 		decreased mesenchymal cell proliferation involved in lung development J:130165
\Ccn3tm1Hko/\Ccn3tm1Hko
(B6.129-Ccn3tm1Hko) 		increased vascular smooth muscle cell proliferation J:172144
\Ccna1tm1Djw/\Ccna1tm1Djw
\Ccna2tm1.1Pisc/\Ccna2tm1.1Pisc
(involves: 129S7/SvEvBrd) 		decreased cell proliferation J:155178
\Ccna1tm1Djw/\Ccna1tm1Djw
\Ccna2tm1.1Pisc/\Ccna2tm1.2Pisc
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd) 		decreased cell proliferation J:155178
\Ccnd3tm1.1(Ccnd2)Iaai/\Ccnd3tm1.1(Ccnd2)Iaai
(involves: 129S6/SvEvTac) 		decreased B cell proliferation J:192031
decreased T cell proliferation J:192031
\Ccnd3tm1Pisc/\Ccnd3tm1Pisc
(Not Specified) 		decreased B cell proliferation J:192031
decreased T cell proliferation J:88120, J:192031
\Ccnd3tm1Pisc/\Ccnd3tm1Pisc
\Cdkn1btm1Mlf/\Cdkn1btm1Mlf
(involves: 129S4/SvJaeSor) 		decreased T cell proliferation J:192031
\Ccnd3tm1Pisc/\Ccnd3tm1Pisc
\Rag2tm1Fwa/\Rag2tm1Fwa
(involves: 129S/SvEv) 		increased T cell proliferation J:88120
\Ccnd3tm1Pisc/\Ccnd3tm1Pisc
\Rb1tm2Brn/\Rb1tm2Brn
\Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * CBA) 		decreased T cell proliferation J:192031
\Ccndbp1tm1Riet/\Ccndbp1tm1Riet
(involves: 129P2/OlaHsd * C57BL/6) 		decreased hepatocyte proliferation J:121623
\Ccne1tm1Clur/\Ccne1tm1Clur
(involves: 129S4/SvJae) 		increased mammary gland epithelial cell proliferation J:136692
\Ccne1tm1Jro/?
\Cdkn1atm1Led/\Cdkn1atm1Led
(either: (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J) or (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * C57BL/6J)) 		decreased fibroblast proliferation J:99695
\Ccne1tm1Jro/?
\Trp53tm1Tyj/\Trp53tm1Tyj
(either: (involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6J) or (involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * C57BL/6J)) 		increased fibroblast proliferation J:99695
\Ccne1tm1Jro/\Ccne1tm1Jro
(either: 129-Ccne1tm1Jro or B6.129-Ccne1tm1Jro) 		increased splenocyte proliferation J:99695
\Ccne1tm1Jro/\Ccne1tm1Jro
(involves: 129/Sv * 129S4/SvJaeSor) 		increased mammary gland epithelial cell proliferation J:136692
\Ccnftm1.1Sje/\Ccnftm1.1Sje
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased cell proliferation J:89060
\Ccr2tm1Ifc/\Ccr2tm1Ifc
(involves: 129S4/SvJae * C57BL/6) 		decreased splenocyte proliferation J:75838
decreased T cell proliferation J:75838
\Ccr5tm1Sush/\Ccr5tm1Sush
(B6.129P2-Ccr5tm1Sush) 		decreased T cell proliferation J:94937
\Ccr6tm1(EGFP)Irw/\Ccr6tm1(EGFP)Irw
(involves: 129S6/SvEvTac * C57BL/6) 		increased T cell proliferation J:85086
\Cd2aptm1Shaw/\Cd2aptm1Shaw
(involves: 129X1/SvJ) 		decreased T cell proliferation J:57971
\Cd3gtm1Amk/\Cd3gtm1Amk
(involves: 129P2/OlaHsd) 		abnormal T cell proliferation J:77504
\Cd4tm1Litt/\Cd4tm1Litt
(involves: 129S2/SvPas) 		decreased T cell proliferation J:50435
\Cd4tm1Litt/\Cd4tm1Nik
\Tg(Lck-cre)3778Nik/0
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2) 		decreased T cell proliferation J:73479
\Cd4tm1Litt/\Cd4tm1Nik
\Tg(Lck-cre)3785Nik/0
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2) 		increased T cell proliferation J:73479
\Cd4tm1Litt/\Cd4tm1Nik
\Tg(Lck-icre)3779Nik/0
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2) 		decreased T cell proliferation J:73479
\Cd5tm1.1Chra/\Cd5tm1.1Chra
(involves: C57BL/6 * FVB/N) 		decreased T cell proliferation J:189919
increased T cell proliferation J:189919
\Cd5tm1.1Chra/\Cd5tm1.1Chra
\Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: C57BL/6 * FVB/N) 		decreased T cell proliferation J:189919
\Cd5tm1Cgn/\Cd5tm1Cgn
(B6.129P2-Cd5tm1Cgn) 		increased T cell proliferation J:189919
\Cd6tm1Linf/\Cd6tm1Linf
(D1.Cg-Cd6tm1Linf) 		decreased B cell proliferation J:238478
\Cd8am2Btlr/\Cd8am2Btlr
(C57BL/6J-Cd8am2Btlr) 		increased CD8-positive, alpha-beta memory T cell proliferation J:236677
\Cd19tm1(cre)Cgn/\Cd19+
\Ctnnbl1tm1.1Crad/\Ctnnbl1tm1.1Crad
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		decreased B cell proliferation J:232010
\Cd19tm1(cre)Cgn/\Cd19+
\Ep300tm2Reck/\Ep300+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6) 		decreased B cell proliferation J:147840
\Cd19tm1(cre)Cgn/\Cd19+
\Gt(ROSA)26Sortm1(ITK/SYK)Jrld/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd) 		increased T cell proliferation J:160931
\Cd19tm1(cre)Cgn/\Cd19+
\Gt(ROSA)26Sortm2(CARD11*L225LI)Jrld/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd) 		increased B cell proliferation J:228288
\Cd19tm1(cre)Cgn/\Cd19+
\Gt(ROSA)26Sortm4(Ikbkb)Rsky/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * C57BL/6) 		increased cell proliferation J:113365
\Cd19tm1(cre)Cgn/\Cd19+
\Igbp1tm1Imku/Y
(involves: 129P2/OlaHsd) 		decreased B cell proliferation J:74619
\Cd19tm1(cre)Cgn/\Cd19+
\Ikbkbtm1Cgn/\Ikbkbtm1.1Cgn
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell proliferation J:79132
\Cd19tm1(cre)Cgn/\Cd19+
\Ikbkbtm2Mka/\Ikbkbtm2Mka
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6) 		decreased B cell proliferation J:82995
\Cd19tm1(cre)Cgn/\Cd19+
\Ikbkgtm1.1Mpa/Y
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell proliferation J:79132
\Cd19tm1(cre)Cgn/\Cd19+
\Inpp5dtm1Rav/\Inpp5dtm1Rav
\Ptentm1Hwu/\Ptentm1Hwu
(involves: 129P2/OlaHsd * 129S4/SvJae) 		increased B cell proliferation J:166155
\Cd19tm1(cre)Cgn/\Cd19+
\Map3k7tm1Aki/\Map3k7tm1.1Aki
(involves: 129P2/OlaHsd * C57BL/6) 		decreased B cell proliferation J:112597
\Cd19tm1(cre)Cgn/\Cd19+
\Myd88em1.1Rsky/\Myd88em1.1Rsky
(involves: C57BL/6NTac) 		increased B cell proliferation J:308792
\Cd19tm1(cre)Cgn/\Cd19+
\Ptentm1Hwu/\Ptentm1Hwu
(involves: 129P2/OlaHsd * 129S4/SvJae) 		increased B cell proliferation J:155314, J:83213
\Cd19tm1(cre)Cgn/\Cd19+
\Ptpn6tm1Rsky/\Ptpn6tm1Rsky
(involves: 129P2/OlaHsd * C57BL/6) 		decreased B cell proliferation J:123568
\Cd19tm1(cre)Cgn/\Cd19+
\Slc3a2tm1.1Mgin/\Slc3a2tm1.1Mgin
(involves: 129 * C57BL/6 * SJL) 		decreased B cell proliferation J:148000
\Cd19tm1(cre)Cgn/\Cd19+
\Tnfaip3tm1.1Awai/\Tnfaip3tm1.1Awai
(involves: 129P2/OlaHsd) 		increased B cell proliferation J:175422
\Cd19tm1(cre)Cgn/\Cd19+
\Ube2ntm1Aki/\Ube2ntm1Aki
(involves: 129P2/OlaHsd * C57BL/6) 		decreased B cell proliferation J:112287
\Cd19tm1(cre)Cgn/\Cd19+
\Wacem2Cya/\Wacem2Cya
(B6.Cg-Cd19tm1(cre)Cgn Wacem2Cya) 		decreased B cell proliferation J:345327
\Cd19tm1Tft/\Cd19tm1Tft
(Not Specified) 		decreased B cell proliferation J:27236
\Cd19tm1Tft/\Cd19tm1Tft
(involves: 129 * C57BL/6) 		decreased B cell proliferation J:71174
\Cd19tm1Tft/\Cd19tm1Tft
\Lyntm1Sor/\Lyntm1Sor
(involves: 129S4/SvJaeSor * C57BL/6) 		decreased B cell proliferation J:71174
\Cd22tm1Eac/\Cd22tm1Eac
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal B cell proliferation J:37451, J:132991
\Cd22tm1Tft/\Cd22tm1Tft
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell proliferation J:92736
\Cd22tm2Tft/\Cd22tm2Tft
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased B cell proliferation J:92736
increased B cell proliferation J:92736
\Cd22tm2Tft/\Cd22tm2Tft
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased B cell proliferation J:208364
\Cd22tm3Tft/\Cd22tm3Tft
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased B cell proliferation J:92736
increased B cell proliferation J:92736
\Cd28tm1Jmg/\Cd28tm1Mak
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6) 		decreased T cell proliferation J:149888, J:124570
\Cd28tm1Ltu/\Cd28tm1Ltu
\Foxp3tm4(YFP/icre)Ayr/\Foxp3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased T cell proliferation J:194503
\Cd28tm1Mak/\Cd28tm1Mak
(involves: 129S2/SvPas * C57BL/6 * DBA/2) 		decreased T cell proliferation J:14194
\Cd28tm1Mak/\Cd28tm1Mak
(NOD.129S2-Cd28tm1Mak) 		increased T cell proliferation J:93421
\Cd28tm1Mak/\Cd28tm1Mak
(involves: 129S2/SvPas) 		decreased T cell proliferation J:205441, J:130882, J:123989
\Cd28tm1Mak/\Cd28tm1Mak
(involves: 129S2/SvPas * NOD) 		decreased T cell proliferation J:35353
\Cd28tm1Mak/\Cd28tm1Mak
(involves: 129S2/SvPas * C57BL/6) 		decreased T cell proliferation J:149888
\Cd28tm1Mak/\Cd28tm1Mak
\Tg(Cd4-cre)1Cwi/?
\Traf6tm2Ywc/\Traf6tm2Ywc
(involves: 129S2/SvPas * C57BL/6 * DBA/2) 		decreased T cell proliferation J:130882
\Cd28tm1Mak/\Cd28tm1Mak
\Tg(TcrLCMV)327Sdz/0
(involves: 129S2/SvPas * C57BL/6 * DBA/2) 		decreased splenocyte proliferation J:123989
decreased T cell proliferation J:123989
\Cd28tm1Pjl/\Cd28tm1Pjl
(involves: 129P2/OlaHsd * C57BL/6) 		increased splenocyte proliferation J:83722
\Cd28tm1Pjl/\Cd28tm1Pjl
\Tg(DO11.10)10Dlo/0
(involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6) 		abnormal T cell proliferation J:25536
\Cd28tm1Pjl/\Cd28tm1Pjl
\Tnfrsf9tm1Byk/\Tnfrsf9tm1Byk
(either: B6.Cg-Cd28tm1Pjl Tnfrsf9tm1Byk or C.Cg-Cd28tm1Pjl Tnfrsf9tm1Byk) 		decreased splenocyte proliferation J:83722
\Cd28tm1Shr/\Cd28tm1Shr
(involves: 129S4/SvJae * BALB/c * C57BL/6) 		decreased T cell proliferation J:68642
\Cd28tm1Shr/\Cd28tm1Shr
\Ctla4tm1Shr/\Ctla4tm1Shr
(C.129S4-Cd28tm1Shr Ctla4tm1Shr) 		decreased T cell proliferation J:68642
\Cd34tm1Szk/\Cd34tm1Szk
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased cell proliferation J:121305
\Cd44tm1.1Ugu/\Cd44tm1.1Ugu
(SJL.129(Cg)-Cd44tm1.1Ugu) 		decreased T cell proliferation J:199279
\Cd44tm1Mak/\Cd44tm1Mak
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased fibroblast proliferation J:105319
\Cd44tm2.1Ugu/\Cd44tm2.1Ugu
(B6.129-Cd44tm2.1Ugu) 		decreased T cell proliferation J:199279
\Cd48tm1Rsr/\Cd48tm1Rsr
(B6.129S4-Cd48tm1Rsr) 		decreased T cell proliferation J:53718
\Cd59atm1Bpm/\Cd59atm1Bpm
(B6.129-Cd59atm1Bpm) 		decreased B cell proliferation J:119703
increased T cell proliferation J:122201
\Cd72c/\Cd72c
(involves: C57BL/6 * MRL) 		increased B cell proliferation J:204782
\Cd72tm1Jrp/\Cd72tm1Jrp
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6)) 		increased B cell proliferation J:76990
\Cd72tm1Tsub/\Cd72tm1Tsub
(involves: C57BL/6J) 		increased B cell proliferation J:204782
\Cd74tm1Eae/\Cd74tm1Eae
(involves: 129S2/SvPas) 		decreased B cell proliferation J:113050, J:132865
decreased cell proliferation J:147772
\Cd74tm1Liz/\Cd74tm1Liz
(involves: 129S/SvEv * C57BL/6J) 		decreased T cell proliferation J:72243
\Cd74tm1Liz/\Cd74tm1Liz
(B6.129S-Cd74tm1Liz) 		decreased T cell proliferation J:28966
\Cd74tm1Liz/\Cd74tm1Liz
(involves: 129S/SvEv * BALB/c * C57BL) 		abnormal T cell proliferation J:110927
\Cd74tm1Liz/\Cd74tm1Liz
(involves: 129S/SvEv * C57BL * C57BL/10 * C57BR) 		abnormal T cell proliferation J:110927
\Cd74tm2Liz/\Cd74tm1Liz
(involves: 129S/SvEv * C57BL/6) 		increased T cell proliferation J:28966
\Cd79atm1(cre)Reth/\Cd79a+
\Ctnnbl1tm1.1Crad/\Ctnnbl1tm1.1Crad
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL) 		abnormal B cell proliferation J:232010
decreased B cell proliferation J:232010
\Cd79atm1(cre)Reth/\Cd79a+
\Huwe1tm1.1Mak/Y
(B6.Cg-Cd79atm1(cre)Reth Huwe1tm1.1Mak) 		decreased B cell proliferation J:181705
\Cd79atm1(cre)Reth/\Cd79a+
\Nr4a1tm1Pcn/\Nr4a1tm1Pcn
(involves: 129 * BALB/c) 		increased B cell proliferation J:306652
\Cd79atm1(cre)Reth/\Cd79a+
\Nr4a1tm1Pcn/\Nr4a1tm1Pcn
\Nr4a3em1Juz/\Nr4a3em1Juz
(involves: 129 * BALB/c * C57BL/6) 		increased B cell proliferation J:306652
\Cd79atm1(cre)Reth/\Cd79a+
\Orai1tm1Smua/\Orai1tm1Smua
\Orai3em1.1Treb/\Orai3em1.1Treb
(involves: BALB/c * C57BL/6J * C57BL/6N) 		decreased B cell proliferation J:345485
\Cd79atm1(cre)Reth/\Cd79a+
\Wastm1.1Ldn/\Was+
(involves: BALB/c * C57BL/6) 		abnormal B cell proliferation J:182528
\Cd79atm6Cgn/\Cd79atm6Cgn
(involves: C57BL/6) 		decreased B cell proliferation J:113407
\Cd79btm3Mnz/\Cd79btm3Mnz
(involves: 129/Sv * C57BL/6) 		decreased B cell proliferation J:128768
\Cd80tm1Shr/\Cd80tm1Shr
(involves: 129S4/SvJae) 		decreased B cell proliferation J:74662
\Cd80tm1Shr/\Cd80tm1Shr
\Cd86tm1Shr/\Cd86tm1Shr
(B6.129S4-Cd80tm1Shr Cd86tm1Shr) 		decreased T cell proliferation J:57613
\Cd80tm1Shr/\Cd80tm1Shr
\Cd86tm2Shr/\Cd86tm2Shr
(involves: 129S4/SvJae) 		abnormal T cell proliferation J:57090
\Cd80tm1Shr/\Cd80tm1Shr
\Cd86tm2Shr/\Cd86tm2Shr
(129.SJL-Cd86tm2Shr) 		decreased cell proliferation J:78992
\Cd80tm1Shr/\Cd80tm1Shr
\Cd86tm2Shr/\Cd86tm2Shr
(involves: 129S4/SvJae * C57BL/6J * SJL) 		decreased cell proliferation J:78992
\Cd80tm1Shr/\Cd80tm1Shr
\Cd86tm2Shr/\Cd86tm2Shr
\Ctla4tm1Shr/\Ctla4tm1Shr
(involves: 129S4/SvJae * BALB/c) 		increased T cell proliferation J:57090
\Cd81tm1Geha/\Cd81tm1Geha
(involves: 129S4/SvJae * C57BL/6) 		increased B cell proliferation J:43975
\Cd81tm1Tmiy/\Cd81tm1Tmiy
(involves: 129/Sv * C57BL/6) 		abnormal T cell proliferation J:41830
decreased B cell proliferation J:41830
increased B cell proliferation J:41830
\Cd83lcd4/\Cd83lcd4
(involves: C57BL/6J) 		decreased T cell proliferation J:92721
\Cd86tm1Shr/\Cd86tm1Shr
(NOD.129S4-Cd86tm1Shr) 		abnormal T cell proliferation J:142046
decreased T cell proliferation J:93421
\Cd86tm1Shr/\Cd86tm1Shr
(B6.129S4-Cd86tm1Shr) 		decreased T cell proliferation J:57613
\Cd151tm1Lka/\Cd151tm1Lka
(C57BL/6-Cd151tm1Lka) 		abnormal T cell proliferation J:91605
\Cd151tm2Nki/\Cd151tm2Nki
(FVB.129P2-Cd151tm2Nki) 		decreased keratinocyte proliferation J:205736
\Cd151tm2Nki/\Cd151tm2Nki
\Itga3tm1Son/\Itga3+
\Krt14tm1(cre)Wbm/?
(FVB.129P2-Cd151tm2Nki Itga3tm1Son Krt14tm1(cre)Wbm) 		decreased keratinocyte proliferation J:205736
\Cd151tm2Nki/\Cd151tm2Nki
\Krt14tm1(cre)Wbm/?
(FVB.129P2-Cd151tm2Nki Krt14tm1(cre)Wbm) 		decreased keratinocyte proliferation J:205736
\Cd163tm1(KOMP)Vlcg/\Cd163tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		abnormal skeletal muscle satellite cell proliferation J:224919
\Cd209atm1.1Cfg/\Cd209atm1.1Cfg
(involves: C57BL/6) 		increased T cell proliferation J:217719
\Cd209dtm1.1Cfg/\Cd209dtm1.1Cfg
(involves: C57BL/6) 		increased B cell proliferation J:217719
\Cd226tm1.1Cln/\Cd226tm1.1Cln
(B6.129P2-Cd226tm1.1Cln) 		decreased T cell proliferation J:159749
\Cd226tm1.1Cln/\Cd226tm1.1Cln
\Tg(TcraTcrb)1100Mjb/0
(B6.Cg-Cd226tm1.1Cln Tg(TcraTcrb)1100Mjb) 		decreased T cell proliferation J:159749
\Cd247tm1Mhu/\Cd247tm1Mhu
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased splenocyte proliferation J:15579
decreased T cell proliferation J:15579
\Cd247tm1Tks/\Cd247tm1Tks
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal T cell proliferation J:15271
\Cd274tm1Lpc/\Cd274tm1Lpc
(C.129S-Cd274tm1Lpc) 		increased T cell proliferation J:165841
\Cd276tm1Mak/\Cd276tm1Mak
(involves: 129P2/OlaHsd * C57BL/6) 		increased T cell proliferation J:84973
\Cd300c2tm1Shib/\Cd300c2tm1Shib
(B6.Cg-Cd300c2tm1Shib) 		increased B cell proliferation J:177613
\Cdc20tm1.1Mama/\Cdc20tm1.2Mama
\Polr2atm1(cre/ERT2)Bbd/\Polr2a+
(involves: 129/Sv * BALB/cJ * C57BL/6 * CD-1 * SJL) 		decreased cell proliferation J:167609
\Cdc20tm1.1Pzg/\Cdc20tm1.1Pzg
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased cell proliferation J:150421
\Cdc25am1Rfp/\Cdc25am1Rfp
(multiple strains) 		increased cell proliferation J:80142
\Cdc25atm1Hpw/\Cdc25atm1.1Hpw
\Cdc25btm1Pjd/\Cdc25btm1Pjd
\Cdc25ctm1Hpw/\Cdc25ctm1Hpw
\Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2) 		abnormal small intestinal crypt cell proliferation J:169457
\Cdc25atm1Hpw/\Cdc25atm1.1Hpw
\Cdc25btm1Pjd/\Cdc25btm1Pjd
\Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2) 		abnormal small intestinal crypt cell proliferation J:169457
\Cdc25atm1Kiyo/\Cdc25a+
\Tg(MMTV-Erbb2)NK1Mul/?
(involves: 129/Sv * C57BL/6 * FVB/N) 		decreased cell proliferation J:123144
\Cdc42tm1.1Rac/\Cdc42tm1.1Rac
\Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL) 		abnormal neuronal precursor proliferation J:197886
\Cdc45tm1Dta/\Cdc45tm1Dta
(involves: 129S4/SvJae * C57BL/6) 		absent inner cell mass proliferation J:70008
\Cdc73Gt(RRE190)Byg/\Cdc73Gt(RRE190)Byg
(involves: 129P2/OlaHsd) 		absent inner cell mass proliferation J:135255
absent trophectoderm cell proliferation J:135255
\Cdc73tm1Btt/\Cdc73tm1Btt
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		decreased cell proliferation J:135255
\Cdh1tm2Kem/\Cdh1tm2Kem
\Tg(Ins2-cre)23Herr/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J) 		increased pancreatic beta cell proliferation J:196410
\Cdhr5tm1Lex/\Cdhr5tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		abnormal enterocyte proliferation J:301471
\Cdk1tm2.1Kald/\Cdk1tm2.1Kald
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129 * C57BL/6 * DBA * SJL) 		decreased hepatocyte proliferation J:182141
\Cdk1tm2.1Kald/\Cdk1tm2.1Kald
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129 * C57BL/6 * CBA * SJL) 		decreased cell proliferation J:182141
\Cdk2tm1Kald/\Cdk2tm1Kald
(involves: 129S1/Sv) 		decreased hepatocyte proliferation J:141249
\Cdk2tm1Kald/\Cdk2tm1Kald
\Cdk4tm1Kiyo/\Cdk4tm1Kiyo
(involves: 129S1/Sv * C57BL/6) 		decreased fetal cardiomyocyte proliferation J:108720
decreased fibroblast proliferation J:108720
\Cdk2tm1Kald/\Cdk2tm1Kald
\Cdk4tm1Kiyo/\Cdk4tm1Kiyo
\Cdkn1btm1Ako/\Cdkn1btm1Ako
(involves: 129S1/Sv * C57BL/6) 		decreased cell proliferation J:108720
\Cdk2tm1Sgo/\Cdk2tm1Sgo
\Cdk4tm1Bbd/\Cdk4tm1Bbd
\Cdk6tm1Bbd/\Cdk6tm1Bbd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased cell proliferation J:124678
\Cdk2tm1Sgo/\Cdk2tm1Sgo
\Cdk4tm2.1Bbd/\Cdk4tm2.1Bbd
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6 * SJL) 		abnormal fetal cardiomyocyte proliferation J:125217
decreased fibroblast proliferation J:125217
\Cdk4tm1.1Bbd/\Cdk4tm1.1Bbd
\Tg(Tyr-NRAS*Q61K)1Bee/0
(FVB.Cg-Cdk4tm1.1Bbd Tg(Tyr-NRAS*Q61K)1Bee) 		abnormal melanocyte proliferation J:222847
\Cdk4tm2.1Bbd/\Cdk4tm2.1Bbd
\Krastm1Bbd/\Krastm2Bbd
\Polr2atm1(cre/ERT2)Bbd/\Polr2atm1(cre/ERT2)Bbd
(involves: 129S1/Sv * 129X1/SvJ) 		decreased cell proliferation J:161780
\Cdk4tm2.2Bbd/\Cdk4tm2.1Bbd
\Krastm1Bbd/\Krastm2Bbd
\Polr2atm1(cre/ERT2)Bbd/\Polr2atm1(cre/ERT2)Bbd
(involves: 129S1/Sv * 129X1/SvJ) 		decreased cell proliferation J:161780
\Cdk5rap2an/\Cdk5rap2an
(B6.Cg-Cdk5rap2an) 		abnormal neuron proliferation J:160533
\Cdk5rap3tm1b(EUCOMM)Hmgu/\Cdk5rap3tm1b(EUCOMM)Hmgu
(involves: C57BL/6N * FVB/N) 		decreased hepatocyte proliferation J:272566
\Cdk6tm1Bbd/\Cdk6tm1Bbd
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		decreased T cell proliferation J:92529
\Cdk7Gt(D032B11)1.1Wrst/\Cdk7Gt(D032B11)1.1Wrst
(involves: 129S2/SvPas * C57BL/6 * SJL) 		absent fibroblast proliferation J:183925
\Cdk11btm1Vjk/\Cdk11btm1Vjk
(involves: 129S6/SvEv * C57BL/6) 		decreased cell proliferation J:89908
\Cdk19em1Smoc/\Cdk19em1Smoc
(C57BL/6JSmoc-Cdk19em1Smoc/Smoc) 		decreased hematopoietic stem cell proliferation J:322947
\Cdkn1atm1Led/\Cdkn1atm1Led
(involves: 129S6/SvEvTac) 		increased fibroblast proliferation J:57882
increased T cell proliferation J:76041
\Cdkn1atm1Led/\Cdkn1atm1Led
\Gadd45atm1Ajf/\Gadd45atm1Ajf
(either: (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6)) 		increased fibroblast proliferation J:57882
increased kidney cell proliferation J:76041
increased T cell proliferation J:76041
\Cdkn1atm1Tyj/\Cdkn1atm1Tyj
(involves: 129S2/SvPas) 		abnormal neuronal precursor proliferation J:90479
increased cell proliferation J:180692
\Cdkn1atm1Tyj/\Cdkn1atm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		increased T cell proliferation J:60292
\Cdkn1atm1Tyj/\Cdkn1atm1Tyj
\Cdkn1btm1Mlf/\Cdkn1btm1Mlf
(involves: 129S2/SvPas * 129S4/SvJaeSor) 		abnormal enterocyte proliferation J:111081
\Cdkn1atm1Tyj/\Cdkn1atm1Tyj
\Cdkn2atm1Rdp/\Cdkn2atm1Rdp
(involves: 129/Sv * 129S2/SvPas * C57BL/6 * C57BL/6J * SJL) 		increased keratinocyte proliferation J:72780
\Cdkn1atm1Tyj/\Cdkn1atm1Tyj
\Csnk1a1tm1.1Ybn/\Csnk1a1tm1.1Ybn
\Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129 * C57BL/6 * CD-1 * DBA/2) 		abnormal enterocyte proliferation J:204886
\Cdkn1atm1Tyj/\Cdkn1atm1Tyj
\Fahtm1Mgo/\Fahtm1Mgo
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6) 		increased hepatocyte proliferation J:138701
\Cdkn1btm1Ako/\Cdkn1btm1Ako
(involves: 129S1/Sv * C57BL) 		abnormal fetal cardiomyocyte proliferation J:57380
\Cdkn1btm1Jro/\Cdkn1btm1Jro
(involves: 129S4/SvJaeSor * C57BL/6) 		decreased cell proliferation J:71780
decreased keratinocyte proliferation J:71780
decreased T cell proliferation J:71780
\Cdkn1btm1Kin/\Cdkn1btm1Kin
\Zfp949tm1Htno/\Zfp949tm1Htno
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ) 		decreased cell proliferation J:259302
\Cdkn1btm1Mlf/\Cdkn1btm1Mlf
(involves: 129S4/SvJaeSor * C57BL/6J) 		increased T cell proliferation J:33400
\Cdkn1btm1Mlf/\Cdkn1btm1Mlf
(involves: 129S4/SvJaeSor * C57BL/6NHsd) 		abnormal cell proliferation J:53290
\Cdkn1btm1Mlf/\Cdkn1btm1Mlf
\Cdkn2dtm1Maro/\Cdkn2dtm1Maro
(involves: 129X1/SvJ * C57BL/6) 		increased cell proliferation J:58522
\Cdkn1btm1Mlf/\Cdkn1btm1Mlf
\Myctm1Atp/\Myc+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * FVB/N) 		decreased T cell proliferation J:73369
\Cdkn2atm1Cjs/\Cdkn2atm1Cjs
(involves: 129X1/SvJ * C57BL/6) 		increased fibroblast proliferation J:44427
\Cdkn2atm1Cjs/\Cdkn2atm1Cjs
\Gt(ROSA)26Sortm1.1(MYC/ERT2)Gev/\Gt(ROSA)26Sortm1.1(MYC/ERT2)Gev
(involves: 129X1/SvJ * C57BL/6 * FVB/N) 		increased cell proliferation J:142030
\Cdkn2atm1Cjs/\Cdkn2atm1Cjs
\Tacstd2tm1Lsm/\Tacstd2tm1Lsm
(involves: 129X1/SvJ * C57BL/6) 		increased keratinocyte proliferation J:182647
\Cdkn2atm1Rdp/\Cdkn2a+
\Lig4tm1Fwa/\Lig4tm1Fwa
(involves: 129/Sv * 129S6/SvEvTac * C57BL/6J * SJL) 		decreased cell proliferation J:63078
\Cdkn2atm1Rdp/\Cdkn2atm1Rdp
(involves: 129/Sv * C57BL/6 * SJL) 		increased fibroblast proliferation J:53805
\Cdkn2atm1Rdp/\Cdkn2atm1Rdp
\Dicer1tm1Snj/\Dicer1tm1Snj
(involves: 129/Sv * 129S7/SvEvBrd * C57BL/6 * SJL) 		increased cell proliferation J:139257
\Cdkn2atm1Rdp/\Cdkn2atm1Rdp
\Lig4tm1Fwa/\Lig4tm1Fwa
(involves: 129/Sv * 129S6/SvEvTac * C57BL/6J * SJL) 		decreased cell proliferation J:63078
\Cdkn2atm1Rdp/\Cdkn2atm1Rdp
\Terctm1Rdp/\Terctm1Rdp
(involves: 129/Sv * C57BL/6J * SJL) 		decreased cell proliferation J:120065
\Cdkn2atm2.1Nesh/\Cdkn2atm2.1Nesh
\Nrastm1.1Nesh/\Nrastm1.1Nesh
\Tg(Tyr-cre/ERT2)13Bos/0
(B6J.Cg-Tg(Tyr-cre/ERT2)13Bos Nrastm1.1Nesh Cdkn2atm2.1Nesh) 		abnormal melanocyte proliferation J:220627
\Cdkn2atm2.1Nesh/\Cdkn2atm2.1Nesh
\Nrastm1Tyj/\Nrastm1Tyj
\Tg(Tyr-cre/ERT2)13Bos/0
(B6J.Cg-Tg(Tyr-cre/ERT2)13Bos Nrastm1Tyj Cdkn2atm2.1Nesh) 		abnormal melanocyte proliferation J:220627
\Cdkn2atm2.1Rdp/\Cdkn2atm2.1Rdp
(involves: 129S6/SvEvTac * FVB/N) 		increased splenocyte proliferation J:71394
\Cdkn2atm2Brn/\Cdkn2atm2Brn
\Krastm4Tyj/\Kras+
\Tg(Pdx1-cre)6Tuv/0
(involves: 129P2/OlaHsd * 129S4/SvJae * FVB/N) 		increased cell proliferation J:195229
\Cdkn2btm1Bbd/\Cdkn2btm1Bbd
(involves: 129S1/Sv * C57BL/6) 		increased fibroblast proliferation J:63299
\Cdkn2btm1Bbd/\Cdkn2btm1Bbd
\Cdkn2ctm1Bbd/\Cdkn2ctm1Bbd
(involves: 129S1/Sv * C57BL/6) 		increased fibroblast proliferation J:63299
\Cdontm1Rsk/\Cdontm1Rsk
(B6.129-Cdontm1Rsk) 		abnormal neuronal precursor proliferation J:109070
\Cdontm2Rsk/\Cdontm2Rsk
(B6.129-Cdontm2Rsk) 		abnormal neuronal precursor proliferation J:109070
\Cdx2tm1Mmt/\Cdx2tm1Mmt
(involves: 129X1/SvJ * C57BL/6) 		absent inner cell mass proliferation J:47050
\Ceacam1tm1Rsb/\Ceacam1tm1Rsb
\Tg(Lck-cre)1Cwi/0
(involves: 129) 		increased T cell proliferation J:116136
\Cebpatm1Gonz/\Cebpatm1Gonz
\Cebpbtm1Es/\Cebpbtm1Es
\Tg(KRT14-cre/ERT)20Efu/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1) 		increased keratinocyte proliferation J:158721
\Cebpatm1Gonz/\Cebpatm1Gonz
\Cebpbtm1Nerl/\Cebpbtm1Nerl
\Tg(KRT14-cre)1Cgn/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * DBA/2) 		increased keratinocyte proliferation J:154022
\Cebpatm1Gonz/\Cebpatm1Gonz
\Tg(KRT14-cre/ERT)20Efu/0
(involves: 129X1/SvJ * C57BL/6 * CD-1) 		increased keratinocyte proliferation J:158721
\Cebpatm1Gonz/\Cebpatm2Nerl
\Cebpbtm1Nerl/\Cebpbtm1Nerl
\Tg(KRT14-cre)1Cgn/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * DBA/2) 		increased keratinocyte proliferation J:154022
\Cebpatm1Gonz/\Cebpatm9Nerl
\Cebpbtm1Nerl/\Cebpbtm1Nerl
\Tg(KRT14-cre)1Cgn/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * DBA/2) 		increased keratinocyte proliferation J:154022
\Cebpatm1Timc/\Cebpatm1Timc
(Not Specified) 		decreased hepatocyte proliferation J:163725
\Cebpbtm1Es/\Cebpbtm1Es
\Tg(KRT14-cre/ERT)20Efu/0
(involves: 129S1/Sv * C57BL/6 * CD-1) 		increased keratinocyte proliferation J:158721
\Cebpbtm2.1Acle/\Cebpbtm2.1Acle
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6) 		decreased cell proliferation J:155795
\Cebpdtm1Pfj/\Cebpdtm1Pfj
(involves: 129S1/Sv) 		increased mammary gland epithelial cell proliferation J:103094
\Cend1tm1.1Rmat/\Cend1tm1.1Rmat
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6) 		abnormal neuron proliferation J:164148
\Cenpetm1Dwc/\Cenpetm1Dwc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal inner cell mass proliferation J:81046
\Cenpftm1Dbdr/\Cenpftm1Dbdr
\Tg(Tnnt2-cre)5Blh/0
(involves: C57BL/6 * DBA/2 * ICR) 		decreased fetal cardiomyocyte proliferation J:185133
\Cep55em1.1Hyli/\Cep55em1.1Hyli
(involves: C57BL/6) 		decreased cell proliferation J:313163
\Cep120tm1.1Blnw/\Cep120tm1.2Blnw
\Tg(Nes-cre)1Atp/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N) 		decreased cerebellar granule cell precursor proliferation J:220629
\Cep135em2Mama/\Cep135em2Mama
(involves: C57BL/6 * C57BL/6J * CBA) 		decreased cell proliferation J:310617
\Cert1Gt(RRF047)Byg/\Cert1Gt(RRF047)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		decreased cell proliferation J:146172
\Cfl1tm1.1Wit/\Cfl1tm1.1Wit
(involves: 129 * C57BL/6 * SJL) 		abnormal neuronal precursor proliferation J:125317
\Chd4em1Flc/\Chd4em1Flc
(C57BL/6J-Chd4em1Flc) 		increased fetal cardiomyocyte proliferation J:338019
\Chd4tm1.1Kge/\Chd4tm1.2Kge
\Tg(CAG-Bgeo/GFP)21Lbe/0
\Tg(Lck-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		decreased T cell proliferation J:109547
\Chd4tm1.2Kge/\Chd4tm1.2Kge
\Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL) 		decreased T cell proliferation J:109547
\Chd7Gt(S20-7E1)Sor/\Chd7+
(involves: 129S4/SvJaeSor) 		abnormal neuronal precursor proliferation J:164582
\Chd7Gt(S20-7E1)Sor/\Chd7+
(129S1.129S4(B6)-Chd7Gt(S20-7E1)Sor) 		decreased cell proliferation J:174086
\Chd7Gt(S20-7E1)Sor/\Chd7Gt(S20-7E1)Sor
(involves: 129S4/SvJaeSor) 		abnormal neuronal precursor proliferation J:164582
\Chd7Gt(S20-7E1)Sor/\Chd7Gt(S20-7E1)Sor
(129S1.129S4(B6)-Chd7Gt(S20-7E1)Sor) 		decreased cell proliferation J:174086
\Chd7Gt(S20-7E1)Sor/\Chd7tm1.1Dmm
\Foxg1tm1(cre)Skm/\Foxg1+
(involves: 129 * C57BL/6 * Swiss Webster) 		abnormal neuronal precursor proliferation J:164582
\Chd7tm2a(EUCOMM)Wtsi/\Chd7tm2a(EUCOMM)Wtsi
(involves: 129S6/SvEvTac * C57BL/6N) 		decreased fetal cardiomyocyte proliferation J:207089
\Chd7tm2c(EUCOMM)Wtsi/\Chd7tm2c(EUCOMM)Wtsi
\Tg(Atoh1-cre)1Bfri/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA) 		decreased cerebellar granule cell precursor proliferation J:242933
\Chek1tm1Jmr/\Chek1+
\Tg(Wap-cre)11738Mam/0
(involves: C57BL/6) 		increased cell proliferation J:91266
\Chek1tm1Jmr/\Chek1tm1Jmr
\Tg(Wap-cre)11738Mam/0
(involves: C57BL/6) 		decreased cell proliferation J:91266
\Chek1tm1Mkt/\Chek1tm1Mkt
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal inner cell mass proliferation J:62918
absent inner cell mass proliferation J:62918
\Chek1tm1Sje/\Chek1tm1Sje
(Not Specified) 		decreased cell proliferation J:62919
\Chi3l1tm1Eli/\Chi3l1tm1Eli
(B6.Cg-Chi3l1tm1Eli) 		decreased splenocyte proliferation J:148490
\Chmp1aGt(XC472)Byg/\Chmp1aGt(XC472)Byg
(B6.129P2-Chmp1aGt(XC472)Byg) 		decreased cerebellar granule cell precursor proliferation J:271138
decreased neuronal precursor proliferation J:271138
\Chordc1tm1Mbra/\Chordc1tm1Mbra
(Not Specified) 		abnormal trophoblast giant cell proliferation J:159109
absent inner cell mass proliferation J:159109
\Chrnb2tm1Jpc/\Chrnb2tm1Jpc
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell proliferation J:103908
\Chst3tm1Tmu/\Chst3tm1Tmu
(involves: 129S2/SvPas) 		increased T cell proliferation J:217719
\Chst14tm1.1Msch/\Chst14tm1.1Msch
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased Schwann cell proliferation J:203583
\Chuktm1Yhu/\Chuktm1Yhu
\Tg(KRT5-cre)5132Jlj/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased keratinocyte proliferation J:141162
\Chuktm2Yhu/\Chuktm2Yhu
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased keratinocyte proliferation J:197037
\Cib1tm1Prse/\Cib1tm1Prse
(involves: 129S6/SvEvTac * C57BL/6) 		decreased cell proliferation J:114645
\Ciitatm1Ccum/\Ciitatm1Ccum
(involves: 129S2/SvPas * C57BL/6J) 		decreased T cell proliferation J:31601
\Cilk1tm1.1Zfu/\Cilk1tm1.1Zfu
(B6.Cg-Cilk1tm1.1Zfu/Zfu) 		decreased mesenchymal cell proliferation involved in lung development J:309653
\Cimap2Retro/\Cimap2Retro
(involves: C57BL/6J) 		increased T cell proliferation J:223336
\Cinda1BALB/c/?
(involves: BALB/c * CcS-4/Dem) 		increased T cell proliferation J:40728
\Cinda2STS/A/?
(involves: BALB/c * CcS-4/Dem) 		increased T cell proliferation J:40728
\Cinda3O20/A/\Cinda3O20/A
(involves: O20/A * OcB-9/Dem) 		decreased T cell proliferation J:95917
\Cinda3OcB9/Dem/\Cinda3O20/A
(involves: O20/A * OcB-9/Dem) 		increased T cell proliferation J:95917
\Cinda4OcB9/Dem/\Cinda4O20/A
(involves: O20/A * OcB-9/Dem) 		increased T cell proliferation J:95917
\Cinda4OcB9/Dem/\Cinda4OcB9/Dem
(involves: O20/A * OcB-9/Dem) 		increased T cell proliferation J:95917
\Cinda5OcB9/Dem/\Cinda5O20/A
(involves: O20/A * OcB-9/Dem) 		increased T cell proliferation J:95917
\Cinda5OcB9/Dem/\Cinda5OcB9/Dem
(involves: O20/A * OcB-9/Dem) 		increased T cell proliferation J:95917
\Cirbptm1Jfuji/\Cirbptm1Jfuji
(B6.129S2-Cirbptm1Jfuji) 		abnormal spermatogonia proliferation J:186425
decreased fibroblast proliferation J:186425
\Cishtm1.2Cdon/\Cishtm1.2Cdon
(B6.129S6(Cg)-Cishtm1.2Cdon) 		increased T cell proliferation J:204829
\Cittm1Fdc/\Cittm1Fdc
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		abnormal spermatogonia proliferation J:80899
\Cks1btm1Sir/\Cks1btm1Sir
\Tg(IghMyc)22Bri/?
(involves: C57BL * C57BL/6 * SJL) 		decreased B cell proliferation J:121564
\Cldn4tm1.1Yham/\Cldn4tm1.1Yham
(B6.129S2-Cldn4tm1.1Yham) 		increased kidney cell proliferation J:195766
\Cldn15tm1Sats/\Cldn15tm1Sats
(involves: C57BL/6) 		abnormal enterocyte proliferation J:135596
\Clec1atm1Yiw/\Clec1atm1Yiw
(involves: C57BL/6J * C57BL/6NSlc) 		decreased CD8-positive, alpha-beta memory T cell proliferation J:329240
\Clec4a2tm1.1Cfg/\Clec4a2tm1.1Cfg
(involves: C57BL/6) 		increased B cell proliferation J:217719
\Clec4dtm1.1Cfg/\Clec4dtm1.1Cfg
(involves: C57BL/6) 		decreased B cell proliferation J:217719
decreased T cell proliferation J:217719
\ClppGt(IST11134F10)Tigm/\ClppGt(IST11134F10)Tigm
(involves: C57BL/6N) 		decreased fibroblast proliferation J:203140
\ClppGt(IST13563G11)Tigm/\ClppGt(IST13563G11)Tigm
(involves: C57BL/6N) 		decreased fibroblast proliferation J:203140
\Clspntm1(KOMP)Vlcg/\Clspn+
(C57BL/6N-Clspntm1(KOMP)Vlcg) 		increased hepatocyte proliferation J:332163
\Cmahtm1Ykoz/\Cmahtm1Ykoz
(B6.129P2-Cmahtm1Ykoz) 		increased B cell proliferation J:121365
\Cmtm7tm2a(EUCOMM)Hmgu/\Cmtm7+
\Rag1tm1Fwa/\Rag1tm1Fwa
(chimera involves: C57BL/6 * C57BL/6N) 		decreased B cell proliferation J:207033
\Cnr1tm1Map/\Cnr1tm1Map
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		abnormal neuronal precursor proliferation J:102006
\Cntftm1Vlcg/\Cntftm1Vlcg
(involves: 129S6/SvEvTac * C57BL/6NTac) 		abnormal neuron proliferation J:186611
\Col1a1tm1(tetO-CTNNB1)Tcd/\Col1a1+
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J) 		abnormal enterocyte proliferation J:193365
\Col1a1tm1(tetO-EWSR1/ATF1)Yasu/\Col1a1+
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6) 		decreased fibroblast proliferation J:194505
\Col1a1tm1(tetO-Fos)Wag/\Col1a1+
\Tg(KRT5-rtTA)T2D6Sgkd/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		increased keratinocyte proliferation J:201145
\Col1a1tm1(tetO-Lin28a)Gqda/\Col1a1+
(involves: 129S4/SvJae * C57BL/6 * CD-1) 		increased cell proliferation J:166568
increased hepatocyte proliferation J:166568
\Col1a1tm1(tetO-SOX2)Mjm/\Col1a1+
\Gt(ROSA)26Sortm1(tTA)Roos/\Gt(ROSA)26Sor+
\Lgr5tm1(cre/ERT2)Cle/\Lgr5+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA/2J) 		increased cell proliferation J:199754
\Col1a1tm1(tetO-Tcfap2c)Hsc/\Col1a1+
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6) 		abnormal enterocyte proliferation J:174049
increased hepatocyte proliferation J:174049
\Col1a1tm1(tetO-YAP1*)Fcam/\Col1a1+
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6) 		abnormal enterocyte proliferation J:141457
increased cell proliferation J:141457
\Col1a1tm1(tetO-YAP1*)Fcam/\Col1a1+
\Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/\Gt(ROSA)26Sor+
\Tg(KRT14-cre)1Amc/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * CBA) 		increased cell proliferation J:171057
\Col1a1tm1(tetO-YAP1*)Fcam/\Col1a1+
\Tg(Cebpb-tTA)#Bjd/0
(involves: 129S4/SvJae * C57BL/6) 		increased hepatocyte proliferation J:141457
\Col1a1tm2(tetO-IDH2*R140Q)Ppp/\Col1a1tm2(tetO-IDH2*R140Q)Ppp
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/?
(involves: 129S4/SvJae * C57BL/6) 		abnormal hematopoietic stem cell proliferation J:210097
increased hematopoietic stem cell proliferation J:210097
\Col1a1tm2(tetO-Pou5f1)Jae/\Col1a1+
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6) 		abnormal cell proliferation J:98920
\Col1a1tm2(tetO-Pou5f1)Jae/\Col1a1+
\Gt(ROSA)26Sortm1(tTA)Roos/\Gt(ROSA)26Sor+
\Lgr5tm1(cre/ERT2)Cle/\Lgr5+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA/2J) 		increased cell proliferation J:199754
\Col1a1tm10(tetO*-RFP/RNAi:Rpa3)Slowe/\Col1a1+
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sortm1(rtTA*M2)Jae
(involves: 129S4/SvJae * C57BL/6) 		abnormal small intestinal crypt cell proliferation J:171348
\Col1a1tm11(tetO*-RFP/RNAi:Rpa3)Slowe/\Col1a1+
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sortm1(rtTA*M2)Jae
(involves: 129S4/SvJae * C57BL/6) 		abnormal small intestinal crypt cell proliferation J:171348
\Col1a1tm17(tetO-GFP,-cas9*)Slowe/\Col1a1+
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6) 		abnormal small intestinal crypt cell proliferation J:222595
\Col1a1tm19(tetO-GFP,-cas9*)Slowe/\Col1a1+
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6) 		abnormal small intestinal crypt cell proliferation J:222595
\Col1a1tm20(tetO-GFP,-cas9*D10A)Slowe/\Col1a1+
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6) 		abnormal small intestinal crypt cell proliferation J:222595
\Col2a1tm1(SOX9)Crm/\Col2a1+
(129S/Sv-Col2a1tm1(SOX9)Crm) 		decreased chondrocyte proliferation J:90567
\Col9a1tm1Jae/\Col9a1tm1Jae
(either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL)) 		increased chondrocyte proliferation J:18628
\Col17a1tm1Tiin/\Col17a1tm1Tiin
(involves: C57BL/6) 		increased fibroblast proliferation J:220622
\Colgalt1tm1.1Gpt/\Colgalt1tm1.1Gpt
(Not Specified) 		decreased hepatocyte proliferation J:283330
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
\Zbtb11tm1.1Lieg/\Zbtb11tm1.1Lieg
(involves: C57BL/6J * C57BL/10 * CBA/Ca) 		decreased hematopoietic stem cell proliferation J:343208
\Comptm1Mbri/\Comp+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased chondrocyte proliferation J:125086
\Comptm1Mbri/\Comptm1Mbri
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased chondrocyte proliferation J:125086
\Copb2em1Rstot/\Copb2em2Rstot
(involves: C57BL/6 * C57BL/6J * CD-1 * DBA/2) 		abnormal neuron proliferation J:252710
increased neuronal precursor proliferation J:252710
\Cops2tm1Nwe/\Cops2tm1Nwe
(involves: 129 * C57BL/6J) 		absent inner cell mass proliferation J:85761
\Cops5tm1Fxc/\Cops5+
(involves: 129S7/SvEvBrd * C57BL/6J) 		decreased cell proliferation J:166561
\Cops5tm1Fxc/\Cops5tm1Fxc
(involves: 129S7/SvEvBrd * C57BL/6J) 		decreased inner cell mass proliferation J:166561
\Cops5tm1Jka/\Cops5tm1Jka
(involves: 129S4/SvJae * C57BL/6) 		abnormal trophoblast giant cell proliferation J:93979
absent inner cell mass proliferation J:93979
\Cops8tm1.1Nwe/\Cops8tm1.1Nwe
(involves: C57BL/6) 		abnormal inner cell mass proliferation J:126339
\Cops8tm1Nwe/\Cops8tm1.1Nwe
\Tg(Cd4-cre)1Cwi/?
(involves: 129S1/Sv * C57BL/6 * DBA/2) 		decreased T cell proliferation J:126339
\Coq7tm1Tsh/\Coq7tm1Tsh
(involves: C57BL/6) 		decreased cell proliferation J:73111
\Coro1atm1Jpie/\Coro1atm1Jpie
(involves: 129 * C57BL/6) 		decreased T cell proliferation J:133258
\Cpa3tm3(icre)Hrr/\Cpa3+
\Fgfr1tm1Upir/\Fgfr1tm1Upir
\Fgfr2tm1Dor/\Fgfr2tm1Dor
\Tg(KRT5-cre)5132Jlj/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * C57BL/6J * DBA/2J) 		increased keratinocyte proliferation J:221184
\Cpeb3em1Gaoxu/\Cpeb3em1Gaoxu
(C57BL/6J-Cpeb3em1Gaoxu) 		decreased granulosa cell proliferation J:323073
\Cpt1atm1.1Pec/\Cpt1atm1.1Pec
\Tg(Cdh5-cre/ERT2)1Rha/0
(Not Specified) 		decreased vascular endothelial cell proliferation J:220527
\Creb1tm1.1Berd/\Creb1tm1.1Berd
(B6NHsd.129S4-Creb1tm1.1Berd) 		increased myoblast proliferation J:177923
\Crhtm1Maj/\Crhtm1Maj
(involves: 129S2/SvPas * C57BL/6) 		decreased T cell proliferation J:98419
increased mesenchymal cell proliferation involved in lung development J:53721
\Criptotm1Eda/\Criptotm1Eda
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * Black Swiss) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		decreased fibroblast proliferation J:51595
\Crlf2tm1Wjl/\Crlf2tm1Wjl
(involves: BALB/c) 		abnormal T cell proliferation J:107431
decreased splenocyte proliferation J:107431
\Crmp1tm1Pako/\Crmp1tm1Pako
(involves: 129/Sv * ICR) 		abnormal neuronal precursor proliferation J:119127
\Crtamtm1Achn/\Crtamtm1Achn
(involves: 129 * C57BL/6) 		increased T cell proliferation J:145314
\Crybb2tm1Itl/\Crybb2tm1Itl
(C57BL/6-Crybb2tm1Itl) 		decreased granulosa cell proliferation J:220082
\Csf2rbtm1Clsc/\Csf2rbtm1Clsc
\Csf2rb2tm1Cgb/\Csf2rb2tm1Cgb
(C.129S1-Csf2rb2tm1Cgb Csf2rbtm1Clsc) 		decreased T cell proliferation J:130939
\Csgalnact1tm1Nari/\Csgalnact1tm1Nari
\Csgalnact2tm1.1Staka/\Csgalnact2tm1.1Staka
\Tg(Col2a1-cre)1Bhr/0
(involves: C57BL/6 * C57BL/6J * SJL) 		decreased chondrocyte proliferation J:256718
\Csnk1a1tm1.1Ybn/\Csnk1a1tm1.1Ybn
\Tg(Vil1-cre/ERT2)23Syr/0
\Trp53tm1Brn/\Trp53tm1Brn
(involves: 129 * C57BL/6 * CD-1 * DBA/2) 		abnormal enterocyte proliferation J:204886
\Csnk1a1tm1.1Ybn/\Csnk1a1tm1.1Ybn
\Tg(Vil1-cre/ERT2)23Syr/0
\Trp53tm3.1Tyj/\Trp53tm3.1Tyj
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * DBA/2) 		abnormal enterocyte proliferation J:291671
\Csnk1a1tm1.1Ybn/\Csnk1a1tm1.1Ybn
\Trp53tm1Brn/\Trp53tm1Brn
\Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		abnormal enterocyte proliferation J:291671
\Csnk1a1tm1.1Ybn/\Csnk1a1tm1.1Ybn
\Trp53tm2.1Tyj/\Trp53tm2.1Tyj
\Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129S1/Sv * 129X1/SvJ * 129S4/SvJae * C57BL/6 * DBA/2) 		abnormal enterocyte proliferation J:291671
\Cspg4tm1Wbst/\Cspg4tm1Wbst
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased cell proliferation J:54319
\Cst6ichq/\Cst6+
(involves: BALB/cJ) 		increased keratinocyte proliferation J:41426
\Csta1em1Gpt/\Csta1em1Gpt
(C57BL/6JGpt-Csta1em1Gpt) 		decreased keratinocyte proliferation J:340112
\Ctc1tm1.1Schg/\Ctc1tm1.1Schg
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased cell proliferation J:184809
decreased fibroblast proliferation J:184809
decreased splenocyte proliferation J:184809
\Ctdp1em1Ntw/\Ctdp1em1Ntw
(involves: C57BL/6 * FVB) 		decreased fibroblast proliferation J:320982
\Cthrc1tm1Haak/\Cthrc1tm1Haak
(B6.129S-Cthrc1tm1Haak) 		decreased osteoblast proliferation J:143940
\Ctla4tm1All/\Ctla4tm1All
\Rag1tm1Mom/\Rag1tm1Mom
\Tg(TcrAND)53Hed/0
(involves: 129S/Sv * 129X1/SvJ * C57BL/6 * SJL) 		increased T cell proliferation J:119845
\Ctla4tm1Shr/\Ctla4tm1Shr
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6)) 		increased T cell proliferation J:30393
\Ctla4tm1Shr/\Ctla4tm1Shr
\Tg(DO11.10)10Dlo/0
(involves: 129S4/SvJae * BALB/c * C3H * C57BL/6) 		increased T cell proliferation J:57090
\Ctnna1tm1Efu/\Ctnna1tm1Efu
\Tg(KRT14-cre)1Efu/?
(involves: 129X1/SvJ) 		increased keratinocyte proliferation J:67797
\Ctnnb1tm1Mmt/\Ctnnb1+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ) 		abnormal small intestinal crypt cell proliferation J:169830
\Ctnnb1tm1Mmt/\Ctnnb1+
\Ptentm1Hwu/\Ptentm1Hwu
\Tg(CYP19A1-cre)1Jri/0
(involves: 129S4/SvJae * 129X1/SvJ * C57BL/6) 		increased granulosa cell proliferation J:186144
\Ctnnb1tm2Kem/\Ctnnb1tm2Kem
\Tg(Dct-lacZ)A12Jkn/0
\Tg(Tyr-cre)1Lru/0
(B6.Cg-Ctnnb1tm2Kem Tg(Tyr-cre)1Lru Tg(Dct-lacZ)A12Jkn) 		decreased melanoblast proliferation J:176245
\Ctnnb1tm2Kem/\Ctnnb1tm2Kem
\Tg(Hoxb7-cre)5526Cmb/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased kidney cell proliferation J:136068
\Ctnnb1tm2Kem/\Ctnnb1tm2Kem
\Tg(KRT14-cre)#Smr/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL/J) 		decreased cell proliferation J:242196
\Ctnnb1tm2Kem/\Ctnnb1tm2Kem
\Tg(KRT14-rtTA)F42Efu/0
\Tg(tetO-EDN1,-lacZ)9Mhus/0
\Tg(Tyr-cre/ERT2)13Bos/0
(involves: C57BL/6J * FVB) 		abnormal melanocyte proliferation J:231435
\Ctnnd1tm1Abre/\Ctnnd1tm1Abre
(involves: 129S6/SvEvTac) 		decreased cell proliferation J:143096
\Ctnnd1tm1Lfr/\Ctnnd1tm1Lfr
\Tg(Pax3-cre)1Joe/0
(involves: 129X1/SvJ * C57BL/6 * SJL) 		increased kidney cell proliferation J:171425
\Ctps1tm1c(KOMP)Wtsi/\Ctps1tm1c(KOMP)Wtsi
\Commd10Tg(Vav1-icre)A2Kio/0
(B6.Cg-Ctps1tm1c(KOMP)Wtsi Commd10Tg(Vav1-icre)A2Kio) 		decreased T cell proliferation J:348981
\Ctps1tm1c(KOMP)Wtsi/\Ctps1tm1c(KOMP)Wtsi
\Ctps2tm1c(EUCOMM)Hmgu/\Ctps2+
\Tg(Cd4-cre)1Cwi/0
(involves: 129S/Sv * C57BL/6 * DBA/2) 		decreased T cell proliferation J:348981
\Ctps1tm1c(KOMP)Wtsi/\Ctps1tm1c(KOMP)Wtsi
\Ctps2tm1c(EUCOMM)Hmgu/\Ctps2tm1c(EUCOMM)Hmgu
\Tg(Cd4-cre)1Cwi/0
(involves: 129S/Sv * C57BL/6 * DBA/2) 		decreased T cell proliferation J:348981
\Ctps1tm1c(KOMP)Wtsi/\Ctps1tm1c(KOMP)Wtsi
\Gt(ROSA)26Sortm1(cre/ERT2)Tyj/\Gt(ROSA)26Sor+
(B6.Cg-Ctps1tm1c(KOMP)Wtsi Gt(ROSA)26Sortm1(cre/ERT2)Tyj) 		decreased T cell proliferation J:348981
\Ctps1tm1c(KOMP)Wtsi/\Ctps1tm1c(KOMP)Wtsi
\Tg(Cd4-cre)1Cwi/0
(involves: 129S/Sv * C57BL/6 * DBA/2) 		decreased T cell proliferation J:348981
\Ctps1tm1c(KOMP)Wtsi/\Ctps1tm1c(KOMP)Wtsi
\Tg(Cd4-cre)1Cwi/0
\Foxp3sf/Y
\Rag1tm1Mom/\Rag1+
(mixed) 		decreased T cell proliferation J:348981
\Ctps1tm1c(KOMP)Wtsi/\Ctps1tm1c(KOMP)Wtsi
\Tg(Cd8a-cre)1Itan/0
(B6(129S4)-Ctps1tm1c(KOMP)Wtsi Tg(Cd8a-cre)1Itan) 		decreased T cell proliferation J:348981
\Ctsltm1.2Thre/\Ctsltm1.2Thre
(involves: C57BL/6 * C57BL/6N) 		increased keratinocyte proliferation J:216506
\Ctsltm1Cptr/\Ctsltm1Cptr
(involves: 129P2/OlaHsd * C57BL/6J) 		increased keratinocyte proliferation J:70118
\Ctsltm1Cptr/\Ctsltm1Cptr
(involves: 129P2/OlaHsd) 		increased keratinocyte proliferation J:216506
\Cul4atm1.1Pra/\Cul4atm1.1Pra
(involves: C57BL/6NTac) 		decreased fibroblast proliferation J:172043
\Cul4atm1.1Pra/\Cul4atm1.1Pra
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * C57BL/6NTac * DBA) 		decreased hepatocyte proliferation J:172043
\Cul4btm1.1Pz/Y
\Tg(CAG-cre)13Miya/0
(involves: 129 * C57BL/6 * C57BL/6J) 		decreased cell proliferation J:199210
\Cul4btm1.1Yxg/Y
(involves: 129X1/SvJ * FVB/N) 		decreased cell proliferation J:199139
\Cux2Gt(OST440231)Lex/\Cux2Gt(OST440231)Lex
(involves: 129S5/SvEvBrd) 		decreased cell proliferation J:131816
\Cux2tm1.1Nieto/\Cux2tm1.1Nieto
(involves: 129S4/SvJae * C57BL/6 * FVB/N * Swiss Webster) 		abnormal neuronal precursor proliferation J:156578
\Cuzd1tm1Bag/\Cuzd1tm1Bag
(involves: 129 * C57BL/6) 		decreased mammary gland epithelial cell proliferation J:242064
\Cx3cr1tm1Litt/\Cx3cr1tm1Litt
(B6.129P2-Cx3cr1tm1Litt) 		decreased vascular smooth muscle cell proliferation J:124722
\Cxadrtm1.1Mds/\Cxadrtm1.1Mds
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J) 		increased fetal cardiomyocyte proliferation J:121400
\Cxcl10tm1Adl/\Cxcl10tm1Adl
(involves: 129S4/SvJae * 129X1/SvJ) 		decreased splenocyte proliferation J:75584
\Cybbtm1Din/?
(B6.129S-Cybbtm1Din/J) 		decreased cell proliferation J:306955
\Cygbtm1Ppam/\Cygbtm1Ppam
\Tg(Myog-cre)1Eno/0
(involves: 129 * C57BL/6) 		decreased cell proliferation J:206378
\Cyldtm1Ref/\Cyldtm1Ref
(B6.129-Cyldtm1Ref) 		abnormal keratinocyte proliferation J:108769
increased cell proliferation J:108769
increased keratinocyte proliferation J:108769
\Cyp2c23Gt(OST85045)Lex/\Cyp2c23Gt(OST85045)Lex
(129-Cyp2c23Gt(OST85045)Lex) 		decreased lung endothelial cell proliferation J:207597
\Cyp2g1tm1(rtTA)Lane/\Cyp2g1+
\Tg(SFTPC-rtTA,tetO-Tnf)320-1Gwho/0
(involves: 129 * C57BL/6 * SJL) 		decreased cell proliferation J:157842
\Cyrenem1Vokh/\Cyrenem1Vokh
(C57BL/6-Cyrenem1Vokh) 		decreased neuronal precursor proliferation J:306598
\Dab2tm1Xxx/\Dab2tm1Xxx
(involves: 129S6/SvEvTac * C57BL/6) 		absent inner cell mass proliferation J:79862
\Dach1tm1Krs/\Dach1tm1Krs
(involves: 129P2/OlaHsd) 		decreased pancreatic beta cell proliferation J:166952
\Daglatm1Pado/\Dagla+
(C57BL/6-Daglatm1Pado) 		abnormal neuron proliferation J:157850
\Daglatm1Pado/\Daglatm1Pado
(C57BL/6-Daglatm1Pado) 		abnormal neuron proliferation J:157850
\DaglbGt(OST195261)Lex/\Daglb+
(B6.129S5-DaglbGt(OST195261)Lex) 		abnormal neuron proliferation J:157850
\DaglbGt(OST195261)Lex/\DaglbGt(OST195261)Lex
(B6.129S5-DaglbGt(OST195261)Lex) 		abnormal neuron proliferation J:157850
\Dapl1em1Nju/\Dapl1em1Nju
(C57BL/6J-Dapl1em1Nju) 		increased cell proliferation J:242244
\Dapp1Gt(OST111213)Lex/\Dapp1Gt(OST111213)Lex
(B6.Cg-Dapp1Gt(OST111213)Lex) 		decreased B cell proliferation J:110009
\Dapp1tm1Mnz/\Dapp1tm1Mnz
(B6.129P2-Dapp1tm1Mnz) 		decreased B cell proliferation J:86182
\Dazap1tm1Pyen/\Dazap1tm1Pyen
(involves: 129S6/SvEvTac) 		abnormal spermatogonia proliferation J:171493
\DbnlGt(betageo)11Byg/\DbnlGt(betageo)11Byg
(involves: 129P2/OlaHsd * C57BL/6) 		decreased T cell proliferation J:119847
\Dcaf1tm1.1Yxi/\Dcaf1tm1.2Yxi
(involves: 129P2/OlaHsd * C57BL/6) 		decreased fibroblast proliferation J:140246
\Dcbld2tm1.1Mhms/\Dcbld2tm1.1Mhms
(B6.129S6-Dcbld2tm1.1Mhms) 		decreased lung endothelial cell proliferation J:207629
\Dckmemi/\Dckmemi
(C57BL/6J-Dckmemi) 		increased T cell proliferation J:184080
\Dclre1atm1Rleg/\Dclre1atm1Rleg
(involves: 129S7/SvEvBrd) 		decreased cell proliferation J:102381
\Dclre1ctm2Mcow/\Dclre1ctm2Mcow
(involves: 129/Sv * C57BL/6) 		decreased B cell proliferation J:96535
decreased T cell proliferation J:96535
\Dcun1d1Gt(RRR261)Byg/\Dcun1d1Gt(RRR261)Byg
(involves: 129P2/OlaHsd) 		decreased fibroblast proliferation J:262901
\Ddr1tm1Wfv/\Ddr1tm1Wfv
(either: (involves: (129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		increased mammary gland epithelial cell proliferation J:68368
\Ddr2tm1Kln/\Ddr2tm1Kln
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased cell proliferation J:74580
\Ddx4tm1Tnc/\Ddx4tm1Tnc
(involves: 129P2/OlaHsd * C57BL/6NJcl) 		decreased primordial germ cell proliferation J:61665
\Ddx11tm1Jiml/\Ddx11tm1Jiml
(involves: 129S/SvEv) 		decreased inner cell mass proliferation J:158490
\Del(3Bglap2-Bglap)2Kry/\Del(3Bglap2-Bglap)2Kry
(involves: 129S7/SvEvBrd) 		decreased pancreatic beta cell proliferation J:126780
\Del(4C4-C5)1Lap/\Del(4C4-C5)1Lap
(involves: 129S6/SvEvTac) 		increased fibroblast proliferation J:158126
increased vascular smooth muscle cell proliferation J:158126
\Del(4D4Mit190-D4Mit51)2Aam/\+
(involves: 129S7/SvEvBrd) 		increased fibroblast proliferation J:121726
\Del(5Kit-Cep135)1Utr/\Del(5Kit-Cep135)1Utr
(C57BL/6JCrlj-Del(5Kit-Cep135)1Utr) 		decreased inner cell mass proliferation J:233978
\Del(7Slx1b-Sept1)4Aam/0
(B6129S-Del(7Slx1b-Sept1)4Aam/J) 		increased neuronal precursor proliferation J:219859
\Del(14Trim13-Dleu2)4Rdf/\Del(14Trim13-Dleu2)4Rdf
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6) 		abnormal B cell proliferation J:156946
\Del(16Es2el-Ufd1l)217Bld/\+
(B6.129S7-Del(16Es2el-Ufd1l)217Bld) 		abnormal neuron proliferation J:201966
\Del(17Fpr1-Fpr2)1Jimw/\Del(17Fpr1-Fpr2)1Jimw
(Not Specified) 		abnormal enterocyte proliferation J:197568
\Del(17Hspa1b-Hsp1a)1Dix/\Del(17Hspa1b-Hsp1a)1Dix
(involves: 129S7/SvEvBrd) 		decreased cell proliferation J:87581
\Dennd1aem1Jgfu/\Dennd1aem1Jgfu
(Not Specified) 		decreased cell proliferation J:276703
decreased hepatocyte proliferation J:276703
\Dgat1tm1Far/\Dgat1tm1Far
(B6J.129S4-Dgat1tm1Far) 		decreased mammary gland epithelial cell proliferation J:128259
\Dgcr8Gt(XG058)Byg/\Dgcr8+
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal neuronal precursor proliferation J:198659
\Dgkztm1Gak/\Dgkztm1Gak
(involves: 129X1/SvJ * C57BL/6) 		increased T cell proliferation J:85149
\Dguoktm1.1Anka/\Dguoktm1.1Anka
(involves: 129 * C57BL/6N) 		increased hepatocyte proliferation J:294620
\Dh/\Dh+
\H2d/\H2d
(NZB.Cg-Dh) 		decreased B cell proliferation J:12036
increased T cell proliferation J:12036
\DhpsGt(RRM039)Byg/\DhpsGt(RRM039)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased cell proliferation J:285882
\Dhx15tm1c(EUCOMM)Wtsi/\Dhx15tm1c(EUCOMM)Wtsi
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C3H * C57BL/6N) 		decreased B cell proliferation J:284624
\Diaph1tm1.1Sna/\Diaph1tm1.1Sna
(B6.Cg-Diaph1tm1.1Sna) 		decreased T cell proliferation J:126090
\Dicer1tm1Bdh/\Dicer1tm1Bdh
\Plekha5Tg(AMH-cre)1Flor/\Plekha5+
(involves: 129/Sv * C57BL/6 * SJL) 		increased Sertoli cell proliferation J:145178
\Dicer1tm1Bdh/\Dicer1tm1Bdh
\Tg(Pax2-cre)1Akg/0
(involves: 129) 		decreased cell proliferation J:200017
\Dicer1tm1Dli/\Dicer1tm1Dli
\Tg(Cd4-cre)1Cwi/?
(involves: 129 * C57BL/6 * DBA/2) 		decreased T cell proliferation J:100546
\Dicer1tm1Mmk/\Dicer1tm1Mmk
\Shhtm1(EGFP/cre)Cjt/\Shh+
(involves: 129 * C57BL/6J) 		increased mesenchymal cell proliferation involved in lung development J:224791
\Dicer1tm1Smr/\Dicer1tm1Smr
\Pax8tm1.1(cre)Mbu/\Pax8+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd) 		increased kidney cell proliferation J:229188
\Dicer1tm1Snj/\Dicer1tm1Snj
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased cell proliferation J:139257
\Dicer1tm1Snj/\Dicer1tm1Snj
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6) 		increased cell proliferation J:139257
\Dido1tm2Cmar/\Dido1tm2Cmar
(involves: 129S1/Sv * 129X1/SvJ) 		decreased embryonic epiblast cell proliferation J:183346
\Dio3tm1Dmst/\Dio3tm1Dmst
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * DBA) 		increased hepatocyte proliferation J:218350
\Dkc1tm1.1Pjma/Y
(B6.129X1(FVB)-Dkc1tm1.1Pjma) 		decreased fibroblast proliferation J:217050
decreased hematopoietic stem cell proliferation J:217050
\Dkk1tm1.1Svo/\Dkk1tm1.2Svo
\Pax8tm1.1(cre)Mbu/\Pax8+
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		increased kidney cell proliferation J:173125
\Dlk1tm1.1Jvs/\Dlk1+
\Myf5tm3(cre)Sor/\Myf5+
(involves: 129P2/SvPas * 129S4/SvJaeSor * C57BL/6 * FVB/N) 		decreased cell proliferation J:167124
\Dlx5tm1Levi/\Dlx5tm1Levi
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		abnormal cell proliferation J:56557
\Dmdmdx/\Dmdmdx
(involves: C57BL/10ScSn) 		abnormal skeletal muscle satellite cell proliferation J:152892
\Dmdmdx/\Dmdmdx
\Mamstrtm1.2Eno/\Mamstrtm1.2Eno
(involves: 129 * C57BL/6 * C57BL/10ScSn) 		abnormal skeletal muscle satellite cell proliferation J:179880
\Dmrt1tm1.1Zark/\Dmrt1tm1.1Zark
(involves: 129 * C57BL/6) 		increased Sertoli cell proliferation J:65541
\Dmrta2tm1.2Fuma/\Dmrta2tm1.2Fuma
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * FVB/N * SJL) 		abnormal neuronal precursor proliferation J:203109
\Dmrta2tm1Ejbd/\Dmrta2tm1Ejbd
(involves: C57BL/6) 		abnormal neuronal precursor proliferation J:215514
\Dnajc27Gt(OST374030)Lex/\Dnajc27Gt(OST374030)Lex
(involves: 129S5/SvEvBrd * C57BL/6N) 		abnormal enterocyte proliferation J:210622
\Dnm1lPy/\Dnm1lPy
(involves: BALB/cAnNCrl * C3H/HeH) 		absent fibroblast proliferation J:161510
\Dnm1ltm1.2Hise/\Dnm1ltm1.2Hise
(involves: 129S/SvEv * C57BL/6 * FVB/N) 		decreased fibroblast proliferation J:153835
\Dnm1ltm1.2Miha/\Dnm1ltm1.2Miha
(involves: C57BL/6J) 		decreased fibroblast proliferation J:158142
\Dnmt1tm1Jae/\Dnmt1tm1Jae
(involves: 129S4/SvJae) 		decreased cell proliferation J:1157
\Dnmt1tm1Okan/\Dnmt1tm2Enl
(involves: 129S4/SvJae) 		decreased cell proliferation J:129049
\Dnmt1tm2Enl/\Dnmt1tm2Enl
(involves: 129S4/SvJae) 		decreased cell proliferation J:129049
\Dock1tm2.1Jfco/\Dock1tm2.1Jfco
\Tg(MMTV-Erbb2*,-cre)1Mul/0
(involves: C57BL/6 * FVB/NJ) 		decreased cell proliferation J:196659
\Dock2m1Hsd/\Dock2m1Hsd
\Siaetm1.2Avrk/\Siaetm1.2Avrk
(B6NHsd.Cg-Siaetm1.2Avrk Dock2m1Hsd) 		increased B cell proliferation J:144035
\Dock8tm1Ysfk/\Dock8tm1Ysfk
(B6.Cg-Dock8tm1Ysfk) 		decreased T cell proliferation J:185165
\Dok1tm1Ppp/\Dok1tm1Ppp
(129S1/Sv-Dok1tm1Ppp) 		abnormal T cell proliferation J:95640
increased fibroblast proliferation J:95640
\Dok1tm1Yyam/\Dok1tm1Yyam
(involves: 129S4/SvJae * C57BL/6) 		increased B cell proliferation J:95641
\Dok3tm1Kplm/\Dok3tm1Kplm
(involves: 129P2/OlaHsd) 		increased B cell proliferation J:280795
\Dot1ltm1.1Tche/\Dot1ltm1.1Tche
(either: (involves: C57BL/6) or (involves: 129/Sv * C57BL/6)) 		decreased cell proliferation J:161427
\Dot1ltm1Tche/\Dot1ltm1.1Tche
\Tg(Myhca-cre)1Abel/0
(Not Specified) 		increased fetal cardiomyocyte proliferation J:168140
\Dp(4D4Mit190-D4Mit51)1Aam/0
(involves: 129S7/SvEvBrd) 		decreased cell proliferation J:121726
\Dph1tm1Bhr/\Dph1tm1Bhr
(involves: 129S4/SvJae) 		decreased fibroblast proliferation J:188600
\Dppa2tm1.1Yam/\Dppa2tm1.1Yam
\Dppa4tm1Yam/\Dppa4tm1Yam
(involves: 129S4/SvJae) 		decreased cell proliferation J:178324
\Dsg2tm1Leu/\Dsg2tm1Leu
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		decreased fibroblast proliferation J:102536
\Dstncorn1/\Dstncorn1
(A.BY-H2bc H2-T18f/SnJ) 		increased cell proliferation J:31798
\Dtx1tm1.1Mzl/\Dtx1tm1.1Mzl
\Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		increased T cell proliferation J:151605
\Dtx1tm1.2Mzl/\Dtx1tm1.2Mzl
(B6.129-Dtx1tm1.2Mzl) 		increased B cell proliferation J:151605
increased T cell proliferation J:151605
\Dusp1tm1Brv/\Dusp1tm1Brv
(involves: 129S2/SvPas * C57BL/6) 		decreased myoblast proliferation J:162340
\Dusp4Gt(XG164)Byg/\Dusp4Gt(XG164)Byg
(B6.129P2-Dusp4Gt(XG164)Byg) 		increased T cell proliferation J:180366
\Dusp5tm1.1Achn/\Dusp5tm1.1Achn
(involves: C57BL/6NCrl) 		increased T cell proliferation J:218203
\Dusp5tm1a(KOMP)Wtsi/\Dusp5tm1a(KOMP)Wtsi
(C57BL/6-Dusp5tm1a(KOMP)Wtsi) 		increased T cell proliferation J:240637
\Dusp10tm1Flv/\Dusp10tm1Flv
(involves: 129S6/SvEvTac) 		decreased T cell proliferation J:92104
\Dusp14Gt(OST210117)Lex/\Dusp14Gt(OST210117)Lex
(B6.129S5-Dusp14Gt(OST210117)Lex) 		increased T cell proliferation J:209403
\Dusp22tm1Tht/\Dusp22tm1Tht
(B6.129S7-Dusp22tm1Tht) 		decreased B cell proliferation J:213253
increased T cell proliferation J:213253
\Dync1h1tm1.1Ics/\Dync1h1+
(involves: C57BL/6 * C57BL/6N * SJL) 		abnormal cell proliferation J:334549
\E2f1tm1Meg/\E2f1tm1Meg
(involves: 129S4/SvJae * C57BL/6) 		decreased T cell proliferation J:76318
\E2f1tm1Meg/\E2f1tm1Meg
\E2f2tm1Zubi/\E2f2tm1Zubi
\E2f3tm2.1Gle/\E2f3tm2.1Gle
(involves: 129 * FVB/N * NIH Black Swiss) 		decreased cell proliferation J:138289
\E2f1tm1Meg/\E2f1tm1Meg
\E2f2tm1Zubi/\E2f2tm1Zubi
\E2f3tm3.1Gle/\E2f3tm3.1Gle
(involves: 129 * FVB/N * NIH Black Swiss) 		decreased cell proliferation J:138289
\E2f1tm1Meg/\E2f1tm1Meg
\E2f3tm2.1Gle/\E2f3tm2.1Gle
(involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N * NIH Black Swiss) 		decreased cell proliferation J:138289
\E2f1tm1Njd/\E2f1tm1Njd
\E2f3tm2Lees/\E2f3tm2Lees
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		decreased cell proliferation J:147270
\E2f2tm1Zubi/\E2f2tm1Zubi
(involves: 129S1/Sv * C57BL/6) 		increased T cell proliferation J:76318
\E2f2tm1Zubi/\E2f2tm1Zubi
\Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * DBA/2J) 		increased T cell proliferation J:76318
\E2f3tm1Lees/\E2f3tm1Lees
(involves: 129S2/SvPas * C57BL/6) 		decreased cell proliferation J:65128
\Ebf1tm1.1Rug/\Ebf1tm1.1Rug
\Polr2atm1(cre/ERT2)Bbd/\Polr2a+
(involves: C57BL/6 * SJL) 		decreased B cell proliferation J:182210
\Ecsittm1Gho/\Ecsittm1Gho
(involves: 129S6/SvEvTac * C57BL/6) 		decreased cell proliferation J:86912
\Ednrbs-36Pub/\Ednrbs-36Pub
(B6.Cg-Ednrbs-36Pub) 		increased cell proliferation J:125229
\Ednrbs-l/\Ednrbs-l
(involves: C57BL/6J * SSL/Le) 		abnormal melanocyte proliferation J:19441
\Ednrbtm1Nrd/\Ednrbtm1Nrd
\Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/\Gt(ROSA)26Sor+
\Tg(Tyr-cre/ERT2)13Bos/0
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6J) 		abnormal melanocyte proliferation J:231435
\Eef1e1Gt(OST377244)Lex/\Eef1e1+
(involves: 129S5/SvEvBrd * C57BL/6) 		increased cell proliferation J:96923
increased splenocyte proliferation J:96923
\Efemp2tm1.2Hiya/\Efemp2tm1.2Hiya
(involves: 129S6/SvEvTac * C57BL/6 * SJL) 		increased vascular endothelial cell proliferation J:170883
increased vascular smooth muscle cell proliferation J:170883
\Egr2tm1Jmi/\Egr2tm1Jmi
(Not Specified) 		increased Schwann cell proliferation J:96641
\Egr2tm4Pch/\Egr2tm4Pch
(involves: BALB/c * C57BL/6) 		increased Schwann cell proliferation J:137156
\Ehd4tm1.1Haba/\Ehd4tm1.1Haba
(involves: C57BL/6 * C57BL/6J * FVB/N) 		increased cell proliferation J:160188
\Eif2ak2tm1Cwe/\Eif2ak2tm1Cwe
(involves: 129S/SvEv * C57BL/6) 		increased T cell proliferation J:66112
\Eif2s2Gt(XH413)Byg/\Eif2s2+
(129-Eif2s2Gt(XH413)Byg Chr 19MOLF/Ei) 		decreased primordial germ cell proliferation J:146879
X/\Eif2s3yem2Asah
(involves: C57BL/6 * DBA/2) 		abnormal spermatogonia proliferation J:244443
X/\Eif2s3yem#Asah
(involves: C57BL/6 * DBA/2) 		abnormal spermatogonia proliferation J:244443
\Eif3etm1Fshb/\Eif3e+
(C57BL/6N-Eif3etm1Fshb) 		decreased fibroblast proliferation J:265010
\Eif4a1tm1.1Bea/\Eif4a1tm1.1Bea
\Tg(Fcer2a-cre)5Mbu/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased B cell proliferation J:344730
\Eif5aGt(RRE174)Byg/\Eif5aGt(RRE174)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased cell proliferation J:285882
\Elavl1tm1.1Atas/\Elavl1tm1.1Atas
\Tnfrsf4tm2(cre)Nik/\Tnfrsf4+
(involves: 129X1/SvJ * C57BL/6) 		decreased T cell proliferation J:207013
\Elavl1tm1Thla/\Elavl1tm1Thla
\Gt(ROSA)26Sortm1(cre/ERT2)Alj/\Gt(ROSA)26Sor+
(involves: 129) 		decreased cell proliferation J:155109
\Elf4tm1Nim/\Elf4tm1Nim
(B6.129S1-Elf4tm1Nim) 		increased B cell proliferation J:79568
increased T cell proliferation J:79568
\Eloatm1Aso/\Eloatm1Aso
(involves: 129S/SvEv * C57BL/6) 		decreased cell proliferation J:119126
\Elof1tm1.1(KOMP)Vlcg/\Elof1tm1.1(KOMP)Vlcg
(B6N(Cg)-Elof1tm1.1(KOMP)Vlcg/J) 		decreased embryonic epiblast cell proliferation J:277394
\Emg1tm1.1Btr/\Emg1tm1.1Btr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1) 		decreased cell proliferation J:230556
\Eml1heco/?
(involves: CD-1) 		abnormal neuronal precursor proliferation J:211342
\Eml1tm1.2Ics/\Eml1tm1.2Ics
(C57BL/6N-Eml1tm1.2Ics) 		abnormal neuronal precursor proliferation J:294769
\Emx1tm1(cre)Krj/\Emx1+
\Esco2tm1.1Ge/\Esco2tm1.1Ge
(involves: 129S2/SvPas * C57BL/6 * SJL) 		abnormal neuronal precursor proliferation J:180371
\Emx1tm1(cre)Krj/\Emx1+
\Rbm8atm1Dlsi/\Rbm8a+
(involves: C57BL/6J) 		increased neuronal precursor proliferation J:221648
\Emx1tm1(cre)Krj/\Emx1+
\Snord118em1Jfch/\Snord118+
(B6.Cg-Emx1tm1(cre)Krj Snord118em1Jfch) 		decreased neuronal precursor proliferation J:344970
\Emx1tm1(cre)Krj/\Emx1+
\Snord118em1Jfch/\Snord118em1Jfch
(B6.Cg-Emx1tm1(cre)Krj Snord118em1Jfch) 		decreased neuronal precursor proliferation J:344970
\En1tm1(Wnt1)Wrst/\En1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased cell proliferation J:91004
\En1tm1Alj/\En1tm8.1Alj
\En2tm1Alj/\En2tm6Alj
\Gt(ROSA)26Sortm1(cre/ERT2)Alj/\Gt(ROSA)26Sor+
(involves: 129S2/SvPas * 129S6/SvEvTac * Swiss Webster) 		abnormal cerebellar granule cell precursor proliferation J:156169
\Enpp1ttw/\Enpp1ttw
(involves: ICR) 		abnormal chondrocyte proliferation J:37369
\Enpp2tm1.1Vart/\Enpp2tm1.1Vart
(B6.Cg-Enpp2tm1.1Vart/Flmg) 		decreased cell proliferation J:159118
\Entpd5tm1Rre/\Entpd5tm1Rre
(involves: 129S5/SvEvBrd * C57BL/6J) 		increased hepatocyte proliferation J:163795
\Eomestm1Rob/\Eomestm1Rob
\Sox1tm1(cre)Take/0
(involves: 129S/SvEv * C57BL/6 * CBA) 		abnormal neuronal precursor proliferation J:138764
\Ep300tm1Dli/\Ep300tm1Dli
(either: 129S4/SvJae or (involves: 129S4/SvJae * C57BL/6)) 		decreased fibroblast proliferation J:47301
\Epcamtm1.2Msiv/\Epcamtm1.2Msiv
(involves: C57BL/6 * FVB/N * SJL) 		abnormal enterocyte proliferation J:210901
\Ephb2tm3.1Jf/\Ephb2tm3.1Jf
\Ephb3tm1Kln/\Ephb3tm1Kln
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * CD-1) 		abnormal small intestinal crypt cell proliferation J:157019
\Ephb6tm1Jwu/\Ephb6tm1Jwu
(involves: 129) 		decreased T cell proliferation J:94701
\Epn1tm1.1Wami/\Epn1tm1.1Wami
\Epn2tm1Ocr/\Epn2tm1Ocr
\Tg(Cdh5-cre/ERT2)CIVE23Mlia/0
(involves: 129X1/SvJ * C57BL/6J) 		increased vascular endothelial cell proliferation J:193966
\Erap1tm1.1Gnie/\Erap1tm1.1Gnie
(involves: 129S6/SvEvTac * C57BL/6) 		decreased T cell proliferation J:143988
\Ercc1tm1Jhjh/\Ercc1tm1Jhjh
(involves: C57BL/6 * FVB/N) 		decreased B cell proliferation J:92471
\Ercc1tm1Jhjh/\Ercc1tm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		decreased cell proliferation J:117488
decreased hepatocyte proliferation J:117488
\Ercc1tm2Jhjh/\Ercc1tm2Jhjh
(involves: 129P2/OlaHsd * C57BL/6) 		decreased cell proliferation J:41161
\Ercc6tm1Gvh/\Ercc6tm1Gvh
\Xpatm1Tnka/\Xpatm1Tnka
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased cerebellar granule cell precursor proliferation J:72574
\Ercc6ltm1.2Ajlc/Y
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N * SJL/J) 		decreased fibroblast proliferation J:271028
\Ercc6ltm1.2Ajlc/\Ercc6l+
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N * SJL/J) 		decreased fibroblast proliferation J:271028
\Ergtm1.1Path/\Ergtm1.1Path
(Not Specified) 		increased vascular endothelial cell proliferation J:227456
\Eri1tm1.2Anse/\Eri1tm1.2Anse
(involves: BALB/cJ * C57BL/6 * SJL) 		decreased cell proliferation J:146701
\Esco2tm1.1Ge/\Esco2tm1.1Ge
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S2/SvPas * C57BL/6 * CBA * SJL) 		decreased cell proliferation J:180371
\Espl1Gt(XL058)Byg/\Espl1+
\Trp53tm1Tyj/\Trp53tm1Tyj
(B6.129-Trp53tm1Tyj Espl1Gt(XL058)Byg) 		increased splenocyte proliferation J:174926
\Espl1tm1.1Tno/\Espl1+
\Pttg1tm1.1Tno/\Pttg1tm1.1Tno
(involves: 129S4/SvJae * C57BL/6J) 		decreased cell proliferation J:107917
\Espl1tm1.1Tno/\Espl1tm1.2Tno
(involves: 129S4/SvJae * C57BL/6J) 		decreased cell proliferation J:107917
\Espl1tm1.2Tno/\Espl1tm1.2Tno
(involves: 129S4/SvJae * C57BL/6J) 		abnormal inner cell mass proliferation J:107917
\Espl1tm2Pzg/\Espl1+
\Meox2tm1(cre)Sor/\Meox2+
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd) 		decreased primordial germ cell proliferation J:131838
\Esr2tm1Unc/\Esr2tm1Unc
(involves: 129P2/OlaHsd) 		abnormal enterocyte proliferation J:107308
\Esrp2tm1(KOMP)Vlcg/\Esrp2tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac) 		increased hepatocyte proliferation J:228040
\Ets1tm1.1Dds/\Ets1tm1.1Dds
(129S6/SvEvTac-Ets1tm1.1Dds) 		increased cell proliferation J:121460
\Ets1tm1Fwa/\Ets1tm1Fwa
(B6.129S4-Ets1tm1Fwa) 		decreased B cell proliferation J:93845
\Ets1tm2Jml/\Ets1tm2Jml
(involves: 129X1/SvJ * C57BL/6) 		decreased T cell proliferation J:50627
\Etv5tm1Kmm/\Etv5tm1Kmm
(involves: 129S6/SvEvTac) 		abnormal spermatogonia proliferation J:100645
\Ext1tm1Yama/\Ext1tm1Yama
(B6.129S5-Ext1tm1Yama) 		decreased cranial neural crest cell proliferation J:152572
\Ext1tm1Yama/\Ext1tm1Yama
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(B6.Cg-H2az2Tg(Wnt1-cre)11Rth Ext1tm1Yama) 		decreased cranial neural crest cell proliferation J:152572
\Extl3tm1.1Okam/\Extl3tm1Okam
\Tg(Ins2-cre)#Okam/0
(involves: 129P2/OlaHsd * ICR) 		decreased cell proliferation J:148348
\Eya1tm1Rilm/\Eya1tm1Rilm
(involves: 129S1/Sv * 129X1/SvJ) 		decreased otic epithelial cell proliferation J:119574
\Eya1tm1Rilm/\Eya1tm1Rilm
\Six1tm1Mair/\Six1tm1Mair
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased cell proliferation J:172023
\Ezh2tm1Jnw/\Ezh2tm1Jnw
(involves: 129P2/OlaHsd) 		absent inner cell mass proliferation J:69977
\Ezh2tm1Tara/\Ezh2tm1Tara
\Ighg1tm1(cre)Cgn/\Ighg1+
(involves: 129P2/OlaHsd) 		decreased B cell proliferation J:199122
\F3tm1.1Dwr/\F3tm1.1Dwr
(involves: 129S1/Sv * 129X1/SvJ * MF1 * Swiss) 		increased vascular smooth muscle cell proliferation J:111390
\Faap100em1Jzc/\Faap100em1Jzc
(involves: C57BL/6J * ICR) 		decreased primordial germ cell proliferation J:339060
\Faddtm1Mpa/\Faddtm1Mpa
\Tg(Vil1-cre)997Gum/0
(B6.Cg-Faddtm1Mpa Tg(Vil1-cre)997Gum) 		abnormal enterocyte proliferation J:175865
\Faddtm2.1Wnt/\Faddtm2.1Wnt
\Tg(Cd4-cre)1Cwi/?
(B6.Cg-Tg(Cd4-cre)1Cwi Faddtm2.1Wnt) 		abnormal T cell proliferation J:162312
\Fads1Gt(IST11525H2)Tigm/\Fads1+
(C57BL/6-Fads1Gt(IST11525H2)Tigm) 		abnormal enterocyte proliferation J:186265
\Fads1Gt(IST11525H2)Tigm/\Fads1Gt(IST11525H2)Tigm
(C57BL/6-Fads1Gt(IST11525H2)Tigm) 		abnormal enterocyte proliferation J:186265
\Fahtm1Mgo/\Fahtm1Mgo
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased hepatocyte proliferation J:138701
\Fam20ctm1.1Cqi/\Fam20ctm1.1Cqi
\Edil3Tg(Sox2-cre)1Amc/\Edil3+
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		decreased chondrocyte proliferation J:185208
\Fam120bem1Qqlg/\Fam120bem1Qqlg
(C57BL/6-Fam120bem1Qqlg) 		decreased fetal cardiomyocyte proliferation J:318650
\Fan1tm1a(KOMP)Wtsi/\Fan1tm1a(KOMP)Wtsi
(129S1.B6-Fan1tm1a(KOMP)Wtsi) 		increased kidney cell proliferation J:242198
\Fanclgcd/\Fanclgcd
(involves: C57BL/6J * CBA/J) 		decreased primordial germ cell proliferation J:80424
\Faslpr/\Faslpr
(MRL/Mp-Faslpr) 		abnormal T cell proliferation J:8267
increased kidney cell proliferation J:27634
\Faslpr/\Faslpr
(C3.MRL-Faslpr) 		abnormal T cell proliferation J:8267
\Faslpr/\Faslpr
\Fcer1gtm1Tks/\Fcer1gtm1Tks
(MRL.Cg-Fcer1gtm1Tks Faslpr) 		increased kidney cell proliferation J:106188
\Faslgld/\Faslgld
(C3H/HeJ-Faslgld) 		abnormal T cell proliferation J:8267
\Fasltm1.1Cgm/\Fasltm1.1Cgm
(involves: 129S2/SvPas * C57BL/6 * C57BL/6N) 		increased B cell proliferation J:168406
increased T cell proliferation J:168406
\Fat4tm1.1Hmc/\Fat4tm1.1Hmc
(involves: 129P2/OlaHsd) 		decreased kidney cell proliferation J:169135
\Fblim1tm1.1Chen/\Fblim1tm1.1Chen
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		decreased cell proliferation J:186501
\Fbxo4tm1.1Jadi/\Fbxo4tm1.1Jadi
(Not Specified) 		increased fibroblast proliferation J:178645
\Fbxo22em1Mkt/\Fbxo22em1Mkt
(involves: C57BL/6N) 		decreased fibroblast proliferation J:236274
\Fbxw11tm2Nakay/\Fbxw11tm1Nakay
(B6.Cg-Fbxw11tm2Nakay Fbxw11tm1Nakay) 		decreased fibroblast proliferation J:228222
\Fcer1gtm1Rav/\Fcer1gtm1Rav
\Tg(Ins2-TFRC/OVA)296Wehi/0
(involves: 129P2/OlaHsd * C57BL/6) 		decreased T cell proliferation J:122114
\Fcer1gtm1Tks/\Fcer1gtm1Tks
(involves: C57BL/6) 		decreased T cell proliferation J:112160
\Fcer2atm1Putt/\Fcer2atm1Putt
(involves: 129S/SvEv * C57BL/6) 		abnormal B cell proliferation J:69547
\Fcs1Pohnpei/\Fcs1Pohnpei
(involves: C57BL/6J * Pohnpei) 		increased cell proliferation J:114559
\Fcs2Pohnpei/\Fcs2Pohnpei
(involves: C57BL/6J * Pohnpei) 		decreased cell proliferation J:114559
\Fcs3C57BL/6J/\Fcs3Pohnpei
\Fcs4Pohnpei/\Fcs4Pohnpei
(involves: C57BL/6J * Pohnpei) 		increased cell proliferation J:114559
\Fcs3Pohnpei/\Fcs3Pohnpei
\Fcs4C57BL/6J/\Fcs4Pohnpei
(involves: C57BL/6J * Pohnpei) 		increased cell proliferation J:114559
\Fcs3Pohnpei/\Fcs3Pohnpei
\Fcs4Pohnpei/\Fcs4Pohnpei
(involves: C57BL/6J * Pohnpei) 		decreased cell proliferation J:114559
\Fdxrtm1Xch/\Fdxr+
(B6.Cg-Fdxrtm1Xch) 		increased fibroblast proliferation J:244082
\Fen1tm1Bhsh/\Fen1tm1Bhsh
(involves: 129S1/Sv) 		decreased cell proliferation J:121378
\Fen1tm2.1Bhsh/\Fen1+
(involves: 129S1/Sv) 		decreased fibroblast proliferation J:218627
\Fen1tm2.1Bhsh/\Fen1tm2.1Bhsh
(involves: 129S1/Sv) 		decreased fibroblast proliferation J:218627
\Fen1tm2Klng/\Fen1tm2Klng
(involves: 129X1/SvJ * C57BL/6) 		decreased cell proliferation J:138901
\Fendrrtm1Bgh/\Fendrrtm2Bgh
(involves: 129S6/SvEvTac * C57BL/6) 		decreased fetal cardiomyocyte proliferation J:191565
\Ferd3ltm1Yono/\Ferd3ltm1Yono
(involves: C57BL/6) 		abnormal neuronal precursor proliferation J:160534
\Fermt1tm1Ref/\Fermt1tm1Ref
(involves: 129S1/Sv * 129X1/SvJ) 		decreased keratinocyte proliferation J:142913
\Fermt2tm1.1Gxo/\Fermt2tm1.1Gxo
\Tg(Prrx1-cre)1Cjt/0
(B6.Cg-Fermt2tm1.1Gxo Tg(Prrx1-cre)1Cjt) 		decreased chondrocyte proliferation J:224370
\Fgf4tm1Gol/\Fgf4tm1Gol
(involves: C57BL/6J) 		decreased inner cell mass proliferation J:22275
\Fgf8tm2Moon/\Fgf8tm1Mrc
\Mesp1tm2(cre)Ysa/\Mesp1+
(involves: C57BL/6 * CBA) 		decreased cell proliferation J:109475
\Fgf9tm1Dor/\Fgf9tm1Dor
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal mesenchymal cell proliferation involved in lung development J:69852
\Fgf9tm1Dor/\Fgf9tm1Dor
(involves: C57BL/6J) 		decreased fetal cardiomyocyte proliferation J:95803
\Fgf16tm1Nit/Y
(C57BL/6-Fgf16tm1Nit) 		decreased fetal cardiomyocyte proliferation J:139637
\Fgfr1tm1Jpa/\Fgfr1tm1Jpa
\Fgfr2tm1Dor/\Fgfr2tm1Dor
\Tg(Pax3-cre)1Joe/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		decreased kidney cell proliferation J:107078
\Fgfr1tm1Upir/\Fgfr1tm1.1Upir
(involves: C57BL/6J) 		decreased fetal cardiomyocyte proliferation J:95803
\Fgfr1tm1Upir/\Fgfr1tm1Upir
\Fgfr2tm1Dor/\Fgfr2tm1Dor
\Tg(KRT5-cre)5132Jlj/0
(involves: 129X1/SvJ * C57BL/6 * C57BL/6J * DBA/2J) 		increased keratinocyte proliferation J:158802, J:221184
\Fgfr1tm2.1Cxd/\Fgfr1+
(involves: 129S6/SvEvTac * FVB/N) 		increased osteoblast proliferation J:63959
\Fgfr2tm1Dor/\Fgfr2tm1.1Dor
\Twist2tm1(cre)Dor/\Twist2+
(involves: 129X1/SvJ) 		decreased cell proliferation J:90391
\Fgfr2tm1Dsn/\Fgfr2tm1Dsn
\Tg(KRT5-cre)5132Jlj/0
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J) 		increased keratinocyte proliferation J:119723
\Fgfr2tm1Ewj/\Fgfr2+
\Tg(EIIa-cre)C5379Lmgd/0
(B6.Cg-Fgfr2tm1Ewj Tg(EIIa-cre)C5379Lmgd) 		increased osteoblast proliferation J:158773
\Fgfr2tm2Ewj/\Fgfr2+
\Tg(EIIa-cre)C5379Lmgd/0
(B6.Cg-Fgfr2tm2Ewj Tg(EIIa-cre)C5379Lmgd) 		increased osteoblast proliferation J:158773
\Fgfr2tm3.1Lni/\Fgfr2tm3.1Lni
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6) 		abnormal osteoblast proliferation J:77698
\Fgfr3tm1.1(FGFR3*)Ytc/\Fgfr3+
(involves: 129) 		decreased chondrocyte proliferation J:287271
\Fgfr3tm1.1(FGFR3*)Ytc/\Fgfr3tm1.1(FGFR3*)Ytc
(involves: 129) 		decreased chondrocyte proliferation J:287271
\Fgfr3tm1.1Iwa/\Fgfr3+
(involves: 129S6/SvEvTac * FVB/N * NIH Black Swiss) 		abnormal chondrocyte proliferation J:70061
\Fgfr3tm3.1Cxd/\Fgfr3tm3.1Cxd
(involves: 129S6/SvEvTac) 		decreased chondrocyte proliferation J:69849
\Fgfr3tm4.1Cxd/\Fgfr3+
(involves: 129S6/SvEvTac * NIH Black Swiss) 		increased chondrocyte proliferation J:63198
increased fibroblast proliferation J:63198
\Fgfrl1tm1True/\Fgfrl1tm1True
(B6.129S6-Fgfrl1tm1True) 		decreased kidney cell proliferation J:153202
\Fgl2tm1Pam/\Fgl2tm1Pam
(B6.129X1-Fgl2tm1Pam) 		increased T cell proliferation J:130895
\Filip1lem1Slib/\Filip1lem1Slib
\Tg(CDX2-cre/ERT2)752Erf/0
(involves: C57BL/6J * SJL/J) 		abnormal enterocyte proliferation J:312351
\Flcntm1Baba/\Flcntm1.1Lss
\Tg(Cdh16-cre)91Igr/0
(involves: C57BL/6 * FVB/N * ICR * SJL) 		increased kidney cell proliferation J:130978
\Flgft/\Flgft
(B6.Cg-Flgft) 		increased splenocyte proliferation J:151110
\Fli1tm1.1Dkw/\Fli1tm1.1Dkw
(B6.129S6-Fli1tm1.1Dkw) 		decreased B cell proliferation J:137876
\Flt1tm1.1Fong/\Flt1tm1.1Fong
\Gt(ROSA)26Sortm1(cre/ERT2)Thl/\Gt(ROSA)26Sor+
(involves: 129S6/SvEvTac * C57BL/6NCr * CD-1) 		increased endothelial cell proliferation J:202202
\Flvcr2tm1.1Tda/\Flvcr2tm1.1Tda
\Tg(Cdh5-cre/ERT2)1Rha/0
(involves: C57BL/6J) 		decreased endothelial cell proliferation J:287134
\Flvcr2tm1.2Tda/\Flvcr2tm1.2Tda
(involves: C57BL/6J) 		decreased endothelial cell proliferation J:287134
\Fmr1tm1Cgr/\Fmr1tm1Cgr
(involves: 129P2/OlaHsd) 		abnormal neuronal precursor proliferation J:159211
\Fn1tm1Ksek/\Fn1tm1Ksek
(involves: 129P2/OlaHsd * 129/Sv) 		decreased fibroblast proliferation J:93250
\Fndc3btm1Maim/\Fndc3btm1Maim
(B6.129S2-Fndc3btm1Maim) 		decreased fibroblast proliferation J:163660
\Fntbtm1.1Bbd/\Fntbtm1.1Bbd
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		decreased inner cell mass proliferation J:98944
\Fntbtm1.1Mbrg/\Fntbtm1.1Mbrg
(involves: 129P2/OlaHsd * C57BL/6) 		decreased fibroblast proliferation J:158937
\Fntbtm1.1Mbrg/\Fntbtm1.1Mbrg
\Tg(KRT14-cre)1Amc/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased keratinocyte proliferation J:158528
\Fntbtm1.1Mbrg/\Fntbtm1.2Mbrg
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * FVB/N) 		decreased fibroblast proliferation J:158937
\Fntbtm1Bbd/\Fntbtm1.1Bbd
\Polr2atm1(cre/ERT2)Bbd/\Polr2atm1(cre/ERT2)Bbd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL) 		decreased cell proliferation J:98944
\Fntbtm1Bbd/\Fntbtm1Bbd
\Polr2atm1(cre/ERT2)Bbd/\Polr2atm1(cre/ERT2)Bbd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL) 		decreased cell proliferation J:98944
\Fostm7Wag/\Fostm7Wag
\Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		decreased cell proliferation J:190150
\Foxa3tm1Khk/\Foxa3tm1Khk
(B6.129P2-Foxa3tm1Khk) 		abnormal primordial germ cell proliferation J:134427
\Foxc1hith/\Foxc1hith
(involves: C57BL/6J) 		abnormal neuron proliferation J:157301
\Foxc1hith/\Foxc1tm1Blh
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal neuron proliferation J:157301
\Foxc1tm1Blh/\Foxc1tm1Blh
(involves: 129S6/SvEvTac) 		abnormal neuron proliferation J:157301
\Foxd3tm1.1Lby/\Foxd3tm1.1Lby
(either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * Black Swiss) or (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * CD-1)) 		abnormal cell proliferation J:79491
\Foxd3tm1Lby/\Foxd3tm1Lby
(either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * Black Swiss) or (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * CD-1)) 		abnormal cell proliferation J:79491
decreased embryonic epiblast cell proliferation J:79491
\Foxd3tm2Lby/\Foxd3tm2Lby
(involves: 129S6/SvEvTac) 		abnormal cell proliferation J:79491
\Foxf1em1Vvk/\Foxf1+
(involves: C57BL/6 * DBA/2) 		decreased lung endothelial cell proliferation J:296328
\Foxg1tm1(cre)Skm/\Foxg1+
\Lrp2tm1Tew/\Lrp2tm1Tew
(involves: 129P2/OlaHsd) 		decreased cell proliferation J:238249
\Foxg1tm1Chzh/\Foxg1tm1Chzh
\Tg(Fzd9-cre/ERT)1Chzh/0
(involves: C57BL/6 * FVB) 		abnormal neuronal precursor proliferation J:182692
\Foxg1tm1M/\Foxg1tm1M
(involves: 129S1/Sv) 		abnormal neuronal precursor proliferation J:78115
\Foxj3Gt(XL913)Byg/\Foxj3Gt(XL913)Byg
(either: 129P2/OlaHsd-Foxj3Gt(XL913)Byg or B6.129P2-Foxj3		 abnormal skeletal muscle satellite cell proliferation J:157260
\Foxl2tm1Tre/\Foxl2tm1Tre
(involves: 129P2/OlaHsd * Black Swiss * CD-1) 		decreased granulosa cell proliferation J:87737
\Foxm1tm1.1Rhc/\Foxm1tm1.1Rhc
(involves: 129X1/SvJ * C57BL/6) 		decreased mesenchymal cell proliferation involved in lung development J:100263
\Foxm1tm1.1Rhc/\Foxm1tm1.1Rhc
(B6.129X1-Foxm1tm1.1Rhc) 		decreased fetal cardiomyocyte proliferation J:119481
\Foxm1tm1Rhc/\Foxm1tm1Rhc
\Tg(Pdx1-cre)89.1Dam/0
(involves: 129X1/SvJ * C57BL/6 * CBA) 		decreased pancreatic beta cell proliferation J:111026
\Foxo1tm1.1Stlp/\Foxo1tm1.1Stlp
\Tg(Lck-cre)1Cwi/0
(involves: 129S4/SvJae) 		decreased T cell proliferation J:154205
\Foxo1tm1Flv/\Foxo1tm1Flv
\Foxp3tm4(YFP/icre)Ayr/\Foxp3+
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ) 		increased T cell proliferation J:189962
\Foxo1tm1Flv/\Foxo1tm1Flv
\Tg(Cd4-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased T cell proliferation J:147057
\Foxo3Gt(XAO26)Byg/\Foxo3Gt(XAO26)Byg
(involves: 129P2/OlaHsd) 		increased T cell proliferation J:93593
\Foxp1tm1Eem/\Foxp1+
\Foxp2tm1Bux/\Foxp2tm1Bux
(involves: 129X1/SvJ * C57BL/6) 		decreased mesenchymal cell proliferation involved in lung development J:121421
\Foxp1tm2.1Eem/\Foxp1tm2.1Eem
\Nkx2-5tm1(cre)Rjs/\Nkx2-5+
(involves: 129 * C57BL/6 * SJL) 		increased fetal cardiomyocyte proliferation J:163662
\Foxp1tm2.1Eem/\Foxp1tm2.1Eem
\Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		decreased fetal cardiomyocyte proliferation J:163662
\Foxp3tm3Tch/Y
(C.129X1-Foxp3tm3Tch) 		increased T cell proliferation J:120636
\Fpr2tm1.2Jimw/\Fpr2tm1.2Jimw
(involves: 129X1/SvJ) 		abnormal enterocyte proliferation J:197568
\fpw/\fpw
(involves: C3H/HeJ * C57BL/6J) 		abnormal spermatogonia proliferation J:151726
decreased cell proliferation J:151726
decreased hepatocyte proliferation J:151726
increased cell proliferation J:151726
\Frmd3em1Zhaj/\Frmd3em1Zhaj
\Tg(MMTV-PyVT)634Mul/0
(B6.Cg-Frmd3em1Zhaj Tg(MMTV-PyVT)634Mul) 		increased mammary gland epithelial cell proliferation J:350496
\Fshrtm1Saco/\Fshrtm1Saco
(involves: 129) 		abnormal spermatogonia proliferation J:70680
\Fts/\Fts
(involves: C3H * C57BL/6 * SJL) 		decreased primordial germ cell proliferation J:168037
\Furintm1Jwmc/\Furintm1Jwmc
\Tg(Gdf9-icre)5092Coo/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J) 		decreased granulosa cell proliferation J:272231
\Furintm1Jwmc/\Furintm1Jwmc
\Tg(Zp3-cre)3Mrt/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J) 		decreased granulosa cell proliferation J:272231
\Fxnem8Lutzy/\Fxnem8Lutzy
(C57BL/6J-Fxnem8Lutzy) 		decreased fibroblast proliferation J:299300
\Fyb1tm1Gak/\Fyb1tm1Gak
(involves: 129S1/Sv * 129X1/SvJ) 		decreased T cell proliferation J:111368, J:126545
\Fyntm1Rmp/\Fyntm1Rmp
(involves: 129S2/SvPas * C57BL/6) 		decreased T cell proliferation J:70886
\Fyntm1Sor/\Fyntm1Sor
(either: 129S7/SvEvBrd-Fyntm1Sor or (involves: 129S7/SvEvBrd * C57BL/6J)) 		decreased T cell proliferation J:2242
\Fyntm1Sor/\Fyntm1Sor
(B6.129S7-Fyntm1Sor) 		abnormal T cell proliferation J:93886
\Fyntm1Sor/\Fyntm1Sor
\Lcktm1Litt/\Lcktm1.1Litt
\Tnfrsf4tm2(cre)Nik/\Tnfrsf4+
(involves: 129S7/SvEvBrd * 129X1/SvJ) 		decreased T cell proliferation J:152472
\Fzd9tm1Uta/\Fzd9tm1Uta
(involves: 129X1/SvJ) 		decreased osteoblast proliferation J:169924
\Fzr1Gt(RRJ067)Byg/\Fzr1Gt(RRJ067)Byg
(involves: 129P2/OlaHsd) 		decreased cell proliferation J:138545
\Fzr1tm1.1Mama/\Fzr1tm1.1Mama
(involves: BALB/cJ * C57BL/6 * SJL) 		decreased cell proliferation J:137456
\G3bp1tm1Tazi/\G3bp1tm1Tazi
(involves: 129S2/SvPas) 		decreased cell proliferation J:101358
\G6pc2tm1.1Pesa/\G6pc2tm1.1Pesa
(NOD.129S2-G6pc2tm1.1Pesa) 		decreased T cell proliferation J:160286
\Gabpatm1Agro/\Gabpatm1Agro
(involves: 129) 		decreased fibroblast proliferation J:126422
\Gabpb2Gt(RRJ488)Byg/\Gabpb2Gt(RRJ488)Byg
(involves: 129P2/OlaHsd) 		increased B cell proliferation J:141846
\Gad1tm1.1Tama/\Gad1+
\Pcntm239Asp/\Pcntm239Asp
(involves: C57BL/6 * C57BL/6J * CBA * FVB/N) 		abnormal neuronal precursor proliferation J:158418
\Gadd45atm1Ajf/\Gadd45atm1Ajf
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129X1/SvJ * C57BL/6)) 		increased fibroblast proliferation J:57882
increased kidney cell proliferation J:76041
increased T cell proliferation J:76041
\Gadd45atm1Ajf/\Gadd45atm1Ajf
\Gadd45btm1Daa/\Gadd45btm1Daa
\Gadd45gtm1Mhol/\Gadd45gtm1Mhol
(either: (involves: 129X1/SvJ) or (involves: 129P2/OlaHsd * 129X1/SvJ)) 		increased cell proliferation J:110650
\Gadd45btm1Flv/\Gadd45btm1Flv
(B6.129S6-Gadd45btm1Flv) 		increased T cell proliferation J:118837
\Gadd45gip1tm1Kong/\Gadd45gip1tm1Kong
(involves: 129P2/OlaHsd * C57BL/6) 		absent inner cell mass proliferation J:156583
decreased cell proliferation J:156583
\Gadd45gip1tm2Kong/\Gadd45gip1tm2Kong
\Tg(Ins2-cre)25Mgn/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		decreased pancreatic beta cell proliferation J:220742
\Gadd45gip1tm2Kong/\Gadd45gip1tm2Kong
\Tg(Vil1-cre)997Gum/0
(involves: 129P2/OlaHsd * C57BL/6J * SJL) 		abnormal small intestinal crypt cell proliferation J:156319
\Gaktm2Legr/\Gaktm2Legr
\Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL) 		abnormal neuronal precursor proliferation J:180119
\Galnt1tm1.1Jxm/\Galnt1tm1.1Jxm
(B6NHsd.Cg-Galnt1tm1.1Jxm) 		increased cell proliferation J:242253
\Gap43tm1Kmr/\Gap43tm1Kmr
(B6.129S1-Gap43tm1Kmr) 		abnormal neuronal precursor proliferation J:126908
\Gapttm1.1Wz/\Gapttm1.1Wz
(Not Specified) 		increased B cell proliferation J:138146
\Gas2l3tm1c(EUCOMM)Hmgu/\Gas2l3tm1c(EUCOMM)Hmgu
\Gt(ROSA)26Sortm2(cre/ERT2)Brn/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N) 		abnormal fetal cardiomyocyte proliferation J:244087
\Gas2l3tm1d(EUCOMM)Hmgu/\Gas2l3tm1d(EUCOMM)Hmgu
(involves: 129S4/SvJaeSor * C57BL/6J * C57BL/6N) 		decreased fetal cardiomyocyte proliferation J:244087
\Gas6tm1Hiar/\Gas6tm1Hiar
(B6.129P2-Gas6tm1Hiar) 		decreased kidney cell proliferation J:112430
\Gata4tm1.1Sad/\Gata4tm1.1Sad
\Gata6tm2.1Sad/\Gata6tm2.1Sad
\Tg(Wt1-cre)1Jbeb/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased fetal cardiomyocyte proliferation J:206877
\Gata4tm1.1Wtp/\Gata4tm1.1Wtp
\Nkx2-5tm1(cre)Rjs/\Nkx2-5+
(involves: 129S7/SvEvBrd) 		decreased fetal cardiomyocyte proliferation J:99203
\Gata4tm1.1Wtp/\Gata4tm1.1Wtp
\Tg(Myh6-cre)2182Mds/0
(involves: FVB/N) 		decreased fetal cardiomyocyte proliferation J:99203
\Gata4tm1Eno/\Gata4+
\Gata6tm1Eno/\Gata6+
(involves: 129/Sv * 129S7/SvEvBrd * C57BL/6) 		decreased fetal cardiomyocyte proliferation J:111824
\Gata4tm1Grg/\Gata4+
(involves: 129 * C57BL/6) 		decreased fetal cardiomyocyte proliferation J:185124
\Gata4tm1Grg/\Gata4tm1Grg
(involves: 129 * C57BL/6) 		decreased fetal cardiomyocyte proliferation J:185124
\Gata4tm1Jml/\Gata4+
\Gata5tm1Eem/\Gata5tm1Eem
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased fetal cardiomyocyte proliferation J:155855
\Gata4tm1Wtp/\Gata4tm1Wtp
(involves: 129 * C57BL/6) 		decreased fetal cardiomyocyte proliferation J:94637
\Gata6tm1Gsv/\Gata6tm1Gsv
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB)) 		decreased inner cell mass proliferation J:52029
\Gata6osem3Zfa/\Gata6osem3Zfa
\Gt(ROSA)26Sortm1Sor/\Gt(ROSA)26Sor+
\Lgr5tm1(cre/ERT2)Cle/\Lgr5+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6) 		abnormal enterocyte proliferation J:268724
\Gatmem1Btlr/\Gatmem1Btlr
(C57BL/6J-Gatmem1Btlr) 		abnormal enterocyte proliferation J:252049
\Gbe1m1Yty/\Gbe1m1Yty
(C3HeB/FeJ-Gbe1m1Yty) 		increased fetal cardiomyocyte proliferation J:167233
\Gcgrem2Smoc/\Gcgrem2Smoc
(C57BL/6J-Gcgrem2Smoc) 		increased pancreatic alpha cell proliferation J:300368
\Gcgrtm1Jcp/\Gcgrtm1Jcp
(DBA/1LacJ-Gcgrtm1Jcp) 		increased pancreatic beta cell proliferation J:176507
\Gcgrtm1Mjch/\Gcgrtm1Mjch
(involves: 129 * C57BL/6J * SJL) 		increased pancreatic alpha cell proliferation J:208604
\Gcgrtm2.1Mjch/\Gcgrtm2.1Mjch
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * DBA * SJL) 		increased pancreatic alpha cell proliferation J:208604
\Gcktm1Ydor/\Gck+
\Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * C57BL/6J * DBA) 		increased pancreatic beta cell proliferation J:302600
\Gclctm1Mwl/\Gclctm1Mwl
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased cell proliferation J:62177
\Gclmtm1Tjka/\Gclmtm1Tjka
(B6.129-Gclmtm1Tjka) 		increased granulosa cell proliferation J:226942
\Gcm1tm1Jcc/\Gcm1+
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		increased cell proliferation J:186528
\Gcn1em2Itohk/\Gcn1em2Itohk
(C57BL/6-Gcn1em2Itohk) 		decreased fibroblast proliferation J:287528
\Gdnftm1Lmgd/\Gdnf+
(B6.129-Gdnftm1Lmgd) 		increased kidney cell proliferation J:168650
\Gdpd2tm1.1Soc/Y
(involves: 129/Sv * BALB/cJ * C57BL/6J) 		increased neuronal precursor proliferation J:291492
\Gdpd2tm1.1Soc/\Gdpd2tm1.1Soc
(involves: 129/Sv * BALB/cJ * C57BL/6J) 		increased neuronal precursor proliferation J:291492
\Gdpd5tm1.1Itl/\Gdpd5tm1.1Itl
(involves: 129 * C57BL/6J) 		abnormal neuronal precursor proliferation J:178550
\Gfertm1(KOMP)Mbp/\Gfer+
(involves: C57BL/6J * C57BL/6N) 		decreased hepatocyte proliferation J:224792
\Gfertm1.1Crg/\Gfertm1.1Crg
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129 * C57BL/6 * DBA) 		increased hepatocyte proliferation J:227242
\Gfi1tm1Wep/\Gfi1tm1Wep
(B6.129-Gfi1tm1Wep) 		abnormal T cell proliferation J:117105
\Gfi1tm1Wep/\Gfi1tm1Wep
\Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		abnormal T cell proliferation J:117105
\Gfra1tm1Jmi/\Gfra1tm2Jmi
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129/Sv * C57BL/6 * CBA * SJL) 		abnormal neuronal precursor proliferation J:122607
\Gfra3tm1Adav/\Gfra3tm1Adav
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1) 		abnormal neuronal precursor proliferation J:71959
\Ggctem1.2Smoc/\Ggctem1.2Smoc
(involves: C57BL/6J) 		decreased fibroblast proliferation J:317466
\Ggctem1.2Smoc/\Ggctem1.2Smoc
\Krastm4Tyj/\Kras+
(involves: 129S4/SvJae * C57BL/6J) 		decreased fibroblast proliferation J:317466
\Ghrtm1.1Dlr/\Ghrtm1.1Dlr
\Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6J * CBA/J) 		decreased pancreatic beta cell proliferation J:284574
\Ghrtm1.1Dlr/\Ghrtm1.1Dlr
\Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C3H * C57BL/6 * DBA) 		decreased pancreatic beta cell proliferation J:173909
\Gimap5m1Btlr/\Gimap5m1Btlr
(involves: C57BL/6J) 		abnormal B cell proliferation J:160090
decreased B cell proliferation J:160090
\Gins1tm1Ntak/\Gins1tm1Ntak
(involves: 129P2/OlaHsd * C57BL/6J) 		absent inner cell mass proliferation J:119867
\Gins4tm1Ntak/\Gins4tm1Ntak
(involves: 129P2/OlaHsd * C57BL/6) 		decreased inner cell mass proliferation J:209708
\Gipc1Gt(OST93079)Lex/\Gipc1Gt(OST93079)Lex
(B6.129S-Gipc1Gt(OST93079)Lex) 		decreased cell proliferation J:122652
increased cell proliferation J:122652
\Git1tm1Bcb/\Git1tm1Bcb
(involves: 129 * C57BL/6) 		decreased vascular endothelial cell proliferation J:158935
\Gja1M1Jrt/\Gja1+
(involves: C3H/HeJ * C57BL/6J) 		decreased granulosa cell proliferation J:146211
\Gja1tm3.1Clo/\Gja1tm3.1Clo
(B6.Cg-Gja1tm1.1Clo) 		abnormal vascular smooth muscle cell proliferation J:212895
\Gjb2tm2.2Kwi/\Gjb2+
\Tg(Pgk1-cre)1Lni/0
(involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6) 		increased keratinocyte proliferation J:166732
\Gli1tm1Alj/\Gli1tm1Alj
\Tg(Shh)#Dje/0
(involves: 129S1/Sv * 129X1/SvJ * Swiss Webster) 		abnormal cell proliferation J:94461
\Gli1tm2Alj/\Gli1+
\Gli2tm1Alj/\Gli2tm1Alj
\Gli3Xt/\Gli3Xt
(involves: 101/H * 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C3H/HeH * C57BL * CBA/H * Swiss Webster) 		abnormal neuronal precursor proliferation J:87948
\Gli2tm1Alj/\Gli2tm1Alj
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		decreased mesenchymal cell proliferation involved in lung development J:49603
\Glrx3Gt(RRF094)Byg/\Glrx3Gt(RRF094)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		decreased fibroblast proliferation J:190794
\Glrxtm3Ysh/\Glrxtm3Ysh
(involves: 129S1/Sv * 129X1/SvJ) 		decreased cell proliferation J:141903
\Gmnntm1.1Kio/\Gmnntm1.2Kio
\Tg(CD2-icre)4Kio/0
(involves: 129S4/SvJae * C57BL/10 * CBA/Ca) 		decreased T cell proliferation J:159657
\Gmnntm1Nyma/\Gmnntm1Nyma
(involves: C57BL/6) 		decreased cell proliferation J:123394
\Gmnntm1Tjm/\Gmnntm1Tjm
\Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6 * C57BL/6J * CBA) 		decreased hematopoietic stem cell proliferation J:171741
\Gna12tm1Citb/\Gna12tm1Citb
\Gna13tm2.1Soff/\Gna13tm2.1Soff
\Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		increased T cell proliferation J:149560
\Gnai2tm1Lbi/\Gnai2tm1Lbi
(involves: 129S7/SvEvBrd) 		increased T cell proliferation J:30507
\Gnb1Gt(prvSStrap)4B8Yiw/\Gnb1Gt(prvSStrap)4B8Yiw
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal neuronal precursor proliferation J:157907
decreased cell proliferation J:157907
\Gng5tm1.1Rbs/\Gng5tm1.1Rbs
(B6J.Cg-Gng5tm1.1Rbs) 		decreased fetal cardiomyocyte proliferation J:215128
\Gnl3Gt(S4-4B1)Sor/\Gnl3Gt(S4-4B1)Sor
(involves: 129S4/SvJaeSor * C57BL/6) 		decreased cell proliferation J:185271
\Gnl3Gt(W223E05)Wrst/\Gnl3+
(Not Specified) 		decreased cell proliferation J:118144
\Gnl3Gt(W223E05)Wrst/\Gnl3Gt(W223E05)Wrst
(Not Specified) 		decreased cell proliferation J:118144
\Gnl3Gt(W223E05)Wrst/\Gnl3Gt(W223E05)Wrst
\Trp53tm1Tyj/\Trp53tm5Tyj
(involves: 129S2/SvPas * 129S4/SvJae) 		decreased cell proliferation J:118144
\Gnl3tm1Rylt/\Gnl3+
(involves: 129X1/SvJ * C57BL/6) 		decreased fibroblast proliferation J:117592
\Gnl3tm2.1Rylt/\Gnl3tm2.1Rylt
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129 * 129S2/SvPas * C57BL/6 * CBA) 		decreased fibroblast proliferation J:198698
\Gnl3tm2.1Rylt/\Gnl3tm2.1Rylt
\Trp53tm1Tyj/\Trp53tm1Tyj
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129 * 129S2/SvPas * C57BL/6 * CBA) 		decreased fibroblast proliferation J:198698
\Gnpnat1tm1Mak/\Gnpnat1tm1Mak
(either: (involves: C57BL/6J) or (involves: CD-1)) 		decreased cell proliferation J:111395
\Gpc6tm1Lex/\Gpc6tm1Lex
(B6N.129S5(B6)-Gpc6tm1Lex/Mmucd) 		decreased chondrocyte proliferation J:245694
\Gpr37l1tm1.2Gtva/\Gpr37l1tm1.2Gtva
(involves: 129S/SvEv * BALB/c * C57BL/6J) 		abnormal neuronal precursor proliferation J:201190
\Gpr37l1tm1.2Gtva/\Gpr37l1tm1.2Gtva
\Ptch1tm1Zim/\Ptch1+
(STOCK Gpr37l1tm1.2Gtva Ptch1tm1Zim/Cnrm) 		decreased cerebellar granule cell precursor proliferation J:272049
\Gpr132tm1Witt/\Gpr132tm1Witt
(involves: 129X1/SvJ * BALB/c) 		increased B cell proliferation J:69473
increased T cell proliferation J:69473
\Gpr161tm1.2Smuk/\Gpr161tm1.2Smuk
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: C57BL/6J * CBA/J) 		increased neuronal precursor proliferation J:316181
\Gpr174tm1Cys/Y
(B6.129-Gpr174tm1Cys) 		increased T cell proliferation J:222307
\Gpr183tm1.2Rbr/\Gpr183tm1.2Rbr
\Ightm1Rbr/\Ightm1Rbr
\Tg(IgkHyHEL10)1Rbr/0
(involves: C57BL/6 * FVB/N * SJL) 		abnormal B cell proliferation J:151883
\Gpx1tm1Kola/\Gpx1tm1Kola
(involves: 129S2/SvPas * CF-1) 		decreased cell proliferation J:87985
\Graptm1Gsf/\Graptm1Gsf
(B6.129-Graptm1Gsf) 		increased T cell proliferation J:76243
\Grb2tm1Lnit/\Grb2tm1Lnit
\Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c * BALB/cJ) 		increased B cell proliferation J:171222
\Grb2tm1Paw/\Grb2tm1Paw
(involves: 129S1/Sv * 129X1/SvJ) 		absent inner cell mass proliferation J:51424
\Grb10tm1.1Fliu/\Grb10tm1.1Fliu
\Tg(Pdx1-cre)6Tuv/0
(involves: 129S/SvEv * C57BL/6 * FVB/N) 		increased pancreatic beta cell proliferation J:208498
\Grhl3tm1Bogi/\Grhl3tm1Bogi
(involves: C57BL/6J) 		increased keratinocyte proliferation J:114626
\Grhl3tm1Jane/\Grhl3tm1Jane
(involves: 129S1/Sv) 		increased keratinocyte proliferation J:178952
\Grm1Tg(p18A4.B)1352Szc/0
(Not Specified) 		abnormal melanocyte proliferation J:32786
\Gsk3btm1Jrw/\Gsk3b+
\Irs2tm1Mfw/\Irs2tm1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		increased pancreatic beta cell proliferation J:135659
\Gt(ROSA)26Sortm1(Bcor*A)Vjba/\Gt(ROSA)26Sortm1(Bcor*A)Vjba
(involves: 129S1/Sv) 		decreased cell proliferation J:231455
\Gt(ROSA)26Sortm1(Bmi1)Aiwa/\Gt(ROSA)26Sor+
\Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		increased hematopoietic stem cell proliferation J:198331
\Gt(ROSA)26Sortm1(CAG-Bcl3,-EGFP)Hoev/\Gt(ROSA)26Sor+
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd) 		decreased B cell proliferation J:208980
\Gt(ROSA)26Sortm1(CAG-Bgeo,-Insc/GFP)Jakn/\Gt(ROSA)26Sortm1(CAG-Bgeo,-Insc/GFP)Jakn
\Tg(Nes-cre)1Wmz/0
(involves: C57BL/6) 		abnormal neuronal precursor proliferation J:178712
\Gt(ROSA)26Sortm1(CAG-Wnt5a,-AcGFP)Skde/\Gt(ROSA)26Sor+
\Pgrtm2(cre)Lyd/\Pgr+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal trophoblast giant cell proliferation J:233595
\Gt(ROSA)26Sortm1(CARD14*)Ribt/\Gt(ROSA)26Sor+
\Tg(KRT14-cre/ERT)20Efu/0
(involves: 129S6/SvEvTac * C57BL/6NCrl * CD-1) 		increased keratinocyte proliferation J:292094
\Gt(ROSA)26Sortm1(cre/ERT2)Thl/\Gt(ROSA)26Sor+
\Kat8tm1Thl/\Kat8+
(involves: 129S1/Sv) 		decreased fibroblast proliferation J:128936
\Gt(ROSA)26Sortm1(cre/ERT2)Thl/\Gt(ROSA)26Sor+
\Kat8tm1Thl/\Kat8tm1Thl
(involves: 129S1/Sv) 		decreased fibroblast proliferation J:128936
\Gt(ROSA)26Sortm1(cre/ERT)Brn/\Gt(ROSA)26Sor+
\Lin9tm1.1Sgau/\Lin9tm1.1Sgau
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * SJL) 		abnormal small intestinal crypt cell proliferation J:162678
decreased fibroblast proliferation J:162678
\Gt(ROSA)26Sortm1(cre/ERT)Brn/\Gt(ROSA)26Sor+
\Ppp1r13ltm1Xlu/\Ppp1r13ltm1Xlu
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J) 		decreased fibroblast proliferation J:177360
\Gt(ROSA)26Sortm1(DTA)Vlcg/\Gt(ROSA)26Sortm1(DTA)Vlcg
\Tg(BGLAP-cre/ERT2)#Stko/0
(involves: 129S1/Sv * FVB/N) 		decreased pancreatic beta cell proliferation J:201507
\Gt(ROSA)26Sortm1(ETV6/SYK)Hjum/\Gt(ROSA)26Sor+
\Cd79atm3(cre/ERT2)Reth/\Cd79a+
(involves: 129S6/SvEvTac * BALB/c) 		increased B cell proliferation J:208904
\Gt(ROSA)26Sortm1(EYFP)Cos/\Gt(ROSA)26Sor+
\Plcg1tm1Gcrp/\Plcg1tm1Rwen
\Tg(Cd4-cre)1Cwi/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2) 		decreased T cell proliferation J:157757
\Gt(ROSA)26Sortm1(EYFP)Cos/\Gt(ROSA)26Sor+
\Cd19tm1(cre)Cgn/\Cd19+
\Rev3ltm1.1Diaz/\Rev3ltm1.1Diaz
(involves: 129P2/OlaHsd * 129X1/SvJ * BALB/c * C57BL/6 * C57BL/6NTac) 		decreased B cell proliferation J:188723
\Gt(ROSA)26Sortm1(Gck)Ydor/\Gt(ROSA)26Sor+
\Tg(Pdx1-cre/Esr1*)#Dam/0
(involves: C57BL/6 * CBA) 		decreased pancreatic beta cell proliferation J:210493
\Gt(ROSA)26Sortm1(GNAQ*)Cvrk/\Gt(ROSA)26Sor+
\Tg(Mitf-cre)7114Gsb/0
(C3FeJ.Cg-Gt(ROSA)26Sortm1(GNAQ*)Cvkr Tg(Mitf-cre)7114Gsb/Cvrk) 		abnormal melanocyte proliferation J:225597
\Gt(ROSA)26Sortm1(GNAQ*)Cvrk/\Gt(ROSA)26Sortm14(CAG-tdTomato)Hze
\Tg(Mitf-cre)7114Gsb/0
(C3FeJ.Cg-Gt(ROSA)26Sortm1(GNAQ*)Cvrk/Gt(ROSA)26Sortm14(CAG-tdTomato)Hze Tg(Mitf-cre)7114Gsb/Cvrk) 		abnormal melanocyte proliferation J:312561
\Gt(ROSA)26Sortm1(Grem1)Svok/\Gt(ROSA)26Sor+
\Tg(Prrx1-cre)1Cjt/0
(involves: 129S1/Sv * C57BL/6J * SJL/J) 		increased cell proliferation J:214075
\Gt(ROSA)26Sortm1(HBEGF)Awai/\Gt(ROSA)26Sor+
\Tg(Krt1-15-cre/PGR*)22Cot/0
(involves: C57BL/6J * SJL/J) 		increased cell proliferation J:244536
\Gt(ROSA)26Sortm1(ITK/SYK)Jrld/\Gt(ROSA)26Sor+
\Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		increased T cell proliferation J:160931
\Gt(ROSA)26Sortm1(Smo/EYFP)Amc/\Gt(ROSA)26Sor+
\Hk2tm1.1Uku/\Hk2tm1.1Uku
\Tg(GFAP-cre)25Mes/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * FVB/N) 		abnormal neuronal precursor proliferation J:210113
\Gt(ROSA)26Sortm1(Wnt4)Bhr/\Gt(ROSA)26Sor+
\Tg(Col2a1-cre)1Bhr/0
(involves: 129S7/SvEvBrd * C57BL/6 * SJL) 		decreased chondrocyte proliferation J:129327
\Gt(ROSA)26Sortm1.1(CAG-Mirc20)Eem/\Gt(ROSA)26Sor+
\Nkx2-5tm1(cre)Rjs/\Nkx2-5+
(involves: 129S7/SvEvBrd * C57BL/6) 		increased fetal cardiomyocyte proliferation J:233994
\Gt(ROSA)26Sortm1.1(MYC/ERT2)Gev/\Gt(ROSA)26Sortm1.1(MYC/ERT2)Gev
(involves: C57BL/6 * FVB/N) 		increased cell proliferation J:142030
\Gt(ROSA)26Sortm1.1(Ubc-BCL3)Sbn/\Gt(ROSA)26Sor+
\Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c * C57BL/6) 		decreased B cell proliferation J:207111
\Gt(ROSA)26Sortm1Sor/\Gt(ROSA)26Sor+
\Tg(Nphs1-cre)33Mska/0
\Tg(Nphs1-IL2RA)18Mska/0
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * DBA/2) 		increased kidney cell proliferation J:126591
\Gt(ROSA)26Sortm2(CAG-Dsred2/EGFP)Luo/\Gt(ROSA)26Sortm1(Notch3*)Sfr
\Notch3tm1.1(cre/ERT2)Sat/\Notch3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac) 		decreased mammary gland epithelial cell proliferation J:201985
\Gt(ROSA)26Sortm2(CAG-Notch2*)Uzs/\Gt(ROSA)26Sor+
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J) 		increased B cell proliferation J:179036
\Gt(ROSA)26Sortm2(H1/tetO-RNAi:Kdm1a)Arte/\Gt(ROSA)26Sor+
(involves: C57BL/6) 		increased hematopoietic stem cell proliferation J:192055
\Gt(ROSA)26Sortm2(Lmp1/CD40)Uzs/\Gt(ROSA)26Sor+
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6) 		increased B cell proliferation J:137122
\Gt(ROSA)26Sortm2(Rnf187)Jhai/\Gt(ROSA)26Sor+
\Krastm4Tyj/\Kras+
\Tg(Vil1-cre)20Syr/0
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * DBA/2) 		abnormal enterocyte proliferation J:173145
\Gt(ROSA)26Sortm2.1(MYC/ERT)Hsc/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor) 		increased cell proliferation J:89756
\Gt(ROSA)26Sortm2Bet/\Gt(ROSA)26Sortm2Bet
\Speer6-ps1Tg(Alb-cre)21Mgn/?
(involves: BALB/c * C57BL/6 * DBA) 		increased hepatocyte proliferation J:174261
\Gt(ROSA)26Sortm2Sho/\Gt(ROSA)26Sor+
\Sp8tm1Smb/\Sp8tm1Smb
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6J * CBA/J) 		decreased cranial neural crest cell proliferation J:200761
\Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky/\Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky
\Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca) 		increased B cell proliferation J:133215
\Gt(ROSA)26Sortm3(HIF1A*)Kael/\Gt(ROSA)26Sortm4(HIF2A*)Kael
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * DBA) 		increased hepatocyte proliferation J:144666
\Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/\Gt(ROSA)26Sor+
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
\Srsf3tm1Pjln/\Srsf3tm1Pjln
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6J * CBA/J) 		decreased cranial neural crest cell proliferation J:308882
\Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/\Gt(ROSA)26Sor+
\Pfkfb3tm1Pec/\Pfkfb3tm1Pec
\Tg(Cdh5-cre/ERT2)1Rha/0
(involves: 129S1/Sv * 129X1/SvJ) 		decreased endothelial cell proliferation J:200070
\Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/\Gt(ROSA)26Sor+
\Pfkfb3tm1Pec/\Pfkfb3tm1Pec
\Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		decreased endothelial cell proliferation J:200070
\Gt(ROSA)26Sortm4(H1/tetO-RNAi:Ezh2)Arte/\Gt(ROSA)26Sor+
(C57BL/6-Gt(ROSA)26Sortm4(H1/tetO-RNAi:Ezh2)Arte) 		decreased mammary gland epithelial cell proliferation J:202724
\Gt(ROSA)26Sortm4(HIF2A*)Kael/\Gt(ROSA)26Sor+
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * DBA) 		increased hepatocyte proliferation J:144666
\Gt(ROSA)26Sortm4(HIF2A*)Kael/\Gt(ROSA)26Sor+
\Tg(KRT14-cre)1Ipc/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * SJL) 		increased keratinocyte proliferation J:144666
\Gt(ROSA)26Sortm5(H1/tetO-RNAi:Ezh2)Arte/\Gt(ROSA)26Sor+
(C57BL/6-Gt(ROSA)26Sortm5(H1/tetO-RNAi:Ezh2)Arte) 		decreased mammary gland epithelial cell proliferation J:202724
\Gt(ROSA)26Sortm7(Pik3ca*,-EGFP)Rsky/\Gt(ROSA)26Sor+
\Tg(CAG-cre/Esr1*)5Amc/0
(B6.Cg-Gt(ROSA)26Sortm7(Pik3ca*,-EGFP)Rsky Tg(CAG-cre/Esr1*)5Amc) 		increased cell proliferation J:264410
\Gt(ROSA)26Sortm9(cre/ESR1)Arte/\Gt(ROSA)26Sor+
\Map3k14tm1.1Gne/\Map3k14tm1.1Gne
(B6(Cg)-Map3k14tm1.1Gne Gt(ROSA)26Sortm9(cre/ESR1)Arte) 		decreased B cell proliferation J:240453
\Gt(ROSA)26Sortm9(cre/ESR1)Arte/\Gt(ROSA)26Sor+
\Pkn2tm1c(KOMP)Wtsi/\Pkn2tm1c(KOMP)Wtsi
(involves: C57BL/6N * C57BL/6NTac) 		decreased fibroblast proliferation J:229595
\Gt(ROSA)26Sortm10(Lmp1)Rsky/\Gt(ROSA)26Sor+
(involves: BALB/cJ) 		increased B cell proliferation J:181546
\Gt(ROSA)26Sortm10(Lmp1)Rsky/\Gt(ROSA)26Sor+
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * BALB/cJ) 		increased B cell proliferation J:181546
\Gt(ROSA)26Sortm11(Lmp1)Rsky/\Gt(ROSA)26Sor+
(involves: C57BL/6) 		increased B cell proliferation J:181546
\Gt(ROSA)26Sortm11(Lmp1)Rsky/\Gt(ROSA)26Sor+
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell proliferation J:181546
\Gtf2itm1Vcam/\Gtf2itm1Vcam
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		decreased embryonic epiblast cell proliferation J:204278
\Guca2atm1.1Mcoh/\Guca2atm1.1Mcoh
(involves: 129P2/OlaHsd * BALB/c) 		abnormal enterocyte proliferation J:80545
\Gys1Gt(OST33395)Lex/\Gys1Gt(OST33395)Lex
(involves: 129S5/SvEvBrd * 129X1/SvJ * C57BL/6J) 		decreased fetal cardiomyocyte proliferation J:92245
\H2-Ab1b-tm1Doi/\H2-Ab1b-tm1Doi
(involves: 129S2/SvPas) 		abnormal neuron proliferation J:170591
\H2-DMatm2Liz/\H2-DMatm2Liz
(involves: C57BL/6 * C57BL/10 * C57BR * CBA) 		decreased T cell proliferation J:111565
\H2b/\H2b
\Nfkbidtm1Clay/\Nfkbidtm1Clay
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(TcraN15,TcrbN15)L2Elre/?
(involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6) 		decreased T cell proliferation J:132071
\H2b/\H2b
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(TcraN15,TcrbN15)L2Elre/?
(involves: 129S/SvEv * C57BL/6) 		increased T cell proliferation J:133112
\H2axtm1Nus/\H2axtm1Nus
(Not Specified) 		decreased cell proliferation J:76360, J:149487
decreased vascular endothelial cell proliferation J:194603
\Hand1tm1(tTA)Prri/\Hand1+
\Tg(tetO-Hand1)1Prri/0
(involves: 129/Sv * C57BL/6) 		increased fetal cardiomyocyte proliferation J:116090
\Hand1tm2(Hand1)Abfi/\Hand1tm2(Hand1)Abfi
(Not Specified) 		decreased cell proliferation J:164028
\Hand1tm2.1(Hand1)Abfi/\Hand1tm2.1(Hand1)Abfi
(Not Specified) 		decreased cell proliferation J:164028
\Hand2tm1Cse/\Hand2+
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: 129S1/Sv * C57BL/6J * CBA/J) 		increased fetal cardiomyocyte proliferation J:155265
\Hap1tm2Xjl/\Hap1tm2Xjl
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129 * C57BL/6 * CBA) 		abnormal neuron proliferation J:224698
\Hap1tm2Xjl/\Hap1tm2Xjl
\Tg(Camk2a-cre)159Kln/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6) 		abnormal neuron proliferation J:224698
\Hapstr1tm1.1Menm/\Hapstr1tm1.2Menm
\Edil3Tg(Sox2-cre)1Amc/\Edil3+
(involves: C57BL/6 * C57BL/6J * CBA) 		decreased fibroblast proliferation J:348964
\Hat1tm1.1Mrpa/\Hat1tm1.1Mrpa
(involves: C57BL/6J) 		decreased fibroblast proliferation J:199077
\Hat1tm1.1Mrpa/\Hat1tm1.1Mrpa
(B6.Cg-Hat1tm1.1Mrpa) 		decreased fibroblast proliferation J:296531
\Havcr2tm1Bmed/\Havcr2tm1Bmed
(B6.Cg-Havcr2tm1Bmed) 		decreased T cell proliferation J:189839
\Hbs1ltm1c(KOMP)Wtsi/\Hbs1ltm1c(KOMP)Wtsi
\En1tm2(cre)Wrst/\En1+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6NTac) 		increased neuronal precursor proliferation J:306384
\Hccstm1Tcc/Y
\Nkx2-5tm2(cre)Rph/\Nkx2-5+
(involves: 129S1/Sv) 		decreased fetal cardiomyocyte proliferation J:143285
\Hccstm1Tcc/\Hccs+
\Nkx2-5tm2(cre)Rph/\Nkx2-5+
\Tg(CAG-EGFP)D4Nagy/0
\Tg(Hmgcr-lacZ)H253Sest/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		abnormal fetal cardiomyocyte proliferation J:143285
\Hcfc1tm1Lwh/\Hcfc1+
\Edil3Tg(Sox2-cre)1Amc/\Edil3+
(involves: C57BL/6 * CBA) 		decreased cell proliferation J:231596
\Hcfc1tm1Lwh/\Hcfc1tm1Lwh
\Edil3Tg(Sox2-cre)1Amc/\Edil3+
(involves: C57BL/6 * CBA) 		decreased cell proliferation J:231596
\Hcls1tm1Wtn/\Hcls1tm1Wtn
(involves: 129P2/OlaHsd * C57BL/6) 		decreased T cell proliferation J:28146
\Hcls1tm2Wtn/\Hcls1tm2Wtn
(involves: 129P2/OlaHsd * C57BL/6) 		decreased T cell proliferation J:28146
\Hdac1tm1.1Mrl/\Hdac1tm1.1Mrl
\Hdac2tm1.1Rdp/\Hdac2tm1.1Rdp
\Gt(ROSA)26Sortm2(cre/ERT2)Brn/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		decreased fibroblast proliferation J:197818
\Hdac1tm1.1Pmt/\Hdac1tm1.1Pmt
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		decreased cell proliferation J:157903
\Hdac1tm1.1Pmt/\Hdac1tm1.1Pmt
\Hdac2tm1.1Pmt/\Hdac2tm1.1Pmt
\Tg(Fcer2a-cre)5Mbu/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA * FVB/N) 		decreased B cell proliferation J:157903
\Hdac1tm1.1Shmc/\Hdac1tm1.1Shmc
\Hdac2tm1.1Shmc/\Hdac2tm1.1Shmc
\Tg(Lck-cre)1Cwi/0
(involves: 129S7/SvEvBrd) 		increased T cell proliferation J:194769
\Hdac2Gt(W035F03)Joe/\Hdac2Gt(W035F03)Joe
(Not Specified) 		increased fetal cardiomyocyte proliferation J:121697
\Hdac2tm1.2Eno/\Hdac2tm1.2Eno
(involves: 129S/SvEv * C57BL/6 * CD-1) 		increased fetal cardiomyocyte proliferation J:123173
\Hdac3tm1Swh/\Hdac3tm1.1Swh
(involves: 129S6/SvEvTac * FVB/N) 		decreased cell proliferation J:134665
\Hdac3tm1Swh/\Hdac3tm1.1Swh
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA) 		increased hepatocyte proliferation J:134288
\Hdgfl2tm1Lex/\Hdgfl2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased fibroblast proliferation J:171883
\Hecw2tm1.1Fhe/\Hecw2tm1.1Fhe
(involves: C57BL/6J) 		decreased neuronal precursor proliferation J:306367
\Hellstm1Rarc/\Hellstm1Rarc
(involves: 129X1/SvJ * C57BL/6J) 		decreased cell proliferation J:107145
\Hey1tm1Kkb/\Hey1tm1Kkb
\Heyltm1Kkb/\Heyltm1Kkb
(B6.Cg-Hey1tm1Kkb Heyltm1Kkb) 		abnormal skeletal muscle satellite cell proliferation J:178310
\Hgftm1Jmw/\Hgftm1Jmw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased hepatocyte proliferation J:97145
\Hgftm1Jmw/\Hgftm1Jmw
\Rag2tm1Fwa/\Rag2tm1Fwa
(involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased hepatocyte proliferation J:97145
\Hgftm1Jmw/\Hgftm1Jmw
\Tg(Mx1-cre)29-4Her/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL) 		decreased hepatocyte proliferation J:97145
\Hhiptm1Amc/\Hhiptm1Amc
(involves: 129S1/Sv * 129X1/SvJ) 		decreased pancreatic beta cell proliferation J:85472
\Hhipl1tm1a(KOMP)Wtsi/\Hhipl1tm1a(KOMP)Wtsi
(B6J.B6N-Hhipl1tm1a(KOMP)Wtsi) 		decreased vascular smooth muscle cell proliferation J:280707
\Hif1atm1Rsjo/\Hif1atm1Rsjo
\Hif1antm1.2Rsjo/\Hif1antm1.2Rsjo
(involves: 129S1/Sv * 129X1/SvJ) 		decreased cell proliferation J:160941
\Hif1atm3Rsjo/\Hif1atm3Rsjo
(involves: 129S1/Sv * 129X1/SvJ) 		decreased cell proliferation J:116762
decreased hepatocyte proliferation J:152724
\Hif1atm3Rsjo/\Hif1atm3Rsjo
\Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		decreased vascular endothelial cell proliferation J:94773
\Hint1tm1Ibw/\Hint1tm1Ibw
(involves: 129 * C57BL/6) 		increased fibroblast proliferation J:84504
\Hipk1tm1Hko/\Hipk1tm1Hko
\Hipk2tm1Hko/\Hipk2tm1Hko
(involves: C57BL/6) 		decreased cell proliferation J:106931
\Hipk2tm1Afus/\Hipk2tm1Afus
(involves: 129X1/SvJ * C57BL/6) 		decreased cell proliferation J:156574
\Hipk3Gt(OST51087)Lex/\Hipk3Gt(OST51087)Lex
(involves: 129S5/SvEvBrd) 		decreased pancreatic beta cell proliferation J:194563
\Hk2tm1.1Uku/\Hk2tm1.1Uku
\Tg(GFAP-cre)25Mes/0
(B6.Cg-Hk2tm1.1Uku Tg(GFAP-cre)25Mes) 		abnormal neuronal precursor proliferation J:210113
\Hltftm1.1Arte/\Hltftm1.1Arte
(Not Specified) 		abnormal neuronal precursor proliferation J:193813
\Hmgn1tm1Mbus/\Hmgn1tm1Mbus
(involves: 129X1/SvJ) 		increased fibroblast proliferation J:100773
\Hmox1tm1.1Gkl/\Hmox1tm1.1Gkl
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129 * 129P2/OlaHsd * BALB/cJ * C57BL/6) 		increased splenocyte proliferation J:148498
\Hmox1tm1Mlee/\Hmox1tm1Mlee
(B6.129S2-Hmox1tm1Mlee) 		increased vascular smooth muscle cell proliferation J:106600
\Hnf1atm1Mya/\Hnf1atm1Mya
(involves: 129S2/SvPas) 		increased hepatocyte proliferation J:31627
\Hnf1atm2Mya/\Hnf1atm2Mya
(involves: 129S2/SvPas) 		increased hepatocyte proliferation J:31627
\Hnrnpltm1.1Tmo/\Hnrnpltm1.1Tmo
\Tg(Lck-cre)548Jxm/0
(B6.Cg-Hnrnpltm1.1Tmo Tg(Lck-cre)548Jxm) 		increased T cell proliferation J:188749
\Hopxtm1Eno/\Hopxtm1Eno
(involves: 129S6/SvEvTac) 		abnormal fetal cardiomyocyte proliferation J:79152
\Hoxb3osem1Kabo/\Hoxb3osem1Kabo
(C57BL/6J-Hoxb3osem1Kabo) 		increased kidney cell proliferation J:345935
\Hoxb3osem1Kabo/\Hoxb3osem1Kabo
\Pkd1tm1.1Pcha/\Pkd1tm1.1Pcha
(involves: 129 * C57BL/6J) 		increased kidney cell proliferation J:345935
\Hoxb3osem1Kabo/\Hoxb3osem1Kabo
\Pkd1tm2Ggg/\Pkd1tm2Ggg
\Tg(Pkhd1-cre)1Igr/0
(involves: 129S4/SvJae * C57BL/6J) 		increased kidney cell proliferation J:345935
\Hprt1b-m3/Y
\Impdh1tm1Bmi/\Impdh1tm1Bmi
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased splenocyte proliferation J:85443
decreased T cell proliferation J:85443
\Hprt1tm1(CAG-NRIP1)Vcls/Y
(involves: 129 * C57BL/6) 		abnormal enterocyte proliferation J:211324
\Hprt1tm1(CAG-NRIP1)Vcls/\Hprt1+
(involves: 129 * C57BL/6) 		abnormal enterocyte proliferation J:211324
\Hprt1tm1(Rcan1)Zyga/\Hprt1+
(B6.129P2-Hprt1tm1(Rcan1)Zyga) 		decreased vascular endothelial cell proliferation J:150286
\Hprt1tm4(CAG-Tbx18*,-Venus)Akis/Y
\Tbx18tm4(cre)Akis/\Tbx18+
(involves: 129S1/SvImJ * NMRI) 		decreased fetal cardiomyocyte proliferation J:210076
\Hprt1tm86(NR2E1,bEMS223)Ems/Y
(B6.Cg-Hprt1tm86(NR2E1,bEMS223)Ems) 		abnormal neuronal precursor proliferation J:183689
\Hprt1tm86(NR2E1,bEMS223)Ems/Y
\Nr2e1frc/\Nr2e1frc
(involves: 129P2/OlaHsd * 129S1/SvImJ * C57BL/6) 		abnormal neuronal precursor proliferation J:183689
\Hrhr/\Hrhr
(HRS/J) 		decreased T cell proliferation J:6375
\Hrhr/\Hrhr
\Ptgs1tm1Unc/\Ptgs1+
(involves: 129P2/OlaHsd * C57BL/6 * SKH1) 		increased cell proliferation J:121635
\Hrhr/\Hrhr
\Ptgs2tm1Unc/\Ptgs2+
(involves: 129P2/OlaHsd * C57BL/6 * SKH1) 		increased cell proliferation J:121635
\Hrhr/\Hrhr
\Tg(KRT14-Ptgs2)1Sumf/0
(involves: C57BL/6 * DBA/2 * FVB/N * SKH1) 		decreased cell proliferation J:121635
\Hrh1tm1Wtn/\Hrh1tm1Wtn
(involves: 129P2/OlaHsd * C57BL/6) 		decreased B cell proliferation J:111704
decreased T cell proliferation J:111704
\Hs6st1tm1Kkm/\Hs6st1tm1Kkm
\Hs6st2tm1.1Kkm/\Hs6st2tm1.1Kkm
(involves: 129P2/OlaHsd) 		decreased cell proliferation J:136555
\Hsd11b1tm1a(KOMP)Wtsi/\Hsd11b1+
(involves: C57BL/6Jcl * C57BL/6N) 		increased fibroblast proliferation J:214146
\Hsd11b1tm1a(KOMP)Wtsi/\Hsd11b1tm1a(KOMP)Wtsi
(involves: C57BL/6Jcl * C57BL/6N) 		abnormal fibroblast proliferation J:214146
increased fibroblast proliferation J:214146
\Hsd17b12Gt(A030E06)Wrst/\Hsd17b12Gt(A030E06)Wrst
(involves: 129S2/SvPas * C57BL/6N) 		decreased inner cell mass proliferation J:160025
\Hsh2dtm1Viss/\Hsh2dtm1Viss
(B6.129-Hsh2dtm1Viss) 		increased T cell proliferation J:111408
\Hspa5baffled/\Hspa5baffled
(FVB.Cg-Hspa5baffled) 		abnormal neuron proliferation J:191772
\Hspa5tm1.1Alee/\Hspa5tm1.1Alee
(involves: 129 * C57BL/6 * FVB/N) 		absent inner cell mass proliferation J:111416
\Hspb1tm1.1Jdn/\Hspb1tm1.1Jdn
(B6.129S2(Cg)-Hspb1tm1.1Jdn) 		decreased fibroblast proliferation J:209117
\Hspb7tm1.2Chen/\Hspb7tm1.2Chen
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		decreased fetal cardiomyocyte proliferation J:256653
\Hspg2tm1Nid/\Hspg2tm1Nid
(involves: 129X1/SvJ * C57BL/6) 		decreased chondrocyte proliferation J:67299
\Htatip2tm1Hx/\Htatip2+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased fibroblast proliferation J:87066
\Htatip2tm1Hx/\Htatip2tm1Hx
(involves: 129P2/OlaHsd * C57BL/6J) 		increased fibroblast proliferation J:87066
\Htr1btm1Rhn/\Htr1btm1Rhn
(involves: 129S2/SvPas) 		increased osteoblast proliferation J:146078
\Htr2btm1Kry/\Htr2btm1Kry
\Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * CBA/J) 		decreased pancreatic beta cell proliferation J:284574
\Htr2btm1Lum/\Htr2btm1Lum
(129S2/SvPas-Htr2btm1Lum) 		decreased fetal cardiomyocyte proliferation J:64067
\Htttm3Szi/\Htttm3Szi
(involves: 129S1/Sv) 		abnormal cell proliferation J:106763
decreased cell proliferation J:106763
\Hus1tm1Led/\Hus1tm1Led
(either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * Black Swiss)) 		absent fibroblast proliferation J:63869
\Hus1tm1Led/\Hus1tm2Rsw
(involves: 129S6/SvEvTac * C57BL/6) 		decreased cell proliferation J:118898
\Huwe1tm1Alas/Y
\Tg(Nes-cre)1Kag/0
(involves: 129S7/SvEvBrd) 		abnormal neuronal precursor proliferation J:152966
\Icmttm1Mbrg/\Icmttm1Mbrg
\Tg(Mx1-cre)1Cgn/?
(involves: 129S4/SvJae * C57BL/6 * CBA) 		decreased cell proliferation J:88170
\Icostm1Mak/\Icostm1Mak
(involves: 129P2/OlaHsd * C57BL/6) 		decreased T cell proliferation J:66702
\Id1tm1Zhu/\Id1tm1Zhu
(involves: 129S1/Sv * C57BL/6J) 		decreased lung endothelial cell proliferation J:125521
\Id1tm1Zhu/\Id1tm1Zhu
\Id3tm1Zhu/\Id3tm1Zhu
(involves: 129S1/Sv * 129S4/SvJaeSor) 		abnormal neuronal precursor proliferation J:86480, J:170418
\Id1tm3Bene/\Id1tm3Bene
\Id2tm1Xdz/\Id2tm1Xdz
\Id3tm1Zhu/\Id3tm1Zhu
\Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJaeSor * C57BL/6 * SJL) 		abnormal neuronal precursor proliferation J:185426
\Id2tm1Mcha/\Id2tm1Mcha
(involves: C57BL/6 * CD-1) 		abnormal neuronal precursor proliferation J:143882
\Id3tm1Zhu/\Id3tm1Zhu
(involves: 129/Sv * C57BL/6) 		decreased B cell proliferation J:56950
\Idd4C57BL/6/\Idd4C57BL/6
(involves: C57BL/6 * DBA/2) 		increased T cell proliferation J:25969
\Idd4C57BL/6/\Idd4C57BL/6
(involves: C57BL/6 * NOD) 		increased T cell proliferation J:25969
\Idd6C57BL/6/\Idd6NOD
(involves: C57BL/6 * NOD) 		decreased T cell proliferation J:72360
\Idd6NOD/\Idd6NOD
(involves: C57BL/6 * NOD) 		decreased T cell proliferation J:72360
\Ier3ip1tm1Arvn/\Ier3ip1tm1Arvn
\Tg(Ins1-cre/ERT)1Lphi/0
(involves: 129S4/SvJaeSor * C57BL/6J * CD-1) 		decreased pancreatic beta cell proliferation J:336782
\Ier3ip1tm1Arvn/\Ier3ip1tm1Arvn
\Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * C57BL/6J * DBA) 		decreased pancreatic beta cell proliferation J:336782
\Ifnb1tm1Acgp/\Ifnb1tm1Acgp
(involves: 129P2/OlaHsd) 		increased T cell proliferation J:86527
\Ifngtm1Ts/\Ifngtm1Ts
(involves: 129S7/SvEvBrd * C57BL/6) 		increased splenocyte proliferation J:66802
\Ifngr1tm1Agt/\Ifngr1tm1Agt
(involves: 129S7/SvEvBrd) 		increased hepatocyte proliferation J:38363
\Ifngr1tm1Agt/\Ifngr1tm1Agt
(involves: 129S7/SvEvBrd * C57BL/6) 		increased splenocyte proliferation J:99347
\Ift20tm1.1Gjp/\Ift20tm1.1Gjp
\Tg(Hoxb7-cre)13Amc/0
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6) 		increased kidney cell proliferation J:141071
\Ift27tm1a(EUCOMM)Hmgu/\Ift27tm1a(EUCOMM)Hmgu
(involves: C57BL/6N) 		decreased keratinocyte proliferation J:224085
\Ift140tm1b(KOMP)Wtsi/\Ift140tm1c(KOMP)Wtsi
\Tg(Hoxb7-cre)13Amc/?
(B6J.B6-Ift140tm1b(KOMP)Wtsi/Ift140tm1c(Komp)Wtsi Tg(Hoxb7-cre)13Amc) 		increased kidney cell proliferation J:181533
\Igf1rtm1Jcbr/\Igf1rtm1Jcbr
\Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * C57BL/6) 		increased hepatocyte proliferation J:221618
\Igf2tm1Rob/\Igf2+
(involves: 129S/SvEv * C57BL/6J) 		increased fetal cardiomyocyte proliferation J:77413
increased hepatocyte proliferation J:77413
\Igf2bp1Gt(OST33739)Lex/\Igf2bp1Gt(OST33739)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased cell proliferation J:89882
\Igf2bp1Gt(OST33739)Lex/\Igf2bp1Gt(OST33739)Lex
(involves: 129S5/SvEvBrd) 		decreased cell proliferation J:207231
\Igfbp7tm1.1Dds/\Igfbp7tm1.1Dds
(involves: CD-1) 		decreased fibroblast proliferation J:212964
decreased mammary gland epithelial cell proliferation J:212964
\Igh-Vtm1(Igh-Vx24)Hmb/\Igh-Vtm1(Igh-Vx24)Hmb
(involves: 129/Sv * C57BL/6) 		increased cell proliferation J:54380
\Ightm1(Myc)Janz/\Igh+
(involves: 129X1/SvJ * C57BL/6) 		increased B cell proliferation J:96785
\Ightm1(Myc)Janz/\Igh+
\Mdm4tm1.1Wahl/\Mdm4tm1.1Wahl
(involves: 129S/Sv * C57BL/6) 		increased splenocyte proliferation J:150341
\Ightm1.2Rsky/\Ightm1.2Rsky
(BALB/c-Ightm1.2Rsky) 		abnormal B cell proliferation J:125719
\Ightm1Mnz/\Ightm1Mnz
(B6.129P2-Ightm1Mnz) 		increased B cell proliferation J:75653
\Ightm1Mnz/\Ightm1Mnz
\Lyntm1Sor/\Lyntm1Sor
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6) 		increased B cell proliferation J:75653
\Ightm2Mnz/\Ightm2Mnz
(B6.129P2-Ightm2Mnz) 		increased B cell proliferation J:75653
\Ightm2Mnz/\Ightm2Mnz
\Lyntm1Sor/\Lyntm1Sor
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6) 		increased B cell proliferation J:75653
\Ighatm1(Myc)Janz/\Igha+
(involves: 129S1/Sv * C57BL/6) 		increased B cell proliferation J:90901
\Ighatm1Grh/\Ighatm1Grh
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased T cell proliferation J:125472
\Ighmtm1(Bcl6)Rdf/?
(involves: 129/Sv * C57BL/6) 		abnormal B cell proliferation J:98937
\Ighmtm1.1(IGH-2)Cog/\Ighmtm1.1(IGH-2)Cog
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		decreased B cell proliferation J:157575
increased B cell proliferation J:157575
\Ighmtm1Cgn/\Ighm+
\Tgfb1tm1Doe/\Tgfb1tm1Doe
(involves: 129S2/SvPas * C57BL/6 * CF-1) 		increased cell proliferation J:99033
\Ighmtm1Cgn/\Ighmtm1Cgn
(involves: 129S2/SvPas) 		decreased T cell proliferation J:112160
\Ighmtm1Cgn/\Ighmtm1Cgn
(NOD.129S2-Ighmtm1Cgn/DvsJ) 		abnormal T cell proliferation J:80859
\Ighmtm1Cgn/\Ighmtm1Cgn
\Tg(IghelMD4)4Ccg/\Tg(IghelMD4)4Ccg
(NOD.Cg-Ighmtm1Cgn Tg(IghelMD4)4Ccg/DvsJ) 		abnormal T cell proliferation J:80859
\Ighmtm3Bgmn/\Ighmtm3Bgmn
(involves: 129) 		decreased B cell proliferation J:131633
\Ighmtm4Bgmn/\Ighmtm4Bgmn
(involves: 129) 		decreased B cell proliferation J:131633
\Ihhtm1Amc/\Ihhtm1Amc
(involves: 129S1/Sv * 129X1/SvJ) 		decreased chondrocyte proliferation J:73071
\Ikbkgtm1.1Chtr/\Ikbkgtm1.1Chtr
\Map3k7tm1Aki/\Map3k7tm1Aki
\Tg(Alb1-cre)7Gsc/0
(involves: 129P2/OlaHsd * FVB/N) 		increased hepatocyte proliferation J:160521
\Ikbkgtm1.1Chtr/\Ikbkgtm1.1Chtr
\Tg(Alb1-cre)7Gsc/0
(involves: FVB/N) 		increased hepatocyte proliferation J:160521
\Ikbkgtm1.1Mpa/\Ikbkgtm1.1Mpa
\Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N) 		increased cell proliferation J:118336
\Ikzf1tm1Kast/\Ikzf1tm1Kast
(involves: 129S2/SvPas) 		decreased B cell proliferation J:82813
\Ikzf1tm1Kge/\Ikzf1+
(involves: 129S4/SvJae * C57BL/6) 		increased T cell proliferation J:29355
\Ikzf1tm1Kge/\Ikzf1+
(involves: 129S4/SvJae * BALB/c) 		increased T cell proliferation J:29355
\Ikzf1tm2Kge/\Ikzf1tm2Kge
(involves: 129S4/SvJae) 		increased T cell proliferation J:37317
\Ikzf3tm1Kge/\Ikzf3tm1Kge
(involves: 129S4/SvJae * C57BL/6) 		increased B cell proliferation J:50626
increased T cell proliferation J:50626
\Ikzf4tm1.1Etms/\Ikzf4tm1.1Etms
(Not Specified) 		decreased T cell proliferation J:295208
\Il1r1tm1Roml/\Il1r1tm1Roml
(C.Cg-Il1r1tm1Roml) 		decreased T cell proliferation J:82863
\Il1rntm1.1Cga/\Il1rntm1.1Cga
\Lyz2tm1(cre)Ifo/\Lyz2+
(D1.Cg-Il1rntm1.1Cga Lyz2tm1(cre)Ifo) 		increased T cell proliferation J:162760
\Il2tm1Hor/\Il2tm1Hor
(involves: 129P2/OlaHsd * C57BL/6) 		decreased splenocyte proliferation J:79241
decreased T cell proliferation J:39989, J:26198
increased B cell proliferation J:16662
increased T cell proliferation J:15223, J:16662
\Il2tm1Hor/\Il2tm1Hor
(C.129P2-Il2tm1Hor) 		increased B cell proliferation J:29799
increased T cell proliferation J:29799
\Il2tm1Hor/\Il2tm1Hor
(B6.129P2-Il2tm1Hor) 		increased T cell proliferation J:28924
\Il2tm1Hor/\Il2tm1Hor
(B6.129P2-Il2tm1Hor/J) 		abnormal T cell proliferation J:190168
\Il2tm1Hor/\Il2tm1Hor
\Il4tm1Cgn/\Il4tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell proliferation J:16662
increased T cell proliferation J:16662
\Il2tm1Hor/\Il2tm1Hor
\Tg(DO11.10)10Dlo/?
(C.Cg-Il2tm1Hor Tg(DO11.10)10Dlo) 		increased T cell proliferation J:88349
\Il2rbtm1Mak/\Il2rbtm1Mak
(B6.129-Il2rbtm1Mak) 		decreased T cell proliferation J:113547
\Il2rbtm1Mak/\Il2rbtm1Mak
(C.129-Il2rbtm1Mak) 		decreased T cell proliferation J:113547
\Il2rgtm1Cgn/Y
(involves: 129 * CB20) 		decreased T cell proliferation J:22521
\Il2rgtm1Cgn/\Il2rgtm1Cgn
(involves: 129 * CB20) 		decreased T cell proliferation J:22521
\Il2rgtm1Wjl/Y
(involves: 129S4/SvJae * C57BL/6) 		decreased T cell proliferation J:24117
\Il4ratm1Tch/\Il4ratm1Tch
(involves: 129X1/SvJ * BALB/c) 		decreased T cell proliferation J:86215
\Il5ratm1Ktk/\Il5ratm1Ktk
(B6.129P2-Il5ratm1Ktk) 		decreased B cell proliferation J:89849
\Il6tm1Kopf/\Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6) 		abnormal skeletal muscle satellite cell proliferation J:131016
\Il6tm1Poli/\Il6tm1Poli
(CAnNCrl.129S(Cg)-Il6tm1Poli) 		abnormal B cell proliferation J:42869
\Il6ratm1.2Jcbr/\Il6ratm1.2Jcbr
(involves: C57BL/6) 		decreased hepatocyte proliferation J:202764
\Il6sttm1Ard/\Il6sttm1Ard
(involves: 129S1/Sv * C57BL/6) 		increased cell proliferation J:79555
\Il7rtm1Abra/\Il7rtm1Abra
(B6.129S4-Il7rtm1Abra) 		abnormal T cell proliferation J:125360
\Il7rtm1Imx/\Il7rtm1Imx
\Tg(Lck-Il7r)1676Trma/?
(involves: 129S7/SvEvBrd * C57BL/6 * SJL) 		decreased T cell proliferation J:66400
\Il10tm1Cgn/\Il10tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6) 		decreased T cell proliferation J:125760
\Il10tm1Cgn/\Il10tm1Cgn
\Vdrtm1Mbd/\Vdrtm1Mbd
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		decreased T cell proliferation J:107077
\Il10ratm1.1Tlg/\Il10ratm1.1Tlg
\Tg(Cd4-cre)1Cwi/?
(B6.Cg-Tg(Cd4-cre)1Cwi Il10ratm1.1Tlg) 		decreased splenocyte proliferation J:189797
\Il15ratm1.1Nsl/\Il15ratm1.1Nsl
(B6.129X1-Il15ratm1.1Nsl) 		abnormal T cell proliferation J:92705
increased T cell proliferation J:92705
\Il15ratm1.1Nsl/\Il15ratm1.1Nsl
\Tg(TcrAND)53Hed/?
(involves: 129X1/SvJ * C57BL/6 * SJL) 		increased T cell proliferation J:92705
\Il15ratm1Ama/\Il15ratm1Ama
(involves: 129X1/SvJ) 		decreased T cell proliferation J:142570
\Il15ratm1Wjl/\Il15ratm1Wjl
(involves: 129 * C57BL/6) 		decreased T cell proliferation J:142570
\Il17a/Il17ftm1.1Impr/\Il17a/Il17ftm1.1Impr
(involves: C57BL/6) 		increased T cell proliferation J:187400
\Il17a/Il17ftm1.1Impr/\Il17a/Il17ftm1.1Impr
(involves: C57BL/6) 		increased T cell proliferation J:187400
\Il17ctm1Lex/\Il17ctm1Lex
(B6.129S5-Il17ctm1Lex) 		decreased keratinocyte proliferation J:178967
\Il20rbtm1Uwe/\Il20rbtm1Uwe
(B6.129P2-Il20rbtm1Uwe) 		increased T cell proliferation J:143497
\Il21rtm1Wjl/\Il21rtm1Wjl
(NOD.Cg-Il21rtm1Wjl) 		decreased T cell proliferation J:139075
\Il23atm1.1Thak/\Il23atm1.1Thak
(C57BL/6-Il23atm1.1Thak) 		decreased T cell proliferation J:143970
\Il27ratm1Mak/\Il27ratm1Mak
(B6.129P2-Il27ratm1Mak) 		increased T cell proliferation J:89509
\Il31ratm1Ngh/\Il31ratm1Ngh
(involves: C57BL/6) 		increased T cell proliferation J:123198
\Ilktm1Star/\Ilktm1Star
\Tg(KRT14-cre)1Amc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		decreased keratinocyte proliferation J:172934
\Ilktm3Ref/\Ilktm3Ref
\Tg(Col2a1-cre)1Asz/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		decreased cell proliferation J:110783
\Impdh1tm1Bmi/\Impdh1tm1Bmi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased T cell proliferation J:85443
\Impdh1tm1Bmi/\Impdh1tm1Bmi
\Impdh2tm1Bmi/\Impdh2+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased splenocyte proliferation J:85443
decreased T cell proliferation J:85443
\Inca1tm1Cmt/\Inca1tm1Cmt
(involves: 129 * C57BL/6N) 		decreased fibroblast proliferation J:175667
\Ing1Gt(F066C08)Irpa/\Ing1Gt(F066C08)Irpa
(involves: 129S2/SvPas) 		increased fibroblast proliferation J:126798
\Ing1Gt(OST206270)Lex/\Ing1Gt(OST206270)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased fibroblast proliferation J:118602
\Ing1Gt(OST206270)Lex/\Ing1Gt(OST206270)Lex
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S5/SvEvBrd * 129S7/SvEvBrd * C57BL/6) 		increased cell proliferation J:118602
\Inhatm1Bay/\Inhatm1Bay
(involves: 129S7/SvEvBrd * C57BL/6) 		increased Sertoli cell proliferation J:125349
\Ino80tm1Schg/\Ino80tm1Schg
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6 * CBA) 		decreased fibroblast proliferation J:221224
\Ins1tm1.1(cre)Thor/\Ins1+
\Med15tm1c(KOMP)Wtsi/\Med15tm1c(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N) 		increased pancreatic beta cell proliferation J:355262
\Ins1tm1Jja/\Ins1tm1Jja
\Ins2tm1Jja/\Ins2tm1Jja
(involves: 129S2/SvPas * C57BL/6) 		increased pancreatic alpha cell proliferation J:106827
increased pancreatic beta cell proliferation J:106827
\Ins2Akita/\Ins2Akita
\Jazf1tm1c(EUCOMM)Wtsi/\Jazf1tm1c(EUCOMM)Wtsi
\Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJaeSor * C57BL/6N * C57BL/6NSlc * CBA/J) 		decreased pancreatic beta cell proliferation J:303318
\Insctm1Jakn/\Insctm1Jakn
\Tg(Nes-cre)1Wmz/0
(involves: C57BL/6) 		abnormal neuronal precursor proliferation J:178712
\Insm1tm1.1(GFP/cre)Mgn/\Insm1tm1.1(GFP/cre)Mgn
(involves: 129S6/SvEvTac * CD-1 * SJL) 		decreased pancreatic endocrine progenitor cell proliferation J:214095
\Ip6k2tm1Dlin/\Ip6k2tm1Dlin
(involves: 129X1/SvJ * Black Swiss * C57BL/6) 		increased fibroblast proliferation J:151345
\Irak4tm1Aki/\Irak4tm1Aki
(involves: 129X1/SvJ * C57BL/6) 		decreased B cell proliferation J:125729
\Irak4tm1Yeh/\Irak4tm1Yeh
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased B cell proliferation J:76098
\Irak4tm2Aki/\Irak4tm2Aki
(involves: 129X1/SvJ * C57BL/6) 		decreased B cell proliferation J:125729
\Irf1tm1Cwe/\Irf1tm1Cwe
(involves: 129) 		abnormal T cell proliferation J:84367
\Irf2tm1Mak/\Irf2tm1Mak
(either: (involves: 129S2/SvPas * C57BL/6J) or (involves: 129S2/SvPas * C57BL/6J * DBA/2)) 		decreased B cell proliferation J:64286
\Irf4tm1.1Rdf/\Irf4tm1.1Rdf
(involves: 129S1/Sv * 129S4/SvJae * C57BL/6) 		decreased B cell proliferation J:112643
\Irf4tm1Mak/\Irf4tm1Mak
(involves: 129P2/OlaHsd) 		decreased B cell proliferation J:42683
decreased T cell proliferation J:42683
\Irf6Gt(OST398253)Lex/\Irf6Gt(OST398253)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased keratinocyte proliferation J:115343
\Irs1Sml/\Irs1Sml
(C3.Cg-Irs1Sml H2b/GrsrJ) 		decreased osteoblast proliferation J:163661
\Irs1tm1Tka/\Irs1tm1Tka
(involves: C57BL/6 * CBA) 		decreased cell proliferation J:89532
\Irs2tm1.1With/\Irs2tm1.1With
(B6.129S6-Irs2tm1.1With) 		decreased granulosa cell proliferation J:122064
\Itga11tm1Dgul/\Itga11tm1Dgul
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased cell proliferation J:122349
\Itgadtm1Bll/\Itgadtm1Bll
(B6.129S7-Itgadtm1Bll) 		decreased T cell proliferation J:90954
\Itgaltm1Bll/\Itgaltm1Bll
(B6.129S7-Itgaltm1Bll) 		decreased T cell proliferation J:90954
\Itgamtm1Bll/\Itgamtm1Bll
(B6.129S7-Itgamtm1Bll) 		decreased T cell proliferation J:90954
\Itgaxtm1Bll/\Itgaxtm1Bll
(B6.129S7-Itgaxtm1Bll) 		increased T cell proliferation J:122187
\Itgb1tm1Ehi/\Itgb1tm1Ehi
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		decreased cell proliferation J:76216
decreased fibroblast proliferation J:76216
\Itgb1tm1Ref/\Itgb1tm1Ref
\Tg(Col2a1-cre)1Asz/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		decreased chondrocyte proliferation J:85994
\Itgb1tm1Ref/\Itgb1tm2Ref
\Tg(Col2a1-cre)1Asz/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		decreased chondrocyte proliferation J:85994
\Itgb1tm1Ref/\Itgb1tm5.1Ref
\Tg(KRT5-cre)5132Jlj/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2J) 		decreased keratinocyte proliferation J:148885
\Itgb1tm1Ref/\Itgb1tm15.1Ref
\Tg(KRT5-cre)5132Jlj/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2J) 		decreased keratinocyte proliferation J:203018
\Itgb1tm1Ross/\Itgb1tm1Ross
\Tg(Hoxb7-cre)13Amc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased kidney cell proliferation J:149831
\Itgb2tm1.1Arte/\Itgb2tm1.1Arte
(involves: C57BL/6NTac) 		decreased T cell proliferation J:202261
\Itgb2tm2Bay/\Itgb2tm2Bay
(involves: 129S7/SvEvBrd * C57BL/6J) 		abnormal T cell proliferation J:48542
\Itgb2tm2Bay/\Itgb2tm2Bay
(involves: 129S7/SvEvBrd) 		decreased T cell proliferation J:90954
\Itgb3tm1Hyn/\Itgb3tm1Hyn
(involves: 129S2/SvPas) 		decreased keratinocyte proliferation J:96049
\Itgb4tm1Fgg/\Itgb4tm1Fgg
(involves: 129S1/Sv * C57BL/6) 		abnormal enterocyte proliferation J:48924
\Itih4tm1Mish/\Itih4tm1Mish
\Sptbn1tm1Mish/\Sptbn1+
(involves: 129S6/SvEvTac * C57BL/6 * NIH Black Swiss) 		decreased hepatocyte proliferation J:132133
\Itih5tm1Jmba/\Itih5tm1Jmba
(involves: BALB/cJ) 		decreased keratinocyte proliferation J:359049
\Itkm1Btlr/\Itkm1Btlr
(C57BL/6J-Itkm1Btlr) 		abnormal cell proliferation J:236673
increased CD8-positive, alpha-beta memory T cell proliferation J:236673
\Itktm1Litt/\Itktm1Litt
(involves: 129S4/SvJae * C57BL/6J) 		decreased T cell proliferation J:31230
\Itktm1Litt/\Itktm1Litt
(involves: 129S4/SvJae) 		decreased T cell proliferation J:54449
\Itktm1Litt/\Itktm1Litt
(B6.129S4-Itktm1Litt) 		decreased T cell proliferation J:141390
\Itktm1Litt/\Itktm1Litt
\Txktm1Pls/\Txktm1Pls
(involves: 129S4/SvJae * 129S6/SvEvTac) 		decreased T cell proliferation J:54449
\Itln1em1Cya/\Itln1em1Cya
(involves: C57BL/6) 		decreased osteoblast proliferation J:282124
\Jak3tm1Flv/\Jak3tm1Flv
(involves: 129S1/Sv) 		abnormal T cell proliferation J:95794
\Jak3tm1Ljb/\Jak3tm1Ljb
(involves: 129S4/SvJae * C57BL/6) 		decreased T cell proliferation J:29722
\Jak3tm1Ljb/\Jak3tm1Ljb
(involves: 129S4/SvJae) 		decreased T cell proliferation J:128694
\Jak3tm1Ljb/\Jak3tm1Ljb
\Tg(Lck-Jak3)1Ljb/0
(involves: 129S4/SvJae * C3H * C57BL/6 * C57BL/10) 		decreased T cell proliferation J:128694
\Jak3tm1Ljb/\Jak3tm1Ljb
\Tg(Lck-Jak3)2Ljb/0
(involves: 129S4/SvJae * C3H * C57BL/6 * C57BL/10) 		decreased T cell proliferation J:128694
\Jarid2Gt(ROSA)1Gel/\Jarid2Gt(ROSA)1Gel
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased fetal cardiomyocyte proliferation J:100923
\Jdp2tm1Kkyo/\Jdp2tm1Kkyo
(involves: 129P2/OlaHsd * C57BL/6) 		increased cell proliferation J:166559
\Juntm1Pa/\Juntm1Pa
(either: (involves: 129S/SvEv * 129X1/SvJ) or (involves: 129X1/SvJ * C57BL/6J)) 		decreased fibroblast proliferation J:13175
\Juntm1Rsjo/\Juntm1Rsjo
\Tg(KRT14-cre)8Brn/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		decreased keratinocyte proliferation J:84743
\Juntm1Wag/\Juntm1Wag
(involves: 129S2/SvPas) 		decreased cell proliferation J:175212
\Juntm1Wag/\Juntm1Wag
(involves: 129S2/SvPas * C57BL/6) 		decreased hepatocyte proliferation J:55508
\Juntm1Wag/\Juntm1Wag
\Tg(Junb)1598Angl/0
(involves: 129S2/SvPas * C57BL/6) 		abnormal cell proliferation J:75359
\Juntm2.1Wag/\Juntm2.1Wag
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		decreased cell proliferation J:53481
\Juntm5.1(Junb)Wag/\Juntm5.1(Junb)Wag
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal cell proliferation J:75359
\Juntm6.1(Jund)Wag/\Juntm6.1(Jund)Wag
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased cell proliferation J:175212
\Juntm6.1(Jund)Wag/\Juntm6.1(Jund)Wag
\Jundtm1Mya/\Jundtm1Mya
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6) 		decreased fibroblast proliferation J:175212
\Jundtm1Mya/\Jundtm1Mya
(either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6)) 		decreased fibroblast proliferation J:65879
increased cell proliferation J:65879
increased T cell proliferation J:89085
\Kank4em1Jhhu/\Kank4em1Jhhu
(C57BL/6J-Kank4em1Jhhu) 		decreased endothelial cell proliferation J:326312
\Kat2atm2Roth/\Kat2atm2Roth
(involves: 129S7/SvEvBrd * C57BL/6J) 		decreased fibroblast proliferation J:121357
\Kat8tm1.1Avo/\Kat8tm1.1Avo
(involves: BALB/cJ * C57BL/6) 		absent inner cell mass proliferation J:139761
decreased trophectoderm cell proliferation J:139761
\Katna1tm1a(KOMP)Wtsi/\Katna1+
(involves: C57BL/6J * C57BL/6N) 		abnormal neuronal precursor proliferation J:284578
decreased neuronal precursor proliferation J:284578
\Katnb1tm1a(EUCOMM)Hmgu/\Katnb1tm1a(EUCOMM)Hmgu
(C57BL/6-Katnb1tm1a(EUCOMM)Hmgu) 		abnormal neuronal precursor proliferation J:220901
decreased fibroblast proliferation J:220901
\Kcna5tm1Hket/\Kcna5tm1Hket
(involves: 129S6/SvEvTac * 129S7/SvEvBrd) 		abnormal cell proliferation J:116545
\Kdf1shd/\Kdf1shd
(involves: C3HeB/FeJ * C57BL/6J) 		increased keratinocyte proliferation J:203995
\Kdm2atm1d(KOMP)Mtok/\Kdm2atm1d(KOMP)Mtok
(involves: C57BL/6 * C57BL/6JJcl * C57BL/6N) 		abnormal neuron proliferation J:217589
\Kdm2btm1Nobu/\Kdm2btm1Nobu
(either: (involves: 129S/SvEv * 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6J)) 		abnormal neuronal precursor proliferation J:171291
\Kdm4btm1.1Okad/\Kdm4btm1.1Okad
(involves: 129P2/OlaHsd) 		decreased mammary gland epithelial cell proliferation J:171678
\Kdm5atm1.1Kael/\Kdm5a+
\Rb1tm1Tyj/\Rb1tm1Tyj
(involves: 129S2/SvPas * 129S6/SvEvTac * FVB/N) 		increased fibroblast proliferation J:175625
\Kdm6btm1.1Cdcn/\Kdm6btm1.1Cdcn
(involves: C57BL/6) 		decreased chondrocyte proliferation J:233350
\Kdm6btm1.1Rfw/\Kdm6btm1.1Rfw
(Not Specified) 		increased cell proliferation J:228713
\Kdm8tm1Tasu/\Kdm8tm1Tasu
(involves: 129S4/SvJae * C57BL/6) 		decreased cell proliferation J:181189
\Kif3atm2Gsn/\Kif3atm2Gsn
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J) 		increased cranial neural crest cell proliferation J:158523
\Kif14lag/\Kif14lag
(B6.D2(129X1)-Kif14lag) 		decreased cell proliferation J:195809
\Kif18agcd2/\Kif18agcd2
(CAST.129S1(B6)-Kif18agcd2/JcsMmjax) 		decreased fibroblast proliferation J:222418
\Kif18atm1Zgwg/\Kif18atm1Zgwg
(either: 129-Kif18atm1Zgwg or (involves: 129 * C57BL/6J)) 		decreased cell proliferation J:211103
\Kif20bmagoo/\Kif20bmagoo
(involves: BALB/c * C57BL/6 * C57BL/6J * FVB/N) 		abnormal neuronal precursor proliferation J:205043
\Kif26atm1.1Noh/\Kif26atm1.1Noh
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J) 		abnormal neuronal precursor proliferation J:154859
\Kittm1Hntr/\Kittm1Hntr
(either: (involves: 129/Sv * C57BL/6 * DBA/2) or (involves: 129S1)) 		abnormal spermatogonia proliferation J:60192
\KitW-e/\KitW-e
(involves: 101 * C3H) 		decreased primordial germ cell proliferation J:16216
\KitlSl-36R/\KitlSl-36R
(C3H-KitlSl-36R) 		decreased primordial germ cell proliferation J:115437
\KitlSl-39R/\KitlSl-39R
(C3.B10Rl-KitlSl-39R) 		decreased primordial germ cell proliferation J:115437
\KitlSl-d/\KitlSl-d
(C3.D2-KitlSl-d) 		decreased primordial germ cell proliferation J:115437
\KitlSl-gb/\KitlSl-gb
(C3.Cg-KitlSl-gb) 		abnormal primordial germ cell proliferation J:115437
\Kitltm2.1Pbes/\Kitltm2.1Pbes
(involves: 129S1/Sv * C57BL/6J * FVB/N) 		decreased cell proliferation J:157170
\Klf4tm1Khk/\Klf4tm1Khk
\Tg(Klf4-cre/ERT)1Wai/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		increased keratinocyte proliferation J:187932, J:189337
\Klf5Gt(XB751)Byg/\Klf5Gt(XB751)Byg
(B6.129P2-Klf5Gt(XB751)Byg) 		decreased inner cell mass proliferation J:168150
decreased trophectoderm cell proliferation J:168150
\Klf5tm1.1Jwel/\Klf5tm1.1Jwel
(Not Specified) 		decreased inner cell mass proliferation J:168150
decreased trophectoderm cell proliferation J:168150
\Klf5tm1Jaw/\Klf5tm1Jaw
\Tg(Pax6-cre,GFP)1Pgr/0
(involves: FVB) 		increased cell proliferation J:175263
\Klf6tm1Fdmn/\Klf6tm1Fdmn
(involves: C57BL/6) 		decreased cell proliferation J:122926
\Klf10tm1Wkle/\Klf10tm1Wkle
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased keratinocyte proliferation J:182595
\Kmt2atm1.1Jjdh/\Kmt2atm1.1Jjdh
(involves: 129X1/SvJ) 		decreased fibroblast proliferation J:112159
\Kmt2atm1.1Jjdh/\Kmt2atm1.1Jjdh
\Kmt2btm1Jjdh/\Kmt2btm1Jjdh
(involves: 129X1/SvJ) 		decreased fibroblast proliferation J:112159
\Kmt2ctm1.1Jwle/\Kmt2ctm1.1Jwle
(involves: 129S4/SvJae * 129X1/SvJ) 		decreased cell proliferation J:116064
\Kmt2dtm1.1Kaig/\Kmt2dtm1.1Kaig
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell proliferation J:228913
\Kmt2dtm1.1Kaig/\Kmt2dtm1.1Kaig
\Tg(Tnnt2-cre)5Blh/0
(B6.Cg-Kmt2dtm1.1Kaig Tg(Tnnt2-cre)5Blh) 		decreased fetal cardiomyocyte proliferation J:229890
\Kmt5btm1.1Jnw/\Kmt5btm1.1Jnw
\Kmt5ctm1.1Jnw/\Kmt5ctm1.1Jnw
(involves: 129 * C57BL/6J) 		decreased fibroblast proliferation J:139510
\Knstrntm1d(KOMP)Wtsi/\Knstrntm1d(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N) 		abnormal spermatogonia proliferation J:232595
\Krastm1.1Hbji/\Krastm1.1Hbji
\Trp53tm5Tyj/\Trp53tm5Tyj
(involves: 129S4/SvJae) 		increased fibroblast proliferation J:220921
\Krastm1Bbd/\Kras+
\Polr2atm1(cre/ERT2)Bbd/\Polr2atm1(cre/ERT2)Bbd
\Raf1tm2Bacc/\Raf1tm2Bacc
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ) 		decreased cell proliferation J:172200
\Krastm1Bbd/\Kras+
\Tg(CMV-cre)1Cgn/?
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6) 		abnormal cell proliferation J:86101
\Krastm1Bbd/\Kras+
\Tg(CMV-cre/ERT)1Ipc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		abnormal fibroblast proliferation J:86101
\Krastm1Bbd/\Krastm2Bbd
\Polr2atm1(cre/ERT2)Bbd/\Polr2atm1(cre/ERT2)Bbd
(involves: 129S1/Sv * 129X1/SvJ) 		increased cell proliferation J:161780
\Krastm1Mok/\Krastm1Mok
(involves: 129S/SvEv * C57BL/6J) 		decreased fetal cardiomyocyte proliferation J:42943
\Krastm4.1Bbd/\Krastm4.1Bbd
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6J * FVB/N) 		increased cell proliferation J:223433
\Krastm4Tyj/\Kras+
\Krt19tm1(cre/ERT)Ggu/\Krt19+
(involves: 129S4/SvJae * 129S6/SvEvTac) 		increased cell proliferation J:172048
\Krastm4Tyj/\Kras+
\Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		increased splenocyte proliferation J:87429
\Krastm4Tyj/\Krastm4Tyj
(B6.129S4-Krastm4Tyj) 		increased cell proliferation J:187371
\Krt2tm1a(KOMP)Wtsi/\Krt2tm1a(KOMP)Wtsi
(involves: C57BL/6N) 		increased keratinocyte proliferation J:214772
\Krt7tm1Whim/\Krt7tm1Whim
(involves: 129P2/OlaHsd * C57BL/6) 		increased cell proliferation J:196575
\Krt9tm1(KOMP)Vlcg/\Krt9tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac) 		increased keratinocyte proliferation J:206051
\Krt16tm1(KOMP)Vlcg/\Krt16tm1(KOMP)Vlcg
(C57BL/6-Krt16tm1(KOMP)Vlcg) 		increased cell proliferation J:184621
\Ksr1tm1Kole/\Ksr1tm1Kole
(involves: 129S1/Sv * C57BL/6) 		decreased cell proliferation J:84644
\Ksr1tm1Shaw/\Ksr1tm1Shaw
(Not Specified) 		decreased T cell proliferation J:75739
\Ksr1tm1Shaw/\Ksr1tm1Shaw
\Tg(DO11.10)10Dlo/0
(involves: BALB/c * C3H * C57BL/6) 		decreased T cell proliferation J:75739
\Lama5tm1Jhm/\Lama5tm2Jhm
\Tg(SFTPC-rtTA)5Jaw/?
\Tg(tetO-cre)1Jaw/?
(involves: 129S1/Sv * 129X1/SvJ) 		decreased cell proliferation J:104565
\Lamtor2tm1.1Lah/\Lamtor2tm1.1Lah
\Tg(KRT5-cre)1Tak/0
(involves: 129P2/OlaHsd * C3H * C57BL/6 * SJL) 		decreased cell proliferation J:119075
\Lancl1tm1.1Pfw/\Lancl1tm1.1Pfw
(involves: 129 * C57BL/6) 		abnormal spermatogonia proliferation J:324139
\Laptm5tm1Jow/\Laptm5tm1Jow
(C57BL/6-Laptm5tm1Jow) 		increased T cell proliferation J:137841
\Larp7tm1Ymat/\Larp7tm1Ymat
(involves: 129P2/OlaHsd * C57BL/6) 		decreased primordial germ cell proliferation J:191206
\Lat2tm1Wz/\Lat2tm1Wz
(B6.Cg-Lat2tm1Wz) 		increased T cell proliferation J:116157
\Lattm1.1Lov/\Lattm1.1Lov
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased T cell proliferation J:77099
increased T cell proliferation J:77099
\Lattm1.1Mal/\Lattm1.1Mal
(involves: 129S2/SvPas) 		increased T cell proliferation J:77098
\Lattm1.1Mal/\Lattm1.1Mal
(involves: 129S2/SvPas * C57BL/6) 		abnormal T cell proliferation J:131351
\Lats1tm1Noj/\Lats1tm1Noj
(involves: 129S2/SvPas * C57BL/6) 		increased fibroblast proliferation J:200232
\Lats2tm1Raz/\Lats2tm1Raz
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal cell proliferation J:93191
decreased cell proliferation J:93191
\Lbca1C57BL/6Igc/\Lbca1C57BL/6Igc
(involves: BALB/cIgc * C57BL/6Igc) 		increased B cell proliferation J:139348
\Lbca2BALB/cIgc/\Lbca2C57BL/6Igc
(involves: BALB/cIgc * C57BL/6Igc) 		increased B cell proliferation J:139348
\Lbca2C57BL/6Igc/\Lbca2C57BL/6Igc
(involves: BALB/cIgc * C57BL/6Igc) 		increased B cell proliferation J:139348
\Lbrlym3/\Lbrlym3
(C57BL/6-Lbrlym3) 		decreased T cell proliferation J:180355
\Lcktm1Dbs/\Lcktm1Dbs
(involves: C3H * C57BL/6) 		decreased T cell proliferation J:114660
\Lcktm1Dbs/\Lcktm1Dbs
\Tg(TcraTcrb)1100Mjb/0
(involves: C3H * C57BL/6) 		decreased T cell proliferation J:114660
\Lcktm1Litt/\Lcktm1.1Litt
\Tnfrsf4tm2(cre)Nik/\Tnfrsf4+
(involves: 129X1/SvJ) 		decreased T cell proliferation J:152472
\Lcp2tm1.1Wz/\Lcp2tm1.1Wz
(B6.Cg-Lcp2tm1.1Wz) 		decreased T cell proliferation J:150304
\Ldlrtm1Her/\Ldlrtm1Her
\Lrp1tm2Her/\Lrp1tm2Her
\Tg(Tagln-cre)1Her/0
(involves: 129S7/SvEvBrd * C57BL/6J * SJL) 		increased vascular smooth muscle cell proliferation J:82871
\Lepob/\Lepob
(involves: C57BL/6) 		decreased T cell proliferation J:164339
\Leprtm4Mgmj/\Leprtm4Mgmj
(B6.Cg-Leprtm4Mgmj) 		decreased T cell proliferation J:164339
\Lgals7tm1Ijmfp/\Lgals7tm1Ijmfp
(involves: 129 * C57BL/6 * SJL) 		increased keratinocyte proliferation J:263069
\Lgals9tm1.1Cfg/\Lgals9tm1.1Cfg
(involves: C57BL/6) 		increased B cell proliferation J:217719
\Lgr4tm1.1(cre/ERT2)Npa/\Lgr4tm1.1(cre/ERT2)Npa
(involves: C57BL/6) 		abnormal epidermal stem cell proliferation J:212415
\Lgr4tm1.1(cre/ERT2)Npa/\Lgr4tm1.1(cre/ERT2)Npa
\Lgr5tm1.1(cre/ERT2)Npa/\Lgr5tm1.1(cre/ERT2)Npa
(involves: C57BL/6) 		abnormal epidermal stem cell proliferation J:212415
decreased kidney cell proliferation J:212415
\Lgr4tm1.1Knis/\Lgr4tm1.1Knis
\Lgr5tm2.1Cle/\Lgr5tm2.1Cle
\Tg(Cyp1a1-cre)1Dwi/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		abnormal small intestinal crypt cell proliferation J:174842
\Lgr4tm1.1Knis/\Lgr4tm1.1Knis
\Tg(Cyp1a1-cre)1Dwi/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		abnormal small intestinal crypt cell proliferation J:174842
\Lgr5tm1(cre/ERT2)Cle/\Lgr5+
\Stk26tm2.1Zzh/\Stk26tm2.1Zzh
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal enterocyte proliferation J:322311
\Lhx5tm1Lmgd/\Lhx5tm1Lmgd
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		abnormal neuronal precursor proliferation J:55103
\Lhx9tm1Lmgd/\Lhx9tm1Lmgd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased primordial germ cell proliferation J:60621
\Liftm1Phb/\Lif+
(involves: 129S2/SvPas * C57BL/6 * DBA/2) 		decreased T cell proliferation J:77410
\Liftm1Phb/\Liftm1Phb
(involves: 129S2/SvPas * C57BL/6 * DBA/2) 		decreased T cell proliferation J:77410
\Liftm1Stw/\Liftm1Stw
(involves: 129S1/Sv * C57BL/6) 		increased vascular endothelial cell proliferation J:137720
\Lig1tm1Dwm/\Lig1tm1Dwm
(involves: 129P2/OlaHsd) 		decreased fibroblast proliferation J:75962
\Lig1tm3Dwm/\Lig1tm3Dwm
(involves: 129P2/OlaHsd * C57BL/6) 		decreased fibroblast proliferation J:77902
\Lig3tm1.1Pmc/\Lig3tm1.1Pmc
\Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL) 		abnormal neuronal precursor proliferation J:170077
\Lig4tiny/\Lig4tiny
(C57BL/6-Lig4tiny) 		decreased fibroblast proliferation J:122725
\Lig4tm1Fwa/\Lig4tm1Fwa
(involves: 129S6/SvEvTac * C57BL/6) 		decreased cell proliferation J:50865
\Lig4tm1Fwa/\Lig4tm1Fwa
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S6/SvEvTac * 129S7/SvEvBrd) 		increased fibroblast proliferation J:63078
\Lig4tm2.1Fwa/\Lig4tm2.1Fwa
(involves: 129S6/SvEvTac) 		decreased T cell proliferation J:157574
\Lims1tm1.2Chen/\Lims1tm1.2Chen
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss) 		decreased cell proliferation J:97635
\Lin9Gt(RRI306)Byg/\Lin9Gt(RRI306)Byg
(involves: 129P2/OlaHsd) 		absent inner cell mass proliferation J:162678
\Llgl1tm1.1Vv/\Llgl1tm1.1Vv
(Not Specified) 		abnormal neuronal precursor proliferation J:89028
\Llgl1tm1Vv/\Llgl1tm1Vv
\Meox2tm1(cre)Sor/\Meox2+
(involves: 129 * 129S4/SvJaeSor * C57BL/6J) 		abnormal neuronal precursor proliferation J:89028
\LmnaDhe/\Lmna+
(B6(D2)-LmnaDhe/TyGrsrJ) 		decreased fibroblast proliferation J:171665
\Lmnb1Gt(XA130)Byg/\Lmnb1Gt(XA130)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased cell proliferation J:91473
\Lmnb1tm1Yxz/\Lmnb1tm1Yxz
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6) 		abnormal neuronal precursor proliferation J:178993
\Lmnb1tm1Yxz/\Lmnb1tm1Yxz
\Lmnb2tm1Yxz/\Lmnb2tm1Yxz
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6) 		abnormal neuronal precursor proliferation J:178993
\Lmnb2tm1Ccof/\Lmnb2tm1Ccof
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal neuronal precursor proliferation J:158610
\Lmnb2tm1Yxz/\Lmnb2tm1Yxz
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6) 		abnormal neuronal precursor proliferation J:178993
\Lmr7BALB/cHeA/?
(involves: BALB/cHeA * STS/A) 		decreased splenocyte proliferation J:108764
\Lmr18BALB/cHeA/\Lmr18BALB/cHeA
(involves: BALB/cHeA * STS/A) 		decreased splenocyte proliferation J:108764
\Lmr18BALB/cHeA/\Lmr18CcS20/Dem
(involves: BALB/cHeA * STS/A) 		decreased splenocyte proliferation J:108764
\Lmx1adr-J/\Lmx1adr-J
(involves: C3H * C57BL/6) 		abnormal cell proliferation J:1460
\Lncucc1em1Bwu/\Lncucc1em1Bwu
(C57BL/6-Lncucc1em1Bwu) 		abnormal enterocyte proliferation J:340220
\Lrfn2Tg(CD2-Myb/en)5Kmw/\Lrfn2+
(involves: C57BL/10 * CBA) 		decreased T cell proliferation J:126456
\Lrfn2Tg(CD2-Myb/en)5Kmw/\Lrfn2Tg(CD2-Myb/en)5Kmw
(involves: C57BL/10 * CBA) 		decreased T cell proliferation J:126456
\Lrig1tm1Ita/\Lrig1tm1Ita
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased keratinocyte proliferation J:77286
\Lrp5tm2Kry/\Lrp5tm2Kry
\Tg(Vil1-cre)20Syr/0
(involves: C57BL/6 * DBA/2) 		decreased osteoblast proliferation J:146078
\Lrrc8atm1.1Geha/\Lrrc8atm1.1Geha
(B6.129S1(Cg)-Lrrc8atm1.1Geha) 		decreased T cell proliferation J:211308
\Ltb4r1tm1Tksh/\Ltb4r1tm1Tksh
(B6.Cg-Ltb4r1tm1Tksh) 		decreased cell proliferation J:118995
\Ltftm1.2Smoc/\Ltftm1.2Smoc
(involves: 129 * C57BL/6J) 		increased cell proliferation J:219007
\Lumtm1Chak/\Lumtm1Chak
(involves: 129S/Sv * CD-1) 		increased fibroblast proliferation J:89489
\Ly6atm1Pmf/\Ly6atm1Pmf
(B6.129P2-Ly6atm1Pmf) 		abnormal T cell proliferation J:42594
\Ly9tm1Mckn/\Ly9tm1Mckn
(involves: 129/Sv * C57BL/6) 		decreased T cell proliferation J:105482
\Ly86tm1Kmiy/\Ly86tm1Kmiy
(involves: 129P2/OlaHsd * C57BL/6) 		decreased B cell proliferation J:109720
\Ly96tm1Kmiy/\Ly96tm1Kmiy
(involves: 129P2/OlaHsd * C57BL/6) 		decreased B cell proliferation J:92494
\LyarGt(RRG292)Byg/\Lyar+
(involves: 129P2/OlaHsd * C57BL/6) 		decreased fibroblast proliferation J:263530
\LyarGt(RRG292)Byg/\LyarGt(RRG292)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		decreased fibroblast proliferation J:263530
\Lyntm1Sor/\Lyntm1Sor
(involves: 129S4/SvJae) 		increased B cell proliferation J:42037
\Lyntm1Sor/\Lyntm1Sor
(involves: 129S4/SvJaeSor) 		increased B cell proliferation J:146161
\Lyntm1Sor/\Lyntm1Sor
(involves: 129S4/SvJaeSor * C57BL/6) 		increased B cell proliferation J:71174
\Lyntm1Tya/\Lyntm1Tya
(involves: 129P2/OlaHsd * C57BL/6) 		decreased B cell proliferation J:29751
\Lynweeb/\Lynweeb
(C57BL/6-Lynweeb) 		increased B cell proliferation J:146161
\Lztr1tm1a(EUCOMM)Wtsi/\Lztr1+
(involves: C57BL/6N) 		increased cell proliferation J:268690
\Lzts1tm1Cro/\Lzts1tm1Cro
(involves: 129 * C57BL/6J) 		decreased fibroblast proliferation J:119989
X/\m1Nish
(involves: C57BL/6N) 		decreased T cell proliferation J:204833
\Mad2l1tm1Sorg/\Mad2l1tm1Sorg
(involves: 129S2/SvPas * C57BL/6) 		absent inner cell mass proliferation J:62829
\Mad2l1bptm1.2Itl/\Mad2l1bptm1.2Itl
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac) 		decreased fibroblast proliferation J:234643
\Mad2l2repro22/\Mad2l2repro22
(C3.B6(Cg)-Mad2l2repro22) 		decreased cell proliferation J:209515
\Magtm1Rod/\Magtm1Rod
(involves: 129S1/Sv * 129X1/SvJ) 		increased B cell proliferation J:217719
\MagohMos2/\Magoh+
(involves: BALB/cJ * C57BL/6J) 		abnormal neuron proliferation J:159625
\Magt1Gt(IST13422E1)Tigm/Y
(involves: C57BL/6N) 		increased B cell proliferation J:260923
\Malt1tm1Mak/\Malt1tm1Mak
(involves: 129P2/OlaHsd) 		decreased T cell proliferation J:109545
\Malt1tm1Vmd/\Malt1tm1Vmd
(involves: C57BL/6N) 		abnormal T cell proliferation J:86770
\Maml1tm1Mkit/\Maml1tm1Mkit
\Maml3tm1Mkit/\Maml3tm1Mkit
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal neuron proliferation J:178680
\Mamstrtm1.2Eno/\Mamstrtm1.2Eno
\Mrtfatm1Eno/\Mrtfatm1Eno
(involves: 129 * C57BL/6) 		abnormal skeletal muscle satellite cell proliferation J:179880
\Map2k5tm1Ctr/\Map2k5tm1Ctr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased cell proliferation J:95388
\Map3k2tm1Bisu/\Map3k2tm1Bisu
(Not Specified) 		increased T cell proliferation J:78072
\Map3k3tm1Bisu/\Map3k3tm2Bisu
\Tg(Lck-cre)548Jxm/0
(involves: C57BL/6 * CBA) 		abnormal T cell proliferation J:145923
\Map3k3tm1Kuro/\Map3k3tm1Kuro
\Tg(Lck-cre)1Jtak/0
(involves: C57BL/6) 		decreased T cell proliferation J:147103
\Map3k7tm1.1Aki/\Map3k7tm1.1Aki
(involves: 129P2/OlaHsd * C57BL/6) 		absent fibroblast proliferation J:112597
\Map3k7tm1Aki/\Map3k7tm1Aki
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		increased hepatocyte proliferation J:160521
\Map3k7tm1Aki/\Map3k7tm1Aki
\Tg(Alb1-cre)7Gsc/0
(involves: 129P2/OlaHsd * FVB/N) 		increased hepatocyte proliferation J:160521
\Map3k7tm1Aki/\Map3k7tm1Aki
\Tg(Lck-cre)1Jtak/0
(involves: 129P2/OlaHsd) 		decreased T cell proliferation J:112837
\Map3k8tm1.1Gkl/\Map3k8tm1.1Gkl
\Tg(Col6a1-cre)1Gkl/0
(involves: C57BL/6 * CBA * FVB/N) 		abnormal enterocyte proliferation J:193546
\Map3k8tm1.2Gkl/\Map3k8tm1.2Gkl
(involves: 129 * C57BL/6J * FVB/N) 		abnormal enterocyte proliferation J:193546
\Map3k8tm1Tmat/\Map3k8tm1Tmat
(involves: 129S/SvEv * C57BL/6) 		increased T cell proliferation J:92844
\Map4k1tm1Tht/\Map4k1tm1Tht
(involves: 129S7/SvEvBrd) 		increased T cell proliferation J:116613
\Map4k3Gt(RRO270)Byg/\Map4k3Gt(RRO270)Byg
(involves: 129P2/OlaHsd) 		decreased T cell proliferation J:177642
\Mapk1tm1Hed/\Mapk1tm1Hed
\Mapk3tm1Gpg/\Mapk3tm1Gpg
\Tg(Lck-cre)1Cwi/0
(involves: 129/Sv * C57BL/6 * DBA/2) 		abnormal T cell proliferation J:113280
\Mapk1tm1Hed/\Mapk1tm1Hed
\Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2) 		decreased T cell proliferation J:113280
\Mapk1tm1Melo/\Mapk1tm1Melo
\Tg(CAG-EGFP)B5Nagy/0
(chimera involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * CD-1) 		decreased fibroblast proliferation J:162580
\Mapk3tm1Gpg/\Mapk3tm1Gpg
(involves: 129) 		decreased T cell proliferation J:58468
\Mapk3tm1Gpg/\Mapk3tm1Gpg
(involves: 129/Sv * C57BL/6 * CD-1) 		decreased fibroblast proliferation J:162580
\Mapk8tm1Flv/\Mapk8tm1Flv
(involves: 129S1/Sv) 		increased T cell proliferation J:51510
\Mapk8tm1Flv/\Mapk8tm1Flv
\Mapk9tm1.1Rjd/\Mapk9tm1.1Rjd
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6) 		decreased fibroblast proliferation J:112737
\Mapk8tm1Rjd/\Mapk8tm1Rjd
\Mapk9tm2.1Rjd/\Mapk9tm2.1Rjd
\Lyz2tm1(cre)Ifo/\Lyz2+
(B6J.Cg-Lyz2tm1(cre)Ifo Mapk9tm2.1Rjd Mapk8tm1Rjd) 		decreased pancreatic beta cell proliferation J:192551
\Mapk8tm1Wag/\Mapk8+
\Mapk9tm1Mka/\Mapk9+
(involves: 129) 		decreased T cell proliferation J:78190
\Mapk8tm1Wag/\Mapk8+
\Mapk9tm1Mka/\Mapk9tm1Mka
(involves: 129) 		decreased T cell proliferation J:78190
\Mapk8tm1Wag/\Mapk8tm1Wag
(involves: 129P2/OlaHsd) 		decreased T cell proliferation J:78190
\Mapk8tm1Wag/\Mapk8tm1Wag
\Mapk9tm1Mka/\Mapk9+
(involves: 129) 		decreased T cell proliferation J:78190
\Mapk9tm1Mka/\Mapk9tm1Mka
(either: (involves: 129S2/SvPas) or (involves: 129S1/Sv * 129X1/SvJ)) 		decreased T cell proliferation J:78129
\Mapk11tm1Jda/\Mapk11tm1Jda
\Mapk14tm1Jda/\Mapk14tm1Jda
(involves: 129 * C57BL/6) 		decreased T cell proliferation J:165966
\Mapk11tm1Jsca/\Mapk11tm1Jsca
(involves: 129P2/OlaHsd) 		increased fetal cardiomyocyte proliferation J:176023
\Mapk11tm1Jsca/\Mapk11tm1Jsca
\Mapk14tm2Nbr/\Mapk14tm2Nbr
\Edil3Tg(Sox2-cre)1Amc/\Edil3+
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		abnormal neuron proliferation J:176023
decreased fetal cardiomyocyte proliferation J:176023
\Mapk14tm1.1Dvb/\Mapk14+
(B6(FVB)-Mapk14tm1.1Dvb) 		decreased pancreatic beta cell proliferation J:151980
increased pancreatic beta cell proliferation J:151980
\Mapk14tm1.1Lex/\Mapk14tm1.1Lex
(involves: 129S4/SvJaeSor * 129S5/SvEvBrd * C57BL/6J) 		increased myoblast proliferation J:119724
\Mapk14tm1Jda/\Mapk14tm1Jda
(B6.Cg-Mapk14tm1Jda) 		decreased T cell proliferation J:146088
\Mapk14tm2Nbr/\Mapk14tm2Nbr
\Polr2atm1(cre/ERT2)Bbd/\Polr2a+
(involves: 129 * C57BL/6 * CD-1 * SJL) 		increased cell proliferation J:122397
\Mapttm1(MAPT)Vln/\Mapttm1(MAPT)Vln
(involves: FVB/N) 		increased cell proliferation J:129032
\Marchf7Gt(ROSABetageo)1Summ/\Marchf7+
(involves: BALB/c) 		increased T cell proliferation J:96167
\Marchf7Gt(ROSABetageo)1Summ/\Marchf7Gt(ROSABetageo)1Summ
(involves: BALB/c) 		increased T cell proliferation J:96167
\Mark2tm1Hpw/\Mark2tm1Hpw
(involves: 129X1/SvJ * C57BL/6) 		decreased B cell proliferation J:68830
increased B cell proliferation J:68830
\Mast4em1Sjkm/\Mast4em1Sjkm
(C57BL/6J-Mast4em1Sjkm) 		abnormal spermatogonia proliferation J:340701
\Mastltm1.1Mama/\Mastltm1.1Mama
(Not Specified) 		decreased fibroblast proliferation J:201971
\Matcap1em1Nki/\Matcap1em1Nki
\Svbpem1Mjom/\Svbpem1Mjom
(involves: C57BL/6) 		decreased neuronal precursor proliferation J:325393
\Matn1tm1Ref/\Matn1tm1Ref
\Matn2tm1Asz/\Matn2tm1Asz
\Matn3tm1Asz/\Matn3tm1Asz
\Matn4tm1.1Asz/\Matn4tm1.1Asz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased hematopoietic stem cell proliferation J:237230
\Matn3tm1Mbri/\Matn3tm1Mbri
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased chondrocyte proliferation J:125104
\Matn4tm1.1Asz/\Matn4tm1.1Asz
(B6.129-Matn4tm1.1Asz) 		increased hematopoietic stem cell proliferation J:237230
\Mau2tm1.1Hpt/\Mau2tm1.1Hpt
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * CBA/J * SJL) 		decreased cranial neural crest cell proliferation J:213338
\Mavstm1Camb/\Mavstm1Camb
(involves: 129S6/SvEvTac * C57BL/6) 		decreased B cell proliferation J:180356
\Maxtm1Rdp/\Maxtm1Rdp
(either: B6.Cg-Maxtm1Rdp or CD1.Cg-Maxtm1Rdp) 		absent inner cell mass proliferation J:59430
\Mbd2tm1Bh/\Mbd2tm1Bh
(NOD.129P2(B6)-Mbd2tm1Bh) 		increased T cell proliferation J:323838
\Mbd3tm2Bh/\Mbd3tm2Bh
\Tg(Vil1-cre)20Syr/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		abnormal small intestinal crypt cell proliferation J:167984
\Mbpshi/\Mbpshi
(involves: BALB/c * C3HeB/Fe * SWV) 		increased T cell proliferation J:48412
\Mcm2Gt(AB0178)Wtsi/\Mcm2+
\Mcm3Gt(RRR002)Byg/\Mcm3+
\Mcm4chaos3/\Mcm4chaos3
(involves: 129P2/OlaHsd * C3HeB/FeJ * C57BL/6J) 		decreased fibroblast proliferation J:165667
\Mcm2Gt(AB0178)Wtsi/\Mcm2+
\Mcm4chaos3/\Mcm4chaos3
(involves: 129P2/OlaHsd * C3HeB/FeJ * C57BL/6J) 		decreased fibroblast proliferation J:165667
\Mcm3tm1.1Geno/\Mcm3tm1.1Geno
(involves: 129S2/SvPas * C57BL/6) 		decreased hematopoietic stem cell proliferation J:227638
\Mcm3aptm1Imku/\Mcm3aptm1Imku
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased B cell proliferation J:88276
\Mcm4chaos3/\Mcm4chaos3
(involves: C3HeB/FeJ * C57BL/6J) 		decreased cell proliferation J:117494
\Mcm4chaos3/\Mcm4Gt(RRE056)Byg
(B6.Cg-Mcm4chaos3 Mcm4Gt(RRE056)Byg) 		decreased fibroblast proliferation J:117494
\Mcm4Gt(RRE056)Byg/\Mcm4Gt(RRE056)Byg
(involves: 129P2/OlaHsd) 		absent inner cell mass proliferation J:117494
\Mcm8tm1.1Geno/\Mcm8tm1.1Geno
(involves: 129S2/SvPas * C57BL/6J) 		decreased fibroblast proliferation J:187623
\Mcm9tm1.1Geno/\Mcm9tm1.1Geno
(involves: 129S2/SvPas * C57BL/6J) 		decreased fibroblast proliferation J:187623
\Mcm10tm1Hlee/\Mcm10tm1Hlee
(involves: 129P2/OlaHsd * C57BL/6) 		decreased cell proliferation J:177618
\Mcph1tm1.1Zqw/\Mcph1tm1.1Zqw
(Not Specified) 		abnormal neuronal precursor proliferation J:180706
\Mcrs1tm1.1(KOMP)Vlcg/\Mcrs1tm1.1(KOMP)Vlcg
(B6N(Cg)-Mcrs1tm1.1(KOMP)Vlcg/J) 		decreased inner cell mass proliferation J:285737
\Mcutm1.1Jmol/\Mcutm1.1Jmol
\Tg(Cdh5-cre)7Mlia/0
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N) 		decreased lung endothelial cell proliferation J:235756
\Mcur1tm1c(KOMP)Wtsi/\Mcur1tm1c(KOMP)Wtsi
\Tg(Cdh5-cre)7Mlia/0
(involves: 129S4/SvJaeSor * C57BL/6N * FVB/N) 		decreased lung endothelial cell proliferation J:235756
\Mdc1Gt(OST441263)Lex/\Mdc1Gt(OST441263)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased cell proliferation J:137341
\Mdm2tm1.1Ypz/\Mdm2tm1.1Ypz
(B6.129-Mdm2tm1.1Ypz) 		increased cell proliferation J:164200
\Mdm2tm1Bay/\Mdm2tm1Mep
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased cell proliferation J:81065
\Mdm2tm3.1Glo/\Mdm2tm3.1Glo
(B6.129S6-Mdm2tm3.1Glo) 		increased fibroblast proliferation J:164201
\Mdm4Gt(VICTR20)7Lex/\Mdm4Gt(VICTR20)7Lex
(involves: 129S5/SvEvBrd) 		decreased cell proliferation J:77907
\Mdm4Gt(VICTR20)7Lex/\Mdm4Gt(VICTR20)7Lex
(involves: 129S5/SvEvBrd * 129S6/SvEvTac * C57BL/6 * FVB/N) 		decreased cell proliferation J:166152
\Mdm4Gt(VICTR20)7Lex/\Mdm4Gt(VICTR20)7Lex
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * 129S5/SvEvBrd) 		increased fibroblast proliferation J:77907
\Mdm4Gt(VICTR20)7Lex/\Mdm4Gt(VICTR20)7Lex
\Trp53tm1Wahl/\Trp53tm1Wahl
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased cell proliferation J:108183
\Mdm4Gt(VICTR20)7Lex/\Mdm4Gt(VICTR20)7Lex
\Trp53tm3Wahl/\Trp53tm3Wahl
(involves: 129S4/SvJae * 129S5/SvEvBrd) 		decreased fibroblast proliferation J:108183
\Mdm4tm1Glo/\Mdm4tm1Glo
(Not Specified) 		decreased cell proliferation J:71532
\Mdm4tm1Zmy/\Mdm4tm1Zmy
(involves: 129 * C57BL/6) 		decreased cell proliferation J:174359
\Med1tm1Rgr/\Med1tm1Rgr
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * 129X1/SvJ)) 		decreased fibroblast proliferation J:61840
\Med1tm2Rgr/\Med1tm2Rgr
(B6.129P2-Med1tm2Rgr) 		decreased mammary gland epithelial cell proliferation J:159303
\Med28tm1.2Vra/\Med28tm1.2Vra
(involves: 129S4/SvJae * C57BL/6) 		absent inner cell mass proliferation J:243694
\Med31l11Jus15/\Med31l11Jus15
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased cell proliferation J:161417
decreased fibroblast proliferation J:161417
\Mef2ctm1Jjs/\Mef2ctm1Jjs
\Tg(Slc5a2-cre)1Tauc/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased kidney cell proliferation J:158762
\Mettm1Sst/\Mettm1Sst
\Tg(Pdx1-cre)89.1Dam/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased pancreatic beta cell proliferation J:196854
\Metap2tm1.2Ccr/\Metap2tm1.2Ccr
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N) 		decreased cell proliferation J:111701
\Mettl1em1Bcgen/\Mettl1em1Bcgen
\Tg(Prrx1-cre)1Cjt/0
(involves: C57BL/6J * SJL/J) 		decreased chondrocyte proliferation J:355649
\Mettl3em1Chhe/\Mettl3em1Chhe
\Tg(Ddx4-cre)1Dcas/0
(involves: C57BL/6J * FVB) 		abnormal spermatogonia proliferation J:250428
\Mex3atm1.1(KOMP)Vlcg/\Mex3atm1.1(KOMP)Vlcg
(involves: 129S4/SvJaeSor * C57BL/6J * C57BL/6NTac) 		abnormal small intestinal crypt cell proliferation J:287423
\Mfngtm1.1Cfg/\Mfngtm1.1Cfg
(involves: C57BL/6) 		increased B cell proliferation J:217719
\Mgat3tm1Pst/\Mgat3tm1Pst
(involves: 129/Sv * C57BL/6 * CD-1 * SJL) 		decreased hepatocyte proliferation J:86643
\Miftm1Gfr/\Miftm1Gfr
(C57BL/6-Miftm1Gfr) 		decreased fibroblast proliferation J:147772
\Miftm2Gfr/\Miftm2Gfr
(C57BL/6-Miftm2Gfr) 		decreased fibroblast proliferation J:147772
\Mir24-1em1Smoc/\Mir24-1em1Smoc
\Mir24-2em1Smoc/\Mir24-2em1Smoc
\Tg(KRT14-cre)1Amc/0
(involves: C57BL/6J * CBA) 		increased keratinocyte proliferation J:306624
\Mir26a-1em1Xfu/\Mir26a-1em1Xfu
\Mir26a-2em1Xfu/\Mir26a-2em1Xfu
(involves: C57BL/6) 		increased pancreatic beta cell proliferation J:286108
\Mir34atm1.1Aven/\Mir34atm1.1Aven
(involves: 129S4/SvJae * C57BL/6) 		abnormal neuronal precursor proliferation J:180144
\Mir139em1Jwli/\Mir139em1Jwli
(C57BL/6J-Mir139em1Jwli) 		abnormal enterocyte proliferation J:280467
\Mir149em1Ydw/\Mir149em1Ydw
(C57BL/6J-Mir149em1Ydw) 		increased hepatocyte proliferation J:294318
\Mir184tm1Ics/\Mir184tm1Ics
(Not Specified) 		increased pancreatic beta cell proliferation J:210552
\Mir185em1Smoc/\Mir185em1Smoc
(Not Specified) 		increased osteoblast proliferation J:278853
\Mirc1tm1.1Tyj/\Mirc1tm1.1Tyj
\Pkd1tm1.1Pcha/\Pkd1tm2Som
\Tg(Cdh16-cre)91Igr/0
(involves: 129 * 129S4/SvJae * C57BL/6 * ICR) 		decreased kidney cell proliferation J:244067
\Mirc1tm1.1Tyj/\Mirc1tm1.1Tyj
\Pkd1tm2Som/\Pkd1tm2Som
\Tg(Cdh16-cre)91Igr/0
(involves: 129S4/SvJae * C57BL/6 * ICR) 		decreased kidney cell proliferation J:244067
\Mirc1tm1.1Tyj/\Mirc1tm1.1Tyj
\Pkd2tm3Som/\Pkd2tm3Som
\Tg(Pkhd1-cre)1Igr/0
(involves: 129S4/SvJae * C57BL/6) 		decreased kidney cell proliferation J:244067
\Mirc14tm1.2Flv/\Mirc14tm1.2Flv
(involves: C57BL/6 * C57BL/6N * FVB/N * SJL) 		decreased T cell proliferation J:203157
\Mirc21tm1.1Kry/\Mirc21tm1.1Kry
\Tg(Col1a1-cre)1Kry/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * FVB/N) 		increased osteoblast proliferation J:185130
\Mirc30tm1.2Rdf/\Mirc30tm1.2Rdf
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6) 		abnormal B cell proliferation J:156946
\Mirc55tm1.1Eno/\Mirc55tm1.1Eno
(Not Specified) 		decreased vascular endothelial cell proliferation J:139708
\Mis18atm1.1Kiik/\Mis18atm1.2Kiik
(B6(129S)-Mis18atm1.1Kiik/Mis18atm1.2Kiik) 		decreased fibroblast proliferation J:188023
\Mis18atm1.2Kiik/\Mis18atm1.2Kiik
(B6(129S)-Mis18atm1.2Kiik) 		decreased inner cell mass proliferation J:188023
\Mispem2Nsas/\Mispem2Nsas
(FVB/NJcl-Mispem2Nsas) 		abnormal enterocyte proliferation J:333842
\Mks1tm1a(EUCOMM)Wtsi/\Mks1tm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N) 		increased cell proliferation J:196290
increased kidney cell proliferation J:196290
\MmachcGt(AZ0348)Wtsi/\MmachcGt(AZ0348)Wtsi
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6) 		decreased trophectoderm cell proliferation J:212387
\Mmp9tm1Tvu/\Mmp9tm1Tvu
(involves: 129S6/SvEvTac * C57BL/6) 		increased T cell proliferation J:88065
\Mmp9tm1Tvu/\Mmp9tm1Tvu
\Tg(KRT14-HPV16)wt1Dh/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2 * FVB/N) 		decreased keratinocyte proliferation J:65699
\Mmp13tm1Jdar/\Mmp13tm1Jdar
(B6.129S-Mmp13tm1Jdar) 		decreased cell proliferation J:150790
\Mmp13tm1Jdar/\Mmp13tm1Jdar
\Mmp9tm1Tvu/\Mmp9tm1Tvu
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N) 		decreased cell proliferation J:150790
\Mmp14tm1Ski/\Mmp14tm1Ski
(B6.Cg-Mmp14tm1Ski) 		decreased kidney cell proliferation J:165029
\Mmp19tm1Rase/\Mmp19tm1Rase
(B6.129P2-Mmp19tm1Rase) 		decreased T cell proliferation J:137128
\Mob1atm1.1Asuz/\Mob1atm1.1Asuz
\Mob1bGt(CC0690)Wtsi/\Mob1bGt(CC0690)Wtsi
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(B6.Cg-Mob1bGt(CC0690)Wtsi Mob1atm1.1Asuz Speer6-ps1Tg(Alb-cre)21Mgn) 		increased hepatocyte proliferation J:228499
\Mob1atm1.1Asuz/\Mob1atm1.1Asuz
\Mob1bGt(CC0690)Wtsi/\Mob1bGt(CC0690)Wtsi
\Tg(KRT14-cre/ERT)20Efu/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1) 		increased keratinocyte proliferation J:193981
\Mob1atm1.2Asuz/\Mob1atm1.2Asuz
\Mob1bGt(CC0690)Wtsi/\Mob1bGt(CC0690)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		absent inner cell mass proliferation J:193981
\Mocosem2(IMPC)Ics/\Mocosem2(IMPC)Ics
(involves: C57BL/6N) 		increased kidney cell proliferation J:336718
\Mogtm1Reid/\Mogtm1Reid
(129/Sv-Mogtm1Reid) 		increased T cell proliferation J:86663
\Mol1BALB/cByJ/\Mol1BALB/cByJ
(involves: BALB/cByJ * C57BL/6ByJ) 		decreased B cell proliferation J:58921
\Morf4l1tm1Kto/\Morf4l1tm1Kto
(involves: 129S7/SvEvBrd) 		decreased cell proliferation J:97640
\MpiGt(OST90588)Lex/\MpiGt(OST90588)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		abnormal cell proliferation J:109220
\Mpltm2.1Wsa/\Mpltm2.1Wsa
\Tg(Pf4-icre)Q3Rsko/0
(involves: C57BL/6) 		increased hematopoietic stem cell proliferation J:208120
\Mpztm3.1Wra/\Mpz+
(FVB.129S2(Cg)-Mpztm3.1Wra) 		increased Schwann cell proliferation J:241742
\Mpztm3.1Wra/\Mpztm3.1Wra
(FVB.129S2(Cg)-Mpztm1.1Wra) 		increased Schwann cell proliferation J:241742
\Mre11atm1Dof/\Mre11atm2.1Dof
(involves: 129S6/SvEvTac) 		decreased cell proliferation J:147247
\Mre11atm2.1Dof/\Mre11atm2.2Dof
(Not Specified) 		decreased cell proliferation J:147247
\Mrps12em1.2Afi/\Mrps12em1.2Afi
(B6N(Cg)-Mrps12em1.2Afi) 		increased hepatocyte proliferation J:284101
\Mt1tm1Bri/\Mt1tm1Bri
\Mt2tm1Bri/\Mt2tm1Bri
(129S7/SvEvBrd-Mt1tm1Bri Mt2tm1Bri/J) 		decreased hepatocyte proliferation J:109814
\Mta2tm1.1Yzha/\Mta2tm1.1Yzha
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		increased kidney cell proliferation J:137101
increased T cell proliferation J:137101
\Mta2tm1Yzha/\Mta2tm1Yzha
\Tg(Lck-cre)#Zhu/0
(involves: 129S4/SvJae * C57BL/6 * SJL) 		increased T cell proliferation J:137101
\Mtdhtm1.2Dsar/\Mtdhtm1.2Dsar
(either: B6.129(FVB)-Mtdhtm1.2Dsar or (129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)) 		decreased macrophage proliferation J:216688
\MtorGt(OST92090)Lex/\MtorGt(OST92090)Lex
(involves: 129S5/SvEvBrd) 		absent inner cell mass proliferation J:137592
\Mtortm1.2Koz/\Mtortm1.2Koz
\Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		decreased T cell proliferation J:150108
\Mtortm1Lgm/\Mtortm1Lgm
(involves: 129S1/Sv * C57BL/6) 		decreased B cell proliferation J:168600
decreased splenocyte proliferation J:168600
\Mtortm1Yam/\Mtortm1Yam
(involves: 129S4/SvJae) 		absent inner cell mass proliferation J:92252
\Mtss1Gt(RRI034)Byg/\Mtss1Gt(RRI034)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased kidney cell proliferation J:158762
\Mtus1Gt(RRA048)Byg/\Mtus1Gt(RRA048)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased cell proliferation J:212144
\Muc2eey/\Muc2eey
(C57BL/6-Muc2eey) 		abnormal enterocyte proliferation J:194148
\Muc2tm1Avel/\Muc2tm1Avel
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal enterocyte proliferation J:75047
increased cell proliferation J:75047
\Muc2wnn/\Muc2wnn
(C57BL/6-Muc2wnn) 		abnormal enterocyte proliferation J:194148
\Muc13tm1.1Mamg/\Muc13tm1.1Mamg
(involves: 129 * C57BL/6) 		abnormal enterocyte proliferation J:313870
\Mus81tm1Chmg/\Mus81tm1Chmg
(involves: 129S4/SvJae * 129S5/SvEvBrd * C57BL/6) 		decreased cell proliferation J:100407
\Mxi1tm1Rdp/\Mxi1tm1Rdp
(involves: 129/Sv * C57BL/6J * SJL) 		increased T cell proliferation J:48236
\Mxra7tm1a(EUCOMM)Wtsi/\Mxra7tm1a(EUCOMM)Wtsi
(involves: C57BL/6N) 		decreased fibroblast proliferation J:334049
\Mybl2tm1.1Epr/\Mybl2tm1.1Epr
\Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA * FVB/N) 		decreased hematopoietic stem cell proliferation J:206816
\Myctm1.1Itl/\Myctm1.1Itl
(involves: 129S6/SvEvTac * C57BL/6NTac) 		abnormal enterocyte proliferation J:188927
\Myctm1Atp/\Myc+
(involves: 129P2/OlaHsd * FVB/N) 		decreased fibroblast proliferation J:73369
decreased T cell proliferation J:73369
\Myctm1Atp/\Myc+
(B6.129P2-Myctm1Atp) 		decreased T cell proliferation J:132730
\Myctm1Atp/\Myctm1Atp
(involves: 129P2/OlaHsd * FVB/N) 		absent fibroblast proliferation J:73369
\Myctm1Atp/\Myctm2.1Atp
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL) 		decreased T cell proliferation J:73369
\Myctm1Jlc/\Myctm1Jlc
(involves: 129S7/SvEvBrd) 		decreased cell proliferation J:79427
\Myctm1Lbox/\Myctm1Lbox
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		increased B cell proliferation J:97900
\Myctm2.1Atp/\Myc+
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		decreased T cell proliferation J:73369
\Myctm2.1Atp/\Myctm2.1Atp
\Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA * FVB/N * SJL) 		absent fibroblast proliferation J:73369
\Myctm2Fwa/\Myctm2Fwa
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S6/SvEvTac) 		decreased B cell proliferation J:67222
\Mycntm1Jrt/\Mycntm1Par
(involves: 129S2/SvPas * C57BL/6J) 		decreased fetal cardiomyocyte proliferation J:15281
\Mycntm1Psk/\Mycntm1Psk
\Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * SJL) 		abnormal neuronal precursor proliferation J:79489
\Myd88tm1Aki/\Myd88tm1Aki
(Not Specified) 		decreased B cell proliferation J:96773
\Myf5tm2Tajb/\Myf5tm2Tajb
(involves: 129S2/SvPas) 		abnormal skeletal muscle satellite cell proliferation J:128921
\Myh10tm2Rsad/\Myh10tm2Rsad
(involves: 129S4/SvJae) 		decreased fetal cardiomyocyte proliferation J:92230
\Myh11tm1.1Dmmz/\Myh11tm1.1Dmmz
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6) 		increased vascular smooth muscle cell proliferation J:212664
\Myt1lem1Jdd/\Myt1l+
(C57BL/6-Myt1lem1Jdd/J) 		decreased neuronal precursor proliferation J:321206
\Nab1tm1Jmi/\Nab1tm1Jmi
\Nab2tm1Jmi/\Nab2tm1Jmi
(involves: 129X1/SvJ) 		increased keratinocyte proliferation J:99824
increased Schwann cell proliferation J:99824
\Nacatm1Dsr/\Nacatm1Dsr
(129S6/SvEvTac-Nacatm1Dsr) 		decreased fetal cardiomyocyte proliferation J:167169
\Nae1tm1c(EUCOMM)Wtsi/\Nae1tm1c(EUCOMM)Wtsi
\Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6J * C57BL/6N * FVB/N * SJL) 		decreased fetal cardiomyocyte proliferation J:261328
\Nap1l1em1Jwji/\Nap1l1em1Jwji
(Not Specified) 		decreased neuronal precursor proliferation J:263406
\Nbntm1Nus/\Nbntm1Nus
(involves: 129 * C57BL/6) 		decreased inner cell mass proliferation J:68993
\Nbntm1Nus/\Nbntm2Nus
\Tg(CD19-cre/ERT2)1Cgn/0
(Not Specified) 		decreased B cell proliferation J:96102
\Nbntm1Xu/\Nbntm1Xu
(Not Specified) 		decreased fibroblast proliferation J:75272
\Nbntm1Zqw/\Nbntm1Zqw
(involves: 129S2/SvPas * C57BL/6) 		absent inner cell mass proliferation J:86563
\Ncam2tm1.1Bdrt/\Ncam2tm1.1Bdrt
(involves: 129S4/SvJae * C57BL/6) 		abnormal neuron proliferation J:233502
\Ncapg2tm1Jdc/\Ncapg2tm1Jdc
(involves: 129S1/Sv * C57BL/6) 		absent inner cell mass proliferation J:87685
\Nckap1lm1Iri/\Nckap1lm1Iri
(involves: C57BL/6) 		decreased T cell proliferation J:141377
\Ncoa3tm1Jxu/\Ncoa3tm1Jxu
(involves: 129S6/SvEvTac * C57BL/6J) 		increased B cell proliferation J:109522
increased T cell proliferation J:109522
\Ncoa3tm1Jxu/\Ncoa3tm1Jxu
\Tg(MMTV-vHaras)SH1Led/0
(involves: 129S6/SvEvTac * C57BL/6J * CD-1) 		decreased mammary gland epithelial cell proliferation J:88789
\Ncoa3tm1Rsd/\Ncoa3tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased cell proliferation J:66454
\Ncoa4tm1Msnt/\Ncoa4tm1Msnt
(B6.Cg-Ncoa4tm1Msnt) 		decreased fibroblast proliferation J:215322
\Ncoa5tm1Hxia/\Ncoa5+
(involves: 129 * C57BL/6) 		increased hepatocyte proliferation J:207622
\Ncoa6tm1.1Jkr/\Ncoa6tm1.1Jkr
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		decreased fetal cardiomyocyte proliferation J:81217
\Ncoa6tm1Hhs/\Ncoa6tm1Hhs
(either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * C57BL/6)) 		decreased fibroblast proliferation J:91083
\Ncoa6tm1Jxu/\Ncoa6tm1Jxu
(involves: 129S6/SvEvTac * C57BL/6) 		decreased fetal cardiomyocyte proliferation J:80175
\Ncor2tm1Rsd/\Ncor2tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal neuronal precursor proliferation J:127720
\Ndfip1Gt(RRD002)Byg/\Ndfip1Gt(RRD002)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased T cell proliferation J:116617
\Ndfip1Gt(RRD002)Byg/\Ndfip1Gt(RRD002)Byg
(involves: 129P2/OlaHsd) 		increased T cell proliferation J:205692
\Ndor1Tg(UBC-cre/ERT2)1Ejb/\Ndor1+
\Rnpc3tm1c(EUCOMM)Wtsi/\Rnpc3tm1c(EUCOMM)Wtsi
(involves: 129S/SvEv * C57BL/6 * C57BL/6N) 		abnormal enterocyte proliferation J:267519
abnormal small intestinal crypt cell proliferation J:267519
\Ndor1Tg(UBC-cre/ERT2)1Ejb/\Ndor1+
\Stag2tm1.1Alos/Y
(involves: 129S6/SvEvTac * C57BL/6NCrl) 		abnormal enterocyte proliferation J:298088
decreased fibroblast proliferation J:298088
\Ndor1Tg(UBC-cre/ERT2)1Ejb/\Ndor1+
\Stag2tm1.1Alos/\Stag2tm1.1Alos
(involves: 129S6/SvEvTac * C57BL/6NCrl) 		abnormal enterocyte proliferation J:298088
decreased fibroblast proliferation J:298088
\Ndrg2tm1Kmori/\Ndrg2+
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj) 		increased fibroblast proliferation J:210264
\Ndrg2tm1Kmori/\Ndrg2tm1Kmori
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj) 		increased fibroblast proliferation J:210264
\Ndst1tm1Je/\Ndst1tm1Je
\Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		decreased endothelial cell proliferation J:208012
\Neat1tm1.1Shna/\Neat1tm1.1Shna
(involves: C57BL/6NCrlj * CBA/JNCrlj) 		decreased mammary gland epithelial cell proliferation J:228123
\Nedd4Gt(XA209)Byg/\Nedd4Gt(XA209)Byg
(involves: 129P2/OlaHsd) 		decreased fibroblast proliferation J:207675
decreased T cell proliferation J:143560
\Nedd4Gt(XB398)Byg/\Nedd4Gt(XB398)Byg
(involves: 129P2/OlaHsd) 		decreased T cell proliferation J:143560
\Neil3tm1Bjor/\Neil3tm1Bjor
(involves: 129 * C57BL/6) 		abnormal neuronal precursor proliferation J:180177
\Neurog2tm4Fgu/\Neurog2tm4Fgu
(involves: MF1) 		abnormal neuronal precursor proliferation J:134976
\Neurog3tm1Fgu/\Neurog3tm3.1Ggr
\Tg(Vil1-cre)20Syr/0
(involves: 129S2/SvPas * C57BL/6 * CD-1 * DBA/2 * SJL) 		abnormal small intestinal crypt cell proliferation J:161480
\Neurog3tm3.1Ggr/\Neurog3tm3.1Ggr
\Tg(Vil1-cre)20Syr/0
(involves: 129S2/SvPas * C57BL/6 * CD-1 * DBA/2 * SJL) 		abnormal small intestinal crypt cell proliferation J:161480
\Nf1tm1Fcr/\Nf1+
\Tg(GFAP-cre)#Gtm/0
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * CBA) 		abnormal neuron proliferation J:176586
\Nf1tm1Par/\Nf1tm1Par
\Rnf7Gt(XE423)Byg/\Rnf7Gt(XE423)Byg
(involves: 129 * C57BL/6) 		decreased cell proliferation J:178926
\Nf1tm1Par/\Nf1tm1Par
\Tg(Fabp7-cre,-lacZ)3Gtm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		abnormal neuronal precursor proliferation J:139866
\Nf1tm1Par/\Nf1tm1Par
\Tg(Prrx1-cre)1Cjt/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL/J) 		increased myoblast proliferation J:173779
\Nfat5tm1Skc/\Nfat5tm1Skc
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased fetal cardiomyocyte proliferation J:175527
\Nfat5tm1Snh/\Nfat5+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased T cell proliferation J:91482
\Nfatc1tm1Rao/\Nfatc1tm1Rao
\Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c) 		decreased B cell proliferation J:177319
\Nfatc1tm1Rao/\Nfatc1tm1Rao
\Tg(Fcer2a-cre)5Mbu/0
(involves: C57BL/6 * CBA) 		decreased B cell proliferation J:177319
\Nfe2l2tm1Mym/\Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * ICR) 		increased kidney cell proliferation J:104016
\Nfe2l2tm1Ywk/\Nfe2l2tm1Ywk
(involves: 129X1/SvJ) 		decreased hepatocyte proliferation J:130473
\Nfkb1tm1Bal/\Nfkb1tm1Bal
(involves: 129P2/OlaHsd * C57BL/6) 		decreased B cell proliferation J:37184, J:30268
\Nfkb1tm1Brv/\Nfkb1tm1Brv
(involves: 129S1/Sv) 		decreased T cell proliferation J:46912
increased B cell proliferation J:46912
\Nfkb1tm1Sley/\Nfkb1tm1Sley
(involves: 129S4/SvJae * 129S8/SvEv) 		decreased T cell proliferation J:142340
\Nfkb2Lym1/\Nfkb2Lym1
(involves: BALB/c) 		decreased B cell proliferation J:154812
\Nfkb2tm1Brv/\Nfkb2tm1Brv
(involves: 129S1/Sv * C57BL/6) 		increased B cell proliferation J:43469
increased T cell proliferation J:43469
\Nfkb2tm2Brv/\Nfkb2tm2Brv
(involves: 129S1/Sv * C57BL/6) 		decreased B cell proliferation J:76380
\Nfkbiatm1.1Pjc/\Nfkbiatm1.1Pjc
(involves: C57BL/6) 		increased T cell proliferation J:163686
\Nfkbiatm1.1Smiy/\Nfkbiatm1.1Smiy
(B6.129-Nfkbiatm1.1Smiy) 		decreased B cell proliferation J:168977
\Nfkbiatm1Fey/\Nfkbiatm1Fey
(involves: 129S6/SvEvTac * C57BL/6) 		decreased T cell proliferation J:110817
increased B cell proliferation J:110817
\Nfkbidm1Btlr/\Nfkbidm1Btlr
(involves: C57BL/6J) 		decreased B cell proliferation J:185495
\Nfkbidtm1Clay/\Nfkbidtm1Clay
(involves: 129S6/SvEvTac * C57BL/6) 		decreased T cell proliferation J:132071
\Nfyatm1Mait/\Nfyatm1.1Mait
(involves: C57BL/6) 		decreased fibroblast proliferation J:87090
\Ngfrtm1Jae/\Ngfrtm1Jae
\Plgtm1Jld/\Plgtm1Jld
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		increased hepatocyte proliferation J:120368
\Niban3tm1Jyw/\Niban3tm1Jyw
(B6.Cg-Niban3tm1Jyw) 		increased B cell proliferation J:282961
\Nipbltm1.1Hpt/\Nipbltm1.1Hpt
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * CBA/J * SJL) 		decreased cranial neural crest cell proliferation J:213338
\Nkx2-3tm1Hha/\Nkx2-3tm1Hha
(involves: 129S4/SvJae * C57BL/6) 		abnormal cell proliferation J:54198
\Nkx2-5tm1.1Gum/\Nkx2-5tm1.1Gum
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6J) 		decreased cell proliferation J:228275
\Nkx2-5tm1Siz/\Nkx2-5tm1Siz
(involves: 129S4/SvJaeSor * C57BL/6J) 		decreased cell proliferation J:69976
\Nkx2-5tm1Siz/\Nkx2-5tm1Siz
\Nkx2-6tm1Siz/\Nkx2-6tm1Siz
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6J) 		decreased cell proliferation J:69976
\Nkx3-1tm1Hha/\Nkx3-1tm1Hha
(involves: 129S4/SvJae * C57BL/6) 		increased cell proliferation J:63764
\Nkx3-2tm1Tno/\Nkx3-2tm1Tno
(involves: 129S4/SvJae * C57BL/6J) 		decreased cell proliferation J:77612
\Nlrp3tm3.1Hhf/\Nlrp3+
(involves: 129) 		decreased cell proliferation J:202147
\Nlrp6tm1Macha/\Nlrp6tm1Macha
(involves: 129S5/SvEvBrd * C57BL/6J) 		abnormal enterocyte proliferation J:173352
\Nmt1tm1.1Poru/\Nmt1tm1.1Poru
\Nmt2tm1.1Poru/\Nmt2tm1.1Poru
\Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL) 		decreased splenocyte proliferation J:226234
decreased T cell proliferation J:226234
\Noc2ltm1.1Arte/\Noc2ltm1.1Arte
\Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca) 		abnormal T cell proliferation J:216490
\Nol3tm1.1Rnkt/\Nol3tm1.1Rnkt
(B6.129-Nol3tm1.1Rnkt) 		decreased cell proliferation J:193803
\NonoGt(YHA266)Byg/Y
(involves: 129P2/OlaHsd * C57BL/6J) 		increased fibroblast proliferation J:193286
\NonoGt(YHA266)Byg/Y
(involves: 129P2/OlaHsd) 		increased fibroblast proliferation J:294120
\Nos2tm1Lau/\Nos2tm1Lau
(involves: 129P2/OlaHsd * C57BL/6) 		increased T cell proliferation J:90903
\Nos2tm1Liew/\Nos2tm1Liew
(involves: 129P2/Ola * MF1) 		increased T cell proliferation J:25755
\Nos3tm1Plh/\Nos3tm1Plh
(involves: 129S4/SvJae * C57BL/6) 		abnormal neuronal precursor proliferation J:101302
\Nos3tm1Unc/\Nos3tm1Unc
(B6.129P2-Nos3tm1Unc/J) 		decreased kidney cell proliferation J:148626
\Nostrintm1.1Oess/\Nostrintm1.1Oess
(B6.129S2(Cg)-Nostrintm1.1Oess) 		decreased vascular endothelial cell proliferation J:188414
\Nostrintm1Oess/\Nostrintm1Oess
\Tg(Tek-cre)12Flv/0
(involves: 129S2/SvPas * C3H * C57BL/6) 		decreased vascular endothelial cell proliferation J:188414
\Notch2tm1Grid/\Notch2tm1Grid
(involves: 129S1/Sv * C57BL/6J) 		decreased kidney cell proliferation J:67157
\Notch3em1Ecan/\Notch3+
(C57BL/6J-Notch3em1Ecan) 		increased osteoblast proliferation J:270682
\Npffr2tm1.2Ics/\Npffr2tm1.2Ics
(involves: C57BL/6N) 		decreased macrophage proliferation J:245025
\Npm1Gt(VICTR37)704Lex/\Npm1Gt(VICTR37)704Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		abnormal cell proliferation J:101353
\Npm1Gt(VICTR37)704Lex/\Npm1Gt(VICTR37)704Lex
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * 129S5/SvEvBrd * C57BL/6) 		increased fibroblast proliferation J:101353
\Npm1tm1Ppp/\Npm1+
(involves: 129S1/Sv * C57BL/6) 		abnormal cell proliferation J:101494
\Npm1tm1Ppp/\Npm1+
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6) 		increased fibroblast proliferation J:101494
\Npm1tm1Ppp/\Npm1tm1Ppp
(involves: 129S1/Sv * C57BL/6) 		decreased fibroblast proliferation J:101494
\Npm1tm2Ppp/\Npm1tm2Ppp
(involves: 129S1/Sv * C57BL/6) 		decreased fibroblast proliferation J:101494
\Nr0b1tm1.1Lja/Y
(involves: 129S1/Sv * 129X1/SvJ) 		increased Sertoli cell proliferation J:71710
\Nr1h2tm1Djm/\Nr1h2tm1Djm
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal spermatogonia proliferation J:120913
\Nr1h2tm1Djm/\Nr1h2tm1Djm
\Nr1h3tm1Djm/\Nr1h3tm1Djm
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal spermatogonia proliferation J:120913
\Nr1h4tm1.2Auw/\Nr1h4tm1.2Auw
(involves: 129 * C57BL/6J) 		increased hepatocyte proliferation J:157882
\Nr1h4tm1Gonz/\Nr1h4tm1Gonz
(involves: 129X1/SvJ * C57BL/6N) 		increased hepatocyte proliferation J:121075
\Nr1i2tm1Sakl/\Nr1i2tm1Sakl
(involves: 129S1/Sv * 129X1/SvJ) 		decreased hepatocyte proliferation J:157882
\Nr2e1frc/\Nr2e1frc
(involves: 129P2/OlaHsd * 129S1/SvImJ) 		abnormal neuronal precursor proliferation J:183689
\Nr4a1tm1Jmi/\Nr4a1tm1Jmi
(involves: 129S2/SvPas) 		increased B cell proliferation J:306652
\Nr4a1tm1Pcn/\Nr4a1tm1Pcn
\Tg(Cr2-cre)3Cgn/0
(involves: 129) 		increased B cell proliferation J:306652
\Nrarptm1Vlcg/\Nrarptm1Vlcg
(involves: C57BL/6J) 		decreased vascular endothelial cell proliferation J:144980
\Nrastm1Tyj/\Nrastm1Tyj
\Tg(Tyr-cre)1Lru/0
(involves: C57BL/6 * DBA/2) 		abnormal melanocyte proliferation J:198244
\Nrbp1tm1.1Dja/\Nrbp1tm1.1Dja
\Gt(ROSA)26Sortm1(cre/ERT)Brn/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6J) 		abnormal enterocyte proliferation J:184685
\Nrbp1tm1.1Dja/\Nrbp1tm1.2Dja
\Gt(ROSA)26Sortm1(cre/ERT)Brn/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6J) 		abnormal enterocyte proliferation J:184685
\Nrf1tm1Rcs/\Nrf1tm1Rcs
(involves: 129X1/SvJ) 		decreased cell proliferation J:67376
\Nrip1tm1Mpk/\Nrip1tm1Mpk
(involves: 129 * C57BL/6J) 		abnormal enterocyte proliferation J:211324
\Nrp2tm1Ddg/\Nrp2tm1Ddg
(involves: C57BL/6) 		decreased cell proliferation J:156869
\Nsrp1tm1.1Cdj/\Nsrp1tm1.1Cdj
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL) 		increased T cell proliferation J:306261
\Ntan1tm1Avar/\Ntan1tm1Avar
(involves: 129) 		decreased splenocyte proliferation J:62140
\Ntn4tm1Wjbr/\Ntn4tm1Wjbr
(B6.129-Ntn4tm1Wjbr) 		increased cell proliferation J:196758
\Ntrk2tm1Rohr/\Ntrk2tm1Rohr
(Not Specified) 		decreased granulosa cell proliferation J:88782
\Nudt7em1Ejj/\Nudt7em1Ejj
(involves: C57BL/6N) 		decreased chondrocyte proliferation J:266261
\Numa1tm1.1Dwc/\Numa1tm1.1Dwc
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL) 		absent fibroblast proliferation J:146214
\Nup98tm1Bmaf/\Nup98+
(involves: 129S6/SvEvTac * C57BL/6) 		decreased T cell proliferation J:110907
increased T cell proliferation J:110907
\Nup160tm1Mdan/\Nup160tm1Mdan
\Gt(ROSA)26Sortm1(cre/ERT2)Tyj/\Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6) 		decreased hematopoietic stem cell proliferation J:301567
\Nupr1tm1Jlio/\Nupr1tm1Jlio
(involves: 129S1/Sv * 129X1/SvJ) 		increased fibroblast proliferation J:133728
\Nus1tm1Wcsa/\Nus1tm1Wcsa
(Not Specified) 		decreased lung endothelial cell proliferation J:230506
\Nus1tm1Wcsa/\Nus1tm1Wcsa
\Tg(Cdh5-cre/ERT2)1Rha/0
(Not Specified) 		decreased endothelial cell proliferation J:230506
\Nxf2tm1.2Jw/Y
(B6.Cg-Nxf2tm1.2Jw) 		abnormal spermatogonia proliferation J:149228
\Oas2M1Apb/\Oas2M1Apb
(involves: C57BL/6J * CBA/CaJ) 		decreased mammary gland epithelial cell proliferation J:248944
\Ociad1tm1.1Msin/\Ociad1tm1.1Msin
(involves: BALB/cJ * C57BL/6NCrlj * CBA/JNCrlj) 		increased hematopoietic stem cell proliferation J:279239
\OgaGt(YTC085)Byg/\OgaGt(YTC085)Byg
(B6J.129P2-OgaGt(YTC085)Byg) 		decreased fibroblast proliferation J:218150
\Ogttm1Gwh/Y
(involves: 129S1/Sv * 129X1/SvJ) 		decreased cell proliferation J:93112
\Opa1tm1.1Hise/\Opa1tm1.2Hise
\Tg(Ins2-cre)25Mgn/0
(involves: 129S/SvEv * C57BL/6 * DBA * SJL) 		decreased pancreatic beta cell proliferation J:183074
\Oprm1tm1Lyu/\Oprm1+
(involves: Black Swiss) 		increased splenocyte proliferation J:39864
\Oprm1tm1Lyu/\Oprm1tm1Lyu
(involves: Black Swiss) 		increased splenocyte proliferation J:39864
\Orc1tm1.1Gle/\Orc1tm1.1Gle
(involves: C57BL/6 * SJL) 		absent fibroblast proliferation J:272584
\Orc1tm1.1Gle/\Orc1tm1.1Gle
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * DBA * SJL) 		increased hepatocyte proliferation J:272584
\Orc1tm1.1Gle/\Orc1tm1.1Gle
\Tg(Cyp1a1-cre)1Dwi/0
(involves: C57BL/6 * CBA * SJL) 		abnormal small intestinal crypt cell proliferation J:272584
\Orc3tm1.1Zhua/\Orc3tm1.1Zhua
\Emx1tm1(cre)Krj/\Emx1+
(involves: 129S2/SvPas) 		decreased neuronal precursor proliferation J:170581
\Otud7btm1Dgen/\Otud7btm1Dgen
(involves: 129 * C57BL/6) 		increased B cell proliferation J:194553
\Otulintm1c(EUCOMM)Hmgu/\Otulintm1c(EUCOMM)Hmgu
\Tg(KRT14-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6N * DBA/2) 		abnormal epidermal stem cell proliferation J:312394
\Otx1tm4(cre)Asim/\Otx1+
\Otx2tm6Asim/\Otx2tm6.1Asim
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		abnormal neuronal precursor proliferation J:83110
\P2rx2em1Xzl/\P2rx2+
(CBA/J-P2rx2em1Xzl) 		decreased dermal fibroblast proliferation J:315007
\P2ry6tm1Jabo/\P2ry6tm1Jabo
\Gt(ROSA)26Sortm9(cre/ESR1)Arte/\Gt(ROSA)26Sor+
(involves: 129 * C57BL/6 * C57BL/6NTac) 		increased T cell proliferation J:179177
\Pa2g4Gt(OST186047)Lex/\Pa2g4Gt(OST186047)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased cell proliferation J:151280
\Pak1ip1mray/\Pak1ip1mray
(involves: C57BL/6J * FVB/NJ) 		decreased cell proliferation J:204457
\Pak2tm1.1Rjak/\Pak2tm1.1Rjak
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased fibroblast proliferation J:171914
\Pak4tm1Amin/\Pak4tm1Amin
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129S2/SvPas * C57BL/6J)) 		decreased cell proliferation J:152821
\Palb2Gt(CG0691)Wtsi/\Palb2Gt(CG0691)Wtsi
(involves: 129P2/OlaHsd * C57BL/6N) 		decreased inner cell mass proliferation J:161528
\Pald1tm1Vlcg/\Pald1tm1Vlcg
(B6.Cg-Pald1tm1Vlcg) 		increased lung endothelial cell proliferation J:254363
\Pals1tm1Caw/\Pals1+
\Emx1tm1(cre)Krj/\Emx1+
(involves: 129S2/SvPas) 		abnormal neuronal precursor proliferation J:160624
\Pals1tm1Caw/\Pals1tm1Caw
\Emx1tm1(cre)Krj/\Emx1+
(involves: 129S2/SvPas) 		abnormal neuronal precursor proliferation J:160624
\Pals1tm1Caw/\Pals1tm1Caw
\Tg(rx3-icre)1Mjam/0
(Not Specified) 		abnormal cell proliferation J:184469
decreased cell proliferation J:184469
\Paqr3tm1Ychn/\Paqr3tm1Ychn
(involves: 129 * C57BL/6J) 		increased keratinocyte proliferation J:139058
\Pargtm1Tmd/\Pargtm1Tmd
(involves: 129X1/SvJ) 		decreased cell proliferation J:95214
\Parp1tm1Zqw/\Parp1tm1Zqw
(involves: 129S2/SvPas * C57BL/6) 		decreased cell proliferation J:23942
\Parp14Gt(OST415485)Lex/\Parp14Gt(OST415485)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased B cell proliferation J:146533
increased B cell proliferation J:146533
\Patz1tm1Pchi/\Patz1+
(involves: C57BL/6J) 		increased fibroblast proliferation J:190572
\Patz1tm1Pchi/\Patz1tm1Pchi
(Not Specified) 		abnormal spermatogonia proliferation J:133515
\Patz1tm1Pchi/\Patz1tm1Pchi
(involves: C57BL/6J) 		decreased fibroblast proliferation J:190572
\Pawrtm1Jmos/\Pawrtm1Jmos
(involves: 129/Sv * CD-1) 		increased B cell proliferation J:85495
increased T cell proliferation J:85495
\Pax1tm2.1Tlu/\Pax1tm2.1Tlu
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ) 		decreased cell proliferation J:198603
\Pax3tm3.1(Pax7)Buck/\Pax3Sp
(involves: 129S2/SvPas) 		decreased cell proliferation J:90568
\Pax3tm3.1(Pax7)Buck/\Pax3tm3.1(Pax7)Buck
(involves: 129S2/SvPas) 		decreased cell proliferation J:90568
\Pax6tm1.1Zkoz/\Pax6tm1.1Zkoz
\Tg(Rax-cre)1Zkoz/0
(Not Specified) 		decreased cell proliferation J:208421
\Pax6tm2(Pax6_i5a,Pax2)Xzh/\Pax6tm2(Pax6_i5a,Pax2)Xzh
(involves: 129S6/SvEvTac) 		abnormal neuronal precursor proliferation J:198381
\Pax6tm2.1(Pax6_i5a,Pax2)Xzh/\Pax6tm2.1(Pax6_i5a,Pax2)Xzh
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N) 		abnormal neuronal precursor proliferation J:198381
\Pax7tm1.1Thbr/\Pax7tm1.1Thbr
(Not Specified) 		abnormal skeletal muscle satellite cell proliferation J:202693
\Pax7tm1.1Thbr/\Pax7tm2.1(cre/ERT2)Fan
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal skeletal muscle satellite cell proliferation J:202693
\Paxip1tm1Gdr/\Paxip1tm1Gdr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased cell proliferation J:82319
decreased inner cell mass proliferation J:82319
\Pbrm1tm1Zhwa/\Pbrm1tm1Zhwa
\Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		decreased T cell proliferation J:236906
\Pbx1tm1Mlc/\Pbx1tm1Mlc
(involves: 129S6/SvEvTac * C57BL/6) 		decreased chondrocyte proliferation J:71996
\Pcbp4Gt(D136D11)Wrst/\Pcbp4Gt(D136D11)Wrst
(involves: 129S2/SvPas * C57BL/6) 		increased fibroblast proliferation J:231514
\Pcsk2tm1Dfs/\Pcsk2tm1Dfs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased pancreatic alpha cell proliferation J:85590
\Pdcd1tm1.1Liux/\Pdcd1tm1.1Liux
(involves: C57BL/6) 		decreased cell proliferation J:190150
\Pdcd1tm1.1Shr/\Pdcd1tm1.1Shr
\Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6) 		decreased T cell proliferation J:153040
increased T cell proliferation J:153040
\Pdcd1tm1Hon/\Pdcd1tm1Hon
(involves: 129S2/SvPas * C57BL/6) 		increased B cell proliferation J:50688
\Pdcd1lg2tm1Dmp/\Pdcd1lg2tm1Dmp
(C.129-Pdcd1lg2tm1Dmp) 		decreased T cell proliferation J:99212
\Pdgfratm12.1Sor/\Pdgfra+
(involves: 129 * C57BL/6) 		increased cell proliferation J:146617
increased fibroblast proliferation J:146617
increased mesenchymal cell proliferation involved in lung development J:146617
\Pdgfratm13.1Sor/\Pdgfra+
(involves: 129 * C57BL/6) 		increased fibroblast proliferation J:146617
\Pdgfrbtm1Msas/\Pdgfrbtm1Msas
(involves: 129 * C57BL/6) 		decreased cell proliferation J:110798
\Pdgfrbtm4Sor/\Pdgfrbtm4Sor
(either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6)) 		decreased fibroblast proliferation J:66516
decreased kidney cell proliferation J:66516
\Pdgfrbtm14(Pdgfrb)Sor/\Pdgfrb+
\Tg(Tagln-cre)1Her/0
(involves: 129S4/SvJaeSor * C57BL/6 * SJL) 		increased vascular smooth muscle cell proliferation J:173602
\Pdpk1tm1Mlw/\Pdpk1tm1Mlw
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2) 		decreased T cell proliferation J:165626
\Pds5btm1.2Alos/\Pds5btm1.2Alos
(involves: 129S2/SvPas) 		decreased cell proliferation J:205601
\Pdx1tm1Cvw/\Pdx1tm4Cvw
\Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 * DBA) 		decreased pancreatic beta cell proliferation J:130389
increased pancreatic alpha cell proliferation J:130389
\Pdx1tm1Egs/\Pdx1+
\Stk11tm1.1Gne/\Stk11tm1.1Gne
(involves: 129S1/Sv * C57BL/6N) 		increased cell proliferation J:195229
\Pdx1tm1Macd/\Pdx1tm1Macd
\Tg(tetO-Ipf1,-EGFP)956.6Macd/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		increased cell proliferation J:101742
\Peli1tm1Tigm/\Peli1tm1Tigm
(involves: 129/Sv * C57BL/6) 		decreased B cell proliferation J:152781
\Pelotm1Imad/\Pelotm1Imad
(either: 129 or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)) 		absent inner cell mass proliferation J:81781
\Pelotm1Slac/\Pelotm1Slac
\En1tm2(cre)Wrst/\En1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		increased neuronal precursor proliferation J:306384
\Pelotm1Slac/\Pelotm1Slac
\Tg(Atoh1-cre)1Bfri/0
(involves: C57BL/6J * CBA) 		increased neuronal precursor proliferation J:306384
\Per1tm1Brd/\Per1tm1Brd
\Per2tm1Brd/\Per2tm1Brd
(involves: 129S7/SvEvBrd) 		increased osteoblast proliferation J:115188
\Per2tm1Drw/\Per2tm1Drw
(B6.129-Per2tm1Drw/J) 		decreased hematopoietic stem cell proliferation J:208598
\Pgap3tm1.1Ymra/\Pgap3tm1.1Ymra
(involves: 129 * C57BL/6) 		decreased T cell proliferation J:181221
increased T cell proliferation J:181221
\Pgap3tm1.1Ymra/\Pgap3tm1.1Ymra
(B6.Cg-Pgap3tm1.1Ymra) 		decreased B cell proliferation J:203443
\Pggt1btm1Mbrg/\Pggt1btm1Mbrg
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6) 		absent fibroblast proliferation J:122107
\Pggt1btm1Mbrg/\Pggt1btm1Mbrg
\Krastm4Tyj/\Kras+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6) 		decreased cell proliferation J:122107
\Pggt1btm1Mbrg/\Pggt1btm1Mbrg
\Tg(KRT14-cre)1Amc/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased keratinocyte proliferation J:158528
\Pgptm1.2Ango/\Pgptm1.2Ango
(involves: 129S4/SvJaeSor * C57BL/6J * FVB/N) 		abnormal fibroblast proliferation J:259970
\Pgrtm1Bwo/\Pgrtm1Bwo
(involves: 129S7/SvEvBrd) 		decreased mammary gland epithelial cell proliferation J:85196
\Pgrtm1Bwo/\Pgrtm1Bwo
(involves: 129S7/SvEvBrd * C57BL/6J) 		increased pancreatic beta cell proliferation J:125584
\Pgrtm2(cre)Lyd/\Pgr+
\Wnt5atm1.1Tpy/\Wnt5atm1.1Tpy
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal trophoblast giant cell proliferation J:233595
\Phb2tm1Tlan/\Phb2tm1Tlan
(involves: C57BL/6 * SJL) 		decreased fibroblast proliferation J:131699
\Phc2tm1Hko/\Phc2tm1Hko
(B6.129-Phc2tm1Hko) 		decreased fibroblast proliferation J:100027
\Phf6em1Wencc/Y
\Tg(Vav1-cre)#Cgp/0
(Not Specified) 		increased hematopoietic stem cell proliferation J:278804
\Phf6em1Wencc/\Phf6em1Wencc
\Tg(Vav1-cre)#Cgp/0
(Not Specified) 		increased hematopoietic stem cell proliferation J:278804
\Phf6tm1.1Avo/Y
\Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * SJL) 		increased hematopoietic stem cell proliferation J:276228
\Phf8tm1.1Hoch/Y
(involves: 129S4/SvJae * C57BL/6) 		decreased cell proliferation J:248400
\Phf14tm1Take/\Phf14tm1Take
(B6.Cg-Phf14tm1Take) 		increased cell proliferation J:184822
increased fibroblast proliferation J:184822
\Phf19tm1.1Ldc/\Phf19tm1.1Ldc
(Not Specified) 		increased hematopoietic stem cell proliferation J:313068
\Phox2btm1.1Heno/\Phox2b+
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)) 		abnormal neuronal precursor proliferation J:190742
decreased enteric neural crest cell proliferation J:190742
\Phox2btm2.1Heno/\Phox2b+
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)) 		abnormal neuronal precursor proliferation J:190742
decreased enteric neural crest cell proliferation J:190742
\Pik3ap1tm1Kuro/\Pik3ap1tm1Kuro
(involves: 129P2/OlaHsd) 		decreased B cell proliferation J:84669
\Pik3c3tm1.1Fawa/\Pik3c3tm1.1Fawa
(involves: 129S4/SvJaeSor * C57BL/6J) 		decreased cell proliferation J:169569
\Pik3c3tm1c(EUCOMM)Wtsi/\Pik3c3tm1c(EUCOMM)Wtsi
(involves: C57BL/6N) 		decreased cell proliferation J:182628
\Pik3catm1.1Waph/\Pik3ca+
(involves: 129S1/Sv * C57BL/6) 		increased fibroblast proliferation J:184382
\Pik3catm1.1Waph/\Pik3ca+
\Tg(MMTV-cre)#Mam/0
(involves: 129S1/Sv * C57BL/6 * FVB) 		increased mammary gland epithelial cell proliferation J:187299
\Pik3catm1Nbm/\Pik3catm1Nbm
(involves: 129S6/SvEvTac) 		decreased cell proliferation J:54237
\Pik3cbtm1.1Ehi/\Pik3cbtm1.1Ehi
(involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6J) 		decreased fibroblast proliferation J:152332
\Pik3cbtm1.1Ehi/\Pik3cbtm1.1Ehi
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6J) 		abnormal spermatogonia proliferation J:165087
\Pik3cbtm1Jjz/\Pik3cbtm1Jjz
(involves: 129 * C57BL/6) 		decreased fibroblast proliferation J:138565
\Pik3cdem1.1Pls/\Pik3cd+
(Not Specified) 		increased B cell proliferation J:282486
\Pik3cdtm1Jni/\Pik3cdtm1Jni
(involves: 129P2/OlaHsd) 		decreased B cell proliferation J:80614
\Pik3cdtm1Tnr/\Pik3cdtm1Tnr
(involves: 129S4/SvJae) 		decreased B cell proliferation J:113491, J:79133
\Pik3cgtm1Pngr/\Pik3cgtm1Pngr
(involves: 129P2/OlaHsd * C57BL/6) 		decreased T cell proliferation J:60347
\Pik3r1tm1Dfr/\Pik3r1tm1Dfr
(involves: 129S6/SvEvTac * C57BL/6) 		decreased B cell proliferation J:52229
\Pik3r1tm1Tka/\Pik3r1tm1Tka
(involves: C57BL/6 * CBA) 		decreased B cell proliferation J:113491, J:52228
\Pim1tm1Pwl/\Pim1tm1Pwl
\Pim2tm1Brn/\Pim2tm1Brn
\Pim3tm1Brn/\Pim3tm1Brn
(involves: 129P/Ola * FVB/N) 		decreased B cell proliferation J:91592
decreased T cell proliferation J:91592
\Pim2tm1Brn/\Pim2tm1Brn
(involves: 129P/Ola * FVB/N) 		decreased T cell proliferation J:91592
\Pin1tm1Tuc/\Pin1tm1Tuc
(B6.129P2-Pin1tm1Tuc) 		decreased primordial germ cell proliferation J:83663
\Pip4k2ctm1b(KOMP)Wtsi/\Pip4k2ctm1b(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N) 		increased T cell proliferation J:234283
\Pip5k1ctm1.2Ref/\Pip5k1ctm1.2Ref
\Tg(TcraTcrb)425Cbn/0
(involves: BALB/c * C57BL/6) 		increased T cell proliferation J:164732
\Piptm1Myal/\Piptm1Myal
(involves: 129S/SvEv * C57BL/6) 		increased cell proliferation J:202016
\Pirbtm1Ttk/\Pirbtm1Ttk
(involves: 129X1/SvJ) 		increased B cell proliferation J:76770
\Pkd1tm1.1Djmp/\Pkd1tm1.2Djmp
\Tg(Cdh16-cre/ERT2)F427Djmp/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NCrl * FVB/N) 		increased kidney cell proliferation J:130079
\Pkd1tm1.1Pcha/\Pkd1tm1.1Pcha
\Pparatm1Gonz/\Pparatm1Gonz
(involves: 129 * 129S4/SvJae * C57BL/6) 		increased kidney cell proliferation J:244067
\Pkd1tm1.1Pcha/\Pkd1tm2Som
\Tg(Cdh16-cre)91Igr/0
(involves: 129 * 129S4/SvJae * C57BL/6 * ICR) 		increased kidney cell proliferation J:244067
\Pkd1tm1.2Djmp/\Pkd1+
(involves: 129P2/OlaHsd * FVB/N) 		increased kidney cell proliferation J:130079
\Pkd1tm1Shh/\Pkd1tm1.1Pcha
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6) 		increased cell proliferation J:193544
\Pkd1tm1Som/\Pkd1+
\Prkcshtm1Som/\Prkcshtm1Som
\Tg(Cdh16-cre)91Igr/0
(involves: 129 * C57BL/6 * C57BL/6J * ICR * SJL) 		increased kidney cell proliferation J:188763
\Pkd1tm1Som/\Pkd1+
\Sec63tm1Som/\Sec63tm1Som
\Tg(Cdh16-cre)91Igr/0
(involves: 129 * C57BL/6 * C57BL/6J * ICR * SJL) 		increased kidney cell proliferation J:188763
\Pkd1tm2Ggg/\Pkd1+
\Tg(Col1a1-cre)1Bek/0
(involves: 129S4/SvJae * CD-1) 		increased osteoblast proliferation J:191967
\Pkd1tm2Ggg/\Pkd1tm2Ggg
\Tg(Col1a1-cre)1Bek/0
(involves: 129S4/SvJae * CD-1) 		increased osteoblast proliferation J:191967
\Pkd1tm2Ggg/\Pkd1tm2Ggg
\Tg(Hoxb7-cre)13Amc/0
(involves: 129S4/SvJae * C57BL/6) 		increased kidney cell proliferation J:171619
\Pkd1tm2Ggg/\Pkd1tm2Ggg
\Tg(Nes-cre)Wme/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		increased kidney cell proliferation J:185855
\Pkd1tm2Som/\Pkd1tm2Som
\Tg(Cdh16-cre)91Igr/0
(involves: 129S4/SvJae * C57BL/6 * ICR) 		increased kidney cell proliferation J:244067
\Pkd1tm3Jzh/\Pkd1tm3Jzh
(involves: 129P2/OlaHsd * 129X1/SvJ) 		decreased chondrocyte proliferation J:139970
\Pkd1tm3Jzh/\Pkd1tm3Jzh
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased chondrocyte proliferation J:139970
\Pkd2tm1.1Gwu/\Pkd2tm1.1Gwu
\Tg(Vil1-cre)997Gum/0
(involves: C57BL/6 * C57BL/6J * SJL) 		increased kidney cell proliferation J:265516
\Pkd2tm1Som/\Pkd2tm2Som
(involves: 129/Sv * C57BL/6J * SJL) 		increased kidney cell proliferation J:158354
\Pkd2tm3Som/\Pkd2tm3Som
\Tg(Pkhd1-cre)1Igr/0
(involves: 129S4/SvJae * C57BL/6) 		increased kidney cell proliferation J:244067
\Pkhd1tm1Gwu/\Pkhd1tm1Gwu
(involves: C57BL/6) 		decreased kidney cell proliferation J:167782
\Pkn1tm1Kik/\Pkn1tm1Kik
(B6.129P2-Pkn1tm1Kik) 		increased B cell proliferation J:193187
\Pkn2tm1a(KOMP)Wtsi/\Pkn2tm1a(KOMP)Wtsi
(involves: C57BL/6N) 		abnormal fibroblast proliferation J:229595
\Pknox1tm1Ngc/\Pknox1+
\Tg(IghMyc)22Bri/0
(involves: C57BL * SJL) 		increased B cell proliferation J:192251
\Pkp1tm2d(KOMP)Wtsi/\Pkp1tm2d(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N * SJL/J) 		decreased keratinocyte proliferation J:233599
\Pkp3tm1.1Fvr/\Pkp3tm1.1Fvr
(involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL) 		increased keratinocyte proliferation J:136451
\Plautm1Mlg/\Plautm1Mlg
(B6.Cg-Plautm1Mlg) 		decreased T cell proliferation J:75303
\Plcg1tm1Gcrp/\Plcg1tm1Rwen
\Tg(Cd4-cre)1Cwi/0
(either: B6.Cg-Plcg1tm1Gcrp/Plcg1tm1Rwen Tg(Cd4-cre)1Cwi or (involves: 129X1/SvJ * C57BL/6 * DBA/2)) 		increased T cell proliferation J:157757
\Plcg2tm1Jni/\Plcg2tm1Jni
(involves: 129P2/OlaHsd) 		decreased B cell proliferation J:80614
\Plcg2tm1Jni/\Plcg2tm1Jni
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell proliferation J:117023
\Plcg2tm1Kuro/\Plcg2tm1Kuro
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		decreased B cell proliferation J:63744
\Plcl2tm1Tta/\Plcl2tm1Tta
(involves: 129P2/OlaHsd) 		increased B cell proliferation J:85960
\Plgtm1Jld/\Plgtm1Jld
(B6.129P2-Plgtm1Jld) 		increased hepatocyte proliferation J:120368
\Plrg1tm2Jcbr/\Plrg1tm2Jcbr
(Not Specified) 		decreased cell proliferation J:149153
\Plxna1tm1Kik/\Plxna1tm1Kik
\Tg(TcraTcrb)425Cbn/?
(involves: BALB/c * C57BL/6) 		decreased T cell proliferation J:161856
\Plxnb1tm1Matl/\Plxnb1tm1Matl
\Plxnb2tm1c(EUCOMM)Wtsi/\Plxnb2tm1Matl
\Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * C57BL/6N * SJL) 		decreased neuronal precursor proliferation J:228347
\Plxnb2tm1Matl/\Plxnb2tm1Matl
(involves: 129P2/OlaHsd * CD-1) 		decreased neuronal precursor proliferation J:190014
\Pmltm1Ppp/\Pmltm1Ppp
(involves: 129S7/SvEvBrd) 		increased fibroblast proliferation J:46381
\Pmp22tm1Ueli/\Pmp22tm1Ueli
(involves: 129S/SvEv * C57BL/6) 		increased Schwann cell proliferation J:98118
\Pnkptm1.1Pmc/\Pnkptm1.1Pmc
\Emx1tm1(cre)Krj/\Emx1+
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6) 		decreased cell proliferation J:226703
\Pnkptm1.1Pmc/\Pnkptm1.1Pmc
\Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * C57BL/6 * SJL) 		decreased cell proliferation J:226703
\Pnkptm1Pmc/\Pnkptm1Pmc
(involves: 129S1/Sv * C57BL/6) 		decreased cell proliferation J:226703
\Pnpbata/\Pnpbata
(C57BL/6JSfdAnu-Pnpbata) 		decreased B cell proliferation J:104190
\Polbtm1.1Jbsw/\Polbtm1.1Jbsw
(involves: 129/Sv * C57BL/6) 		decreased cell proliferation J:183837
decreased fibroblast proliferation J:183837
\Pold1tm1Uchi/\Pold1tm1Uchi
(C57BL/6-Pold1tm1Uchi) 		absent inner cell mass proliferation J:144992
\Pold1tyrn/\Pold1tyrn
(C57BL/6J-Pold1tyrn) 		decreased cell proliferation J:327432
\Pold3em1Linl/\Pold3em1Linl
(involves: C57BL/6 * DBA/2) 		abnormal trophoblast giant cell proliferation J:263620
decreased inner cell mass proliferation J:263620
\Pole4tm1(KOMP)Vlcg/\Pole4tm1(KOMP)Vlcg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac * FVB/N) 		decreased fibroblast proliferation J:261973
\Polmtm1Crey/\Polmtm1Crey
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal B cell proliferation J:85190
\Polr2mtm1.1Rgr/\Polr2mtm1.1Rgr
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6 * DBA) 		increased hepatocyte proliferation J:291184
\Pomctm1Low/\Pomctm1Low
(involves: 129S2/SvPas * C57BL/6) 		increased splenocyte proliferation J:102955
\Pomgnt1tm1Stk/\Pomgnt1tm1Stk
(involves: 129S/SvEv) 		abnormal skeletal muscle satellite cell proliferation J:144928
\Pot1atm1.1Schg/\Pot1atm1.1Schg
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased cell proliferation J:112184
\Pot1atm1Schg/\Pot1atm1.1Schg
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased cell proliferation J:112184
\Pou2af1tm1Rgr/\Pou2af1tm1Rgr
(either: (involves: 129P2/OlaHsd) or (involves: 129S1/Sv)) 		decreased B cell proliferation J:35785
increased B cell proliferation J:114816
\Pou3f3tm1Tno/\Pou3f3tm1Tno
(involves: 129S4/SvJae * C57BL/6J) 		decreased kidney cell proliferation J:84756
\Ppardtm1Wwah/\Ppard+
(Not Specified) 		increased keratinocyte proliferation J:71272
\Ppardtm1Wwah/\Ppardtm1Wwah
(Not Specified) 		decreased keratinocyte proliferation J:96826
\Ppargtm1Tka/\Pparg+
(involves: C57BL/6 * CBA * ICR) 		increased B cell proliferation J:58222
\Ppm1dtm1Lad/\Ppm1dtm1Lad
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased B cell proliferation J:74284
decreased T cell proliferation J:74284
\Ppm1dtm1Lad/\Ppm1dtm1Lad
(involves: 129S7/SvEvBrd) 		decreased pancreatic beta cell proliferation J:151980
\Ppp1r13ltm1.1Xlu/\Ppp1r13l+
(involves: 129 * BALB/cJ * C57BL/6J) 		decreased fibroblast proliferation J:177360
\Ppp1r13ltm1.1Xlu/\Ppp1r13ltm1.1Xlu
(involves: 129 * BALB/cJ * C57BL/6J) 		decreased fibroblast proliferation J:177360
decreased keratinocyte proliferation J:177360
\Ppp2r3ctm1Imku/\Ppp2r3ctm1Imku
\Tg(CD19-cre/ERT2)1Cgn/?
(involves: C57BL/6) 		decreased B cell proliferation J:100706
\Ppp2r5cGt(XP0444)Wtsi/\Ppp2r5cGt(XP0444)Wtsi
\Ppp2r5dGt(RRT114)Byg/\Ppp2r5dGt(RRT114)Byg
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J) 		decreased fibroblast proliferation J:348684
\Ppp3catm1Jse/\Ppp3catm1Jse
(either: (involves: 129S4/SvJae * Black Swiss) or (involves: 129S4/SvJae * C57BL/6)) 		decreased T cell proliferation J:71750
\Ppp3cbM1Btlr/\Ppp3cb+
(C57BL/6J-Ppp3cbM1Btlr) 		increased CD8-positive, alpha-beta memory T cell proliferation J:236670
\Ppp3cbM1Btlr/\Ppp3cbM1Btlr
(C57BL/6J-Ppp3cbM1Btlr) 		increased CD8-positive, alpha-beta memory T cell proliferation J:236670
\Ppp3cbm2Btlr/\Ppp3cb+
(C57BL/6J-Ppp3cbm2Btlr) 		increased CD8-positive, alpha-beta memory T cell proliferation J:236671
\Ppp3cbm2Btlr/\Ppp3cbm2Btlr
(C57BL/6J-Ppp3cbm2Btlr) 		increased CD8-positive, alpha-beta memory T cell proliferation J:236671
\Ppp3cbtm1Jmk/\Ppp3cbtm1Jmk
(involves: 129S6/SvEvTac * C57BL/6) 		decreased T cell proliferation J:77729
\Ppp3cbtm1Jmk/\Ppp3cbtm1Jmk
(involves: 129S6/SvEvTac) 		decreased T cell proliferation J:109586
\Ppp3r1tm2Grc/\Ppp3r1tm2.1Grc
\Tg(Pax3-cre)1Joe/0
(involves: 129S6/SvEvTac) 		decreased cell proliferation J:89217
\Ppp3r1tm2Grc/\Ppp3r1tm2Grc
\Tg(Pax3-cre)1Joe/0
(involves: 129S6/SvEvTac) 		decreased cell proliferation J:89217
\Ppp5ctm1.2Rhon/\Ppp5ctm1.2Rhon
(B6.129X1-Ppp5ctm1.2Rhon) 		decreased fibroblast proliferation J:178164
\Pramel1em1Liuw/\Pramel1em1Liuw
(involves: C57BL/6) 		abnormal spermatogonia proliferation J:342835
\Pramel13em2Dean/\Pramel13em2Dean
(involves: C57BL/6J * DBA/2J) 		abnormal spermatogonia proliferation J:282232
\Prdm11tm1.1Ahl/\Prdm11tm1.1Ahl
(B6.129(C)-Prdm11tm1.1Ahl) 		increased megakaryocyte progenitor cell proliferation J:222765
\Prdm16tm1.1Brsp/\Prdm16tm1.1Brsp
\Tg(myl7.L-cre)1118Tmhn/0
(involves: 129 * C57BL/6J * MF1) 		decreased fetal cardiomyocyte proliferation J:326525
\Prdx1tm1Rave/\Prdx1tm1Rave
(involves: 129S6/SvEvTac * C57BL/6) 		decreased cell proliferation J:84677
\Prkab1Gt(RRR454)Byg/\Prkab1Gt(RRR454)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal neuronal precursor proliferation J:146618
\Prkcbtilc/\Prkcbtilc
(involves: C57BL/6JSfdAnu) 		decreased B cell proliferation J:221236
\Prkcbtm1Tara/\Prkcbtm1Tara
(involves: 129) 		decreased B cell proliferation J:34818
\Prkcdtm1Kin/\Prkcdtm1Kin
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell proliferation J:76135, J:143854
\Prkcdtm1Qxu/\Prkcdtm1Qxu
\Tg(IghelMD4)4Ccg/0
\Tg(ML5sHEL)5Ccg/0
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal B cell proliferation J:76134
\Prkcetm1Bsca/\Prkcetm1Bsca
(involves: 129P2/OlaHsd * C57BL/6) 		decreased T cell proliferation J:103337
\Prkchtm1.2Gasc/\Prkchtm1.2Gasc
(involves: C57BL/6 * FVB/N * SJL) 		decreased T cell proliferation J:186080
\Prkchtm1.2Gasc/\Prkchtm1.2Gasc
\Prkcqtm1Litt/\Prkcqtm1Litt
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL) 		decreased T cell proliferation J:186080
\Prkcqtm1.1Bai/\Prkcqtm1.1Bai
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased T cell proliferation J:83733
\Prkcqtm1Litt/\Prkcqtm1Litt
(involves: 129P2/OlaHsd) 		decreased T cell proliferation J:83922, J:123989
\Prkcqtm1Litt/\Prkcqtm1Litt
(B6.129P2-Prkcqtm1Litt) 		decreased splenocyte proliferation J:129421
decreased T cell proliferation J:94285
\Prkcqtm1Litt/\Prkcqtm1Litt
(involves: 129P2/OlaHsd * C57BL/6) 		decreased T cell proliferation J:186080
\Prkcqtm1Litt/\Prkcqtm1Litt
(either: (involves: 129/Sv * 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6)) 		decreased T cell proliferation J:141930
\Prkcqtm1Litt/\Prkcqtm1Litt
\Tcratm1Mom/\Tcratm1Mom
(involves: 129P2/OlaHsd * 129S2/SvPas) 		decreased T cell proliferation J:135589
\Prkcqtm1Litt/\Prkcqtm1Litt
\Tg(TcrLCMV)327Sdz/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		decreased splenocyte proliferation J:123989
decreased T cell proliferation J:123989
\Prkdcscid/\Prkdcscid
(C.BKa-Prkdcscid) 		decreased B cell proliferation J:6958
decreased T cell proliferation J:6958
\Prlrtm1Cnp/\Prlr+
(B6.129P2-Prlrtm1Cnp/J) 		abnormal neuron proliferation J:83248
\Prmt5Gt(RRA014)Byg/\Prmt5Gt(RRA014)Byg
(involves: 129P2/OlaHsd) 		absent inner cell mass proliferation J:166736
\Prmt5tm2c(EUCOMM)Wtsi/\Prmt5tm2c(EUCOMM)Wtsi
\Tg(Nes-cre)1Kln/0
(B6.Cg-Prmt5tm2c(EUCOMM)Wtsi Tg(Nes-cre)1Kln) 		abnormal neuronal precursor proliferation J:201152
\Prmt6tm1.2Rchd/\Prmt6tm1.2Rchd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * FVB/N) 		decreased fibroblast proliferation J:199753
\Prnptm2Edin/\Prnptm2Edin
(B6.129P2-Prnptm2Edin) 		abnormal neuronal precursor proliferation J:107170
\Prnptm2Edin/\Prnptm2Edin
\Tg(Prnp)a20Cwe/0
(B6.Cg-Prnptm2Edin Tg(Prnp)a20Cwe) 		abnormal neuronal precursor proliferation J:107170
\Prnptm2Lnq/\Prnptm2Lnq
(involves: 129P2/OlaHsd * C57BL/6N) 		abnormal neuron proliferation J:200974
\Prnptm3Lnq/\Prnptm3Lnq
(involves: 129P2/OlaHsd * C57BL/6N) 		abnormal neuron proliferation J:200974
\Prox1tm1Gco/\Prox1tm1Gco
(involves: 129S1/Sv * 129X1/SvJ * NMRI) 		decreased hepatocyte proliferation J:63128
\Prpf19tm1Glri/\Prpf19tm1Glri
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6) 		absent inner cell mass proliferation J:121379
decreased cell proliferation J:121379
\Prss8em1Bug/\Prss8em1Bug
\Spint2Gt(KST272)Byg/\Spint2Gt(KST272)Byg
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J * FVB/NJ * NIH Black Swiss) 		abnormal enterocyte proliferation J:261068
\Psen1tm1Jzt/\Psen1tm1Jzt
\Tg(Camk2a-cre)T29-1Stl/0
(involves: C57BL/6 * CBA) 		decreased cell proliferation J:73252
\Psen1tm1Shs/\Psen1tm1Shs
(involves: C57BL/6) 		abnormal neuronal precursor proliferation J:91975
\Psmb10tm1Mgro/\Psmb10tm1Mgro
(involves: 129S2/SvPas * C57BL/6) 		decreased T cell proliferation J:125058
\Psmb11tm1(Psmb8)Khog/\Psmb11tm1(Psmb8)Khog
(involves: C57BL/6) 		increased T cell proliferation J:196156
\Psmd4tm1Smta/\Psmd4tm1Smta
(involves: C57BL/6 * CBA) 		absent inner cell mass proliferation J:126546
\Psme3tm1Jjm/\Psme3tm1Jjm
(B6.129X1-Psme3tm1Jjm) 		decreased fibroblast proliferation J:88626
\Psme3tm1Tchi/\Psme3tm1Tchi
(involves: C57BL/6J * CBA) 		decreased cell proliferation J:89182
\Psmg1tm1.1Smta/\Psmg1tm1.1Smta
\Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * CBA * SJL) 		decreased cerebellar granule cell precursor proliferation J:162790
\Ptbp1tm1Msol/\Ptbp1tm1Msol
(B6J.129-Ptbp1tm1Msol) 		decreased cell proliferation J:223915
\Ptch1tm1Bjw/\Ptch1tm1Bjw
\Tg(Atoh1-cre)1Bfri/0
(involves: 129T2/SvEms * C57BL/6 * CBA) 		abnormal neuronal precursor proliferation J:139573
\Ptch1tm1Bjw/\Ptch1tm1Bjw
\Tg(Atoh1-cre/Esr1*)14Fsh/0
(involves: 129T2/SvEms * FVB/N) 		abnormal neuronal precursor proliferation J:139573
\Ptch1tm1Yy/\Ptch1tm1.1Yy
\Tg(Col2a1-cre)1Bhr/0
(involves: C57BL/6 * SJL) 		increased chondrocyte proliferation J:112462
\Ptentm1Engc/\Ptentm1Engc
(involves: CD-1) 		increased cell proliferation J:210487
\Ptentm1Hwu/\Ptentm1Hwu
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA) 		increased hepatocyte proliferation J:218587
\Ptentm1Hwu/\Ptentm1Hwu
\Tg(CYP19A1-cre)1Jri/0
(involves: 129S4/SvJae) 		increased granulosa cell proliferation J:138315
\Ptentm1Hwu/\Ptentm1Hwu
\Tg(Gfap-cre)77.6Mvs/0
(involves: 129S4/SvJae * BALB/c * C57BL/6NHsd) 		abnormal neuronal precursor proliferation J:146630
\Ptentm1Hwu/\Ptentm1Hwu
\Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6 * DBA) 		increased pancreatic beta cell proliferation J:106937
\Ptentm1Hwu/\Ptentm1Hwu
\Tg(Nkx2-1-cre)2Sand/0
(involves: 129S4/SvJae * BALB/c * C57BL/6) 		increased lung endothelial cell proliferation J:167962
\Ptentm1Hwu/\Ptentm1Hwu
\Tg(Vil1-cre)997Gum/0
(involves: 129S4/SvJae * BALB/c * C57BL/6J * SJL) 		abnormal small intestinal crypt cell proliferation J:150553
\Ptentm1Hwu/\Ptentm1Hwu
\Vhltm1Jae/\Vhltm1Jae
\Tg(Cdh16-cre)91Igr/0
(involves: 129S4/SvJae * BALB/c * C57BL/6J * ICR) 		increased kidney cell proliferation J:137073
\Ptentm2Mak/\Ptentm2Mak
\Smad4tm2.1Cxd/\Smad4tm2.1Cxd
\Tg(KRT5-cre)1Xya/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac) 		increased keratinocyte proliferation J:101602
\Ptentm2Mak/\Ptentm2Mak
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		increased hepatocyte proliferation J:138099
\Ptentm2Mak/\Ptentm2Mak
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * DBA) 		increased hepatocyte proliferation J:90905
\Ptentm2Mak/\Ptentm2Mak
\Tg(SFTPC-rtTA)5Jaw/0
\Tg(tetO-cre)1Jaw/0
(involves: 129 * 129P2/OlaHsd * C57BL/6 * C57BL/6J) 		increased mesenchymal cell proliferation involved in lung development J:127405
\Ptger4tm1Sna/\Ptger4tm1Sna
(involves: 129P2/OlaHsd * C57BL/6) 		decreased T cell proliferation J:83725
\Ptges3tm1Nkt/\Ptges3tm1Nkt
(involves: 129P2/OlaHsd * C57BL/6) 		decreased fibroblast proliferation J:125188
\Pthlhtm2Ack/\Pthlhtm2Ack
(involves: 129S2/SvPas * C57BL/6) 		decreased cell proliferation J:142669
decreased chondrocyte proliferation J:142669
\Ptk2tm1Heen/\Ptk2tm1Heen
(involves: 129/Sv * C57BL/6) 		decreased fibroblast proliferation J:157804
\Ptk2tm1Lfr/\Ptk2tm1Ilic
\Tg(KRT5-cre)5132Jlj/0
(involves: 129X1/SvJ * C57BL/6 * CBA * DBA/2J) 		decreased keratinocyte proliferation J:107206
\Ptmatm1.1Got/\Ptma+
(involves: C57BL/6J * C57BL/6NTac) 		abnormal neuron proliferation J:240549
\Ptp4a2Gt(AQ0673)Wtsi/\Ptp4a2Gt(AQ0673)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		decreased cell proliferation J:190411
\Ptpmt1tm1.1Jedi/\Ptpmt1tm1.1Jedi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		decreased cell proliferation J:176087
\Ptpmt1tm1Ckq/\Ptpmt1tm1Ckq
(B6.Cg-Ptpmt1tm1Ckq) 		absent inner cell mass proliferation J:178313
\Ptpn6me/\Ptpn6me
(involves: C3H/HeN * C57BL/6J * NFS) 		increased splenocyte proliferation J:30994
\Ptpn9tm1Dny/\Ptpn9tm1Dny
(B6.129-Ptpn9tm1Dny) 		decreased T cell proliferation J:118880
\Ptpn11tm1Bgn/\Ptpn11+
(involves: 129S4/SvJae * C57BL/6J) 		increased cell proliferation J:91609
\Ptpn11tm1Bgn/\Ptpn11tm1Bgn
(involves: 129S4/SvJae * C57BL/6J) 		increased cell proliferation J:91609
\Ptpn11tm1Gsf/\Ptpn11tm1Gsf
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		increased hepatocyte proliferation J:172422
\Ptpn11tm1Paw/\Ptpn11tm1Paw
(involves: 129S1/Sv * 129X1/SvJ) 		decreased cell proliferation J:106624
\Ptpn11tm5Bgn/\Ptpn11tm5Bgn
(involves: 129S4/SvJae * C57BL/6J) 		decreased trophectoderm cell proliferation J:106624
\Ptpn12tm1Vei/\Ptpn12tm1Vei
\Tg(Cd4-cre)1Cwi/0
(B6.Cg-Tg(Cd4-cre)1Cwi Ptpn12tm1Vei) 		decreased T cell proliferation J:163910
\Ptpn22tm1.1Draw/\Ptpn22+
(involves: 129 * C57BL/6) 		increased B cell proliferation J:201448
increased T cell proliferation J:201448
\Ptpn22tm1.1Draw/\Ptpn22tm1.1Draw
(involves: 129 * C57BL/6) 		increased B cell proliferation J:201448
increased T cell proliferation J:201448
\Ptpn22tm1.1Kas/\Ptpn22tm1.1Kas
(involves: C57BL/6) 		increased B cell proliferation J:176519
increased T cell proliferation J:176519
\Ptpn22tm1.1Kas/\Ptpn22tm1.1Kas
\Tg(TcraTcrb)425Cbn/0
(involves: BALB/c * C57BL/6) 		increased T cell proliferation J:176519
\Ptprctm1Mak/\Ptprctm1Mak
(involves: 129/Sv * C57BL/6) 		decreased B cell proliferation J:13163
decreased T cell proliferation J:13163
\Ptprcaptm1Tkda/\Ptprcaptm1Tkda
(involves: 129X1/SvJ) 		decreased B cell proliferation J:48387
decreased T cell proliferation J:48387
\PtprfGt(ST534)Byg/\PtprfGt(ST534)Byg
(D.129P2-PtprfGt(ST534)Byg) 		increased cell proliferation J:108603
\Ptprvtm1Asmi/\Ptprvtm1Asmi
(involves: 129P2/OlaHsd * C57BL/6J) 		increased pancreatic beta cell proliferation J:152695
\Ptprvtm1Kry/\Ptprvtm1Kry
\Tg(Col1a1-cre)1Kry/0
(involves: FVB) 		increased pancreatic beta cell proliferation J:126780
\Pttg1tm1Pzg/\Pttg1tm1Pzg
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased cell proliferation J:121688
\Pttg1tm1Sme/\Pttg1tm1Sme
(involves: 129S4/SvJae * C57BL/6) 		decreased pancreatic beta cell proliferation J:82724
\Puratm1Herm/\Pura+
(involves: 129P2/OlaHsd * BALB/c) 		abnormal neuron proliferation J:179606
\Puratm1Herm/\Puratm1Herm
(involves: 129P2/OlaHsd * BALB/c) 		abnormal neuron proliferation J:179606
\Puratm1Kkh/\Pura+
(involves: 129) 		decreased cell proliferation J:85759
\Puratm1Kkh/\Puratm1Kkh
(involves: 129) 		decreased cell proliferation J:85759
decreased neuronal precursor proliferation J:85759
\Pxdnmhdakta048/\Pxdnmhdakta048
(involves: C3HeB/FeJ * C57BL/6J) 		decreased cell proliferation J:213336
\Pygo2tm1.1Xdai/\Pygo2tm1.2Xdai
\Tg(KRT14-cre)#Smr/0
(involves: 129P2/OlaHsd * C57BL/6J * SJL/J) 		decreased mammary gland epithelial cell proliferation J:163218
\Pygo2tm1.2Xdai/\Pygo2tm1.2Xdai
(involves: 129P2/OlaHsd) 		decreased mammary gland epithelial cell proliferation J:163218
\R3hdmltm1Mita/\R3hdmltm1Mita
(B6.Cg-R3hdmltm1Mita) 		abnormal skeletal muscle satellite cell proliferation J:282737
\Rab7tm1.1Ale/\Rab7tm1.1Ale
\Tg(Cd4-cre)1Cwi/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		decreased T cell proliferation J:211733
\Rab10tm1Tax/\Rab10tm1Tax
(B6.Cg-Rab10tm1Tax) 		decreased cell proliferation J:262459
\Rab11atm1.1Ngao/\Rab11atm1.1Ngao
\Tg(Vil1-cre)997Gum/0
(involves: 129S4/SvJae * C57BL/6J * SJL) 		abnormal small intestinal crypt cell proliferation J:215917
\Rab11atm1.1Ngao/\Rab11atm1.1Ngao
\Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		abnormal small intestinal crypt cell proliferation J:278932, J:215917
\Rac1tm1Djk/\Rac1tm1Djk
\Tg(Nkx2-5-cre)9Eno/0
(involves: 129S4/SvJae * BALB/c * C57BL/6) 		decreased fetal cardiomyocyte proliferation J:321017
\Rac1tm1Tyb/\Rac1tm2Tyb
\Edil3Tg(Sox2-cre)1Amc/\Edil3+
(involves: 129S4/SvJae * C3H * C57BL/6 * CBA) 		decreased cell proliferation J:173526
\Rac2tm1Mddw/\Rac2tm1Mddw
(involves: 129S/SvEv * C57BL/6) 		decreased T cell proliferation J:119437
\Rac2tm1Mddw/\Rac2tm1Mddw
(involves: 129S/SvEv) 		decreased vascular endothelial cell proliferation J:131305
\Rac2tm1Mddw/\Rac2tm1Mddw
\Tg(TcrAND)53Hed/0
(involves: 129S/SvEv * C57BL/6 * SJL) 		decreased T cell proliferation J:119437
\Racgap1tm1Mahi/\Racgap1tm1Mahi
\Tg(Stra8-icre)1Reb/0
(involves: C57BL/6 * FVB/NJ) 		abnormal spermatogonia proliferation J:206583
\Rad50tm1Jpt/\Rad50tm1Jpt
(involves: 129S7/SvEvBrd) 		decreased cell proliferation J:56083
\Rad50tm1Jpt/\Rad50tm3Jpt
\Tg(Mx1-cre)1Cgn/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA) 		decreased hepatocyte proliferation J:144766
\Rad51tm1Hst/\Rad51tm1Hst
(involves: 129S7/SvEvBrd * C57BL/6) 		absent inner cell mass proliferation J:36540
decreased cell proliferation J:36540
\Rad51tm1Hst/\Rad51tm1Hst
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased cell proliferation J:36540
\Rad54l2Gt(A016E03)Oaj/\Rad54l2Gt(A016E03)Oaj
(involves: ICR) 		decreased cell proliferation J:121844
decreased fibroblast proliferation J:121844
\Raf1tm1Zim/\Raf1tm1Zim
(involves: 129/Sv * CD-1) 		decreased fibroblast proliferation J:50696
\Raf1tm3Ulb/\Raf1tm3Ulb
(Not Specified) 		decreased cell proliferation J:141095
\Rag1tm1Mom/\Rag1tm1Mom
(involves: 129S7/SvEvBrd) 		abnormal neuron proliferation J:170591
\Rag2tm1Avla/\Rag2tm1Avla
(involves: 129/Sv * C57BL/6) 		decreased T cell proliferation J:122108
\Rag2tm1Fwa/\Rag2tm1Fwa
\Sos1tm1.1Les/\Sos1tm1.1Les
\Tg(Lck-cre)1Cwi/0
(involves: 129S/SvEv * C57BL/6) 		decreased T cell proliferation J:174536
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(TcrHEL3A9)1Mmd/0
(involves: 129S/SvEv * C57BL/6) 		abnormal T cell proliferation J:78309
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(TcrHEL3A9)1Mmd/0
\Tg(TLK2mHEL)2Ccg/0
(involves: 129S/SvEv * C57BL/6) 		abnormal T cell proliferation J:78309
\Ralatm1.2Cjm/\Ralatm1.2Cjm
\Ralbtm1.1Cjm/\Ralbtm1.1Cjm
(involves: C57BL/6 * C57BL/6J) 		decreased fibroblast proliferation J:199742
\Ranbp1Gt(S17-6E1)1.1Sor/\Ranbp1Gt(S17-6E1)1.1Sor
(B6.129S4(129S6)-Ranbp1Gt(S17-6E1)1.1Sor) 		abnormal neuronal precursor proliferation J:235630
\Ranbp9Gt(RHA056)Byg/\Ranbp9Gt(RHA056)Byg
(B6.129P2-Ranbp9Gt(RHA056)Byg) 		abnormal spermatogonia proliferation J:173615
\Rangrftm1.1Tke/\Rangrftm1.1Tke
(involves: C57BL/6) 		increased fibroblast proliferation J:325055
\Rap1atm1Tze/\Rap1atm1Tze
(involves: 129P2/OlaHsd * C57BL/6) 		decreased T cell proliferation J:144145
\Rapgef2tm1.2Hous/\Rapgef2tm1.2Hous
(involves: 129S1/Sv) 		decreased cell proliferation J:165879
\Raratm3.1Ipc/\Rara+
\Trim24tm1.1Los/\Trim24tm1.1Los
(involves: 129/Sv * C57BL/6 * SJL) 		increased hepatocyte proliferation J:130210
\Raratm3Ipc/\Rara+
\Speer6-ps1Tg(Alb-cre)21Mgn/?
\Trim24tm1Los/\Trim24tm1Los
(involves: 129/Sv * C57BL/6 * DBA * SJL) 		increased hepatocyte proliferation J:130210
\Raratm3Ipc/\Raratm3Ipc
\Speer6-ps1Tg(Alb-cre)21Mgn/?
\Trim24tm1Los/\Trim24tm1Los
(involves: 129/Sv * C57BL/6 * DBA * SJL) 		increased hepatocyte proliferation J:130210
\Rarres1tm1.2Mhl/\Rarres1tm1.2Mhl
(involves: 129S1/SvImJ * C57BL/6 * FVB/N * NIH Black Swiss) 		increased B cell proliferation J:324270
\Rasgrf2tm1Esn/\Rasgrf2tm1Esn
\Vav1tm1Tyb/\Vav1tm1Tyb
(involves: 129S1/Sv * 129S2/SvPas * C57BL/10 * C57BR/cd) 		decreased T cell proliferation J:128985
\Rasgrp1lag/\Rasgrp1lag
(involves: 129 * C57BL/6) 		decreased T cell proliferation J:85189
\Rasgrp1tm1.1Wz/\Rasgrp1tm1.1Wz
(B6.Cg-Rasgrp1tm1.1Wz) 		decreased T cell proliferation J:225109
\Rassf5tm1Kina/\Rassf5tm1Kina
(B6.Cg-Rassf5tm1Kina) 		increased B cell proliferation J:168749
increased T cell proliferation J:168749
\Rassf9Tg(PDLIM7*)2Cml/\Rassf9Tg(PDLIM7*)2Cml
(involves: ICR) 		increased keratinocyte proliferation J:171677
\Rb1tm1Brd/\Rb1tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal cell proliferation J:2516
\Rb1tm1Dwg/\Rb1tm1Dwg
(involves: 129/Sv * C57BL/6) 		increased fibroblast proliferation J:105548
\Rb1tm1Tyj/\Rb1tm1Tyj
(involves: 129S2/SvPas) 		increased fibroblast proliferation J:105548
\Rb1tm1Tyj/\Rb1tm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		increased cell proliferation J:81082
\Rb1tm1Tyj/\Rb1tm1Tyj
\Trim27Gt(XP0484)Wtsi/\Trim27Gt(XP0484)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		increased cell proliferation J:189317
\Rb1tm1Tyj/\Rb1tm2Brn
\Rbl1tm1Tyj/\Rbl1tm1Tyj
\Trp53tm1Brn/\Trp53tm1Tyj
\Tg(Chx10-EGFP/cre,-ALPP)2Clc/0
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * SJL) 		abnormal cell proliferation J:120315
\Rb1tm2Brn/\Rb1tm2Brn
\Rbl1tm1Htr/\Rbl1+
\Tg(En2-cre)22Alj/0
(involves: 129P2/OlaHsd * CD-1) 		abnormal neuronal precursor proliferation J:83783
\Rb1tm2Brn/\Rb1tm2Brn
\Rbl1tm1Htr/\Rbl1tm1Htr
\Tg(En2-cre)22Alj/0
(involves: 129P2/OlaHsd * CD-1) 		abnormal neuronal precursor proliferation J:83783
\Rb1tm2Brn/\Rb1tm2Brn
\Tg(Col1a1-cre)1Bek/0
(involves: 129 * CD-1) 		abnormal organ of Corti supporting cell proliferation J:96345
\Rb1tm2Brn/\Rb1tm2Brn
\Tg(Cyp1a1-cre)1Dwi/0
(involves: 129 * C57BL/6 * CBA) 		abnormal enterocyte proliferation J:215358
\Rb1tm2Brn/\Rb1tm2Brn
\Tg(En2-cre)22Alj/0
(involves: 129P2/OlaHsd * CD-1) 		abnormal neuronal precursor proliferation J:83783
\Rb1tm2Brn/\Rb1tm2Brn
\Tg(Pou4f3-cre)1Devet/0
(involves: 129 * 129S/SvEv) 		abnormal organ of Corti supporting cell proliferation J:109453
\Rb1cc1tm1.1Guan/\Rb1cc1tm1.1Guan
\Tg(Tek-cre)12Flv/0
(B6.Cg-Rb1cc1tm1.1Guan Tg(Tek-cre)12Flv) 		increased hematopoietic stem cell proliferation J:167258
\Rbfox2tm1.1Dblk/\Rbfox2tm1.1Dblk
\Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * SJL) 		decreased cerebellar granule cell precursor proliferation J:181631
\Rbfox3tm1a(EUCOMM)Hmgu/\Rbfox3tm1a(EUCOMM)Hmgu
(B6Dnk;B6N-Rbfox3tm1a(EUCOMM)Hmgu/H) 		decreased neuronal precursor proliferation J:240501
\Rbl1tm1Mru/\Rbl1tm1Mru
(involves: 129S4/SvJae * BALB/cJ) 		increased cell proliferation J:51060
increased fibroblast proliferation J:51060
\Rbl1tm1Mru/\Rbl1tm1Mru
(involves: 129S4/SvJae * BALB/c * C57BL/6) 		abnormal neuronal precursor proliferation J:92520
\Rbl1tm3.1Jsag/\Rbl1tm3.1Jsag
(involves: C57BL/6) 		increased fibroblast proliferation J:161509
\Rbl2tm1Mru/\Rbl2tm1Mru
(involves: 129S4/SvJae * BALB/cJ) 		abnormal cell proliferation J:50516
\Rbm3tm1Ttg/\Rbm3tm1Ttg
(involves: 129P2/OlaHsd) 		decreased fibroblast proliferation J:174947
\Rbp4tm1Gott/\Rbp4tm1Gott
(involves: 129/Sv * C57BL/6 * CD-1) 		abnormal fetal cardiomyocyte proliferation J:82903
\Rbpjtm1Hon/\Rbpjtm1Hon
\Tg(Lck-cre)19Hhan/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		increased T cell proliferation J:168475
\Rbpjtm1Kyo/\Rbpjtm1Kyo
(involves: 129S2/SvPas) 		decreased fetal cardiomyocyte proliferation J:119151
\Rbx1Gt(XB674)Byg/\Rbx1+
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased cell proliferation J:147759
\Rbx1Gt(XB674)Byg/\Rbx1Gt(XB674)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased cell proliferation J:147759
\Rc3h1san/\Rc3h1san
(involves: C57BL/6JSfdAnu) 		increased T cell proliferation J:199407
\Rc3h1tm1.1Mass/\Rc3h1tm1.1Mass
\Rc3h2tm1c(KOMP)Wtsi/\Rc3h2tm1c(KOMP)Wtsi
\Tg(Cd4-cre)1Cwi/?
(involves: C57BL/6N * DBA/2) 		increased T cell proliferation J:196136
\Rcan1tm1Fmc/\Rcan1tm1Fmc
(involves: 129S4/SvJae) 		decreased T cell proliferation J:85148
\Rcan1tm1Jmol/\Rcan1tm1Jmol
\Rcan2tm1Jmol/\Rcan2tm1Jmol
(involves: 129 * C57BL/6) 		decreased T cell proliferation J:109586
\Rcan1tm1Jmol/\Rcan1tm1Jmol
\Rcan2tm1Jmol/\Rcan2tm1Jmol
\Ppp3cbtm1Jmk/\Ppp3cbtm1Jmk
(involves: 129S6/SvEvTac * C57BL/6) 		decreased T cell proliferation J:109586
\Rcor2tm1c(EUCOMM)Wtsi/\Rcor2tm1c(EUCOMM)Wtsi
\Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * C57BL/6N * SJL) 		decreased neuronal precursor proliferation J:235702
\Recql4tm1Furu/\Recql4tm1Furu
(Not Specified) 		decreased inner cell mass proliferation J:85891
\Recqltm1Pjb/\Recqltm1Pjb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased fibroblast proliferation J:118989
\Reg2tm1Lchr/\Reg2tm1Lchr
(involves: 129P2/OlaHsd * C57BL/6) 		decreased hepatocyte proliferation J:140235
\Reltm1Grd/\Rel+
(involves: 129S1/Sv * C57BL/6) 		decreased B cell proliferation J:28435
\Reltm1Grd/\Reltm1Grd
(involves: 129S1/Sv * C57BL/6) 		decreased B cell proliferation J:28435
decreased T cell proliferation J:28435
\Reltm1Grd/\Reltm1Grd
\Relatm1Bal/\Relatm1Bal
\Tnftm1Ljo/\Tnftm1Ljo
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJae) 		decreased cell proliferation J:91366
\Reltm1Hcl/\Rel+
(involves: 129S4/SvJae * C57BL/6) 		decreased T cell proliferation J:53513
\Reltm1Hcl/\Reltm1Hcl
(involves: 129S4/SvJae * C57BL/6) 		decreased B cell proliferation J:75621
decreased T cell proliferation J:53513, J:79107
\Relatm1Yuo/\Relatm1Yuo
(involves: 129S/SvEv) 		decreased B cell proliferation J:63099
decreased T cell proliferation J:63099
\RelbTg(H2-K1/GH1)106Bri/\RelbTg(H2-K1/GH1)106Bri
(C57BL/6-RelbTg(H2-K1/GH1)106Bri) 		decreased T cell proliferation J:76450
\Relbtm1Brv/\Relbtm1Brv
(involves: 129S2/SvPas * C57BL/6) 		decreased B cell proliferation J:40630
\Relbtm1Brv/\Relbtm1Brv
(either: (involves: 129S2/SvPas) or (involves: C57BL/6) or (involves: 129S2/SvPas * C57BL/6)) 		increased keratinocyte proliferation J:63950
\Relttm1Hlee/\Relttm1Hlee
(Not Specified) 		increased T cell proliferation J:266480
\Rettm1Jmi/\Rettm1Jmi
(involves: 129X1/SvJ) 		increased cell proliferation J:71881
\Rev3ltm1Rsky/\Rev3ltm1.1Rsky
\Tg(Cr2-cre)3Cgn/?
(involves: C57BL/6) 		decreased B cell proliferation J:146453
\Rflnatm1Tfur/\Rflnatm1Tfur
\Rflnbtm1Sia/\Rflnbtm1Sia
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj) 		decreased chondrocyte proliferation J:210363
\Rgcctm1Hrus/\Rgcctm1Hrus
(involves: 129S6/SvEvTac * C57BL/6) 		increased T cell proliferation J:279555
\Rgs2tm1Pngr/\Rgs2tm1Pngr
(involves: C57BL/6J) 		abnormal T cell proliferation J:77273
\Rhebtm1.1Yelg/\Rhebtm1.1Yelg
(B6.129P2-Rhebtm1.1Yelg) 		decreased fibroblast proliferation J:170999
\Rhoatm1.1Tpal/\Rhoa+
\Tg(Cd4-cre/ERT2)11Gnri/0
(involves: C57BL/6) 		increased T cell proliferation J:257764
\Rhoatm1Jrel/\Rhoatm1Jrel
\Tg(Pou3f4-cre)32Cren/0
(involves: CD-1) 		abnormal neuronal precursor proliferation J:171199
\Rhoatm1Yuyo/\Rhoatm1Yuyo
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: C57BL/6J * CBA/J) 		abnormal neuron proliferation J:172044
\Rhogtm1Tnr/\Rhogtm1Tnr
(involves: 129) 		increased B cell proliferation J:87580
\Rhohtm1Brak/\Rhohtm1Brak
(involves: 129/Sv * C57BL/6) 		abnormal T cell proliferation J:143161
decreased T cell proliferation J:143161
increased T cell proliferation J:143161
\Rictortm1.1Klg/\Rictortm1.1Klg
\Tg(Mx1-cre)1Cgn/0
(B6.Cg-Rictortm1.1Klg Tg(Mx1-cre)1Cgn) 		decreased T cell proliferation J:189736
\Rictortm1.1Mgn/\Rictortm1.1Mgn
\Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * DBA) 		decreased pancreatic beta cell proliferation J:170129
\Rictortm1.2Mgn/\Rictortm1.2Mgn
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL) 		decreased cell proliferation J:119564
\Rif1Gt(A045A01)Wrst/\Rif1Gt(A045A01)Wrst
(involves: 129S2/SvPas * C57BL/6J) 		decreased cell proliferation J:155449
\Rif1tm1.1Sbcb/\Rif1tm1.1Sbcb
(involves: C57BL/6 * C57BL/6J) 		decreased cell proliferation J:155449
\Ripk2tm1Flv/\Ripk2tm1Flv
(involves: 129S1/Sv) 		decreased T cell proliferation J:75400
\Ripk2tm1Ghc/\Ripk2tm1Ghc
(involves: 129S4/SvJae * C57BL/6) 		decreased T cell proliferation J:75401
\Ripply3tm1Sjt/\Ripply3tm1Sjt
(involves: 129S1/Sv * C57BL/6) 		increased pancreatic beta cell proliferation J:214095
\Rnaseh2btm1a(EUCOMM)Wtsi/\Rnaseh2btm1a(EUCOMM)Wtsi
(involves: C57BL/6N) 		decreased cell proliferation J:186180
decreased fibroblast proliferation J:186986
\Rnaseh2btm1c(EUCOMM)Wtsi/\Rnaseh2btm1c(EUCOMM)Wtsi
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N * SJL) 		decreased B cell proliferation J:186986
\Rnf7Gt(XE423)Byg/\Rnf7Gt(XE423)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		decreased cell proliferation J:178926
\Rnf7tm1c(EUCOMM)Wtsi/\Rnf7tm1c(EUCOMM)Wtsi
\Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * C57BL/6N * SJL) 		decreased cerebellar granule cell precursor proliferation J:205551
\Rnf8Gt(AS0574)Wtsi/\Rnf8Gt(AS0574)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		decreased fibroblast proliferation J:161240
\Rnf8Gt(RRR260)Byg/\Rnf8Gt(RRR260)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		decreased fibroblast proliferation J:161240
\Rnf19aGt(OST244733)Lex/\Rnf19aGt(OST244733)Lex
(B6.129S5-Rnf19aGt(OST244733)Lex) 		abnormal neuron proliferation J:250032
\Rnf43tm1Cle/\Rnf43tm1Cle
\Znrf3tm1Cle/\Znrf3tm1Cle
\Tg(Vil1-cre/ERT2)23Syr/0
(involves: C57BL/6 * DBA/2) 		abnormal small intestinal crypt cell proliferation J:186765
\Rnf128tm1.1Flv/Y
(involves: 129S6/SvEvTac * C57BL/6) 		increased T cell proliferation J:153216
\Rnf128tm1.1Flv/Y
\Tg(TcraTcrb)425Cbn/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6) 		decreased T cell proliferation J:153216
\Rnf128tm1.1Flv/\Rnf128tm1.1Flv
(involves: 129S6/SvEvTac * C57BL/6) 		increased T cell proliferation J:153216
\Rnf128tm1.1Flv/\Rnf128tm1.1Flv
\Tg(TcraTcrb)425Cbn/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6) 		decreased T cell proliferation J:153216
\Rnf128tm1Cdon/\Rnf128tm1Cdon
(involves: C57BL/6) 		increased T cell proliferation J:160681
\Rnf128tm1Cdon/\Rnf128tm1Cdon
(involves: 129 * C57BL/6) 		increased splenocyte proliferation J:160681
\Rnf128tm1Cdon/\Rnf128tm1Cdon
\Tg(TcraTcrb)425Cbn/0
(involves: 129 * BALB/c * C57BL/6) 		increased splenocyte proliferation J:160681
\Rnf146tm1.1Rtpl/\Rnf146tm1.1Rtpl
\Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: C57BL/6J * CD-1) 		decreased osteoblast proliferation J:244583
\Rnf149em1Staa/\Rnf149em1Staa
(involves: BALB/c * C57BL/6) 		increased cell proliferation J:335358
\Robo1tm1Matl/\Robo1tm1Matl
(involves: 129X1/SvJ) 		increased mammary gland epithelial cell proliferation J:141875
\Rock2tm1.1Itl/\Rock2+
\Tg(Tagln-cre)1Her/0
(B6.Cg-Rock2tm1.1Itl Tg(Tagln-cre)1Her) 		decreased vascular smooth muscle cell proliferation J:222206
\Roratmgc26/\Roratmgc26
(involves: D7R75M) 		abnormal neuron proliferation J:171777
decreased cerebellar granule cell precursor proliferation J:171777
\Rpa1tm1Wed/\Rpa1tm1Wed
(involves: 129/Sv * C57BL/6J * SJL) 		decreased cell proliferation J:99303
\Rpl27aSfa/\Rpl27a+
(C57BL/6J-Rpl27aSfa) 		increased hematopoietic stem cell proliferation J:174216
\Rpl29tm1Udel/\Rpl29tm1Udel
(129S6/SvEvTac-Rpl29tm1Udel) 		decreased fibroblast proliferation J:117229
\Rpl39lem1Hqi/\Rpl39lem1Hqi
(involves: C57BL/6J) 		abnormal spermatogonia proliferation J:317811
\Rps6ka4tm1Jsca/\Rps6ka4tm1Jsca
\Rps6ka5tm1Jsca/\Rps6ka5tm1Jsca
(Not Specified) 		decreased T cell proliferation J:124301
\Rps12em1.1Nbakr/\Rps12+
(involves: C57BL/6J * FVB/N) 		abnormal hematopoietic stem cell proliferation J:338970
\Rptortm1Lex/\Rptortm1Lex
(involves: 129S/SvEvBrd) 		decreased inner cell mass proliferation J:137592
\Rr28tm1Tilg/\Rr28+
\Igf2tm1Rob/\Igf2+
(involves: 129S/SvEv * 129S1/Sv * C57BL/6J) 		increased fetal cardiomyocyte proliferation J:77413
increased hepatocyte proliferation J:77413
\Rr170tm1.1Iku/\Rr170tm1.1Iku
(B6.Cg-Rr170tm1.1Iku) 		decreased T cell proliferation J:333539
\Rr273em1Issa/\Rr273em1Issa
(involves: C57BL/6J * DBA/2J) 		decreased cell proliferation J:333875
\Rragcem1Efe/\Rragc+
(Not Specified) 		decreased B cell proliferation J:320567
\Rras2Gt(OST361011)Lex/\Rras2Gt(OST361011)Lex
(involves: 129S5/SvEvBrd) 		decreased B cell proliferation J:151653
\Rreb1em1Rtpl/\Rreb1+
(C57BL/6J-Rreb1em1Rtpl) 		increased cell proliferation J:296982
\Rrm2bGt(OST85254)Lex/\Rrm2bGt(OST85254)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		increased kidney cell proliferation J:186071
\Rtf2tm1c(KOMP)Wtsi/\Rtf2tm1d(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N * FVB/N * SJL) 		decreased fibroblast proliferation J:360903
\Runx2tm1Jals/\Runx2tm1Jals
(involves: 129S7/SvEvBrd * C57BL/6) 		increased osteoblast proliferation J:143532
\Runx3tm1Yg/\Runx3tm1Yg
(involves: 129S1/Sv * 129X1/SvJ * ICR) 		decreased osteoblast proliferation J:224290
\Ruvbl1tm1.2Oxbk/\Ruvbl1tm1.2Oxbk
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * SJL) 		decreased inner cell mass proliferation J:220926
\Rxratm1Rev/\Rxratm1Rev
(involves: 129S4/SvJae * C57BL/6) 		decreased hepatocyte proliferation J:18047
\Rxratm2Ipc/\Rxratm4Ipc
\Tg(KRT14-cre)1Ipc/0
(involves: 129S2/SvPas * C57BL/6 * SJL) 		increased keratinocyte proliferation J:67149
\S1pr2tm1Rlp/\S1pr2tm1Rlp
(involves: 129S6/SvEvTac * C57BL/6) 		increased B cell proliferation J:174313
\Sac3d1tm1Hnaka/\Sac3d1tm1Hnaka
(involves: 129P2/OlaHsd) 		increased T cell proliferation J:144601
\Sall1tm4.1Ryn/\Sall1tm4.1Ryn
\Sall4tm3Ryn/\Sall4tm4Ryn
(involves: 129P2/OlaHsd) 		decreased cell proliferation J:159449
\Sall4tm1Ryn/\Sall4tm1Ryn
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased inner cell mass proliferation J:118119
\Sall4tm1Yam/\Sall4tm1Yam
(involves: 129S4/SvJae * C57BL/6J) 		decreased cell proliferation J:158264
decreased inner cell mass proliferation J:158264
\Samsn1tm1Xyw/\Samsn1tm1Xyw
(B6.129P2-Samsn1tm1Xyw) 		increased B cell proliferation J:158032
increased T cell proliferation J:158032
\Saraftm1c(KOMP)Wtsi/\Saraftm1c(KOMP)Wtsi
\Tg(Pgk1-cre)1Lni/0
(involves: 129S4/SvJaeSor * BALB/c * C57BL/6J * C57BL/6N) 		decreased fibroblast proliferation J:337869
decreased neuronal precursor proliferation J:337869
\Sash3tm1Hlz/\Sash3tm1Hlz
(B6.129P2-Sash3tm1Hlz) 		decreased T cell proliferation J:102171
\Satb1tm1Kos/\Satb1tm1Kos
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal T cell proliferation J:61085
\Sav1tm1.1Dupa/\Sav1tm1.1Dupa
\Tg(Vil1-cre)997Gum/0
(involves: 129P2/OlaHsd * C57BL/6J * SJL) 		abnormal enterocyte proliferation J:165471
\Sav1tm1.1Rjo/\Sav1tm1.1Rjo
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * CD-1 * DBA * SJL) 		increased hepatocyte proliferation J:156531
\Sav1tm1Dlim/\Sav1tm1Dlim
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal enterocyte proliferation J:134270
\Sbdstm1Jrom/\Sbdstm1Jrom
(involves: 129S6/SvEvTac * C57BL/6J) 		absent inner cell mass proliferation J:112167
\Sbno1tm1.1Hssk/\Sbno1tm1.1Hssk
(involves: C57BL/6) 		decreased cell proliferation J:266780
\Scube2tm1.1Rbya/\Scube2tm1.1Rbya
(B6.129-Scube2tm1.1Rbya) 		decreased chondrocyte proliferation J:226676
\Sdc1tm1Cma/\Sdc1tm1Cma
(either: C.Cg-Sdc1tm1Cma or B6.Cg-Sdc1tm1Cma) 		abnormal cell proliferation J:80682
\Sdc2tm1c(KOMP)Wtsi/\Sdc2tm1c(KOMP)Wtsi
\Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/0
(involves: C57BL/6J * C57BL/6N * CBA) 		decreased endothelial cell proliferation J:276769
decreased vascular endothelial cell proliferation J:276769
\Sdc2tm1d(KOMP)Wtsi/\Sdc2tm1d(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N) 		decreased vascular endothelial cell proliferation J:276769
\Sec61a1m1Gek/\Sec61a1m1Gek
(C57BL/6J-Sec61a1m1Gek) 		increased hepatocyte proliferation J:164159
\Sel1lGt(CA0017)Wtsi/\Sel1lGt(CA0017)Wtsi
(involves: 129P2/OlaHsd) 		decreased hepatocyte proliferation J:158780
\Selenoktm1.2Itl/\Selenoktm1.2Itl
(involves: BALB/cJ * C57BL/6) 		decreased T cell proliferation J:169169
\Selltm1Pest/\Selltm1Pest
(involves: 129S4/SvJae) 		increased T cell proliferation J:111233
\Selltm1Pest/\Selltm1Pest
(involves: 129S4/SvJae * C57BL/6) 		decreased T cell proliferation J:112550
\Sema4dtm1Kik/\Sema4dtm1Kik
(involves: 129P2/OlaHsd * C57BL/6) 		decreased B cell proliferation J:66033
\Septin7tm1Mgl/\Septin7tm1Mgl
(involves: 129P2/OlaHsd * C3H * C57BL/6) 		decreased fibroblast proliferation J:223786
\Septin9tm2.1Emfu/\Septin9tm2.1Emfu
\Tg(Lck-cre)548Jxm/0
(involves: C57BL/6 * CBA) 		decreased T cell proliferation J:205027
\Serpina3gtm1.1Arp/\Serpina3gtm1.1Arp
(involves: C57BL/6) 		decreased T cell proliferation J:189782
\Serpina3gtm1.1Arp/\Serpina3gtm1.1Arp
\Tg(TcrLCMV)#Sdz/0
(involves: C57BL/6 * DBA/2) 		decreased T cell proliferation J:189782
\Serpinb5tm1Zha/\Serpinb5+
(involves: 129) 		decreased cell proliferation J:89192
\Serpinb5tm1Zha/\Serpinb5tm1Zha
(involves: 129) 		absent inner cell mass proliferation J:89192
decreased cell proliferation J:89192
decreased inner cell mass proliferation J:89192
\Serpine2tm1Dmn/\Serpine2tm1Dmn
(B6.129P2-Serpine2tm1Dmn) 		increased cell proliferation J:121263
\Serpine2tm1Dmn/\Serpine2tm1Dmn
\Tg(Thy1-Serpine2)2Dmn/?
(involves: 129P2/OlaHsd * C57BL/6) 		decreased Schwann cell proliferation J:121223
\Sertad2Gt(OST98734)Lex/\Sertad2Gt(OST98734)Lex
(involves: 129S5/SvEvBrd) 		decreased fibroblast proliferation J:196054
\Sesn1tm1a(EUCOMM)Wtsi/\Sesn1tm1a(EUCOMM)Wtsi
(involves: C57BL/6N) 		increased T cell proliferation J:240602
\Sesn2Gt(W077E06)Wrst/\Sesn2Gt(W077E06)Wrst
(B6.129S2-Sesn2Gt(W077E06)Wrst) 		decreased lung fibroblast proliferation J:160854
\Setdb1tm1.1Yshk/\Setdb1tm1.1Yshk
\Emx2tm2(cre)Sia/\Emx2+
(involves: C57BL/6NCrlj * CBA/JNCrlj) 		abnormal neuronal precursor proliferation J:188109
\Setdb1tm1Enl/\Setdb1tm1Enl
(involves: 129S4/SvJae) 		decreased inner cell mass proliferation J:89058
\Setdb1tm2.1Enl/\Setdb1tm2.2Enl
(involves: 129/Sv * C57BL/6) 		decreased cell proliferation J:161089
\Sf3b4em1Mce/\Sf3b4+
(C57BL/6J-Sf3b4em1Mce) 		decreased neuronal precursor proliferation J:285287
\Sfntm1Mak/\Sfntm1Mak
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell proliferation J:168328
\Sfntm1Mul/\Sfntm1Mul
\Tg(MMTV-cre)7Mul/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		increased cell proliferation J:159517
\Sgpp1tm1(KOMP)Vlcg/\Sgpp1tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		increased keratinocyte proliferation J:199597
\Sgpp2tm1Rlp/\Sgpp2tm1Rlp
(B6.129S6-Sgpp2tm1Rlp) 		decreased pancreatic beta cell proliferation J:235035
\Sh2b1tm2.1Lr/\Sh2b1tm2.1Lr
\Tg(Pdx1-cre)89.1Dam/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL) 		increased pancreatic beta cell proliferation J:209019
\Sh2b3tm1Paw/\Sh2b3tm1Paw
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		increased cell proliferation J:77248
\Sh2d1atm1Cpt/Y
(involves: 129S4/SvJae * C57BL/6) 		increased T cell proliferation J:97756
\Sh2d1atm1Cpt/\Sh2d1a+
(involves: 129S4/SvJae * C57BL/6) 		increased T cell proliferation J:97756
\Sh2d1atm1Cpt/\Sh2d1atm1Cpt
(involves: 129S4/SvJae * C57BL/6) 		increased T cell proliferation J:97756
\Sh2d1atm1Pls/\Sh2d1atm1Pls
(either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * C57BL/6)) 		increased T cell proliferation J:70032
\Sh2d2atm1Jbs/\Sh2d2atm1Jbs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased T cell proliferation J:64938
\Sh3bp2tm1Geha/\Sh3bp2tm1Geha
(Not Specified) 		decreased B cell proliferation J:110319
\Sh3bp2tm1Rtpl/\Sh3bp2tm1Rtpl
(B6.129P2-Sh3bp2tm1Rtpl) 		decreased B cell proliferation J:121380
\Sharpincpdm/\Sharpincpdm
(C57BL/KaLawRij-Sharpincpdm) 		increased keratinocyte proliferation J:31745
\ShhDsh/\Shh+
(B10Rl.Cg-ShhDsh) 		decreased chondrocyte proliferation J:97323
\Shhtm1Amc/\Shhtm1Amc
(involves: 129/Sv * C57BL/6J * CBA/J) 		decreased keratinocyte proliferation J:50051
\Shmt2em1Jiha/\Shmt2em1Jiha
(involves: C57BL/6JJcl) 		decreased fibroblast proliferation J:259713
\Shroom3Gt(ROSA53)Sor/\Shroom3Gt(ROSA53)Sor
(B6.129S4-Shroom3Gt(ROSA53)Sor/J) 		increased fetal cardiomyocyte proliferation J:293794
\Sigirrtm1Lix/\Sigirrtm1Lix
(involves: 129S6/SvEvTac * BALB/c) 		abnormal splenocyte proliferation J:85151
\Siglechtm1.1Cfg/\Siglechtm1.1Cfg
(involves: C57BL/6) 		increased T cell proliferation J:217719
\Sirt2tm1.1Cxd/\Sirt2tm1.1Cxd
(either: (involves: C57BL/6 * FVB/N) or (involves: FVB/N * NIH Black Swiss)) 		decreased fibroblast proliferation J:177486
\Sirt6tm1Fwa/\Sirt6tm1Fwa
(involves: 129S6/SvEvTac * 129X1/SvJ) 		decreased cell proliferation J:112817
\Sit1tm1Lsmn/\Sit1tm1Lsmn
(B6.Cg-Sit1tm1Lsmn) 		increased T cell proliferation J:100408
\Six1tm1Mair/\Six1tm1Mair
(involves: 129S2/SvPas) 		decreased otic epithelial cell proliferation J:84417
\Six1tm1Rsd/\Six1tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ) 		decreased cell proliferation J:86619
\Skap1Gt713Lex/\Skap1Gt713Lex
(B6.129S5-Skap1Gt713Lex) 		decreased T cell proliferation J:126545
\Skap2Gt(VICTR20)21Lex/\Skap2Gt(VICTR20)21Lex
(B6.129S5-Skap2Gt(VICTR20)21Lex) 		decreased B cell proliferation J:101373
\Skitm1Cco/\Ski+
(involves: 129P2/OlaHsd * C57BL/6) 		increased fibroblast proliferation J:73349
\Skitm1Cco/\Skitm1Cco
(involves: 129P2/OlaHsd * Black Swiss) 		increased fibroblast proliferation J:73349
\Skiltm1.1Kluo/\Skiltm1.1Kluo
(B6.129P2-Skiltm1.1Kluo) 		decreased fibroblast proliferation J:154718
\Skiltm1Spw/\Skiltm1Spw
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		decreased T cell proliferation J:84554
\Skiltm2Spw/\Skiltm2Spw
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		decreased T cell proliferation J:84554
\Skor2Tn(sb-Tyr)1799B.CA7BOve/\Skor2Tn(sb-Tyr)1799B.CA7BOve
(involves: FVB/N) 		decreased cerebellar granule cell precursor proliferation J:178891
\Skor2Tn(sb-Tyr)1799B.CA7Ove/\Skor2Tn(sb-Tyr)1799B.CA7Ove
(involves: FVB/N) 		decreased cerebellar granule cell precursor proliferation J:178818
\Skp2tm1Kin/\Skp2tm1Kin
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal cell proliferation J:62130
\Slc3a2tm1.1Merl/\Slc3a2+
\Tg(Vil1-cre)997Gum/0
(B6.Cg-Slc3a2tm1.1Merl Tg(Vil1-cre)997Gum) 		abnormal enterocyte proliferation J:173946
\Slc6a4tm2.1Rbl/\Slc6a4tm2.1Rbl
(involves: 129S4/SvJae * 129S6/SvEvTac) 		abnormal small intestinal crypt cell proliferation J:237081
\Slc6a8tm1.1Lbar/Y
\Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * C57BL/6J * C57BL/6N * SJL) 		abnormal neuron proliferation J:238578
\Slc6a8tm1.2Lbar/Y
(involves: 129 * 129S1/Sv * C57BL/6J * C57BL/6N) 		abnormal neuron proliferation J:238578
\Slc7a11m1Mtka/\Slc7a11m1Mtka
(C57BL/6-Slc7a11m1Mtka) 		decreased fibroblast proliferation J:159323
\Slc7a11tm1Hsat/\Slc7a11tm1Hsat
(involves: 129P2/OlaHsd * C57BL/6) 		decreased fibroblast proliferation J:102902
\Slc8a1tm1Herc/\Slc8a1+
(involves: 129 * CD-1) 		increased pancreatic beta cell proliferation J:186743
\Slc18a1tm1Dgen/\Slc18a1tm1Dgen
(B6.129P2-Slc18a1tm1Dgen/J) 		abnormal neuron proliferation J:194189
\Slc20a1tm1.2Lbek/\Slc20a1tm1.2Lbek
(involves: 129S2/SvPas * BALB/c * C57BL/6 * C57BL/6J) 		decreased cell proliferation J:157997
decreased hepatocyte proliferation J:157997
\Slc24a3em#Ebje/\Slc24a3em#Ebje
(C57BL/6J-Slc24a3em#Ebje) 		abnormal enterocyte proliferation J:308448
\Slc26a2tm1Aros/\Slc26a2tm1Aros
(involves: 129S7/SvEvBrd * C57BL/6J) 		decreased cell proliferation J:97104
\Slc26a3tm1Sole/\Slc26a3tm1Sole
(involves: 129S6/SvEvTac * C57BL/6) 		increased cell proliferation J:117587
\Slc27a4pskn/\Slc27a4pskn
(involves: FVB) 		increased keratinocyte proliferation J:194779
\Slc30a2tm1Kgna/\Slc30a2tm1Kgna
(involves: 129 * C57BL/6) 		decreased mammary gland epithelial cell proliferation J:264481
increased mammary gland epithelial cell proliferation J:264481
\Slc35e1em1Cya/\Slc35e1em1Cya
(C57BL/6J-Slc35e1em1Cya) 		decreased keratinocyte proliferation J:340684
\Slc38a4em#Smtb/\Slc38a4+
(C57BL/6NSlc-Slc38a4em#Ogu) 		abnormal trophoblast giant cell proliferation J:280426
\Slc38a4em#Smtb/\Slc38a4em#Smtb
(C57BL/6NSlc-Slc38a4em#Ogu) 		abnormal trophoblast giant cell proliferation J:280426
\Slc39a4tm2Gka/\Slc39a4tm2Gka
\Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		abnormal small intestinal crypt cell proliferation J:187178
\Slc39a7tm1.1Tfk/\Slc39a7tm1.1Tfk
\Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		abnormal enterocyte proliferation J:236234
\Slc39a8tm1.2Mrl/\Slc39a8tm1.2Mrl
(B6(Cg)-Slc39a8tm1.2Mrl) 		increased fetal cardiomyocyte proliferation J:258360
\Slc39a14tm1Lex/\Slc39a14tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased hepatocyte proliferation J:236296
\Slfn2m1Btlr/\Slfn2m1Btlr
(C57BL/6J-Slfn2m1Btlr) 		abnormal T cell proliferation J:158985
decreased T cell proliferation J:158985
\Slit2tm1Matl/\Slit2tm1Matl
\Slit3tm1.1Dor/\Slit3tm1.1Dor
(involves: 129S1/Sv * 129S2/SvPas) 		increased mammary gland epithelial cell proliferation J:141875
\SlkGt(BC0415)Wtsi/\SlkGt(BC0415)Wtsi
(involves: 129P2/OlaHsd * FVB/N) 		decreased fibroblast proliferation J:211339
\Slpd1NZB/BlNJ/\Slpd1NZB/BlNJ
(involves: DBA/2J * NZB/BlNJ) 		increased B cell proliferation J:124364
\Slpitm1Nkw/\Slpitm1Nkw
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell proliferation J:82214
\Slurp1tm1Lex/\Slurp1tm1Lex
(Not Specified) 		increased keratinocyte proliferation J:210836
\Slurp2tm1Lex/\Slurp2tm1Lex
(involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6) 		increased keratinocyte proliferation J:231067
\Smad1tm1Abr/\Smad1tm1.1Abr
\Tg(Col1a1-cre)1Kry/0
(involves: BALB/cJ * C57 * FVB) 		decreased osteoblast proliferation J:172689
\Smad2tm1.1Epb/\Smad2tm1.1Epb
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129/Sv * C57BL/6 * DBA * SJL) 		increased hepatocyte proliferation J:119642
\Smad2tm1Cxd/\Smad2+
\Smad3tm1Cxd/\Smad3+
(involves: 129S6/SvEvTac * NIH Black Swiss) 		decreased hepatocyte proliferation J:70388
\Smad3tm1Xfw/\Smad3tm1Xfw
(involves: 129/Sv * C57BL/6) 		abnormal B cell proliferation J:53948
abnormal cell proliferation J:53948
abnormal T cell proliferation J:53948
\Smad4tm1Cxd/\Smad4tm1Cxd
(involves: 129S6/SvEvTac) 		decreased cell proliferation J:46852
decreased embryonic epiblast cell proliferation J:46852
decreased inner cell mass proliferation J:46852
\Smad4tm1Mak/\Smad4tm1Mak
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * C57BL/6J * CD-1)) 		decreased cell proliferation J:45399
\Smad4tm2.1Cxd/\Smad4tm2.1Cxd
\Tg(KRT5-cre)1Xya/0
(involves: 129S6/SvEvTac) 		increased keratinocyte proliferation J:101602
\Smad7Gt(YHC053)Byg/\Smad7+
\Tbx1tm1Bld/\Tbx1+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J) 		increased vascular smooth muscle cell proliferation J:212881
\Smad7tm1.1Ink/\Smad7tm1.1Ink
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2) 		decreased T cell proliferation J:184670
\Smad7tm1Rheu/\Smad7tm1Rheu
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		decreased B cell proliferation J:120714
\Smarca1tm1.1Pick/Y
(involves: 129S4/SvJae * CD-1) 		abnormal neuronal precursor proliferation J:183998
\Smarca1tm1.1Pick/\Smarca1tm1.1Pick
(involves: 129S4/SvJae * CD-1) 		abnormal neuronal precursor proliferation J:183998
\Smarca5tm1Ais/\Smarca5tm1Ais
(involves: 129/Sv * C57BL/6 * SJL) 		absent inner cell mass proliferation J:86695
\Smarcal1tm1.1Cfbo/\Smarcal1tm1.1Cfbo
(either: B6.129-Smarcal1tm1.1Cfbo or (involves: 129 * C57BL/6)) 		decreased fibroblast proliferation J:183899
\Smarcb1Gt(OST32815)Lex/\Smarcb1Gt(OST32815)Lex
(either: (involves: 129 * 129S5/SvEvBrd) or (involves: 129S5/SvEvBrd * C57BL/6)) 		absent inner cell mass proliferation J:69009
absent trophectoderm cell proliferation J:69009
\Smarcb1tm1Mya/\Smarcb1tm2Mya
\Tg(Alb1-cre)7Gsc/0
(involves: 129S2/SvPas * FVB/N) 		increased hepatocyte proliferation J:103919
\Smarcc1tm2.1Rhs/\Smarcc1tm2.1Rhs
\Tg(Mx1-cre)1Cgn/0
(involves: BALB/c * C57BL/6 * CBA) 		decreased B cell proliferation J:184060
\Smarcc2tm1.1Stoy/\Smarcc2tm1.1Stoy
(involves: 129S1/Sv * C57BL/6) 		abnormal neuronal precursor proliferation J:197141
\Smarcc2tm1.1Stoy/\Smarcc2tm1.1Stoy
\Emx1tm1(cre)Krj/\Emx1+
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6) 		abnormal neuronal precursor proliferation J:197141
\Smarcd3tm1.2Bbr/\Smarcd3tm1.2Bbr
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * ICR * SJL)) 		decreased fetal cardiomyocyte proliferation J:257963
\Smg1Gt(RRT449)Byg/\Smg1Gt(RRT449)Byg
(B6.129P2-Smg1Gt(RRT449)Byg) 		decreased cell proliferation J:196053
\Smg6tm1.2Zqw/\Smg6tm1.2Zqw
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased inner cell mass proliferation J:222980
\Smotm1Amc/\Smotm2Amc
\Tg(Col2a1-cre)10Amc/0
(involves: 129X1/SvJ) 		decreased chondrocyte proliferation J:73071
\Smotm2Amc/\Smotm2Amc
\Nkx3-2tm1(cre)Wez/\Nkx3-2+
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ) 		abnormal enterocyte proliferation J:199664
\Snap29tm1c(EUCOMM)Wtsi/\Snap29tm1c(EUCOMM)Wtsi
\Tg(KRT14-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6N * DBA/2) 		increased keratinocyte proliferation J:236759
\Snrnp40em1Btlr/\Snrnp40swp
(C57BL/6J-Snrnp40em1Btlr/Snrnp40swp) 		decreased T cell proliferation J:282417
\Sod1tm1Cje/\Sod1tm1Cje
(involves: C57BL/6J * CD-1) 		decreased fibroblast proliferation J:42265
\Sod2tm1Smel/\Sod2tm1Smel
\Tg(KRT14-cre/ERT)20Efu/0
(involves: C57BL/6J * CD-1) 		decreased keratinocyte proliferation J:226565
\Sos1tm1.1Les/\Sos1tm1.1Les
\Tg(Lck-cre)1Cwi/0
(involves: 129 * C57BL/6) 		decreased T cell proliferation J:174536
\Sos1tm1.2Rak/\Sos1+
(involves: 129S/Sv * C57BL/6 * FVB/N * SJL) 		increased fetal cardiomyocyte proliferation J:171873
\Sos1tm1.2Rak/\Sos1tm1.2Rak
(involves: 129S/Sv * C57BL/6 * FVB/N * SJL) 		increased fetal cardiomyocyte proliferation J:171873
\Sostdc1tm1Snd/\Sostdc1tm1Snd
(involves: C57BL/6) 		decreased chondrocyte proliferation J:216098
increased osteoblast proliferation J:216098
\Sox2tm1Okud/\Sox2tm1Okud
\Tg(Nes-cre)1Sasa/?
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal neuronal precursor proliferation J:138323
\Sox2tm4.1Skn/\Sox2tm4.1Skn
\Tg(Sox2-cre/ERT2)1Skn/0
(involves: 129S1/Sv * 129S4/SvJae) 		abnormal neuronal precursor proliferation J:154650
\Sox9em1(cre/ERT2)Tchn/\Sox9+
\Stk26tm2.1Zzh/\Stk26tm2.1Zzh
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal enterocyte proliferation J:322311
\Sox9tm1Gsr/\Sox9tm1Gsr
\Shhtm1(EGFP/cre)Cjt/\Shh+
(involves: 129P2/OlaHsd) 		decreased cell proliferation J:202984
\Sox10tm7.1(Sox10)Weg/\Sox10tm7.1(Sox10)Weg
\Tg(Dhh-cre)1Mejr/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL) 		abnormal neuron proliferation J:162692
\Sox11tm1.1Llei/\Sox11tm1.1Llei
\Tg(Nes-cre/ERT2)73Lfp/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		abnormal neuronal precursor proliferation J:198233
\Sox11tm1.2Llei/\Sox11tm1.2Llei
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6) 		abnormal neuronal precursor proliferation J:198233
\Sox11tm1.2Vlf/\Sox11tm1.2Vlf
\Sox4tm1.1Vlf/\Sox4tm1.1Vlf
(involves: 129 * C57BL/6 * FVB/N) 		decreased cell proliferation J:175338
\Sox13tm1Jskg/\Sox13tm1Jskg
(involves: C57BL/6) 		increased T cell proliferation J:117301
\Sox17tm2Sjm/\Sox17tm2Sjm
\Tg(Cdh5-cre/ERT2)1Rha/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased endothelial cell proliferation J:234137
\Sp2tm1.1Htg/\Sp2+
\Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * SJL) 		decreased neuronal precursor proliferation J:194076
\Sp2tm1.1Htg/\Sp2tm1.1Htg
\Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * SJL) 		decreased neuronal precursor proliferation J:194076
\Sp2tm1.2Sus/\Sp2tm1.2Sus
(involves: 129P2/OlaHsd * C57BL/6) 		absent fibroblast proliferation J:158671
\Sp8tm2.1Aman/\Sp8tm2.1Aman
\Foxg1tm1(cre)Skm/\Foxg1+
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal neuronal precursor proliferation J:160653
\Sp9tm1.1Zyan/\Sp9tm1.1Zyan
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased neuronal precursor proliferation J:238868
\Spi1tm1Sing/\Spi1+
\Spibtm1Mcs/\Spib+
(involves: 129S/SvEv * 129X1/SvJ) 		decreased B cell proliferation J:88257
\Spi1tm1Sing/\Spi1+
\Spibtm1Mcs/\Spibtm1Mcs
(involves: 129S/SvEv * 129X1/SvJ) 		decreased B cell proliferation J:88257
\Spi1tm4.1Dgt/\Spi1tm4.1Dgt
(B6.129(Cg)-Spi1tm4.1Dgt) 		increased hematopoietic stem cell proliferation J:196609
\Spibtm1Mcs/\Spibtm1Mcs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased B cell proliferation J:88257
\Spibtm1Mcs/\Spibtm1Mcs
(involves: 129S1/Sv * 129X1/SvJ) 		decreased B cell proliferation J:45245
\Spin4em1Jbn/Y
(involves: C57BL/6J) 		increased chondrocyte proliferation J:347154
\Spin4em2Jbn/Y
(involves: C57BL/6J) 		increased chondrocyte proliferation J:347154
\Spink5tm2.1Hov/\Spink5tm2.1Hov
\Tg(KRT5-cre/ERT2)2Ipc/0
(involves: C57BL/6 * C57BL/6JRj * SJL) 		increased keratinocyte proliferation J:357366
\Spint1tm2.1Hk/\Spint1tm2.1Hk
\Tg(Vil1-cre)997Gum/0
(involves: C57BL/6 * C57BL/6J * SJL) 		abnormal enterocyte proliferation J:179937
\Spntm1Bam/\Spntm1Bam
(involves: 129S4/SvJae * C57BL/6) 		increased T cell proliferation J:29272, J:88252
\Sppl2achompB/\Sppl2achompB
(involves: C57BL/6) 		decreased B cell proliferation J:194595
\Sprnem1Jvt/\Sprnem1Jvt
(FVB/NJ-Sprnem1Jvt) 		decreased mammary gland epithelial cell proliferation J:289583
\Sprtntm1.2Yjm/\Sprtntm1.2Yjm
(involves: 129S/SvEv * C57BL/6) 		decreased inner cell mass proliferation J:225198
\Sprtntm1Yjm/\Sprtntm1.2Yjm
(involves: 129S/SvEv * C57BL/6) 		decreased fibroblast proliferation J:225198
\Spta1sph-ha/\Spta1sph-ha
(either: (B6.D1-Spta1sph-ha x WB.D1-Spta1sph-ha)F1 or (WB.D1-Spta1sph-ha x B6.D1-Spta1sph-ha)F1) 		increased B cell proliferation J:1967
increased T cell proliferation J:1967
\Sptan1Gt(RRQ171)Byg/\Sptan1Gt(RRQ171)Byg
(B6.129P2-Sptan1Gt(RRQ171)Byg) 		increased cell proliferation J:186305
\Sptbn1tm1a(EUCOMM)Wtsi/\Sptbn1tm1a(EUCOMM)Wtsi
(involves: C57BL/6N) 		decreased fetal cardiomyocyte proliferation J:219548
\Sptbn1tm1c(EUCOMM)Wtsi/\Sptbn1tm1c(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N) 		decreased fetal cardiomyocyte proliferation J:219548
\Sptbn1tm1Mish/\Sptbn1+
(involves: 129S6/SvEvTac * C57BL/6) 		decreased hepatocyte proliferation J:132133
\Srctm1Mul/\Srctm1Mul
\Tg(MMTV-PyVT)#Mul/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		decreased cell proliferation J:181822
\Srpk1tm1Xdfu/\Srpk1tm1Xdfu
(involves: 129) 		decreased cell proliferation J:213142
\Srsf5em1Nju/\Srsf5em1Nju
(C57BL/6JGpt-Srsf5em1Nju) 		decreased fetal cardiomyocyte proliferation J:311867
\Ssbp3Tg(SOD1)1Hssk/\Ssbp3Tg(SOD1)1Hssk
(involves: C3H/He * C57BL/6) 		decreased cell proliferation J:98485
\Ssu72tm1Cwl/\Ssu72tm1Cwl
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(B6.Cg-Ssu72tm1Cwl Speer6-ps1Tg(Alb-cre)21Mgn) 		increased hepatocyte proliferation J:309624
\St3gal2tm1Jxm/\St3gal2tm1Jxm
(Not Specified) 		decreased T cell proliferation J:217719
\St6galnac2tm1.1Cfg/\St6galnac2tm1.1Cfg
(involves: 129S1/Sv * 129X1/SvJ) 		increased B cell proliferation J:217719
\St8sia1tm1Kfk/\St8sia1tm1Kfk
(Not Specified) 		increased T cell proliferation J:73818
\St14tm2Bug/\St14tm3Bug
\Tg(Vil1-cre)997Gum/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * Black Swiss * C57BL/6 * SJL) 		abnormal enterocyte proliferation J:153070
\Stag1Gt(P099A04)Wrst/\Stag1+
(involves: 129S2/SvPas) 		decreased cell proliferation J:184720
\Stag1Gt(P099A04)Wrst/\Stag1Gt(P099A04)Wrst
(involves: 129S2/SvPas) 		decreased cell proliferation J:184720
decreased fibroblast proliferation J:184720
\Stag2tm1.1Alos/Y
\Tg(CAG-cre)1Nagy/0
(involves: 129S6/SvEvTac * C57BL/6NCrl) 		decreased cell proliferation J:298088
\Stamtm2Sug/\Stamtm2Sug
\Stam2tm1Sug/\Stam2tm1Sug
\Tg(Lck-cre)I57Jxm/0
(involves: 129S4/SvJae * C57BL/6 * ICR) 		decreased T cell proliferation J:80617
\Stat3tm1Aki/\Stat3tm1Aki
(involves: 129P2/OlaHsd) 		decreased inner cell mass proliferation J:40106
\Stat3tm1Xyfu/\Stat3tm1.1Xyfu
\Tg(Ttr-cre)10-3Xyfu/?
(involves: 129S1/Sv * C57BL/6) 		decreased hepatocyte proliferation J:128719
\Stat3tm2Aki/\Stat3tm2Aki
\Tg(Lck-cre)1Jtak/0
(involves: 129P2/OlaHsd) 		decreased T cell proliferation J:50443
\Stat4tm1Gru/\Stat4tm1Gru
(involves: 129S2/SvPas * BALB/c) 		abnormal T cell proliferation J:34059
\Stat5atm1.1Wjl/\Stat5atm1.1Wjl
\Stat5btm2.1Wjl/\Stat5btm2.1Wjl
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N) 		decreased T cell proliferation J:187325
\Stat5atm2Mam/\Stat5atm2Mam
\Stat5btm1Mam/\Stat5btm1Mam
\Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		decreased cell proliferation J:155489
\Stat5atm2Mam/\Stat5atm2Mam
\Tg(Ins2-cre)23Herr/0
(involves: 129S6/SvEvTac * C57BL/6J * CBA/J) 		decreased pancreatic beta cell proliferation J:284574
\Stat5btm1Hwd/\Stat5btm1Hwd
(involves: C57BL/6) 		decreased T cell proliferation J:112035
\Stat5btm1Mam/\Stat5btm1Mam
\Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		decreased cell proliferation J:155489
\Stat6tm1Aki/\Stat6tm1Aki
(involves: 129P2/OlaHsd) 		decreased B cell proliferation J:32561
decreased T cell proliferation J:32561
\Stat6tm1Gru/\Stat6tm1Gru
(129S2/SvPas-Stat6tm1Gru) 		decreased T cell proliferation J:31932
\Stat6tm1Gru/\Stat6tm1Gru
(involves: 129S2/SvPas) 		decreased mammary gland epithelial cell proliferation J:184505
\Stat6tm1Jni/\Stat6tm1Jni
(involves: 129S/SvEv) 		abnormal B cell proliferation J:32607
\Stim1tm1Kuro/\Stim1tm1Kuro
\Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c * C57BL/6) 		decreased B cell proliferation J:172608
\Stim1tm1Kuro/\Stim1tm1Kuro
\Stim2tm1.1Kuro/\Stim2tm1.1Kuro
\Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c * C57BL/6) 		decreased B cell proliferation J:172608
\Stim1tm1Rao/\Stim1tm1Rao
\Stim2tm1Rao/\Stim2tm1Rao
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL) 		decreased T cell proliferation J:133262
\Stip1tm1.2Mamp/\Stip1tm1.2Mamp
(involves: C57BL/6) 		decreased fibroblast proliferation J:201097
\Stk3tm1.1Jav/\Stk3tm1.1Jav
\Stk4tm1Kina/\Stk4tm1Kina
\Tg(Nkx2-1-cre)2Sand/?
(involves: 129 * C57BL/6) 		increased lung endothelial cell proliferation J:197340
\Stk3tm1.1Jav/\Stk3tm1Jav
\Stk4Gt(AJ0315)Wtsi/\Stk4Gt(AJ0315)Wtsi
(involves: 129 * C57BL/6) 		increased hepatocyte proliferation J:153945
\Stk3tm1.1Rjo/\Stk3tm1.1Rjo
\Stk4tm1.1Rjo/\Stk4tm1.1Rjo
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * CD-1 * DBA * SJL) 		increased hepatocyte proliferation J:156531
\Stk3tm1.1Yy/\Stk3tm1Yy
\Stk4tm1.1Yy/\Stk4tm1.1Yy
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * CBA * DBA) 		increased hepatocyte proliferation J:156541
\Stk3tm1.1Yy/\Stk3tm1Yy
\Stk4tm1.1Yy/\Stk4tm1.1Yy
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6 * CBA) 		increased hepatocyte proliferation J:156541
\Stk3tm1Dlim/\Stk3tm1Dlim
\Stk4tm1Dlim/\Stk4tm1Dlim
(Not Specified) 		abnormal cell proliferation J:155001
\Stk3tm1Jav/\Stk3tm1Jav
\Stk4Gt(AJ0315)Wtsi/\Stk4Gt(AJ0315)Wtsi
(involves: 129 * C57BL/6) 		increased hepatocyte proliferation J:153945
\Stk4Gt(AJ0315)Wtsi/\Stk4Gt(AJ0315)Wtsi
(B6.129P2-Stk4Gt(AJ0315)Wtsi) 		increased T cell proliferation J:142674
\Stk4tm1.1Kina/\Stk4tm1.1Kina
(involves: C57BL/6) 		increased T cell proliferation J:148791
\Stk17btm1Hed/\Stk17btm1Hed
(involves: 129X1/SvJ * C57BL/6) 		increased T cell proliferation J:94685
\Stk17btm1Hed/\Stk17btm1Hed
(B6.129X1-Stk17btm1Hed) 		increased T cell proliferation J:94685
\Stk26tm2.1Zzh/\Stk26tm2.1Zzh
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal enterocyte proliferation J:322311
\Stx2tm1Dcru/\Stx2+
(involves: 129X1/SvJ * C57BL/6J) 		abnormal small intestinal crypt cell proliferation J:110376
\Stx2tm1Dcru/\Stx2tm1Dcru
(involves: 129X1/SvJ * C57BL/6J) 		abnormal small intestinal crypt cell proliferation J:110376
\Sucnr1tm1Dgen/\Sucnr1tm1Dgen
(B6.129P2-Sucnr1tm1Dgen) 		decreased T cell proliferation J:143337
\Sulf1tm1Clrm/\Sulf1tm1Clrm
(involves: 129S2/SvPas * C57BL/6) 		increased fibroblast proliferation J:116527
\Sulf2tm1Clrm/\Sulf2tm1Clrm
(involves: 129S2/SvPas * C57BL/6) 		increased fibroblast proliferation J:116527
\Sumo2tm1Weiy/\Sumo2tm1Weiy
(involves: 129 * C57BL/6) 		decreased cell proliferation J:217019
\Suz12Gt(Betageo)1Khe/\Suz12Gt(Betageo)1Khe
(involves: 129P2/OlaHsd * C57BL/6) 		decreased cell proliferation J:93307
\Syislem1Bzuo/\Syislem1Bzuo
(involves: C57BL/6) 		decreased myoblast proliferation J:266240
\Syktm1.1Tara/\Syktm1.1Tara
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell proliferation J:114816
\tw73/\tw73
(involves: M. m. musculus) 		decreased embryonic epiblast cell proliferation J:175675
\Tab2tm2.1Aki/\Tab2tm2.1Aki
\Tab3tm1Aki/\Tab3tm1Aki
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6) 		decreased B cell proliferation J:195289
\Tada3tm1.1Viba/\Tada3tm1.1Viba
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		decreased fibroblast proliferation J:190249
\Tada3tm1.2Viba/\Tada3tm1.2Viba
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL) 		abnormal trophoblast giant cell proliferation J:190249
\Taf4tm1.1Idvd/\Taf4tm1.1Idvd
(Not Specified) 		increased fibroblast proliferation J:125257
\Taf4tm1Idvd/\Taf4tm1Idvd
\Tg(KRT14-cre/ERT2)1Ipc/0
(involves: C57BL/6 * SJL) 		increased keratinocyte proliferation J:124111
\Taf4btm1Rtj/\Taf4btm1Rtj
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased granulosa cell proliferation J:119191
\Taf4btm1Rtj/\Taf4btm1Rtj
(B6.129-Taf4btm1Rtj) 		abnormal spermatogonia proliferation J:97245
\Taf7tm1.1Dss/\Taf7tm1.2Dss
\Tg(Cd8a*-cre)B8Asin/0
(involves: C57BL/6) 		decreased T cell proliferation J:185745
\Taf10tm1.1Lzt/\Taf10tm1.1Lzt
(involves: 129 * C57BL/6 * SJL) 		absent inner cell mass proliferation J:101819
\Tamalintm1.1Tes/\Tamalintm1.1Tes
(B6.129S1-Tamalintm1.1Tes) 		abnormal neuron proliferation J:181614
\Tanktm1Aki/\Tanktm1Aki
(involves: 129/Sv * C57BL/6) 		increased B cell proliferation J:151757
\Tardbptm1.1Ckjs/\Tardbptm1.1Ckjs
(involves: C57BL/6J * FVB/N) 		absent inner cell mass proliferation J:155958
\Tarm1tm1Yiw/\Tarm1tm1Yiw
(involves: C57BL/6 * C57BL/6NSlc) 		decreased T cell proliferation J:301164
\Tasp1tm1.1Jjdh/\Tasp1tm1.1Jjdh
(involves: 129X1/SvJ) 		decreased cell proliferation J:112159
\Tbc1d10ctm1.2Psou/\Tbc1d10ctm1.2Psou
(involves: 129S2/SvPas * C57BL/6J) 		increased T cell proliferation J:211913
\Tbx1tm1Bld/\Tbx1+
(involves: 129S7/SvEvBrd * C57BL/6J) 		increased vascular smooth muscle cell proliferation J:212881
\Tbx20tm1.1Rph/\Tbx20tm1.1Rph
(involves: C57BL/6) 		decreased fetal cardiomyocyte proliferation J:98489
\Tbx20tm1.1Sev/\Tbx20tm1.1Sev
(involves: 129S6/SvEvTac * C57BL/6) 		decreased fetal cardiomyocyte proliferation J:98516
\Tbx20tm1Akis/\Tbx20tm1Akis
(involves: 129S1/SvImJ * NMRI) 		decreased fetal cardiomyocyte proliferation J:98806
\Tcf3tm1Xhsu/\Tcf3tm1Xhsu
\Tg(Lck-Stat5b*)1Mafa/0
(involves: 129X1/SvJ * C57BL/6 * FVB/N) 		increased B cell proliferation J:132669
\Tcf3tm2Cmu/\Tcf3tm2Cmu
(involves: 129P2/OlaHsd) 		increased cell proliferation J:118827
\Tcf7l1tm1.1Efu/\Tcf7l1tm1.1Efu
\Tcf7l2tm1Cle/\Tcf7l2tm1Cle
\Tg(KRT14-cre)1Efu/0
(involves: 129/Sv * 129P2/OlaHsd) 		decreased keratinocyte proliferation J:155012
\Tcf7l2tm1.1(EGFP/cre)Mrc/\Tcf7l2tm1.1(EGFP/cre)Mrc
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal enterocyte proliferation J:170088
\Tcf7l2tm1.1(EGFP/cre)Mrc/\Tcf7l2tm2.1Mrc
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6NCrl) 		abnormal enterocyte proliferation J:170088
\Tcf7l2tm1.1(EGFP/cre)Mrc/\Tcf7l2tm2.2Mrc
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal enterocyte proliferation J:170088
\Tcf7l2tm2.1Cle/\Tcf7l2tm2.1Cle
\Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		abnormal enterocyte proliferation J:185753
\Tcf7l2tm2.2Mrc/\Tcf7l2tm2.2Mrc
(involves: 129S1/Sv) 		abnormal enterocyte proliferation J:170088
\Tcf12tm3Zhu/\Tcf12tm3Zhu
\Tcf3tm4Zhu/\Tcf3tm4Zhu
\Tg(Lck-cre)#Zhu/0
(involves: 129S4/SvJae * C57BL/6 * SJL/J) 		increased T cell proliferation J:129570
\Tcof1tm1Mjd/\Tcof1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/1) 		decreased cranial neural crest cell proliferation J:112900
\Tcratm1Mjo/\Tcratm1Mjo
(involves: 129P2/OlaHsd) 		abnormal neuron proliferation J:170591
decreased T cell proliferation J:110898
\Tdo2tm1Tnak/\Tdo2tm1Tnak
(B6.129-Tdo2tm1Tnak) 		abnormal neuronal precursor proliferation J:177903
\Tead1tm1Hssk/\Tead1tm1Hssk
\Tead2tm1Hssk/\Tead2tm1Hssk
(either: (involves: C57BL/6 * CBA) or (involves: C57BL/6 * CBA * CD-1)) 		decreased cell proliferation J:131426
\Ten1em1(IMPC)Hmgu/\Ten1em1(IMPC)Hmgu
(involves: C57BL/6NCrl) 		decreased cell proliferation J:365069
\Tent5cem1Adki/\Tent5cem1Adki
(involves: C57BL/6JTar * CBA/WTar) 		decreased B cell proliferation J:252302
\Terctm1Rdp/\Terctm1Rdp
(involves: 129/Sv * C57BL/6J * SJL) 		abnormal fetal cardiomyocyte proliferation J:110900
decreased B cell proliferation J:60223
decreased T cell proliferation J:60223
\Terctm1Rdp/\Terctm1Rdp
(involves: 129/Sv * C57BL/6 * C57BL/6J * SJL) 		abnormal enterocyte proliferation J:125218
\Terf1tm1.1Blas/\Terf1tm1.1Blas
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		decreased cell proliferation J:152077
\Terf1tm1Tdl/\Terf1tm1Tdl
(involves: 129S2/SvPas) 		absent inner cell mass proliferation J:85440
\Terttm1.1Phan/\Terttm1.1Phan
\Tg(Col1a2-cre/ERT,-ALPP)7Cpd/0
(involves: C57BL/6 * DBA/2) 		decreased lung fibroblast proliferation J:239734
\Terttm2.1Rdp/\Terttm2.1Rdp
(involves: C57BL/6) 		abnormal neuronal precursor proliferation J:167227
\Terttm3Rdp/\Terttm3Rdp
(involves: C57BL/6) 		decreased cell proliferation J:186105
\Tespa1tm1Smoc/\Tespa1tm1Smoc
(B6.129-Tespa1tmSmoc) 		decreased T cell proliferation J:186446
increased T cell proliferation J:186446
\Tet1tm1.1Gxu/\Tet1tm1.1Gxu
\Tg(Nes-EGFP)33Enik/0
(involves: 129 * BALB/cBy * C57BL/6 * C57BL/6J) 		abnormal neuronal precursor proliferation J:201001
\Tet1tm1Gxu/\Tet1tm1.1Gxu
\Tg(Nes-cre/ERT2)KEisc/0
(involves: 129 * C57BL/6J) 		abnormal neuronal precursor proliferation J:201001
\Tet1tm1Gxu/\Tet1tm1Gxu
(involves: 129 * C57BL/6J) 		abnormal neuronal precursor proliferation J:201001
\Tex10tm1(KOMP)Vlcg/\Tex10tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		decreased inner cell mass proliferation J:224684
\Tfamtm1.1Ncdl/\Tfamtm1.1Ncdl
\Tg(KRT14-cre)1Amc/0
(involves: C57BL/6 * CBA) 		increased keratinocyte proliferation J:213840
\Tfrctm3.1Nca/\Tfrctm3.1Nca
\Tg(Vil1-cre)20Syr/0
(involves: 129S4/SvJae * C57BL/6 * CD-1 * DBA/2) 		abnormal enterocyte proliferation J:224823
\Tfrctm3.1Nca/\Tfrctm3.1Nca
\Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129S4/SvJae * C57BL/6 * CD-1 * DBA/2) 		abnormal enterocyte proliferation J:224823
\Tg(Actb-Tnfsf4)1Nish/0
(B6.D2-Tg(Actb-Tnfsf4)1Nish) 		increased T cell proliferation J:80214
\Tg(AGER)#Eca/0
(C57BL/6J-Tg(AGER)#Eca) 		decreased lung endothelial cell proliferation J:205092
\Tg(AGER)#Eca/\Tg(AGER)#Eca
(C57BL/6J-Tg(AGER)#Eca) 		decreased lung endothelial cell proliferation J:205092
\Tg(Alb-E2F1)8Sst/0
(involves: C57BL/6J * CBA/J) 		increased hepatocyte proliferation J:65354
\Tg(Alb-PDGFC)#Jcam/0
(involves: C57BL/6) 		increased hepatocyte proliferation J:96979
\Tg(Alb-REG3A)24Lchr/0
(involves: C57BL/6 * CBA) 		increased hepatocyte proliferation J:140235, J:84698
\Tg(AMH-Fshr*D580H)#Hht/0
(involves: FVB/N) 		increased cell proliferation J:160015
increased granulosa cell proliferation J:160015
\Tg(AZIP/F)1Vsn/0
(FVB-Tg(AZIP/F)1Vsn/J) 		increased pancreatic beta cell proliferation J:145998
\Tg(BCL2)36Wehi/?
(B6.Cg-Tg(BCL2)36Wehi/J) 		abnormal B cell proliferation J:90963
\Tg(BCL2L1)2Cbt/0
(Not Specified) 		increased keratinocyte proliferation J:65162
\Tg(BLG-STAT5A)15Itb/0
(involves: FVB/N) 		increased mammary gland epithelial cell proliferation J:80588
\Tg(CAG-COX7A2L)#Sinos/0
(involves: C57BL/6) 		increased fibroblast proliferation J:215964
\Tg(CAG-Lyn*)#Paau/0
(B6.Cg-Tg(CAG-Lyn*)#Paau) 		increased keratinocyte proliferation J:151886
\Tg(CD2-Ceacam1*4L)1Rsb/0
(involves: C57BL/6) 		decreased T cell proliferation J:116136
\Tg(CD2-Myb/en)2Kmw/?
(involves: C57BL/10 * CBA) 		decreased T cell proliferation J:126456
\Tg(CD2-Myb/en)2Kmw/\Tg(CD2-Myb/en)2Kmw
(involves: C57BL/10 * CBA) 		decreased T cell proliferation J:126456
\Tg(CD2-Nfat5)1Snh/0
(involves: BALB/c * C57BL/6) 		decreased splenocyte proliferation J:80066
decreased T cell proliferation J:80066
\Tg(CD2-S1PR1)1Ejg/?
(involves: C57BL/6 * DBA/2) 		decreased T cell proliferation J:96558
\Tg(CD2-Tgfbr2)1Grs/0
(C57BL/6-Tg(CD2-Tgfbr2)1Grs/Nci) 		increased T cell proliferation J:97523
\Tg(CD2-Tgfbr2)1Grs/?
(C57BL/6-Tg(CD2-Tgfbr2)1Grs/Nci) 		increased T cell proliferation J:93665
\Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
(involves: C57BL/6) 		abnormal T cell proliferation J:217939
\Tg(Cd4-cre)1Cwi/0
\Trmt6em1Hbgl/\Trmt6em1Hbgl
(involves: C57BL/6 * DBA/2J) 		decreased T cell proliferation J:336736
\Tg(Cd4-cre)1Cwi/0
\Trmt61aem1Hbgl/\Trmt61aem1Hbgl
(involves: C57BL/6 * DBA/2J) 		decreased T cell proliferation J:336736
\Tg(Cd4-Dtx1)1Mzl/?
(involves: C57BL/6) 		decreased T cell proliferation J:151605
\Tg(Cd4-TGFBR2)16Flv/?
(involves: C3H * C57BL/6 * C57BL/10 * C57BR/cd) 		abnormal T cell proliferation J:97554
\Tg(Cd4-TGFBR2)16Flv/?
(involves: C3H * C57BL/6) 		abnormal T cell proliferation J:134473
\Tg(CD19)1Tft/0
(involves: C57BL/6 * C57BL/6J * SJL) 		increased B cell proliferation J:27236
\Tg(CD19)1Tft/\Tg(CD19)1Tft
(involves: C57BL/6 * C57BL/6J * SJL) 		increased B cell proliferation J:27236
\Tg(Cd79b-TCL1A)BKTeit/0
(involves: C3H * C57BL/6) 		increased B cell proliferation J:79703
increased T cell proliferation J:79703
\Tg(CMV-cat,-ROCK2*)3-1Koba/0
\Tg(Tagln-cre)1Her/0
(involves: C57BL/6 * C57BL/6JJcl * DBA/2 * SJL) 		decreased fetal cardiomyocyte proliferation J:242116
\Tg(CMV-cre)1Cgn/0
\Trp53tm4Att/\Trp53+
(involves: 129S4/SvJae * BALB/cJ * C57BL/6J) 		decreased cell proliferation J:217080
\Tg(Col1a1-Atf4)1Kry/0
(involves: FVB) 		decreased pancreatic beta cell proliferation J:152695
\Tg(Col1a1-Cthrc1)1Haak/0
(B6.Cg-Tg(Col1a1-Cthrc1)1Haak) 		increased osteoblast proliferation J:143940
\Tg(Col1a1-Mir34c)#Kry/0
(B6.Cg-Tg(Col1a1-Mir34c)#Kry) 		decreased osteoblast proliferation J:185130
\Tg(Col1a1-Ptprv)1Kry/?
(Not Specified) 		decreased pancreatic beta cell proliferation J:126780
\Tg(CYP1A1-PPARD)#Jfoe/0
(involves: C57BL/6J * CBA) 		increased keratinocyte proliferation J:158907
increased T cell proliferation J:158907
\Tg(Dct-Grm1)ESzc/0
(involves: C57BL/6J) 		abnormal melanocyte proliferation J:83183
\Tg(Dct-Grm1)ESzc/0
(C57BL/6J-Tg(Dct-Grm1)ESzc) 		abnormal melanocyte proliferation J:230115
\Tg(Dct-lacZ)A12Jkn/0
\Tg(Tyr-Ctnnb1/EGFP)#Lru/0
(B6.Cg-Tg(Tyr-Ctnnb1/EGFP)#Lru Tg(Dct-lacZ)A12Jkn) 		decreased melanoblast proliferation J:176245
\Tg(Disc1/EGFP)M19Sshe/0
(involves: C57BL/6JCrl * CBA/CaCrl) 		abnormal neuron proliferation J:143557
\Tg(DYRK1A)36Wjs/0
(involves: C57BL/6NCrjBgi) 		abnormal neuron proliferation J:166796
abnormal neuronal precursor proliferation J:166796
\Tg(EIIa-cre)C5379Lmgd/0
\Tg(Rnu6-RNAi:Bccip)4Zshn/0
(involves: C57BL/6 * FVB/N) 		decreased cell proliferation J:176115
decreased inner cell mass proliferation J:176115
\Tg(EmuSR-HDAC9)1468Kpet/0
(involves: C57BL/6 * CBA) 		increased B cell proliferation J:237420
\Tg(Gfap-gp120)#Lms/0
(involves: C57BL/6 * SJL) 		decreased neuronal precursor proliferation J:170738
\Tg(Gfap-TK)7.1Mvs/0
(involves: C57BL/10 * CBA * CFLP) 		abnormal cell proliferation J:113202
\Tg(H2-Ea-G6pc2)69Tkay/?
(NOD-Tg(H2-Ea-G6pc2)69Tkay) 		decreased T cell proliferation J:117352
\Tg(H2-Ea-Ins2)1Wehi/0
(NOD/ShiLtJWehi-Tg(H2-Ea-Ins2)1Wehi) 		abnormal T cell proliferation J:100232
\Tg(H2-Ea-Ins2)1Wehi/\Tg(H2-Ea-Ins2)1Wehi
(NOD/ShiLtJWehi-Tg(H2-Ea-Ins2)1Wehi) 		decreased T cell proliferation J:117352
\Tg(H2-K-DUSP5)21Wjl/0
(involves: C57BL/6J * CBA) 		decreased T cell proliferation J:138077
\Tg(H2-K-HLA-G,B2M)1Alm/0
(CBA/Ca-Tg(H2-K-HLA-G,B2M)1Alm/CmwJ) 		increased T cell proliferation J:140016
\Tg(H2-K-MC159/EGFP)13Fkmc/0
(involves: C57BL/6) 		increased B cell proliferation J:138050
\Tg(H2KmPCC)2939Stoe/0
\Tg(Tcra2B4)1Mmd/0
\Tg(Tcrb2B4)1Mmd/0
(involves: C3H/HeJ * C57BL/6 * SJL) 		decreased T cell proliferation J:50143
\Tg(Hoxc13)61B1Awg/0
(FVB-Tg(Hoxc13)61B1Awg) 		increased keratinocyte proliferation J:68213
\Tg(Hoxc13)61U4Awg/0
(FVB-Tg(Hoxc13)61U4Awg) 		increased keratinocyte proliferation J:68213
\Tg(Igh-Lmp2a)ERlon/0
(involves: C57BL/6 * SJL) 		abnormal B cell proliferation J:129571
\Tg(Igh-Mir29a,-Mir29b-1,-hrGFP)#Cro/0
(FVB/N-Tg(Igh-Mir29a,-Mir29b-1,-hrGFP)#Cro) 		increased B cell proliferation J:162077
\Tg(Igh-Mir155)8Cro/0
(involves: FVB/N) 		increased B cell proliferation J:109591
\Tg(Igh-V-CD40lg)#Tsub/0
(involves: C57BL/6) 		increased splenocyte proliferation J:89855
\Tg(IghelMD4)4Ccg/\Tg(IghelMD4)4Ccg
(NOD.B6-Tg(IghelMD4)4Ccg/DvsJ) 		abnormal T cell proliferation J:80859
\Tg(IghMyc)22Bri/0
\Xiaptm1Hs/\Xiaptm1Hs
(B6.Cg-Xiaptm1Hs Tg(IghMyc)22Bri) 		decreased B cell proliferation J:138979
\Tg(ILK3mHEL)3Ccg/0
\Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6JSfd * C57BL/10Sg * C57BR/cd) 		abnormal T cell proliferation J:78309
\Tg(Ins2-HA)165Bri/0
(B10.Cg- H2d Tg(Ins2-HA)165Bri/ShrmJ) 		decreased T cell proliferation J:86430
\Tg(Ins2-Mir184)4Mnpy/0
(Not Specified) 		decreased pancreatic beta cell proliferation J:210552
\Tg(Ins2-Nos2)40Okam/0
\Tg(Kdr-AGER)102Hyam/0
(involves: C57BL/6J * CBA/J * CD-1 * DBA/2) 		increased kidney cell proliferation J:70495
\Tg(Ins2-rtTA)2Efr/0
\Tg(tetO-Ago2)30Mnpy/0
(involves: C57BL/6 * CBA) 		increased pancreatic beta cell proliferation J:210552
\Tg(Ins2-rtTA)2Efr/0
\Tg(tetO-Mir184)#Mnpy/0
(involves: C57BL/6 * CBA) 		decreased pancreatic beta cell proliferation J:210552
\Tg(Ins2-TCF1*P291)2Kya/0
(involves: C57BL/6 * SJL) 		decreased pancreatic beta cell proliferation J:73760
\Tg(Ins2-TFRC/OVA)296Wehi/0
\1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(involves: C57BL/6 * FVB) 		decreased T cell proliferation J:122114
\Tg(Ins-MYC/Er)1Gev/0
(involves: C57BL/6 * CBA) 		increased cell proliferation J:142030
\Tg(IRS1)1Mhep/0
(FVB-Tg(IRS1)1Mhep) 		increased hepatocyte proliferation J:92999
\Tg(KRT5-Akt1*)Jmpa/0
(involves: C57BL/6 * DBA/2 * DBA/2J * FVB/N) 		decreased keratinocyte proliferation J:144831
increased cell proliferation J:144831
\Tg(KRT5-IKBKB)2Armz/0
(involves: C57BL/6 * DBA/2) 		increased keratinocyte proliferation J:160072
\Tg(KRT5-rtTA)1Glk/0
\Tg(tetO-Tfrc/EGFP/Ova)#Sfz/0
\Tg(tetO/CMV-Tslp)#Sfz/0
(involves: C3H * C57BL/6 * FVB/N) 		increased T cell proliferation J:199558
\Tg(KRT5-rtTA)1Glk/0
\Tg(tetO-TGFB1*C223S*C225S)1Glk/0
(involves: FVB/N) 		abnormal cell proliferation J:70670
decreased cell proliferation J:70670
\Tg(KRT5-rtTA)1Glk/0
\Tg(tetO/CMV-Tslp)#Sfz/0
(C.Cg-Tg(KRT5-rtTA)1Glk Tg(tetO/CMV-Tslp)#Sfz) 		increased B cell proliferation J:182756
\Tg(KRT5-rtTA)#Glk/0
\Tg(tetO-cre)1Jaw/0
\Wnt10atm1Smr/\Wnt10atm1Smr
(involves: 129X1/SvJ * C57BL/6 * FVB/N) 		decreased cell proliferation J:242196
\Tg(KRT5-rtTA)#Glk/0
\Tg(tetO-Mir31)#Zhyu/0
(involves: C57BL/6J * FVB/N) 		increased mammary gland epithelial cell proliferation J:271420
\Tg(KRT5-Stat3*A661C*N663C)1Jdg/0
(involves: FVB) 		increased keratinocyte proliferation J:95458
\Tg(KRT5-Terf2)PMBlas/Y
(involves: C57BL/6 * CBA) 		decreased keratinocyte proliferation J:102653
\Tg(KRT5-TGFB1)F2020Xjw/0
(involves: C57BL/6 * DBA/2 * ICR) 		decreased keratinocyte proliferation J:90118
\Tg(KRT5-tTA)1216Glk/0
\Tg(tetO-TGFB1*C223S*C225S)1Glk/0
(involves: FVB/N) 		decreased cell proliferation J:70670
\Tg(KRT14-cre)8Brn/0
\Tg(KRT5-Akt1*)Jmpa/0
\Trp53tm1Brn/\Trp53tm1Brn
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * DBA/2J * FVB/N) 		increased cell proliferation J:144831
increased keratinocyte proliferation J:144831
\Tg(KRT14-HPV16)wt1Dh/0
(FVB.Cg-Tg(KRT14-HPV16)wt1Dh/Nci) 		increased keratinocyte proliferation J:65699
\Tg(KRT14-rtTA)F42Efu/0
\Tg(tetO-EDN1,-lacZ)9Mhus/0
(involves: C57BL/6J * FVB) 		abnormal melanocyte proliferation J:231435
\Tg(KRT14-Snai1)1Efu/0
(involves: CD-1) 		increased keratinocyte proliferation J:229072
\Tg(KRT14-VP16/NR1I2)13Sdub/?
(involves: C57BL/6) 		increased keratinocyte proliferation J:258435
\Tg(LANA,vFLIP,vCYC)801Dtmr/?
(involves: C57BL/6) 		increased B cell proliferation J:196403
\Tg(Lck-Bcl2l1)1Cant/?
(B6.Cg-Tg(Lck-Bcl2l1)1Cant) 		increased T cell proliferation J:77507
\Tg(Lck-Cxadr)1Jdgr/0
(FVB-Tg(Lck-Cxadr)1Jdgr) 		decreased T cell proliferation J:109884
\Tg(Lck-FADD)1Hed/0
(involves: BALB/c * C57BL/6) 		abnormal T cell proliferation J:100451
\Tg(LCK-NFKBIA)5Dwb/0
(involves: C57BL/6 * DBA/2) 		decreased T cell proliferation J:93003
\Tg(Lck-Socs3)1Kubo/0
(Not Specified) 		decreased T cell proliferation J:128797
\Tg(Lck-Sox13)#Jskg/0
(involves: C57BL/6) 		decreased T cell proliferation J:117301
\Tg(Lck-Stat5b*)1Mafa/0
(Not Specified) 		increased B cell proliferation J:132669
\Tg(Lck-Stk17b)26.1Wals/?
(B6.Cg-Tg(Lck-Stk17b)26.1Wals) 		increased T cell proliferation J:149973
\Tg(Lck-Tnfsf4)1Nish/0
(B6.Cg-Tg(Lck-Tnfsf4)1Nish) 		increased T cell proliferation J:80214
\Tg(Lck-Tnfsf14)24Yxf/?
(C57BL/6-Tg(Lck-Tnfsf14)24Yxf) 		increased T cell proliferation J:129951
\Tg(Lck/Emu-Rftn1)1Ayos/?
(involves: C57BL/6) 		increased T cell proliferation J:150299
\Tg(Ly6a-GCSAM)102AIsg/0
(involves: C57BL/6J * CBA) 		increased B cell proliferation J:221238
\Tg(ML5sHEL)5Ccg/0
\Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd) 		abnormal T cell proliferation J:78309
\Tg(ML5sHEL)5Ccg/0
\Tg(TcrHEL3A9)1Mmd/0
\Tg(TLK2mHEL)2Ccg/0
(involves: C57BL/6JSfd * C57BL/10 * C57BR/cd) 		abnormal T cell proliferation J:78309
\Tg(MMTV-NCOA3)#Mybr/0
(FVB/N-Tg(MMTV-NCOA3)#Mybr) 		decreased mammary gland epithelial cell proliferation J:93548
\Tg(MMTV-PyVT)#Mul/0
(B6.FVB-Tg(MMTV-PyVT)#Mul) 		decreased B cell proliferation J:147923
decreased splenocyte proliferation J:147923
decreased T cell proliferation J:147923
\Tg(MMTV-rtTA)1Lach/0
\Tg(tetO-MYC)1Lach/0
(involves: FVB) 		increased mammary gland epithelial cell proliferation J:67498
\Tg(Mpz-RAF1/ESR1)A668Ayld/0
(involves: C57BL/6J * CBA/J) 		increased Schwann cell proliferation J:182703
\Tg(MT2A-TGFBR2)#Rser/0
(involves: C57BL/6 * DBA) 		abnormal cell proliferation J:158480
\Tg(Myh6-Actc1dt)2Kwan/0
(involves: C57BL/6) 		decreased fetal cardiomyocyte proliferation J:297375
\Tg(Myl2-FGF19)1Dfre/?
(involves: FVB) 		increased hepatocyte proliferation J:77160
\Tg(Nes-cre)1Kln/0
\Ube4bem1Bcgen/\Ube4bem1Bcgen
(involves: C57BL/6N * SJL) 		decreased neuronal precursor proliferation J:332423
\Tg(Nes-cre)1Kln/0
\Zfp568tm1Ckjs/\Zfp568tm1Ckjs
(involves: C57BL/6J * SJL) 		abnormal neuronal precursor proliferation J:192224
\Tg(Nes-cre)1Wme/\Tg(Nes-cre)1Wme
(involves: C57BL/6 * CBA) 		decreased neuronal precursor proliferation J:112466
\Tg(Nes-cre/ERT2)1Imayo/0
(involves: C57BL/6) 		decreased neuronal precursor proliferation J:112466
\Tg(Nes-cre/ERT2)4Imayo/0
(involves: C57BL/6) 		decreased neuronal precursor proliferation J:112466
\Tg(Neurod2-Smo*A2)#Jols/0
(C57BL/6-Tg(Neurod2-Smo*A2)#Jols) 		abnormal neuron proliferation J:189258
\Tg(Pgk-tetR,tetO-RNAi:Pum3)#Yuj/0
\Tg(Pou5f1-EGFP)2Mnn/0
(involves: C57BL/6 * C57BL/6J * CBA/CaJ) 		decreased primordial germ cell proliferation J:338852
\Tg(Pkd1)6Mtru/0
(involves: C57BL/6J * CBA/J) 		increased hepatocyte proliferation J:157952
increased kidney cell proliferation J:157952
\Tg(Pkd1)26Mtru/0
(involves: C57BL/6J * CBA/J) 		increased hepatocyte proliferation J:157952
increased kidney cell proliferation J:157952
\Tg(Pten)1Srn/0
(involves: C57BL/6 * CBA) 		decreased cell proliferation J:182671
\Tg(Rnu6-RNAi:Bccip)4Zshn/0
(FVB/N-Tg(Rnu6-RNAi:Bccip)4Zshn) 		decreased cell proliferation J:176115
\Tg(SFTPC-rtTA)5Jaw/0
\Tg(tetO-Fgf9,-EGFP)#Dor/0
(involves: FVB) 		increased mesenchymal cell proliferation involved in lung development J:224791
\Tg(Shh)#Dje/0
(involves: Swiss Webster) 		abnormal cell proliferation J:94461
\Tg(Sox3)1Pqt/0
\Tg(Sox3-EGFP)NrPqt/0
(involves: C57BL/6 * CBA) 		increased cell proliferation J:184232
\Tg(Tagln-Ager)#Yon/?
(C57BL/6-Tg(Tagln-Ager)#Yon) 		decreased vascular smooth muscle cell proliferation J:82620
\Tg(Tagln-tTA)1Mrab/0
\Tg(tetO-Mcpt1)1Mrab/0
(involves: C57BL/6 * SJL) 		increased cell proliferation J:70031
\Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: C57BL/6) 		increased cell proliferation J:83278
\Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129P2/OlaHsd * C57BL/6) 		decreased T cell proliferation J:189919
increased T cell proliferation J:189919
\Tg(Tcra,Tcrb)3Ayr/0
(involves: C57BL/6 * DBA/2) 		decreased T cell proliferation J:80775
\Tg(Tcra,Tcrb)24Efro/0
(D1.Cg-Tg(Tcra,Tcrb)24Efro) 		decreased T cell proliferation J:104243
increased T cell proliferation J:104243
\Tg(TcrAND)53Hed/?
(involves: A/WySnSg * C57BL/6 * C57BL/10SnSg * SJL) 		abnormal T cell proliferation J:85777
\Tg(TcraR28,TcrbR28)KRNDim/0
(involves: C57BL/6 * NOD * SJL) 		abnormal T cell proliferation J:36815
\Tg(TcraTcrb)425Cbn/0
\Trim30atm1Yjk/\Trim30atm1Yjk
(involves: 129P2/OlaHsd * BALB/c * C57BL/6) 		increased T cell proliferation J:215171
\Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6) 		increased T cell proliferation J:92867
\Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6) 		increased T cell proliferation J:73608
\Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd) 		abnormal T cell proliferation J:78309
\Tg(TcrHEL3A9)1Mmd/0
\Tg(TLK2mHEL)2Ccg/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd) 		abnormal T cell proliferation J:78309
\Tg(TcrLCMV)327Sdz/0
(involves: C57BL/6 * DBA/2) 		decreased T cell proliferation J:77696
\Tg(tetO-Mir24-1)#Smoc/0
\Tg(KRT14-rtTA)F42Efu/0
(involves: FVB) 		decreased keratinocyte proliferation J:306624
X/\Tg(Tlr7)6Boll
(involves: C57BL/6) 		increased splenocyte proliferation J:127600
\Tg(Ttr-Cdkn1a)36Tvd/?
(B6.Cg-Tg(Ttr-Cdkn1a)36Tvd) 		decreased hepatocyte proliferation J:94077
\Tg(Ttr-KLF6)1Fdmn/?
(Not Specified) 		decreased hepatocyte proliferation J:122903
\Tg(Tyr-NRAS*Q61K)1Bee/0
(involves: C57BL/6J * DBA/2) 		abnormal melanocyte proliferation J:193443
\Tg(UAS-Shh)1Rth/0
\Tg(Wnt1-GAL4)1Rth/0
(involves: C57BL/6J * CBA/J) 		increased cell proliferation J:57948
\Tg(Umod*C147W)958Lura/0
(involves: FVB) 		increased kidney cell proliferation J:161532
\Tg(Vav1-Lin28b)C3Apla/0
(involves: C57BL/6) 		increased T cell proliferation J:189197
\Tg(Vav1-STAT5B*N642H)726Biat/0
(C57BL/6NCrl-Tg(Vav1-STAT5B*N642H)726Biat) 		increased T cell proliferation J:257519
\Tg(Vil-SLC3A2)HEMerl/0
(involves: FVB/N) 		abnormal enterocyte proliferation J:173946
\Tgfbr1tm1.1Karl/\Tgfbr1tm1.1Karl
\Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * CBA) 		increased hematopoietic stem cell proliferation J:86262
\Tgfbr2tm1.2Hlm/\Tgfbr2tm1.2Hlm
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: 129S6/SvEvTac * C57BL/6J * CBA/J) 		decreased cranial neural crest cell proliferation J:86042
\Tgfbr2tm1Sjkm/\Tgfbr2+
(Not Specified) 		increased hepatocyte proliferation J:71591
\Tgfbr3tm1Stv/\Tgfbr3tm1Stv
(involves: 129/Sv * C57BL/6) 		decreased fetal cardiomyocyte proliferation J:83727
\Tgif1tm1Dwot/\Tgif1tm1Dwot
\Tgif2tm1Dwot/\Tgif2tm1Dwot
(involves: 129S/SvEv * 129X1/SvJ * C57BL/6J) 		decreased embryonic epiblast cell proliferation J:157256
\Tgif1tm1Pah/\Tgif1tm1Pah
(involves: 129S/SvEv * CD-1) 		decreased cell proliferation J:109616
\Thap11tm1.1Tpz/\Thap11tm1.1Tpz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		absent inner cell mass proliferation J:136306
\Themistm1Gasc/\Themistm1Gasc
(B6.129S-Themistm1Gasc) 		decreased T cell proliferation J:151074
\Themistm1Hasu/\Themistm1Hasu
(involves: C57BL/6 * CBA) 		increased T cell proliferation J:153235
\Thraem1Ffla/\Thra+
(C57BL/6-Thraem1Ffla) 		abnormal enterocyte proliferation J:268664
\Thraem2Ffla/\Thra+
(C57BL/6-Thraem2Ffla) 		abnormal enterocyte proliferation J:268664
\Thratm1Jas/\Thratm1Jas
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal enterocyte proliferation J:84537
\Thratm2Jas/\Thratm2Jas
(involves: 129) 		abnormal enterocyte proliferation J:84537
\Thratm3Jas/\Thratm3Jas
(involves: 129) 		abnormal enterocyte proliferation J:84537
\Thypr1DBA/2J/?
(involves: C57BL/6J * DBA/2J) 		increased T cell proliferation J:76931
\Thypr2DBA/2J/?
(involves: C57BL/6J * DBA/2J) 		increased T cell proliferation J:76931
\Tiam1tm1Jgc/\Tiam1tm1Jgc
(involves: 129P2/OlaHsd * FVB) 		decreased cell proliferation J:77148
\Ticam1tm1Aki/\Ticam1tm1Aki
(involves: 129P2/OlaHsd) 		decreased splenocyte proliferation J:84679
\Tifabtm1.1Dsta/\Tifab+
(involves: 129 * C57BL/6 * C57BL/6J) 		decreased hematopoietic stem cell proliferation J:229024
\Tifabtm1.1Dsta/\Tifabtm1.1Dsta
(involves: 129 * C57BL/6 * C57BL/6J) 		decreased hematopoietic stem cell proliferation J:229024
\TigarGt(EUCE0047g05)Hmgu/\TigarGt(EUCE0047g05)Hmgu
(involves: 129P2/OlaHsd) 		abnormal small intestinal crypt cell proliferation J:198650
\Tigittm1Sdl/\Tigittm1Sdl
(involves: C57BL/6) 		increased T cell proliferation J:168902
\Timd4tm1Kuch/\Timd4tm1Kuch
(C57BL/6-Timd4tm1Kuch) 		increased splenocyte proliferation J:160747
\Tincrem1Kei/\Tincrem1Kei
(Not Specified) 		decreased keratinocyte proliferation J:339811
\Tiraptm1Medz/\Tiraptm1Medz
(involves: 129S1/Sv * C57BL/6) 		decreased B cell proliferation J:96773
\Tjp1tm1.1Whun/\Tjp1tm1.1Whun
\Tjp2tm2Whun/\Tjp2tm2Whun
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6N * C57BL/6NTac * DBA/2) 		increased hepatocyte proliferation J:306936
\Tjp2tm1Whun/\Tjp2tm1Whun
(either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6)) 		decreased cell proliferation J:132649
\Tle3tm1.1Pton/\Tle3tm1.1Pton
\Tle4tm1.1Dasw/\Tle4tm1.1Dasw
\Tg(Pdx1-cre)6Tuv/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * FVB/N) 		decreased pancreatic beta cell proliferation J:307817
\Tln2tm2Crit/\Tln2tm2Crit
(involves: 129P2/OlaHsd * C57BL/6) 		decreased fibroblast proliferation J:190037
\Tlr2tm1Kir/\Tlr2tm1Kir
(B6.129-Tlr2tm1Kir) 		decreased splenocyte proliferation J:121930
\Tlr4tm1.1Djh/\Tlr4tm1.1Djh
(involves: FVB/N) 		abnormal enterocyte proliferation J:192520
abnormal fibroblast proliferation J:192520
\Tlr4tm1Aki/\Tlr4tm1Aki
(involves: 129P2/OlaHsd * C57BL/6) 		decreased B cell proliferation J:76115
\Tlr7em2Anu/Y
(C57BL/6NCrl-Tlr7em2Anu) 		decreased B cell proliferation J:324448
\Tlr7tm1Flv/Y
(B6.129S1-Tlr7tm1Flv) 		decreased splenocyte proliferation J:127600
\Tlr9m3Btlr/\Tlr9m3Btlr
(C57BL/6J-Tlr9m3Btlr) 		decreased B cell proliferation J:128406
\Tlr9m4Btlr/\Tlr9+
(C57BL/6J-Tlr9m4Btlr) 		decreased B cell proliferation J:132489
\Tmem258tm1.1(KOMP)Vlcg/\Tmem258+
(involves: C57BL/6NTac) 		abnormal enterocyte proliferation J:240635
\Tmpotm1.1Foi/\Tmpotm1.1Foi
(involves: 129S1/Sv * C57BL/6) 		abnormal enterocyte proliferation J:145628
\Tnftm1Gkl/\Tnftm1Gkl
(involves: 129S/SvEv * C57BL/6) 		decreased keratinocyte proliferation J:56068
\Tnftm2Gkl/\Tnf+
(involves: 129S/SvEv * C57BL/6J) 		increased cell proliferation J:264147
increased fibroblast proliferation J:264147
\Tnfaip3tm2Ama/\Tnfaip3tm2Ama
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell proliferation J:163917
\Tnfrsf1atm1Imx/\Tnfrsf1atm1Imx
(C57BL/6-Tnfrsf1atm1Imx) 		abnormal neuron proliferation J:112713
\Tnfrsf1btm1Mwm/\Tnfrsf1btm1Mwm
(B6.129S2-Tnfrsf1btm1Mwm/J) 		decreased T cell proliferation J:107039
\Tnfrsf4tm1Nik/\Tnfrsf4tm1Nik
(involves: 129S4/SvJae * C57BL/6) 		decreased T cell proliferation J:58979, J:64552
\Tnfrsf9tm1Byk/\Tnfrsf9tm1Byk
(B6.Cg-Tnfrsf9tm1Byk) 		increased T cell proliferation J:83996
\Tnfrsf9tm1Byk/\Tnfrsf9tm1Byk
(C.Cg-Tnfrsf9tm1Byk) 		increased splenocyte proliferation J:83722
increased T cell proliferation J:83996
\Tnfrsf13btm1Rjb/\Tnfrsf13btm1Rjb
(involves: 129X1/SvJ * C57BL/6) 		increased B cell proliferation J:69474
\Tnfrsf13btm1Vmd/\Tnfrsf13btm1Vmd
(involves: C57BL/6) 		increased B cell proliferation J:70172
\Tnfrsf13cBcmd1/\Tnfrsf13cBcmd1
(A/WySnJ) 		decreased B cell proliferation J:122315
decreased T cell proliferation J:92334
\Tnfrsf14tm1Kpf/\Tnfrsf14tm1Kpf
(B6.129P2-Tnfrsf14tm1Kpf) 		increased T cell proliferation J:99456
\Tnfrsf18tm1Ppp/\Tnfrsf18tm1Ppp
(involves: 129/Sv * C57BL/6) 		increased T cell proliferation J:77393
\Tnfrsf21tm1Ddy/\Tnfrsf21tm1Ddy
(involves: 129S1/Sv * 129X1/SvJ) 		increased B cell proliferation J:109341
increased T cell proliferation J:70594
\Tnfrsf21tm1Vmd/\Tnfrsf21tm1Vmd
(involves: C57BL/6) 		increased T cell proliferation J:72761
\Tnfsf4tm1Shr/\Tnfsf4tm1Shr
(involves: 129S4/SvJae) 		decreased T cell proliferation J:59203
\Tnfsf4tm1Sug/\Tnfsf4tm1Sug
(B6.129S4-Tnfsf4tm1Sug) 		decreased T cell proliferation J:80214
\Tnfsf13tm1Pod/\Tnfsf13tm1Pod
(B6.Cg-Tnfsf13tm1Pod) 		increased T cell proliferation J:141374
\Tnfsf13btm1Msc/\Tnfsf13btm1Msc
(involves: 129S2/SvPas) 		decreased T cell proliferation J:92334
\Tnfsf14tm1Ddy/\Tnfsf14tm1Ddy
(involves: 129S1/Sv * 129X1/SvJ) 		decreased T cell proliferation J:84366
\Tnfsf14tm1Kpf/\Tnfsf14tm1Kpf
(involves: 129P2/OlaHsd * C57BL/6) 		decreased splenocyte proliferation J:77250
decreased T cell proliferation J:77250
\Tnip1tm1.1Pcoh/\Tnip1tm1.1Pcoh
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell proliferation J:176826
\Tnni2tm1Sgao/\Tnni2+
(involves: 129 * ICR) 		decreased osteoblast proliferation J:228857
\Tnni3ktm1.1Tfo/\Tnni3ktm1.1Tfo
(involves: C57BL/6) 		abnormal cell proliferation J:249318
\Tnrc6aGt(XE786)Byg/\Tnrc6aGt(XE786)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		decreased cell proliferation J:182447
\Tns3Gt(XK294)Byg/\Tns3Gt(XK294)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		decreased chondrocyte proliferation J:96666
\Tob1tm1Tya/\Tob1tm1Tya
(involves: 129S4/SvJae * C57BL/6) 		increased cell proliferation J:66504
\Top1mttm1.1Hlzh/\Top1mttm1.1Hlzh
(Not Specified) 		decreased fibroblast proliferation J:189886
\Top3atm1Jcw/\Top3atm1Jcw
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal inner cell mass proliferation J:45652
\Topbp1tm1.2Dsh/\Topbp1tm1.2Dsh
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * C57BL/6J) 		decreased cell proliferation J:170406
\ToporsGt(DTM034)Byg/\ToporsGt(DTM034)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased fibroblast proliferation J:325276
\Tph1tm1c(KOMP)Wtsi/\Tph1tm1c(KOMP)Wtsi
\Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6J * CBA/J) 		decreased pancreatic beta cell proliferation J:284574
\Tph1tm1Kry/\Tph1tm1Kry
\Tg(Vil1-cre)20Syr/0
(involves: C57BL/6 * DBA/2) 		increased osteoblast proliferation J:146078
\Tpt1tm1.1Atel/\Tpt1tm1.1Atel
(involves: C57BL/6) 		decreased cell proliferation J:150991
\Tpt1tm1.1Yen/\Tpt1tm1.1Yen
(involves: 129 * C57BL/6) 		decreased embryonic epiblast cell proliferation J:127458
\Tpx2Gt(D028B03)1.1Wrst/\Tpx2Gt(D028B03)1.1Wrst
(involves: 129S2/SvPas * C57BL/6J) 		decreased cell proliferation J:184948
\Tra2btm1.1Bwir/\Tra2btm1.1Bwir
\Tg(Ddx4-cre)1Dcas/0
(involves: 129S4/SvJae * C57BL/6J * C57BL/6N * SJL) 		abnormal spermatogonia proliferation J:360846
\Traf1tm1Tsi/\Traf1tm1Tsi
(involves: 129S4/SvJae * C57BL/6) 		increased T cell proliferation J:72327
\Traf5tm1Hna/\Traf5tm1Hna
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal B cell proliferation J:57114
abnormal T cell proliferation J:57114
\Traf6tm1Mak/\Traf6tm1Mak
(involves: 129P3/J) 		decreased B cell proliferation J:54467
\Traiptm1Jarh/\Traiptm1Jarh
(involves: C57BL/6J) 		decreased cell proliferation J:127324
\Trap1Gt(E150H04)Wrst/\Trap1Gt(E150H04)Wrst
(involves: 129P2/OlaHsd * C57BL/6) 		decreased fibroblast proliferation J:226880
\Trem2em2Bwef/\Trem2em2Bwef
(involves: C57BL/6J * DBA/2J * FVB/N) 		decreased macrophage proliferation J:242126
\Trim24tm1.1Los/\Trim24tm1.1Los
(involves: 129/Sv * C57BL/6 * SJL) 		increased hepatocyte proliferation J:130210
\Trim29tm1c(EUCOMM)Wtsi/\Trim29tm1c(EUCOMM)Wtsi
\Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6J * C57BL/6N * C57BL/6NTac) 		increased T cell proliferation J:349246
\Trim30atm1Yjk/\Trim30atm1Yjk
(B6.129P2-Trim30atm1Yjk) 		increased T cell proliferation J:215171
\Trim71em1Ktka/\Trim71+
(Not Specified) 		abnormal neuron proliferation J:335575
\Trim71tm1695Arte/\Trim71tm1695Arte
\Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * C57BL/6J * C57BL/6NTac * SJL) 		abnormal neuron proliferation J:335575
\Trmq3FVB/N/?
(involves: DBA/1J * FVB/N) 		abnormal T cell proliferation J:94347
\Trp53tm1.1Manf/\Trp53tm1.1Manf
(Not Specified) 		decreased hematopoietic stem cell proliferation J:201153
\Trp53tm1.1Manf/\Trp53tm1.1Manf
(involves: C57BL/6J) 		decreased hematopoietic stem cell proliferation J:201153
\Trp53tm1.1Wgu/\Trp53tm1.1Wgu
(involves: 129S6/SvEvTac * C57BL/6) 		increased fibroblast proliferation J:186159
\Trp53tm1.2Awbr/\Trp53tm1.2Awbr
(involves: C57BL/6) 		increased cell proliferation J:173271
increased splenocyte proliferation J:173271
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S7/SvEvBrd) 		increased cell proliferation J:110650, J:118602
increased fibroblast proliferation J:175018, J:57882, J:186159
\Trp53tm1Sia/\Trp53tm1Sia
(involves: C57BL/6 * CBA) 		abnormal cell proliferation J:36762
\Trp53tm1Tyj/\Trp53+
(involves: 129S2/SvPas) 		increased fibroblast proliferation J:95316
\Trp53tm1Tyj/\Trp53tm1.1Dgk
(involves: 129S * 129X1/SvJ * C57BL/6) 		increased cell proliferation J:180576
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		decreased cell proliferation J:170976
increased fibroblast proliferation J:95318
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas) 		increased fibroblast proliferation J:77907
\Trp53tm1Wahl/\Trp53tm1Wahl
(involves: 129S4/SvJae) 		increased fibroblast proliferation J:64367
\Trp53tm2.1Snj/\Trp53+
(involves: 129S4/SvJae * C57BL/6) 		increased fibroblast proliferation J:175018
\Trp53tm2.1Snj/\Trp53tm2.1Snj
(involves: 129S4/SvJae * C57BL/6) 		increased fibroblast proliferation J:175018
\Trp53tm2.1Tyj/\Trp53+
(involves: 129S4/SvJae) 		increased cell proliferation J:95316
\Trp53tm2.1Wgu/\Trp53tm2.1Wgu
(involves: 129S6/SvEvTac * C57BL/6) 		increased fibroblast proliferation J:186159
\Trp53tm2Xu/\Trp53tm2Xu
(involves: 129S6/SvEvTac) 		decreased T cell proliferation J:109354
\Trp53tm3.1Glo/\Trp53+
(B6.129S7-Trp53tm3.1Glo) 		increased fibroblast proliferation J:95318
\Trp53tm3.1Glo/\Trp53tm3.1Glo
(B6.129S7-Trp53tm3.1Glo) 		increased fibroblast proliferation J:95318
\Trp53tm3.1Tyj/\Trp53+
(involves: 129S4/SvJae) 		increased cell proliferation J:95316
\Trp53tm3Wahl/\Trp53tm3Wahl
(involves: 129S4/SvJae) 		increased cell proliferation J:108183
\Trp53bp1Gt(OST94324)Lex/\Trp53bp1Gt(OST94324)Lex
(involves: 129S5/SvEvBrd) 		decreased cell proliferation J:83164
\Trp53bp1tm1Jc/\Trp53bp1tm1Jc
(involves: 129 * C57BL/6) 		decreased cell proliferation J:82512
\Trp53bp2tm1Xlu/\Trp53bp2tm1Xlu
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal neuronal precursor proliferation J:162396
\Trp63tm1Sin/\Trp63tm1Sin
(Not Specified) 		decreased keratinocyte proliferation J:181275
\Trp63tm2Brd/\Trp63tm2Brd
(involves: 129S7/SvEvBrd) 		decreased cell proliferation J:100483
\Trp63tm3.1Aam/\Trp63+
(involves: 129S7/SvEvBrd * BALB/c * C57BL/6) 		decreased keratinocyte proliferation J:294158
\Trp63tm3.1Brd/\Trp63tm3.1Brd
(involves: 129S7/SvEvBrd) 		decreased cell proliferation J:100483
\Trp63tm3Aam/\Trp63+
(involves: 129S7/SvEvBrd) 		decreased keratinocyte proliferation J:294158
\Trpv1tm1Jul/\Trpv1tm1Jul
(B6.129X1-Trpv1tm1Jul/J) 		abnormal neuronal precursor proliferation J:102006
\Tsc22d3tm1.1Ric/Y
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal spermatogonia proliferation J:179667
\Tsg101tm1Mak/\Tsg101tm1Mak
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * CD-1)) 		absent inner cell mass proliferation J:67553
decreased cell proliferation J:67553
\TsnGt(OST63223)Lex/\TsnGt(OST63223)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased cell proliferation J:85466
\Tspan32Gt(pMS-1)1Jmt/\Tspan32Gt(pMS-1)1Jmt
(involves: 129S1/Sv) 		increased T cell proliferation J:78033
\Tspyl5em1Yuya/\Tspyl5em1Yuya
(C57BL/6-Tspyl5em1Yuya) 		abnormal spermatogonia proliferation J:350814
\Ttc21btm2c(KOMP)Wtsi/\Ttc21baln
\Gt(ROSA)26Sortm1(cre/ERT)Nat/\Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129X1/SvJ * A/J * C57BL/6N) 		increased kidney cell proliferation J:213263
\Tuba1aem1Rstot/\Tuba1aem1Rstot
(involves: C57BL/6J * C57BL/6N) 		increased neuronal precursor proliferation J:278765
\Tuba1aquas/\Tuba1aquas
(involves: C57BL/6J) 		decreased neuronal precursor proliferation J:278765
increased neuronal precursor proliferation J:278765
\Tubb2bbrdp/\Tubb2bbrdp
(involves: A/J * FVB) 		abnormal neuronal precursor proliferation J:201099
\Tubgcp4tm1Rzh/\Tubgcp4tm1Rzh
(involves: 129S6/SvEv * C57BL/6) 		decreased cell proliferation J:282705
\Tulp3m1Kflj/\Tulp3m1Kflj
(involves: C57BL/6J * FVB/NJ) 		increased kidney cell proliferation J:284006
\Tusc2tm1Avi/\Tusc2tm1Avi
(involves: 129S1/Sv) 		decreased T cell proliferation J:309768
\Txn1tm1Mmt/\Txn1tm1Mmt
(involves: 129S2/SvPas * C57BL/6) 		absent inner cell mass proliferation J:35059
\Txniptm1Yu/\Txniptm1Yu
(involves: 129) 		increased T cell proliferation J:96677
\Txnrd1tm1.1Marc/\Txnrd1tm1.1Marc
(involves: 129P2/OlaHsd * C57BL/6J) 		absent fibroblast proliferation J:96818
decreased cell proliferation J:96818
\Txnrd2tm1.1Marc/\Txnrd2tm1.1Marc
(involves: 129P2/OlaHsd * C57BL/6) 		decreased fetal cardiomyocyte proliferation J:94136
decreased fibroblast proliferation J:94136
\Tyrobptm1Lll/\Tyrobptm1Lll
(involves: 129P2/OlaHsd * C57BL/6) 		decreased T cell proliferation J:64763
\Tyrobptm1Ttk/\Tyrobptm1Ttk
(B6.129P2-Tyrobptm1Ttk) 		increased B cell proliferation J:177613
\Ubash3btm1Jni/\Ubash3btm1Jni
\Ubash3atm1Jni/\Ubash3atm1Jni
(Not Specified) 		increased T cell proliferation J:89761
\Ubctm1Rrk/\Ubctm1Rrk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased cell proliferation J:122574
\Ube2cem1Gpt/\Ube2cem1Gpt
(C57BL/6J-Ube2cem1Gpt) 		decreased cell proliferation J:333347
\Ube2nGt(OST374154)Lex/\Ube2n+
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased B cell proliferation J:120846
decreased T cell proliferation J:120846
\Ube2otm1.1(KOMP)Mbp/\Ube2otm1.1(KOMP)Mbp
(involves: C57BL/6 * C57BL/6N * FVB/N) 		decreased fibroblast proliferation J:239679
\Ubr4tm1.2Nkt/\Ubr4tm1.2Nkt
\Edil3Tg(Sox2-cre)1Amc/\Edil3+
(involves: 129S6/SvEvTac * C57BL/6 * CBA * SJL) 		increased cell proliferation J:203460
\Ubr5tm1Ckww/\Ubr5tm1Ckww
(involves: 129X1/SvJ * C57BL/6) 		decreased cell proliferation J:92269
\Uhrf1tm1Smoc/\Uhrf1tm1Smoc
\Tg(Amh-cre)8815Reb/0
(involves: C57BL/6J * FVB/N) 		decreased Sertoli cell proliferation J:324178
\Uimc1tm1.2Amj/\Uimc1tm1.2Amj
(involves: BALB/cJ * C57BL/6) 		decreased fibroblast proliferation J:191827
\Unc93b1tm1.1Kmiy/\Unc93b1tm1.1Kmiy
(involves: 129P2/OlaHsd * C57BL/6) 		decreased B cell proliferation J:174308
increased B cell proliferation J:174308
\Upf2tm1Btp/\Upf2tm1Btp
\En1tm2(cre)Wrst/\En1+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ) 		increased neuronal precursor proliferation J:306384
\Upf2tm1Btp/\Upf2tm1Btp
\Tg(Atoh1-cre)1Bfri/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased neuronal precursor proliferation J:306384
\Upf2tm1Btp/\Upf2tm1Btp
\Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased T cell proliferation J:134765
\Upf3bGt(IST14619B5)Tigm/Y
(involves: C57BL/6J * C57BL/6N) 		increased neuronal precursor proliferation J:253157
\Upf3bGt(IST14619B5)Tigm/\Upf3bGt(IST14619B5)Tigm
(involves: C57BL/6J * C57BL/6N) 		increased neuronal precursor proliferation J:253157
\Urahplt2/\Urahplt2
(C57BL/6-Urahplt2) 		increased T cell proliferation J:267227
\Usp11tm1Tac/Y
(involves: 129 * C57BL/6) 		increased fibroblast proliferation J:270214
\Usp17lctm1Khb/\Usp17lctm1Khb
(either: 129-Usp17lctm1Khb or (involves: 129S/SvEv * C57BL/6J)) 		decreased cell proliferation J:191761
\Utf1tm1Okud/\Utf1tm1Okud
(B6.129P2-Utf1tm1Okud) 		decreased cell proliferation J:204409
\Vav1tm1Tyb/\Vav1tm1Tyb
(involves: 129S2/SvPas * 129S8/SvEv) 		decreased T cell proliferation J:113270
\Vav1tm1Tyb/\Vav1tm1Tyb
(involves: 129S2/SvPas) 		decreased T cell proliferation J:86654
\Vav1tm1Tyb/\Vav1tm1Tyb
(involves: 129S2/SvPas * C57BL/10 * C57BR/cd) 		decreased T cell proliferation J:128985
\Vav1tm1Tyb/\Vav1tm1Tyb
\Vav2tm1Kdf/\Vav2tm1Kdf
(involves: 129S1/Sv * 129S2/SvPas) 		decreased B cell proliferation J:86654
decreased T cell proliferation J:86654
\Vav1tm1Tyb/\Vav1tm1Tyb
\Vav2tm1Kdf/\Vav2tm1Kdf
\Vav3tm1Swat/\Vav3tm1Swat
(involves: 129S1/Sv * 129S2/SvPas * 129S6/SvEvTac * C57BL/6) 		decreased B cell proliferation J:86654
decreased T cell proliferation J:86654
\Vav1tm1Tyb/\Vav1tm1Tyb
\Vav2tm1Tnr/\Vav2tm1Tnr
(involves: 129P2/OlaHsd * 129S2/SvPas) 		decreased B cell proliferation J:69807
\Vav1tm1Tyb/\Vav1tm1Tyb
\Vav3tm1Swat/\Vav3tm1Swat
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6) 		decreased B cell proliferation J:86654
decreased T cell proliferation J:86654
\Vav1tm2Bbd/\Vav1tm2Bbd
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		decreased T cell proliferation J:47596
\Vav1tm2Bbd/\Vav1tm2Bbd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased B cell proliferation J:55647, J:69806
\Vav1tm2Bbd/\Vav1tm2Bbd
\Vav2tm1Kdf/\Vav2tm1Kdf
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased B cell proliferation J:69806
\Vav1tm2Tyb/\Vav1tm2Tyb
(involves: 129S4/SvJae * 129S8/SvEv) 		decreased T cell proliferation J:113270
\Vav2tm1Kdf/\Vav2tm1Kdf
(involves: 129S1/Sv * C57BL/6) 		decreased B cell proliferation J:69806
\Vav2tm1Tnr/\Vav2tm1Tnr
(involves: 129P2/OlaHsd) 		decreased B cell proliferation J:69807
\Vcltm1Eda/\Vcltm1Eda
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss) 		increased fibroblast proliferation J:45781
\Vdrtm1Ska/\Vdrtm1Ska
(involves: C57BL/6NCrlj * CBA/JNCrlj) 		decreased splenocyte proliferation J:112519
\Vegfatm2Gne/\Vegfatm2.1Nagy
\Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL) 		abnormal neuron proliferation J:86207
\Vegfatm2Gne/\Vegfatm2Gne
\Tg(SFTPC-rtTA)5Jaw/0
\Tg(tetO-cre)1Jaw/0
(involves: 129 * C57BL/6) 		decreased mesenchymal cell proliferation involved in lung development J:124125
\Vgll4tm1b(EUCOMM)Hmgu/\Vgll4tm1b(EUCOMM)Hmgu
(involves: C57BL/6N * CBA) 		increased cell proliferation J:273437
\Vgll4tm1b(EUCOMM)Hmgu/\Vgll4tm1c(EUCOMM)Hmgu
\Tg(Tek-cre)1Ywa/0
(involves: C57BL/6N * CBA * SJL) 		increased cell proliferation J:273437
\Vhltm1Jae/\Vhltm1Jae
(involves: 129S4/SvJae) 		decreased cell proliferation J:160941
\Vhltm1Jae/\Vhltm1Jae
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA) 		increased hepatocyte proliferation J:144666
\Vhltm1Jae/\Vhltm1Jae
\Tg(KRT14-cre)1Ipc/0
(involves: 129S4/SvJae * C57BL/6 * SJL) 		increased keratinocyte proliferation J:144666
\Vipr1tm1Msod/\Vipr1tm1Msod
(B6.129-Vipr1tm1Msod) 		abnormal enterocyte proliferation J:177616
\Vps25m1Lis/\Vps25m1Lis
(involves: C3H * C57BL/6J) 		increased cell proliferation J:223082
\Vps35tm1.1Hckn/\Vps35tm1.1Hckn
\Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		abnormal small intestinal crypt cell proliferation J:223191
\Vrk1Gt(RRR178)Byg/\Vrk1Gt(RRR178)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal spermatogonia proliferation J:156653
\Vsig4tm1Gne/\Vsig4tm1Gne
(C57BL/6-Vsig4tm1Gne) 		abnormal enterocyte proliferation J:281762
\Wapltm1.1Jmpt/\Wapltm1.2Jmpt
\Gt(ROSA)26Sortm9(cre/ESR1)Arte/\Gt(ROSA)26Sor+
(involves: 129 * C57BL/6 * C57BL/6NTac * SJL) 		absent fibroblast proliferation J:205429
\Wastm1Itl/Y
(Not Specified) 		decreased T cell proliferation J:153247
\Wastm1Itl/\Wastm1Itl
(Not Specified) 		decreased T cell proliferation J:153247
\Wastm1Sbs/Y
(involves: 129S6/SvEvTac) 		decreased T cell proliferation J:153247
\Wastm1Sbs/\Wastm1Sbs
(either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6)) 		decreased T cell proliferation J:48836
\Wastm1Sbs/\Wastm1Sbs
(involves: BALB/c) 		decreased T cell proliferation J:84131
\Wastm1Sbs/\Wastm1Sbs
(involves: 129S6/SvEvTac) 		decreased T cell proliferation J:153247
\Wastm2Itl/Y
(Not Specified) 		decreased T cell proliferation J:153247
\Wastm2Itl/\Wastm2Itl
(Not Specified) 		decreased T cell proliferation J:153247
\Wasltm1.1Ttha/\Wasltm1.1Ttha
\Tg(KRT14-cre)1Amc/0
(involves: C57BL/6 * C57BL/6N * CBA) 		increased keratinocyte proliferation J:271857
\Wasltm1Sbs/\Wasltm1Sbs
(either: (involves: 129P2/OlaHsd * 129S/SvEv) or (involves: 129P2/OlaHsd * C57BL/6)) 		decreased fibroblast proliferation J:72053
\Wdfy3disc/\Wdfy3disc
(involves: C57BL/6J * FVB/NJ) 		abnormal neuronal precursor proliferation J:225200
\Wdhd1em1Isyu/\Wdhd1em1Isyu
(Not Specified) 		decreased cell proliferation J:306382
\Wdr4em1Bcgen/\Wdr4em1Bcgen
(involves: C57BL/6J) 		decreased chondrocyte proliferation J:355649
\Wdr13tm1Kuma/Y
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		increased pancreatic beta cell proliferation J:225111
\Wdr62tm1.1Jfch/\Wdr62tm1.1Jfch
(involves: 129S1/SvImJ * C57BL/6N) 		decreased cell proliferation J:282438
\Wee1tm1.1Cxd/\Wee1tm1.1Cxd
(involves: 129S6/SvEvTac * FVB/N) 		decreased embryonic epiblast cell proliferation J:228492
\Wipf1tm1Geha/\Wipf1tm1Geha
(involves: 129S6/SvEvTac) 		decreased T cell proliferation J:74719
increased B cell proliferation J:74719
\Wlstm1.1Arte/\Wlstm1.1Arte
\Krt14tm1(cre)Wbm/\Krt14+
(involves: 129P2/OlaHsd * C57BL/6) 		increased keratinocyte proliferation J:202499
increased T cell proliferation J:202499
\Wlstm1Xzg/\Wlstm1Xzg
\Tg(Msx2-cre)5Rem/0
(Not Specified) 		decreased cell proliferation J:184918
\Wlstm1Xzg/\Wlstm1Xzg
\Tg(Prrx1-cre)1Cjt/0
(involves: C57BL/6J * SJL/J) 		decreased cell proliferation J:184918
\Wnt2tm1.1(rtTA)Eem/\Wnt2tm1.1(rtTA)Eem
(involves: 129X1/SvJ * C57BL/6) 		decreased mesenchymal cell proliferation involved in lung development J:153098
\Wnt6tm1Akis/\Wnt6tm1Akis
(involves: 129P2/OlaHsd * CD-1 * NMRI) 		decreased cell proliferation J:193969
\Wnt7btm1Eem/\Wnt7btm1Eem
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		abnormal mesenchymal cell proliferation involved in lung development J:79395
\Wnt7btm2Amc/\Wnt7btm2.1Amc
\Edil3Tg(Sox2-cre)1Amc/\Edil3+
(involves: 129X1/SvJ * C57BL/6 * CBA) 		abnormal kidney cell proliferation J:142685
decreased kidney cell proliferation J:142685
decreased mesenchymal cell proliferation involved in lung development J:134483
\Xbp1tm1.2Geno/\Xbp1tm1.2Geno
(involves: 129S2/SvPas * C57BL/6) 		decreased cell proliferation J:211440
\Xbp1tm1Glm/\Xbp1tm1Glm
(involves: 129S2/SvPas) 		decreased hepatocyte proliferation J:59916
\Xrcc6tm1Fwa/\Xrcc6tm1Fwa
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased cell proliferation J:44361
X/\Yaa
(B6.SB-Yaa/J) 		increased splenocyte proliferation J:127600
\Yap1tm1.1Dupa/\Yap1tm1.1Dupa
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		increased hepatocyte proliferation J:162628
\Yap1tm1.1Dupa/\Yap1tm1.1Dupa
\Tg(Vil1-cre)997Gum/0
(involves: 129P2/OlaHsd * C57BL/6J * SJL) 		abnormal enterocyte proliferation J:165471
\Yap1tm1.1Fcam/\Yap1tm1.1Fcam
\Tg(KRT14-cre)1Amc/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		decreased cell proliferation J:171057
increased cell proliferation J:171057
\Yap1tm1.1Fcam/\Yap1tm2.1Fcam
\Tg(KRT14-cre)1Amc/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		decreased cell proliferation J:171057
\Ybx1tm1Ley/\Ybx1tm1Ley
(either: 129X1/SvJ-Ybx1tm1Ley or (involves: 129X1/SvJ * C57BL/6)) 		decreased fibroblast proliferation J:99099
\Ybx1tm1Tuch/\Ybx1tm1Tuch
(involves: 129S/SvEv * C57BL/6) 		decreased fibroblast proliferation J:117725
\Ywhaetm1Awb/\Ywhaetm1Awb
(involves: 129S6/SvEvTac) 		decreased fetal cardiomyocyte proliferation J:192860
\Yy1tm1Yshi/\Yy1tm2Yshi
(involves: 129S4/SvJae) 		decreased cell proliferation J:108369
\Zap70m1Saka/\Zap70m1Saka
(involves: BALB/c) 		decreased T cell proliferation J:154166, J:86607
\Zap70m1Saka/\Zap70m1Saka
\Tg(DO11.10)10Dlo/0
(involves: BALB/c * C3H * C57BL/6) 		decreased T cell proliferation J:86607
\Zap70tm1.1Mmal/\Zap70tm1.1Mmal
\Tg(TcrLCMV)327Sdz/0
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * DBA/2) 		abnormal T cell proliferation J:71099
\Zap70tm2.1Weis/\Zap70tm2.1Weis
(C.129S4-Zap70tm2.1Weis) 		decreased T cell proliferation J:154166
\Zbtb7ctm1Mwhu/\Zbtb7ctm1Mwhu
(involves: 129S4/SvJae * C57BL/6) 		decreased cell proliferation J:181490
\Zbtb16tm1Ppp/\Zbtb16tm1Ppp
(involves: 129S1/Sv) 		abnormal spermatogonia proliferation J:91129
\Zbtb17tm1Cksn/\Zbtb17tm1Cksn
\Krt14tm1(cre)Wbm/\Krt14+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ) 		increased keratinocyte proliferation J:123966
\Zbtb17tm1Elr/\Zbtb17tm1Elr
(involves: 129X1/SvJ * C57BL/6) 		decreased cell proliferation J:86265
\Zbtb18tm1Haok/\Zbtb18tm1Haok
(involves: 129) 		abnormal neuronal precursor proliferation J:196306
\Zbtb32tm1Iho/\Zbtb32tm1Iho
(involves: BALB/c) 		increased T cell proliferation J:94944
\Zbtb32tm1Iho/\Zbtb32tm1Iho
(involves: C57BL/6) 		increased T cell proliferation J:94944
\Zbtb32tm2Ppp/\Zbtb32tm2Ppp
(involves: 129S1/Sv) 		increased T cell proliferation J:95119
\Zc3h4em1(IMPC)Mbp/\Zc3h4em1(IMPC)Mbp
(C57BL/6NCrl-Zc3h4em1(IMPC)Mbp/Mmucd) 		absent inner cell mass proliferation J:279207, J:301719
decreased cell proliferation J:301719
\Zc3h12dtm1Tom/\Zc3h12dtm1Tom
(B6.Cg-Zc3h12dtm1Tom) 		increased T cell proliferation J:209383
\Zcchc8em1Sgao/\Zcchc8em1Sgao
(involves: C57BL/6 * DBA/2) 		decreased cell proliferation J:297024
\Zeb1m1Btlr/\Zeb1m1Btlr
(involves: C57BL/6J) 		decreased B cell proliferation J:185495
\Zfattm2.1Sawa/\Zfattm2.1Sawa
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * C57BL/6JJcl * C57BL/6NCrSlc * DBA/2) 		decreased T cell proliferation J:187164
\Zfp24tm1Jifu/\Zfp24tm1Jifu
(involves: 129X1/SvJ * C57BL/6J) 		absent inner cell mass proliferation J:156988
\Zfp36l1tm1.1Tnr/\Zfp36l1tm1.1Tnr
\Zfp36l2tm1.1Tnr/\Zfp36l2tm1.1Tnr
\Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca * SJL) 		increased cell proliferation J:162388
\Zfp36l1tm1Pjb/\Zfp36l1tm1Pjb
(Not Specified) 		decreased cell proliferation J:91579
\Zfp131tm1.1Mytk/\Zfp131tm1.1Mytk
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * C57BL/6N * DBA/2) 		decreased T cell proliferation J:271921
\Zfp131tm1.1Mytk/\Zfp131tm1.2Mytk
\Tg(Lck-cre)1Jtak/0
(involves: C57BL/6N * FVB/N) 		decreased T cell proliferation J:271921
\Zfp296tm1Miya/\Zfp296tm1Miya
(B6.129P2-Zfp296tm1Miya) 		decreased primordial germ cell proliferation J:255491
\Zfp423tm1Reed/\Zfp423tm1Reed
(involves: 129 * C57BL/6) 		abnormal cerebellar granule cell precursor proliferation J:122606
\Zfp574em1Btlr/\Zfp574em1Btlr
(C57BL/6J-Zfp574em1Btlr) 		decreased B cell proliferation J:354285
\Zfp750tm1b(EUCOMM)Wtsi/\Zfp750tm1b(EUCOMM)Wtsi
(B6(Cg)-Zfp750tm1b(EUCOMM)Wtsi) 		abnormal epidermal stem cell proliferation J:335426
\Zfp830tm1Cota/\Zfp830tm1Cota
(either: (involves: 129S2/SvPas) or (involves: 129S2/SvPas * C57BL/6N)) 		absent inner cell mass proliferation J:99352
absent trophectoderm cell proliferation J:99352
decreased inner cell mass proliferation J:99352
\Zfp830tm2.1Cota/\Zfp830tm2.2Cota
\Gt(ROSA)26Sortm2(cre/ERT2)Brn/?
(involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6) 		decreased cell proliferation J:171647
\Zfp949tm1Htno/\Zfp949tm1Htno
(involves: 129S1/Sv * 129X1/SvJ) 		decreased cell proliferation J:259302
\Zfyve16tm2a(KOMP)Wtsi/\Zfyve16tm2a(KOMP)Wtsi
(C57BL/6N-Zfyve16tm2a(KOMP)Wtsi) 		decreased B cell proliferation J:302014
\Zglp1tm1Eem/\Zglp1tm1Eem
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal spermatogonia proliferation J:116977
\Zmiz1tm1Zsu/\Zmiz1tm1Zsu
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased cell proliferation J:128915
\Zpr1tm1Rjd/\Zpr1tm1Rjd
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased inner cell mass proliferation J:97582
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
03/25/2025
MGI 6.24 		The Jackson Laboratory